{ "meta": { "tracker_site_url": "https://psilocybin-research.com", "publication_tracker_url": "https://psilocybin-research.com/", "generated_at_utc": "2026-08-23 23:50:45", "record_count": 980, "schema_variant": "rights-safe-core-v1", "text_redistribution": "Source-derived abstracts, descriptions, keywords, and unrestricted payload text are not redistributed." }, "papers": [ { "id": 1990, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.", "authors": "Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2026-09-01", "publication_year": 2026, "doi": "10.1177/28314425251404460", "pubmed_id": "42539893", "openalex_id": "https://openalex.org/W7116873484", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42539893/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:27:44", "bibtex": null, "source_record_id": "PMID:42539893", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42539893/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42539893", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42539893/", "doi": "10.1177/28314425251404460", "pmid": "42539893", "publication_date": "2026-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 46, "title": "Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.", "authors": "Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC", "journal": "Journal of clinical psychology", "publication_date": "2026-09-01", "publication_year": 2026, "doi": "10.1002/jclp.70167", "pubmed_id": "42296474", "openalex_id": "https://openalex.org/W7164838909", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42296474/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:44", "bibtex": null, "source_record_id": "PMID:42296474", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42296474/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42296474", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42296474/", "doi": "10.1002/jclp.70167", "pmid": "42296474", "publication_date": "2026-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5875, "title": "JAMA study examines Oregon's psilocybin services model", "authors": "Canady Valerie A.", "journal": "Mental Health Weekly", "publication_date": "2026-08-24", "publication_year": 2026, "doi": "10.1002/mhw.34984", "pubmed_id": null, "openalex_id": "https://openalex.org/W7203871494", "source_url": "https://doi.org/10.1002/mhw.34984", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-22 01:20:15", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34984", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/mhw.34984", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1002/mhw.34984", "source_url": "https://doi.org/10.1002/mhw.34984", "doi": "10.1002/mhw.34984", "pmid": "", "publication_date": "2026-08-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3540, "title": "Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07211438", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-23 01:23:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07211438", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07211438", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07211438", "source_url": "https://clinicaltrials.gov/study/NCT07211438", "doi": "", "pmid": "", "publication_date": "2026-08-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5877, "title": "The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review", "authors": "Clark Rachel N", "journal": "Lynchburg Journal of Medical Science", "publication_date": "2026-08-20", "publication_year": 2026, "doi": "10.63932/3067-7106.1087", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.63932/3067-7106.1087", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-22 01:20:15", "last_checked": "2026-08-23 01:20:15", "bibtex": null, "source_record_id": "DOI:10.63932/3067-7106.1087", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.63932/3067-7106.1087", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.63932/3067-7106.1087", "source_url": "https://doi.org/10.63932/3067-7106.1087", "doi": "10.63932/3067-7106.1087", "pmid": "", "publication_date": "2026-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5869, "title": "The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies", "authors": "Michael J. Broman, Jhuma N. Acharya, Kaltum Ahmed, Stacey B. Armstrong, Alan K. Davis", "journal": "Current Addiction Reports", "publication_date": "2026-08-18", "publication_year": 2026, "doi": "10.1007/s40429-026-00774-8", "pubmed_id": null, "openalex_id": "https://openalex.org/W7203711549", "source_url": "https://doi.org/10.1007/s40429-026-00774-8", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety,Toxicity,Abuse Liability", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-20 01:20:19", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "DOI:10.1007/s40429-026-00774-8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s40429-026-00774-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40429-026-00774-8", "source_url": "https://doi.org/10.1007/s40429-026-00774-8", "doi": "10.1007/s40429-026-00774-8", "pmid": "", "publication_date": "2026-08-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3490, "title": "A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-18", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07570654", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-23 01:23:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07570654", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07570654", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07570654", "source_url": "https://clinicaltrials.gov/study/NCT07570654", "doi": "", "pmid": "", "publication_date": "2026-08-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5866, "title": "Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care", "authors": "Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements", "journal": null, "publication_date": "2026-08-17", "publication_year": 2026, "doi": "10.5281/zenodo.21983116", "pubmed_id": null, "openalex_id": "https://openalex.org/W7203633773", "source_url": "https://doi.org/10.5281/zenodo.21983116", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-19 01:20:25", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.21983116", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.21983116", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.21983116", "source_url": "https://doi.org/10.5281/zenodo.21983116", "doi": "10.5281/zenodo.21983116", "pmid": "", "publication_date": "2026-08-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5865, "title": "Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.", "authors": "Strika-Bruneau L, Elhssaini C, Fauvel B, Kervadec E, Bezo A, Amirouche A, Benyamina A, Romeo B.", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-08-17", "publication_year": 2026, "doi": "10.1177/02698811261473436", "pubmed_id": "42609034", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811261473436", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Systematic Review,Review Article,Safety,Drug Interactions", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-19 01:20:04", "last_checked": "2026-08-23 01:20:15", "bibtex": null, "source_record_id": "PMID:42609034", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811261473436", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42609034", "source_url": "https://doi.org/10.1177/02698811261473436", "doi": "10.1177/02698811261473436", "pmid": "42609034", "publication_date": "2026-08-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5742, "title": "An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life", "authors": "Charles Raison", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07719088", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Mechanism of Action,Biomarkers,Aging,Epigenetics,Cellular Senescence,Longevity,Oxidative Stress,Wellbeing,Clinical Trial,Observational Study,Animal Study,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-23 01:25:56", "last_checked": "2026-08-23 01:23:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07719088", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07719088", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07719088", "source_url": "https://clinicaltrials.gov/study/NCT07719088", "doi": "", "pmid": "", "publication_date": "2026-08-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3626, "title": "The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults", "authors": "Region Skane", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07169747", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Biomarkers,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-21 01:27:47", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07169747", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07169747", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07169747", "source_url": "https://clinicaltrials.gov/study/NCT07169747", "doi": "", "pmid": "", "publication_date": "2026-08-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3678, "title": "Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06692192", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Brain Imaging,Wellbeing,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-20 01:29:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06692192", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06692192", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06692192", "source_url": "https://clinicaltrials.gov/study/NCT06692192", "doi": "", "pmid": "", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3485, "title": "PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)", "authors": "Nathan Brashares Sackett", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06853912", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-20 01:29:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06853912", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06853912", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06853912", "source_url": "https://clinicaltrials.gov/study/NCT06853912", "doi": "", "pmid": "", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3440, "title": "Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial", "authors": "Brigham and Women's Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07296094", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-20 01:29:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07296094", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07296094", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07296094", "source_url": "https://clinicaltrials.gov/study/NCT07296094", "doi": "", "pmid": "", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3587, "title": "Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06349083", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06349083", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06349083", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06349083", "source_url": "https://clinicaltrials.gov/study/NCT06349083", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3581, "title": "Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality", "authors": "The University of Texas Health Science Center, Houston", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06706232", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06706232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "source_url": "https://clinicaltrials.gov/study/NCT06706232", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3574, "title": "Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids", "authors": "Roswell Park Cancer Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06827054", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Spirituality,Clinical Trial,Cancer Patients,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06827054", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06827054", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06827054", "source_url": "https://clinicaltrials.gov/study/NCT06827054", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3426, "title": "A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder", "authors": "Claudio N Soares", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06969170", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06969170", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06969170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06969170", "source_url": "https://clinicaltrials.gov/study/NCT06969170", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5858, "title": "Psychedelic Therapy for Depression", "authors": "Saanvi Gutta", "journal": null, "publication_date": "2026-08-11", "publication_year": 2026, "doi": "10.5281/zenodo.21893916", "pubmed_id": null, "openalex_id": "https://openalex.org/W7202215062", "source_url": "https://doi.org/10.5281/zenodo.21893916", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-13 01:20:27", "last_checked": "2026-08-18 01:20:14", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.21893916", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.21893916", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.21893916", "source_url": "https://doi.org/10.5281/zenodo.21893916", "doi": "10.5281/zenodo.21893916", "pmid": "", "publication_date": "2026-08-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5852, "title": "Psilocybin Recovery Intervention for Stopping Methamphetamine Use", "authors": "Nicky Mehtani, MD, MPH", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07756736", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-08-12 01:27:30", "last_checked": "2026-08-18 01:24:17", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07756736", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07756736", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07756736", "source_url": "https://clinicaltrials.gov/study/NCT07756736", "doi": "", "pmid": "", "publication_date": "2026-08-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3532, "title": "A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05711940", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05711940", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "source_url": "https://clinicaltrials.gov/study/NCT05711940", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3521, "title": "A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05624268", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05624268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "source_url": "https://clinicaltrials.gov/study/NCT05624268", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3495, "title": "A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07516405", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07516405", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07516405", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07516405", "source_url": "https://clinicaltrials.gov/study/NCT07516405", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3453, "title": "Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06506019", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06506019", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06506019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06506019", "source_url": "https://clinicaltrials.gov/study/NCT06506019", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3262, "title": "'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.", "authors": "Ham R, Gardner J, Carter A, Liknaitzky P.", "journal": "Psychology and psychotherapy", "publication_date": "2026-08-10", "publication_year": 2026, "doi": "10.1111/papt.70098", "pubmed_id": "42572818", "openalex_id": null, "source_url": "https://doi.org/10.1111/papt.70098", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-17 01:20:29", "bibtex": null, "source_record_id": "PMID:42572818", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/papt.70098", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42572818", "source_url": "https://doi.org/10.1111/papt.70098", "doi": "10.1111/papt.70098", "pmid": "42572818", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5784, "title": "Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.", "authors": "Dean JG, Hurwitz E, Furnish T, Castellanos J, McKinty A, Farrell B, Barrows D, Peck SK, Trim J, Samadhi E, Renwick G, Mudge R, Vieten C, Cuccurazzu B, Coleman P, Lin A, Geyer MA, Zeidan F, Halberstadt AL.", "journal": "The journal of pain", "publication_date": "2026-08-07", "publication_year": 2026, "doi": "10.1016/j.jpain.2026.106404", "pubmed_id": "42567236", "openalex_id": "https://openalex.org/W7201834409", "source_url": "https://doi.org/10.1016/j.jpain.2026.106404", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Mechanism of Action,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-08 01:20:18", "last_checked": "2026-08-14 01:20:15", "bibtex": null, "source_record_id": "PMID:42567236", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpain.2026.106404", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42567236", "source_url": "https://doi.org/10.1016/j.jpain.2026.106404", "doi": "10.1016/j.jpain.2026.106404", "pmid": "42567236", "publication_date": "2026-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5781, "title": "Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.", "authors": "Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA.", "journal": "CNS drugs", "publication_date": "2026-08-07", "publication_year": 2026, "doi": "10.1007/s40263-026-01326-4", "pubmed_id": "42566154", "openalex_id": "https://openalex.org/W7201866252", "source_url": "https://doi.org/10.1007/s40263-026-01326-4", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Consciousness,Clinical Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-08 01:20:06", "last_checked": "2026-08-14 01:20:19", "bibtex": null, "source_record_id": "PMID:42566154", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-026-01326-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42566154", "source_url": "https://doi.org/10.1007/s40263-026-01326-4", "doi": "10.1007/s40263-026-01326-4", "pmid": "42566154", "publication_date": "2026-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5746, "title": "Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease", "authors": "National Institute on Aging (NIA)", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07721467", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Mitochondrial Function,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Older Adults,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-24 01:25:24", "last_checked": "2026-08-14 01:24:53", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07721467", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07721467", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07721467", "source_url": "https://clinicaltrials.gov/study/NCT07721467", "doi": "", "pmid": "", "publication_date": "2026-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3704, "title": "Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder", "authors": "Trent Emerick", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07406828", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-13 01:25:57", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07406828", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "source_url": "https://clinicaltrials.gov/study/NCT07406828", "doi": "", "pmid": "", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3582, "title": "Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731621", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-13 01:25:57", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731621", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "source_url": "https://clinicaltrials.gov/study/NCT06731621", "doi": "", "pmid": "", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3507, "title": "An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy", "authors": "University of Southern California", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06233344", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Spirituality,Clinical Trial,Observational Study,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-13 01:25:57", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06233344", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06233344", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06233344", "source_url": "https://clinicaltrials.gov/study/NCT06233344", "doi": "", "pmid": "", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3437, "title": "Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer", "authors": "Yvan Beaussant, MD, MSci", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06001749", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-12 01:27:30", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06001749", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06001749", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06001749", "source_url": "https://clinicaltrials.gov/study/NCT06001749", "doi": "", "pmid": "", "publication_date": "2026-08-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5773, "title": "Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.", "authors": "Schaefer DA, Agrawal M, Mazzola E, Leff MK, Leeks C, Kematick BS, Beaussant Y.", "journal": "Journal of pain and symptom management", "publication_date": "2026-08-03", "publication_year": 2026, "doi": "10.1016/j.jpainsymman.2026.07.030", "pubmed_id": "42546985", "openalex_id": "https://openalex.org/W7172261546", "source_url": "https://doi.org/10.1016/j.jpainsymman.2026.07.030", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-04 01:20:19", "last_checked": "2026-08-10 01:20:17", "bibtex": null, "source_record_id": "PMID:42546985", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpainsymman.2026.07.030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42546985", "source_url": "https://doi.org/10.1016/j.jpainsymman.2026.07.030", "doi": "10.1016/j.jpainsymman.2026.07.030", "pmid": "42546985", "publication_date": "2026-08-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3565, "title": "Psilocybin as a Treatment for Chronic Pain in Smokers", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07118332", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-10 01:26:25", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07118332", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07118332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07118332", "source_url": "https://clinicaltrials.gov/study/NCT07118332", "doi": "", "pmid": "", "publication_date": "2026-08-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 66, "title": "Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians.", "authors": "Boehnke KF, Pouyan N, Aday JS", "journal": "Drugs", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1007/s40265-026-02339-5", "pubmed_id": "42243569", "openalex_id": "https://openalex.org/W7163536837", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42243569/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Observational Study,Animal Study,Healthcare Workers,Safety,Drug Interactions,Contraindications,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42243569", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42243569/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42243569", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42243569/", "doi": "10.1007/s40265-026-02339-5", "pmid": "42243569", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 63, "title": "Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.", "authors": "Lu S, Zhang Z, Xue X, Jiang Y, Zhang C, Liu P, He D, Shen W, Yang S, Wang F", "journal": "Hearing research", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1016/j.heares.2026.109701", "pubmed_id": "42289149", "openalex_id": "https://openalex.org/W7163574586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42289149/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42289149", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42289149/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42289149", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42289149/", "doi": "10.1016/j.heares.2026.109701", "pmid": "42289149", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1, "title": "A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.", "authors": "Graham M, Ge Y, Pacula RL, Pessar SC, Wilkins C, Hall W, Hammond D", "journal": "The International journal on drug policy", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1016/j.drugpo.2026.105348", "pubmed_id": "42247761", "openalex_id": "https://openalex.org/W7163656829", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42247761/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Observational Study,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42247761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42247761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42247761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42247761/", "doi": "10.1016/j.drugpo.2026.105348", "pmid": "42247761", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3576, "title": "A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-31", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07336238", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07336238", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "source_url": "https://clinicaltrials.gov/study/NCT07336238", "doi": "", "pmid": "", "publication_date": "2026-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5761, "title": "Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression", "authors": "Joshua Rosenblat", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07737990", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-31 01:27:07", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07737990", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07737990", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07737990", "source_url": "https://clinicaltrials.gov/study/NCT07737990", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5760, "title": "Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for Post-Traumatic Stress Disorder", "authors": "Tel-Aviv Sourasky Medical Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07737054", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Psychological Flexibility,Clinical Trial,Randomized Controlled Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-31 01:27:07", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07737054", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07737054", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07737054", "source_url": "https://clinicaltrials.gov/study/NCT07737054", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5759, "title": "Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial", "authors": "Armstrong Stacey B., Levin Adam W., Sepeda Nathan D., Shaub Hillary, Hunter Taweh, Douglas Angela, Lancelotta Rafaelle, Davis Alan K.", "journal": "Communications Medicine", "publication_date": "2026-07-30", "publication_year": 2026, "doi": "10.1038/s43856-026-01767-4", "pubmed_id": "42533157", "openalex_id": "https://openalex.org/W7171854693", "source_url": "https://doi.org/10.1038/s43856-026-01767-4", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-31 01:20:20", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42533157", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s43856-026-01767-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42533157", "source_url": "https://doi.org/10.1038/s43856-026-01767-4", "doi": "10.1038/s43856-026-01767-4", "pmid": "42533157", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3647, "title": "Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06512220", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06512220", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06512220", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06512220", "source_url": "https://clinicaltrials.gov/study/NCT06512220", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3591, "title": "Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06518720", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06518720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "source_url": "https://clinicaltrials.gov/study/NCT06518720", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3654, "title": "An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD", "authors": "Scottsdale Research Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07275970", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07275970", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07275970", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07275970", "source_url": "https://clinicaltrials.gov/study/NCT07275970", "doi": "", "pmid": "", "publication_date": "2026-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3542, "title": "Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05866471", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05866471", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05866471", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05866471", "source_url": "https://clinicaltrials.gov/study/NCT05866471", "doi": "", "pmid": "", "publication_date": "2026-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3529, "title": "Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06299319", "substance_tags": "psilocybin", "topic_tags": "Addiction,OCD,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Case Report,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06299319", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06299319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06299319", "source_url": "https://clinicaltrials.gov/study/NCT06299319", "doi": "", "pmid": "", "publication_date": "2026-07-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5758, "title": "A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in Depression", "authors": "Danial Beniameen, Armya Beniameen", "journal": "Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal", "publication_date": "2026-07-27", "publication_year": 2026, "doi": "10.26685/urncst.1027", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171560399", "source_url": "https://doi.org/10.26685/urncst.1027", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Consciousness,Biomarkers,Aging,Clinical Trial,Systematic Review,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-30 01:20:13", "last_checked": "2026-07-30 01:20:13", "bibtex": null, "source_record_id": "DOI:10.26685/urncst.1027", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26685/urncst.1027", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26685/urncst.1027", "source_url": "https://doi.org/10.26685/urncst.1027", "doi": "10.26685/urncst.1027", "pmid": "", "publication_date": "2026-07-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5788, "title": "Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review", "authors": "Nicholas Vucak, Raimondo Bruno, Julio Quealy, James G. Casimaty, Susan L. Rossell, D Castle, Nicola Acevedo", "journal": "Psychedelics", "publication_date": "2026-07-26", "publication_year": 2026, "doi": "10.1016/j.psyche.2026.100030", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171322300", "source_url": "https://doi.org/10.1016/j.psyche.2026.100030", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Randomized Controlled Trial,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:00", "last_checked": "2026-08-09 08:25:00", "bibtex": null, "source_record_id": "DOI:10.1016/j.psyche.2026.100030", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psyche.2026.100030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psyche.2026.100030", "source_url": "https://doi.org/10.1016/j.psyche.2026.100030", "doi": "10.1016/j.psyche.2026.100030", "pmid": "", "publication_date": "2026-07-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5747, "title": "Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?", "authors": "Parr BA, Young WB, Silberstein SD", "journal": "Expert review of neurotherapeutics", "publication_date": "2026-07-23", "publication_year": 2026, "doi": "10.1080/14737175.2026.2706794", "pubmed_id": "42493477", "openalex_id": "https://openalex.org/W7170155380", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42493477/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-25 01:20:04", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42493477", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42493477/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42493477", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42493477/", "doi": "10.1080/14737175.2026.2706794", "pmid": "42493477", "publication_date": "2026-07-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5740, "title": "Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations", "authors": "Cervera-Sanchez Miguel Benjamin, San-Juan Daniel, Díaz-Peregrino Roberto, Camacho-Castillo Evelin Zulema, Bringas-Ortiz Sthefany Anahi, Padilla-Cabezutd Christian", "journal": "British Journal of Clinical Pharmacology", "publication_date": "2026-07-21", "publication_year": 2026, "doi": "10.1002/bcp.70690", "pubmed_id": "42482371", "openalex_id": null, "source_url": "https://doi.org/10.1002/bcp.70690", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-23 01:20:05", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42482371", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/bcp.70690", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42482371", "source_url": "https://doi.org/10.1002/bcp.70690", "doi": "10.1002/bcp.70690", "pmid": "42482371", "publication_date": "2026-07-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3686, "title": "PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07610135", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07610135", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07610135", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07610135", "source_url": "https://clinicaltrials.gov/study/NCT07610135", "doi": "", "pmid": "", "publication_date": "2026-07-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5736, "title": "A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults", "authors": "Levy-Cooperman N, Sellers E, Glue P, Szeto I, Brown D, Jarecki-Smith J, Tyler WJ, McDonnell MB.", "journal": "medRxiv", "publication_date": "2026-07-19", "publication_year": 2026, "doi": "10.64898/2026.07.16.26358273", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.07.16.26358273", "substance_tags": "psilocybin,psilocin", "topic_tags": "Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-20 01:20:48", "last_checked": "2026-08-09 08:14:49", "bibtex": null, "source_record_id": "DOI:10.64898/2026.07.16.26358273", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.07.16.26358273", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.07.16.26358273", "source_url": "https://doi.org/10.64898/2026.07.16.26358273", "doi": "10.64898/2026.07.16.26358273", "pmid": "", "publication_date": "2026-07-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5734, "title": "Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression", "authors": "Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra Blicharz, Wojciech Kozdraś, Lidia Kozaczko, Gabriela Szewczyk, Elżbieta Bukowczan, Alicja Zając, Damian Broda, Alicja Benecka", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-07-17", "publication_year": 2026, "doi": "10.5281/zenodo.21406174", "pubmed_id": null, "openalex_id": "https://openalex.org/W7169604178", "source_url": "https://doi.org/10.5281/zenodo.21406174", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-19 01:20:13", "last_checked": "2026-08-09 08:25:00", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.21406174", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.21406174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.21406174", "source_url": "https://doi.org/10.5281/zenodo.21406174", "doi": "10.5281/zenodo.21406174", "pmid": "", "publication_date": "2026-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3691, "title": "Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06067737", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Healthcare Workers,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06067737", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06067737", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06067737", "source_url": "https://clinicaltrials.gov/study/NCT06067737", "doi": "", "pmid": "", "publication_date": "2026-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5735, "title": "Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder", "authors": "Jakub Bajer, Aleksandra Włodarczyk, Hubert Kulawinek, Julia Obersztyn, Krzysztof Kasparek, Marta Czech, Grzegorz Kasparek, Adrianna Szczecińska, Wiktoria Glanert, Aleksandra Mliczek, Piotr Mrozek", "journal": "Journal of Education Health and Sport", "publication_date": "2026-07-16", "publication_year": 2026, "doi": "10.12775/jehs.2026.94.73071", "pubmed_id": null, "openalex_id": "https://openalex.org/W7169523177", "source_url": "https://doi.org/10.12775/jehs.2026.94.73071", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-19 01:20:13", "last_checked": "2026-08-09 08:25:00", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2026.94.73071", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2026.94.73071", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2026.94.73071", "source_url": "https://doi.org/10.12775/jehs.2026.94.73071", "doi": "10.12775/jehs.2026.94.73071", "pmid": "", "publication_date": "2026-07-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5725, "title": "Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder", "authors": "Dougherty Robert F., Modlin Nadav Liam, McGowan Niall M., Staples Patrick, Williams Ella, Clarke Patrick, Shafiei Mario, Leininger Carly, Alti Merve, Croal Megan, Marwood Lindsey, Kirlić Namik, Ryslik Gregory A., Goodwin Guy M.", "journal": "Journal of Psychopharmacology", "publication_date": "2026-07-16", "publication_year": 2026, "doi": "10.1177/02698811261464988", "pubmed_id": "42460632", "openalex_id": "https://openalex.org/W7169098728", "source_url": "https://doi.org/10.1177/02698811261464988", "substance_tags": "psilocybin", "topic_tags": "PTSD,Consciousness,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-17 01:20:04", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42460632", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1177/02698811261464988", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42460632", "source_url": "https://doi.org/10.1177/02698811261464988", "doi": "10.1177/02698811261464988", "pmid": "42460632", "publication_date": "2026-07-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3648, "title": "Mechanistic Studies of Psilocybin in Headache Disorders", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06464367", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Neuroplasticity,Brain Imaging,Biomarkers,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06464367", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06464367", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06464367", "source_url": "https://clinicaltrials.gov/study/NCT06464367", "doi": "", "pmid": "", "publication_date": "2026-07-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5718, "title": "National bill seeks to jump-start psychedelic treatment for veterans", "authors": "Gary Enos", "journal": "Alcoholism & Drug Abuse Weekly", "publication_date": "2026-07-11", "publication_year": 2026, "doi": "10.1002/adaw.34973", "pubmed_id": null, "openalex_id": "https://openalex.org/W7168096739", "source_url": "https://doi.org/10.1002/adaw.34973", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Veterans", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-14 01:20:14", "last_checked": "2026-08-09 08:25:00", "bibtex": null, "source_record_id": "DOI:10.1002/adaw.34973", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/adaw.34973", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/adaw.34973", "source_url": "https://doi.org/10.1002/adaw.34973", "doi": "10.1002/adaw.34973", "pmid": "", "publication_date": "2026-07-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5714, "title": "Psychedelics produce enduring enhancement of reward responsiveness in male rats.", "authors": "Thomas CW, LaMalfa KS, Whelan TP, Blackmore T, Golden CT, Pizzagalli DA, Bergman J, Gilmour G, Kangas BD", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2026-07-10", "publication_year": 2026, "doi": "10.1038/s41386-026-02475-2", "pubmed_id": "42432161", "openalex_id": "https://openalex.org/W7167926471", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42432161/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42432161", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42432161/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42432161", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42432161/", "doi": "10.1038/s41386-026-02475-2", "pmid": "42432161", "publication_date": "2026-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3502, "title": "PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial", "authors": "Bruyère Health Research Institute.", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07063862", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Receptor Pharmacology,Default Mode Network,Aging,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07063862", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "source_url": "https://clinicaltrials.gov/study/NCT07063862", "doi": "", "pmid": "", "publication_date": "2026-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3467, "title": "PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial", "authors": "Ottawa Hospital Research Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04754061", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Aging,Microdosing,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04754061", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "source_url": "https://clinicaltrials.gov/study/NCT04754061", "doi": "", "pmid": "", "publication_date": "2026-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5686, "title": "Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.", "authors": "Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo", "journal": "Open MIND", "publication_date": "2026-07-09", "publication_year": 2026, "doi": "10.17605/osf.io/guqxr", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167787527", "source_url": "https://osf.io/guqxr", "substance_tags": "psilocybin,psilocin", "topic_tags": "OCD,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Animal Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-11 01:20:14", "last_checked": "2026-08-09 08:25:01", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/guqxr", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/guqxr", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/guqxr", "source_url": "https://osf.io/guqxr", "doi": "10.17605/osf.io/guqxr", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3610, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06341426", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06341426", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "source_url": "https://clinicaltrials.gov/study/NCT06341426", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3537, "title": "Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06624137", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Headache / Migraine,Brain Imaging,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06624137", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06624137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06624137", "source_url": "https://clinicaltrials.gov/study/NCT06624137", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5676, "title": "Psilocybin therapy for adult females with anorexia nervosa: pilot study", "authors": "Douglass Hannah M., Spriggs Meg J., Godfrey Kate, Danby Jennifer L., de Magalhaes Frederico J. C., Macdonald Lauren, Alderton Kirsty L., Archer Stephanie, Ahmad Kirran, Martell Jonny, Frias Jennifer T., Sawicka Gabriela, Read Tim, Blemings Allan, Lafrance Adele, Nicholls Dasha, Erritzoe David, Park Rebecca J., Nutt David J., Carhart-Harris Robin L.", "journal": "The British Journal of Psychiatry", "publication_date": "2026-07-08", "publication_year": 2026, "doi": "10.1192/bjp.2026.10687", "pubmed_id": "42414058", "openalex_id": "https://openalex.org/W7167587921", "source_url": "https://doi.org/10.1192/bjp.2026.10687", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Headache / Migraine,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-08 01:20:22", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42414058", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1192/bjp.2026.10687", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42414058", "source_url": "https://doi.org/10.1192/bjp.2026.10687", "doi": "10.1192/bjp.2026.10687", "pmid": "42414058", "publication_date": "2026-07-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3652, "title": "Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04161066", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04161066", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04161066", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04161066", "source_url": "https://clinicaltrials.gov/study/NCT04161066", "doi": "", "pmid": "", "publication_date": "2026-07-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3982, "title": "Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?", "authors": "Matthew A. Boehm, Oriana Mayorga", "journal": "Journal of Science Policy & Governance", "publication_date": "2026-07-02", "publication_year": 2026, "doi": "10.38126/jspg280103", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167073096", "source_url": "https://doi.org/10.38126/jspg280103", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:30", "last_checked": "2026-08-09 08:25:03", "bibtex": null, "source_record_id": "DOI:10.38126/jspg280103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.38126/jspg280103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.38126/jspg280103", "source_url": "https://doi.org/10.38126/jspg280103", "doi": "10.38126/jspg280103", "pmid": "", "publication_date": "2026-07-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3976, "title": "Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions", "authors": "Koning Elena, Richard Jérémie, Keshen Aaron", "journal": "International Journal of Eating Disorders", "publication_date": "2026-07-02", "publication_year": 2026, "doi": "10.1002/eat.70164", "pubmed_id": "42393007", "openalex_id": "https://openalex.org/W7167014213", "source_url": "https://doi.org/10.1002/eat.70164", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 01:20:05", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42393007", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/eat.70164", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42393007", "source_url": "https://doi.org/10.1002/eat.70164", "doi": "10.1002/eat.70164", "pmid": "42393007", "publication_date": "2026-07-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5720, "title": "Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study", "authors": "Meyer Thomas D, Vale Lauren N, Ibrahim Maya, Olmos Carolina, Quevedo João, Soares Jair C", "journal": "BMJ Open", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1136/bmjopen-2026-118471", "pubmed_id": "42442821", "openalex_id": "https://openalex.org/W7168165083", "source_url": "https://doi.org/10.1136/bmjopen-2026-118471", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-15 01:20:04", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42442821", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2026-118471", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42442821", "source_url": "https://doi.org/10.1136/bmjopen-2026-118471", "doi": "10.1136/bmjopen-2026-118471", "pmid": "42442821", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3547, "title": "A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06902974", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06902974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06902974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06902974", "source_url": "https://clinicaltrials.gov/study/NCT06902974", "doi": "", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 468, "title": "Provider perspectives on challenges in treatment during psychedelic therapy.", "authors": "Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ", "journal": "Psychopharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1007/s00213-025-06907-7", "pubmed_id": "41139739", "openalex_id": "https://openalex.org/W4415564957", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41139739/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Aging,Clinical Trial,Review Article,Observational Study,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:41139739", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41139739/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41139739", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41139739/", "doi": "10.1007/s00213-025-06907-7", "pmid": "41139739", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 185, "title": "An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder", "authors": "Grant Jon E., Boutouis Sophia, O’Brien Margaret, Avila Laurie, Neelapu Megha, Ehsan Dustin", "journal": "Clinical Neuropharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1097/wnf.0000000000000683", "pubmed_id": "41973961", "openalex_id": "https://openalex.org/W7154114794", "source_url": "https://doi.org/10.1097/wnf.0000000000000683", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41973961", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1097/wnf.0000000000000683", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41973961", "source_url": "https://doi.org/10.1097/wnf.0000000000000683", "doi": "10.1097/wnf.0000000000000683", "pmid": "41973961", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 171, "title": "Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.", "authors": "Orsini DK, Wong S, Di Luch S, Chan B, Vasudeva S, Lovell GFM, Le GH, Jones BDM, Chisamore N, Mollica A, Johnson DE, Kaczmarek ES, Goel A, Burke MJ, Mansur R, McIntyre RS, Husain MI, Rosenblat JD", "journal": "JAMA psychiatry", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2026.0255", "pubmed_id": "41984443", "openalex_id": "https://openalex.org/W7154469221", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41984443/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:41984443", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41984443/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41984443", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41984443/", "doi": "10.1001/jamapsychiatry.2026.0255", "pmid": "41984443", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 17, "title": "Psychedelics, entactogens and psychoplastogens for depression and related disorders.", "authors": "Hoyer D", "journal": "British journal of pharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1111/bph.70088", "pubmed_id": "40518133", "openalex_id": "https://openalex.org/W4411319821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:40518133", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40518133", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "doi": "10.1111/bph.70088", "pmid": "40518133", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 14, "title": "Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.", "authors": "Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D", "journal": "British journal of pharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1111/bph.70181", "pubmed_id": "40891276", "openalex_id": "https://openalex.org/W4413906381", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:40891276", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40891276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "doi": "10.1111/bph.70181", "pmid": "40891276", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 303, "title": "Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”", "authors": "Sjöström David, Schau Rybäck Olea, Claesdotter Knutsson Emma, Kajonius Petri, Jensen Sondén Oskar, Carlbring Per, Björkstrand Johannes, Movahed Rad Pouya", "journal": "PLOS One", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1371/journal.pone.0352246", "pubmed_id": "42378255", "openalex_id": "https://openalex.org/W7166779507", "source_url": "https://doi.org/10.1371/journal.pone.0352246", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Brain Imaging,Aging,Wellbeing,Personality Change,Clinical Trial,Randomized Controlled Trial,Review Article,Adolescents,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:03", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42378255", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0352246", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42378255", "source_url": "https://doi.org/10.1371/journal.pone.0352246", "doi": "10.1371/journal.pone.0352246", "pmid": "42378255", "publication_date": "2026-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 22, "title": "Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.", "authors": "Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT", "journal": "Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1007/s40211-026-00584-4", "pubmed_id": "42377806", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42377806/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Aging,Epigenetics,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42377806", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42377806/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42377806", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42377806/", "doi": "10.1007/s40211-026-00584-4", "pmid": "42377806", "publication_date": "2026-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3979, "title": "Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development", "authors": "Stefanie Enriquez Geppert, Lisa Bevers, Arvid Rosander, Peter Fodran, Vince Polito", "journal": "University of Groningen research database (University of Groningen / Centre for Information Technology)", "publication_date": "2026-06-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7167168218", "source_url": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:27", "last_checked": "2026-08-09 08:25:04", "bibtex": null, "source_record_id": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "source_url": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "doi": "", "pmid": "", "publication_date": "2026-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3494, "title": "5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05452772", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05452772", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05452772", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05452772", "source_url": "https://clinicaltrials.gov/study/NCT05452772", "doi": "", "pmid": "", "publication_date": "2026-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 29, "title": "Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.", "authors": "Guidetti C, Fava M, Papakostas GI", "journal": "Molecular psychiatry", "publication_date": "2026-06-25", "publication_year": 2026, "doi": "10.1038/s41380-026-03722-0", "pubmed_id": "42350785", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42350785/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42350785", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42350785/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42350785", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42350785/", "doi": "10.1038/s41380-026-03722-0", "pmid": "42350785", "publication_date": "2026-06-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3987, "title": "Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.", "authors": "Claudino Dos Santos JC, Bolan SJ, Lodetti G, Viana GL, Rico EP, Gonçalves CL", "journal": "Journal of psychiatric research", "publication_date": "2026-06-23", "publication_year": 2026, "doi": "10.1016/j.jpsychires.2026.06.035", "pubmed_id": "42385294", "openalex_id": "https://openalex.org/W7165638399", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42385294/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Animal Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42385294", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42385294/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42385294", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42385294/", "doi": "10.1016/j.jpsychires.2026.06.035", "pmid": "42385294", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3986, "title": "Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care", "authors": "Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti", "journal": "Translational Psychiatry", "publication_date": "2026-06-23", "publication_year": 2026, "doi": "10.1038/s41398-026-04203-2", "pubmed_id": "42342649", "openalex_id": "https://openalex.org/W7165728379", "source_url": "https://doi.org/10.1038/s41398-026-04203-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Personality Change,Mystical Experience,Clinical Trial,Animal Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-07-04 06:34:34", "bibtex": null, "source_record_id": "PMID:42342649", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-026-04203-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42342649", "source_url": "https://doi.org/10.1038/s41398-026-04203-2", "doi": "10.1038/s41398-026-04203-2", "pmid": "42342649", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3650, "title": "Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07048743", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07048743", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "source_url": "https://clinicaltrials.gov/study/NCT07048743", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3637, "title": "Psilocybin-Assisted Therapy for Prolonged Grief", "authors": "University of Virginia", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06724289", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Spirituality,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06724289", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06724289", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06724289", "source_url": "https://clinicaltrials.gov/study/NCT06724289", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3460, "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06416085", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06416085", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06416085", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06416085", "source_url": "https://clinicaltrials.gov/study/NCT06416085", "doi": "", "pmid": "", "publication_date": "2026-06-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 35, "title": "Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.", "authors": "Low ZXB", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2026-06-20", "publication_year": 2026, "doi": "10.1016/j.pnpbp.2026.111717", "pubmed_id": "42034276", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42034276/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42034276", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42034276/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42034276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42034276/", "doi": "10.1016/j.pnpbp.2026.111717", "pmid": "42034276", "publication_date": "2026-06-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3024, "title": "Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes", "authors": "Frick A, Blest-Hopley G, Grin M, Erritzoe D, Nutt D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2026-06-19", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9880403/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:51", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9880403/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9880403/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "doi": "10.21203/rs.3.rs-9880403/v1", "pmid": "", "publication_date": "2026-06-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1924, "title": "Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico", "authors": "Leeman Lawrence, Armstrong Maya, Menashi Dara, Nayo-Washington Hanifa, Marseille Elliot, Herrera Janus, Romero Crystal, Page-Reeves Janet", "journal": "Frontiers in Public Health", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1845943", "pubmed_id": "42395285", "openalex_id": "https://openalex.org/W7165032301", "source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "substance_tags": "psilocybin", "topic_tags": "PTSD,Aging,Clinical Trial,Veterans,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42395285", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42395285", "source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "doi": "10.3389/fpubh.2026.1845943", "pmid": "42395285", "publication_date": "2026-06-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1927, "title": "Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA", "authors": "SAIMSARA", "journal": "SAIMSARA Journal", "publication_date": "2026-06-15", "publication_year": 2026, "doi": "10.62487/saimsara7a54f680", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164845889", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Mechanism of Action,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.62487/saimsara7a54f680", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.62487/saimsara7a54f680", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.62487/saimsara7a54f680", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "doi": "10.62487/saimsara7a54f680", "pmid": "", "publication_date": "2026-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1926, "title": "Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis", "authors": "Labra-Lorenzana Angel, Lima-Sánchez Dania Nimbe, Delaflor-Wagner Christian Alejandro, Martínez-Hernández Diana, Ramos-Jiménez Christian, Toledo-Lozano Christian Gabriel", "journal": "Psychiatry International", "publication_date": "2026-06-15", "publication_year": 2026, "doi": "10.3390/psychiatryint7030137", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164820747", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.3390/psychiatryint7030137", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/psychiatryint7030137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3390/psychiatryint7030137", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "doi": "10.3390/psychiatryint7030137", "pmid": "", "publication_date": "2026-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3997, "title": "THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY", "authors": "Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.31435/ijitss.2(50).2026.5605", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165128977", "source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5605", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 06:34:35", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.2(50).2026.5605", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5605", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.2(50).2026.5605", "source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5605", "doi": "10.31435/ijitss.2(50).2026.5605", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3702, "title": "Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-sampling", "authors": "Robin Carhart-Harris, PhD, MA", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05698511", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05698511", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05698511", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05698511", "source_url": "https://clinicaltrials.gov/study/NCT05698511", "doi": "", "pmid": "", "publication_date": "2026-06-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 59, "title": "Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy", "authors": "Tarbi Elise C., Bhatia Ian, Balach Nabil, Buehler Suzannah, Demeo-Meres Magdalena, Gramling Cailin, Thambi Tej, Hart Julia, Reblin Maija, Rizzo Donna M., Gramling Robert, Agrawal Manish, Manetta Emily", "journal": "Healthcare", "publication_date": "2026-06-05", "publication_year": 2026, "doi": "10.3390/healthcare14111589", "pubmed_id": "42278842", "openalex_id": "https://openalex.org/W7163680882", "source_url": "https://doi.org/10.3390/healthcare14111589", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42278842", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/healthcare14111589", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42278842", "source_url": "https://doi.org/10.3390/healthcare14111589", "doi": "10.3390/healthcare14111589", "pmid": "42278842", "publication_date": "2026-06-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3558, "title": "The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults", "authors": "University of Calgary", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06768944", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Biomarkers,Wellbeing,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06768944", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06768944", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06768944", "source_url": "https://clinicaltrials.gov/study/NCT06768944", "doi": "", "pmid": "", "publication_date": "2026-06-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 70, "title": "Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.", "authors": "Kelly JR, Sheridan C, Iusan P, Coakley L, Burke L, Brennan C, MacDonald A, Ivers JH, Trepel D, Tormey G, Finnegan M, Young GW, Harkin A", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2026-06-02", "publication_year": 2026, "doi": "10.1093/ijnp/pyag028", "pubmed_id": "42113605", "openalex_id": "https://openalex.org/W7160867854", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42113605/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42113605", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42113605/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42113605", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42113605/", "doi": "10.1093/ijnp/pyag028", "pmid": "42113605", "publication_date": "2026-06-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4004, "title": "From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern Psychiatry", "authors": "Gaurav Uppal, Naima Gul, Asha Dhandapani, Sathyan Soundararajan, Khushboo Kansal", "journal": "BJPsych Open", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1192/bjo.2026.11141", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166698621", "source_url": "https://doi.org/10.1192/bjo.2026.11141", "substance_tags": "psilocybin", "topic_tags": "Addiction,Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "DOI:10.1192/bjo.2026.11141", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2026.11141", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/bjo.2026.11141", "source_url": "https://doi.org/10.1192/bjo.2026.11141", "doi": "10.1192/bjo.2026.11141", "pmid": "", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1940, "title": "Psilocybin shows rapid relief for depression symptoms", "authors": "Canady Valerie A.", "journal": "Mental Health Weekly", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1002/mhw.34890", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162755829", "source_url": "https://doi.org/10.1002/mhw.34890", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34890", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/mhw.34890", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1002/mhw.34890", "source_url": "https://doi.org/10.1002/mhw.34890", "doi": "10.1002/mhw.34890", "pmid": "", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 217, "title": "Psilocybin: Chemical Foundations and Emerging Therapeutic Potential", "authors": "Patil Shivaputra A., Hunsberger Holly C.", "journal": "Mini-Reviews in Medicinal Chemistry", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.2174/0113895575429775260119043318", "pubmed_id": "41879500", "openalex_id": "https://openalex.org/W7140303704", "source_url": "https://doi.org/10.2174/0113895575429775260119043318", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Longevity,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:41879500", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.2174/0113895575429775260119043318", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41879500", "source_url": "https://doi.org/10.2174/0113895575429775260119043318", "doi": "10.2174/0113895575429775260119043318", "pmid": "41879500", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 83, "title": "Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations", "authors": "Yonezawa Kengo, Hirata Mayuko, Takano Hiroaki, Kusudo Keisuke, Tomiyama Sota, Harada Lisa, Suzuki Kouta, Nutt David J., Uchida Hiroyuki, Tani Hideaki", "journal": "Psychiatry and Clinical Neurosciences", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1111/pcn.70042", "pubmed_id": "41749057", "openalex_id": "https://openalex.org/W7131868995", "source_url": "https://doi.org/10.1111/pcn.70042", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Brain Imaging,Aging,Spirituality,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41749057", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1111/pcn.70042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41749057", "source_url": "https://doi.org/10.1111/pcn.70042", "doi": "10.1111/pcn.70042", "pmid": "41749057", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 81, "title": "Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.", "authors": "Varela YM, de O Tavares VD, Delgado LM, de Faria HAT, Menezes LQ, Almeida RM, Agrícola P, de Carvalho BS, Bienemann B, Falchi-Carvalho M, Cavalcanti-Ribeiro P, Palhano-Fontes F, Fernandes-Osterhold G, de Araujo DB, Galvão-Coelho N", "journal": "European archives of psychiatry and clinical neuroscience", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1007/s00406-025-02188-5", "pubmed_id": "41902950", "openalex_id": "https://openalex.org/W7141898289", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41902950/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:41902950", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41902950/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41902950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41902950/", "doi": "10.1007/s00406-025-02188-5", "pmid": "41902950", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 78, "title": "Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [F]FDG-PET study.", "authors": "Egger K, Bozsak R, Aicher HD, Sari H, Poetzsch SN, Rominger A, Martin-Soelch C, Smallridge JW, Dornbierer D, Quednow BB, Scheidegger M, Cumming P", "journal": "Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1177/0271678x261454172", "pubmed_id": "42220002", "openalex_id": "https://openalex.org/W7163070014", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42220002/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Clinical Trial,Healthy Volunteers,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42220002", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42220002/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42220002", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42220002/", "doi": "10.1177/0271678x261454172", "pmid": "42220002", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 77, "title": "Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex", "authors": "Houff Jenna, Williams Andrew, Allen Obie, Gisabella Barbara, Pantazopoulos Harry, Del Arco Alberto", "journal": "European Journal of Neuroscience", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1111/ejn.70574", "pubmed_id": "42226515", "openalex_id": "https://openalex.org/W7163205006", "source_url": "https://doi.org/10.1111/ejn.70574", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Biomarkers,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42226515", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1111/ejn.70574", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42226515", "source_url": "https://doi.org/10.1111/ejn.70574", "doi": "10.1111/ejn.70574", "pmid": "42226515", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 74, "title": "Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study.", "authors": "Poppe C, Lyck L, Bechtold L, Repantis D", "journal": "Brain and behavior", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1002/brb3.71544", "pubmed_id": "42304595", "openalex_id": "https://openalex.org/W7164930745", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42304595/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42304595", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42304595/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42304595", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42304595/", "doi": "10.1002/brb3.71544", "pmid": "42304595", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 73, "title": "Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.", "authors": "Rosa WE, Napolitano S, McAndrew N, Jenkins B, Lichtenthal WG, Applebaum AJ, Breitbart W, Agrawal M", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1177/28314425251363983", "pubmed_id": "42311441", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42311441/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42311441", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42311441/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42311441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42311441/", "doi": "10.1177/28314425251363983", "pmid": "42311441", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4006, "title": "Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.", "authors": "L Belinger, N M Rieser, E J E Engeli, L Becciolini, M Clamote, M Pribis, F Saissi, G.A. Florineth, N L Hehl, M Herdener, K H Preller", "journal": "Open Access CRIS of the University of Bern", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.48620/98266", "pubmed_id": null, "openalex_id": "https://openalex.org/W7163021326", "source_url": "https://doi.org/10.48620/98266", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Healthy Volunteers,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "DOI:10.48620/98266", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48620/98266", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48620/98266", "source_url": "https://doi.org/10.48620/98266", "doi": "10.48620/98266", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 97, "title": "Psilocybin-induced neurocardiogenic syncope: a case report", "authors": "Atiq Mazen A., Weisman Eli, Guerra Rodrigo B., Martinez Luis Luna, Yaden David B., Barrett Frederick S., Nayak Sandeep, Sayali Ceyda", "journal": "Psychopharmacology", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1007/s00213-026-07079-8", "pubmed_id": "42207275", "openalex_id": "https://openalex.org/W7162662445", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Consciousness,Aging,Emotional Processing,Clinical Trial,Case Report,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42207275", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1007/s00213-026-07079-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42207275", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "doi": "10.1007/s00213-026-07079-8", "pmid": "42207275", "publication_date": "2026-05-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 99, "title": "Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial", "authors": "Mertens Lea J., Betzler Felix, Brand Manuela, Evens Ricarda, Jungaberle Andrea, Jungaberle Henrik, Kärtner Laura, Majić Tomislav, Schmitz Christian N., Ströhle Andreas, Scharf Dennis, Spangemacher Moritz, Wolff Max, Assadi Zahra, Bahri Scharif, Becher Lilith, Färber Luca V., Harder Henry, Kirchen Niklas, Kulakova Eugenia, Kunz Linda C., Meijer Andy, Rohrmoser Barbara, Wellek Stefan, Berger Moritz M., Koslowski Michael, Gründer Gerhard", "journal": "Psychotherapy and Psychosomatics", "publication_date": "2026-05-27", "publication_year": 2026, "doi": "10.1159/000552272", "pubmed_id": "42201843", "openalex_id": "https://openalex.org/W7162570449", "source_url": "https://doi.org/10.1159/000552272", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42201843", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1159/000552272", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42201843", "source_url": "https://doi.org/10.1159/000552272", "doi": "10.1159/000552272", "pmid": "42201843", "publication_date": "2026-05-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5697, "title": "Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.", "authors": "Laursen DRT, Salazar J, Jürgens G, Hróbjartsson A", "journal": "Journal of clinical epidemiology", "publication_date": "2026-05-25", "publication_year": 2026, "doi": "10.1016/j.jclinepi.2026.112345", "pubmed_id": "42190765", "openalex_id": "https://openalex.org/W7162326878", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42190765/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:42190765", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42190765/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42190765", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42190765/", "doi": "10.1016/j.jclinepi.2026.112345", "pmid": "42190765", "publication_date": "2026-05-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4012, "title": "Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential", "authors": "Dallas T Mason", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162235135", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4011, "title": "The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach", "authors": "Rachel N Clark", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162225828", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3614, "title": "Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07506395", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07506395", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07506395", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07506395", "source_url": "https://clinicaltrials.gov/study/NCT07506395", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3636, "title": "A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-20", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07582120", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Psychological Flexibility,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07582120", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07582120", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07582120", "source_url": "https://clinicaltrials.gov/study/NCT07582120", "doi": "", "pmid": "", "publication_date": "2026-05-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 123, "title": "Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression", "authors": "Yngwe Hampus, Plavén-Sigray Pontus, Ekman Carl Johan, Henje Eva, Berglund Anders, Tiger Mikael, Beckman Maria, Lundberg Johan", "journal": "JAMA Network Open", "publication_date": "2026-05-15", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.12589", "pubmed_id": "42138922", "openalex_id": "https://openalex.org/W7161294763", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42138922", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42138922", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "doi": "10.1001/jamanetworkopen.2026.12589", "pmid": "42138922", "publication_date": "2026-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3606, "title": "Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)", "authors": "Alan Davis", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07216404", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07216404", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "source_url": "https://clinicaltrials.gov/study/NCT07216404", "doi": "", "pmid": "", "publication_date": "2026-05-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3035, "title": "Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.", "authors": "Jacob Cohen, Peter Parbo, Per Trads Ørskov, Dirk Wildgruber, Benjamin Kreifelts, ulrich kirk, Oke Gerke, Martin Korsbak Madsen, Mikael Palner", "journal": "PsyArXiv", "publication_date": "2026-05-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Biomarkers,Aging,Microdosing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "doi": "", "pmid": "", "publication_date": "2026-05-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3022, "title": "Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review", "authors": "Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ.", "journal": "Research Square", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9283280/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:50", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "doi": "10.21203/rs.3.rs-9283280/v1", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4019, "title": "From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice", "authors": "Jessie Kim, Liam Lochhead, Cory R. Weissman", "journal": "Pharmacology Research & Perspectives", "publication_date": "2026-05-10", "publication_year": 2026, "doi": "10.1002/prp2.70262", "pubmed_id": "42108552", "openalex_id": "https://openalex.org/W7160830727", "source_url": "https://doi.org/10.1002/prp2.70262", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:08", "bibtex": null, "source_record_id": "PMID:42108552", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/prp2.70262", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42108552", "source_url": "https://doi.org/10.1002/prp2.70262", "doi": "10.1002/prp2.70262", "pmid": "42108552", "publication_date": "2026-05-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3570, "title": "The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.", "authors": "University Medical Center Groningen", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06782724", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Brain Imaging,Biomarkers,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06782724", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "source_url": "https://clinicaltrials.gov/study/NCT06782724", "doi": "", "pmid": "", "publication_date": "2026-05-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1955, "title": "1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power", "authors": "Reid Matthew, Weisman Eli, Martinez Luis Luna, Coon William, Barrett Frederick", "journal": "SLEEPJ", "publication_date": "2026-05-08", "publication_year": 2026, "doi": "10.1093/sleep/zsag091.1079", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160609961", "source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1093/sleep/zsag091.1079", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1093/sleep/zsag091.1079", "source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "doi": "10.1093/sleep/zsag091.1079", "pmid": "", "publication_date": "2026-05-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3496, "title": "Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05710237", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05710237", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "source_url": "https://clinicaltrials.gov/study/NCT05710237", "doi": "", "pmid": "", "publication_date": "2026-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 127, "title": "Psilocybin in the Treatment of Cocaine Use Disorder", "authors": "Hendricks Peter S., Lappan Sara N., Shelton Richard C., Lahti Adrienne C., Cropsey Karen L., Johnson Matthew W., Bradley Melissa, Simonsson Otto, Davis Lori L., Grossman Daniel H., Ortiz Cynthia E.", "journal": "JAMA Network Open", "publication_date": "2026-05-07", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.11029", "pubmed_id": "42096204", "openalex_id": "https://openalex.org/W7160534089", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42096204", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42096204", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "doi": "10.1001/jamanetworkopen.2026.11029", "pmid": "42096204", "publication_date": "2026-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3620, "title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05947383", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05947383", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "source_url": "https://clinicaltrials.gov/study/NCT05947383", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3613, "title": "Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study", "authors": "University of North Carolina, Chapel Hill", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06303739", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06303739", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06303739", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06303739", "source_url": "https://clinicaltrials.gov/study/NCT06303739", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3536, "title": "A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder", "authors": "Stanford University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07479550", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07479550", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "source_url": "https://clinicaltrials.gov/study/NCT07479550", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3577, "title": "A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04353921", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04353921", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04353921", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04353921", "source_url": "https://clinicaltrials.gov/study/NCT04353921", "doi": "", "pmid": "", "publication_date": "2026-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3559, "title": "A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07565909", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07565909", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "source_url": "https://clinicaltrials.gov/study/NCT07565909", "doi": "", "pmid": "", "publication_date": "2026-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1962, "title": "356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s Disease", "authors": "Bradley Ellen, Kelley D Parker, Picard Martin, Szigeti Balazs, Sakai Kimberly, Fernandes Gisele, Ostrem Jill, Tanner Caroline, Finley Patrick, Ludwig Connie, Llerena Katiah, Busby Zach, McKernan Amber, Zuzuarregui Jose Rafael, Bock Meredith, Wang Aliss, Penn Andrew, Woolley Josh, O'Donovan Aoife", "journal": "Biological Psychiatry", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1016/j.biopsych.2026.03.590", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155621718", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.590", "substance_tags": "psilocybin", "topic_tags": "Biomarkers,Mitochondrial Function,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2026.03.590", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1016/j.biopsych.2026.03.590", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.590", "doi": "10.1016/j.biopsych.2026.03.590", "pmid": "", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 150, "title": "The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.", "authors": "Greenway KT, Garel N, Dinh-Williams LL, Thibault Lévesque J, Kaelen M, Dagenais-Beaulé V, de la Salle S, Erritzoe D, Looper K, Turecki G, Rej S, Richard-Devantoy S", "journal": "The British journal of psychiatry: the journal of mental science", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1192/bjp.2025.102", "pubmed_id": "40528492", "openalex_id": "https://openalex.org/W4411430663", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40528492/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:40528492", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40528492/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40528492", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40528492/", "doi": "10.1192/bjp.2025.102", "pmid": "40528492", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 148, "title": "Landscape analysis of pre-registered clinical trials involving classical psychedelics.", "authors": "Uyar A, Forbrich L, Lueken U, Evens R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811251371690", "pubmed_id": "41121524", "openalex_id": "https://openalex.org/W4415412000", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41121524/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41121524", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41121524/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41121524", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41121524/", "doi": "10.1177/02698811251371690", "pmid": "41121524", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 143, "title": "The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures.", "authors": "Scholle P, Wenke Š, Nekovářová T, Zaytseva Y, Tylš F, Brunovský M, Horáček J, Andrashko V, Koudelka V, Viktorinová M, Viktorin V, Hájková K, Kuchař M, Páleníček T", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811251389552", "pubmed_id": "41479142", "openalex_id": "https://openalex.org/W7118000985", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41479142/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41479142", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41479142/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41479142", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41479142/", "doi": "10.1177/02698811251389552", "pmid": "41479142", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 139, "title": "Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience.", "authors": "Kerr-Gaffney J, Myrtle S, Askari F, Bird C, Modlin NL, Young AH, Rucker J", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811251408769", "pubmed_id": "41588876", "openalex_id": "https://openalex.org/W7125792237", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41588876/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Wellbeing,Personality Change,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41588876", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41588876/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41588876", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41588876/", "doi": "10.1177/02698811251408769", "pmid": "41588876", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 138, "title": "Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.", "authors": "Lewis BR, Reid MJ, Novick AM, Byrne K, Niciu MJ, Fonzo GA, Meyer TD, Feifel D, El-Mallakh RS, Soares J, Suppes T, Barrett FS", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811251413490", "pubmed_id": "41645048", "openalex_id": "https://openalex.org/W7128008256", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41645048/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41645048", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41645048/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41645048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41645048/", "doi": "10.1177/02698811251413490", "pmid": "41645048", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 137, "title": "Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.", "authors": "Goldy SP, Sepeda ND, Hilbert SN, Bari BA, Garcia-Romeu A, Gukasyan N, Barrett FS, Yaden DB, Nayak SM", "journal": "Psychiatry research", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1016/j.psychres.2026.117010", "pubmed_id": "41747432", "openalex_id": "https://openalex.org/W7128814597", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41747432/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41747432", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41747432/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41747432", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41747432/", "doi": "10.1016/j.psychres.2026.117010", "pmid": "41747432", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 134, "title": "A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder", "authors": "Moreno Francisco A., Allen Katja E., Wiegand Christopher B., Dunne Rajan, Prickett James I., Bayze Brian, Allen John J. B.", "journal": "Journal of Psychopharmacology", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811261424214", "pubmed_id": "41825921", "openalex_id": "https://openalex.org/W7135170485", "source_url": "https://doi.org/10.1177/02698811261424214", "substance_tags": "psilocybin", "topic_tags": "OCD,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41825921", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1177/02698811261424214", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41825921", "source_url": "https://doi.org/10.1177/02698811261424214", "doi": "10.1177/02698811261424214", "pmid": "41825921", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 133, "title": "Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression", "authors": "Mertens Lea J., Koslowski Michael, Betzler Felix, Brand Manuela, Evens Ricarda, Kärtner Laura, Jungaberle Andrea, Jungaberle Henrik, Majić Tomislav, Schmitz Christian N., Ströhle Andreas, Scharf Dennis, Spangemacher Moritz, Wolff Max, Assadi Zahra, Bahri Scharif, Becher Lilith, Färber Luca V., Kirchen Niklas, Kulakova Eugenia, Kunz Linda, Meijer Andy, Rohrmoser Barbara, Wellek Stefan, Berger Moritz M., Gründer Gerhard", "journal": "JAMA Psychiatry", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2026.0132", "pubmed_id": "41848690", "openalex_id": "https://openalex.org/W7138853109", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41848690", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41848690", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "doi": "10.1001/jamapsychiatry.2026.0132", "pmid": "41848690", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 131, "title": "Psychological support in psychedelic-assisted therapy clinical trials: A systematic review.", "authors": "Brusky B, M'Bailara K, Alla F, Barrault M", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811261424204", "pubmed_id": "41859988", "openalex_id": "https://openalex.org/W7139121355", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41859988/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41859988", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41859988/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41859988", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41859988/", "doi": "10.1177/02698811261424204", "pmid": "41859988", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 114, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM", "authors": "Beidas Zeina, Ragnhildstveit Anya, Blackman Adam, Anderson Thomas, Fewster Emily, Syed Omer A., Sobolenko Valentyne, Kanca Ismail Kaan, Son Tatiana, Farb Norman, Petranker Rotem", "journal": "BJPsych Open", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1192/bjo.2026.12000", "pubmed_id": "42125778", "openalex_id": "https://openalex.org/W7161014612", "source_url": "https://doi.org/10.1192/bjo.2026.12000", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:42125778", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42125778", "source_url": "https://doi.org/10.1192/bjo.2026.12000", "doi": "10.1192/bjo.2026.12000", "pmid": "42125778", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5709, "title": "Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety Recommendations", "authors": "Nayak SM, Sepeda ND, Dick MN, Tiwari P, Zahid Z, Sayalı C, Weiss BM, Yaden DB, Garcia-Romeu A, Barnett BS, Barrett FS.", "journal": "medRxiv", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.64898/2026.04.28.26351625", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.04.28.26351625", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:14:51", "bibtex": null, "source_record_id": "DOI:10.64898/2026.04.28.26351625", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.04.28.26351625", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.04.28.26351625", "source_url": "https://doi.org/10.64898/2026.04.28.26351625", "doi": "10.64898/2026.04.28.26351625", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3509, "title": "Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05883540", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05883540", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05883540", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05883540", "source_url": "https://clinicaltrials.gov/study/NCT05883540", "doi": "", "pmid": "", "publication_date": "2026-04-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3658, "title": "Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder", "authors": "Portland VA Research Foundation, Inc", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04982796", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04982796", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04982796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04982796", "source_url": "https://clinicaltrials.gov/study/NCT04982796", "doi": "", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3567, "title": "Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy", "authors": "Kyle Greenway", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07373535", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07373535", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "source_url": "https://clinicaltrials.gov/study/NCT07373535", "doi": "", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1968, "title": "Psilocybin as an alternative to conventional treatments: A systematic review", "authors": "Cahuasqui-Mendoza Deivid Antonio", "journal": "Gaceta Médica de Caracas", "publication_date": "2026-04-22", "publication_year": 2026, "doi": "10.47307/gmc.2026.134.s2.32", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155199454", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "doi": "10.47307/gmc.2026.134.s2.32", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3436, "title": "Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06430541", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06430541", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06430541", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06430541", "source_url": "https://clinicaltrials.gov/study/NCT06430541", "doi": "", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2978, "title": "The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes", "authors": "Khosravi Mohsen, De Berardis Domenico, Tusconi Massimo", "journal": "Mental Wellness", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.4081/mw.2026.40", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155066504", "source_url": "https://doi.org/10.4081/mw.2026.40", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.4081/mw.2026.40", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.4081/mw.2026.40", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.4081/mw.2026.40", "source_url": "https://doi.org/10.4081/mw.2026.40", "doi": "10.4081/mw.2026.40", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2977, "title": "Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials", "authors": "Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari", "journal": "Open Access Indonesian Journal of Medical Reviews", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.37275/oaijmr.v6i2.883", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155091271", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "doi": "10.37275/oaijmr.v6i2.883", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5711, "title": "Sustained Effects of Low-to-Moderate Doses of Psilocybin on Brain Connectivity", "authors": "Bhagavan C, Dandash O, Carter O, Bryson A, Kanaan RA.", "journal": "medRxiv", "publication_date": "2026-04-20", "publication_year": 2026, "doi": "10.64898/2026.04.17.26351147", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.04.17.26351147", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Consciousness,Aging,Clinical Trial,Review Article,Observational Study,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:14:52", "bibtex": null, "source_record_id": "DOI:10.64898/2026.04.17.26351147", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.04.17.26351147", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.04.17.26351147", "source_url": "https://doi.org/10.64898/2026.04.17.26351147", "doi": "10.64898/2026.04.17.26351147", "pmid": "", "publication_date": "2026-04-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 168, "title": "Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.", "authors": "Gondi CS, Gnanamony M, Gondi TP, Nersesyan L, Demirkhanyan L", "journal": "Current issues in molecular biology", "publication_date": "2026-04-18", "publication_year": 2026, "doi": "10.3390/cimb48040417", "pubmed_id": "42042077", "openalex_id": "https://openalex.org/W7154992046", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42042077/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:42042077", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42042077/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42042077", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42042077/", "doi": "10.3390/cimb48040417", "pmid": "42042077", "publication_date": "2026-04-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3117, "title": "Psilocybin’s Kinematic Effect on Manual Dexterity", "authors": "Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O.", "journal": "Research Square", "publication_date": "2026-04-15", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9291780/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9291780/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9291780/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "doi": "10.21203/rs.3.rs-9291780/v1", "pmid": "", "publication_date": "2026-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 172, "title": "A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience", "authors": "Back Anthony L., McGregor Bonnie A., Thorn Leslie L., Harvey Kalin, Blom Dianna, Callan George, Guy John, Kumar Sameet, Hershberg Rob, Layer Melissa, Levin Jackie, Myers Susanna, Perez Juliana, Salmonson Kathy, Thompson Peter, Whinney Joseph", "journal": "Frontiers in Public Health", "publication_date": "2026-04-14", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1810904", "pubmed_id": "42058096", "openalex_id": "https://openalex.org/W7154396122", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:42058096", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42058096", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "doi": "10.3389/fpubh.2026.1810904", "pmid": "42058096", "publication_date": "2026-04-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3578, "title": "CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06319378", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06319378", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06319378", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06319378", "source_url": "https://clinicaltrials.gov/study/NCT06319378", "doi": "", "pmid": "", "publication_date": "2026-04-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3670, "title": "Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy Participants", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06180759", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Clinical Trial,Case Report,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06180759", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06180759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06180759", "source_url": "https://clinicaltrials.gov/study/NCT06180759", "doi": "", "pmid": "", "publication_date": "2026-04-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 200, "title": "Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.", "authors": "Schindler EAD, Gottschalk CH, Pittman BP, D'Souza DC", "journal": "Headache", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1111/head.70024", "pubmed_id": "41459830", "openalex_id": "https://openalex.org/W7117472148", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41459830/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41459830", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41459830/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41459830", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41459830/", "doi": "10.1111/head.70024", "pmid": "41459830", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 199, "title": "Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions.", "authors": "Weiser S, Jung S, Bardl B, Kufs JE, Janevska S, Valiante V, Hoffmeister D, Regestein L", "journal": "Biotechnology and bioengineering", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1002/bit.70137", "pubmed_id": "41467547", "openalex_id": "https://openalex.org/W7117540352", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41467547/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41467547", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41467547/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41467547", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41467547/", "doi": "10.1002/bit.70137", "pmid": "41467547", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 198, "title": "Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols", "authors": "Swieczkowski Damian, Kwaśny Aleksander, Sadko Krzysztof, Cubała Wiesław Jerzy", "journal": "European Neuropsychopharmacology", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1016/j.euroneuro.2025.112746", "pubmed_id": "41546918", "openalex_id": "https://openalex.org/W7124418318", "source_url": "https://doi.org/10.1016/j.euroneuro.2025.112746", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41546918", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.euroneuro.2025.112746", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41546918", "source_url": "https://doi.org/10.1016/j.euroneuro.2025.112746", "doi": "10.1016/j.euroneuro.2025.112746", "pmid": "41546918", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 197, "title": "Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis.", "authors": "Olejnik P, Kamińska K, Gołembiowska K, Kasarełło K", "journal": "Pharmacological reports: PR", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1007/s43440-026-00824-y", "pubmed_id": "41557251", "openalex_id": "https://openalex.org/W7124985959", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41557251/", "substance_tags": "psilocybin", "topic_tags": "Biomarkers,Clinical Trial,Animal Study,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41557251", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41557251/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41557251", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41557251/", "doi": "10.1007/s43440-026-00824-y", "pmid": "41557251", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 196, "title": "Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin", "authors": "Žuljević Marija Franka, Mijatović Antonija, Orhanović Renata, Goasdoué Glenn, Gujinović Diana", "journal": "Journal of Clinical Epidemiology", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1016/j.jclinepi.2026.112170", "pubmed_id": "41581835", "openalex_id": "https://openalex.org/W7125471543", "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41581835", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41581835", "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "doi": "10.1016/j.jclinepi.2026.112170", "pmid": "41581835", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 194, "title": "PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial.", "authors": "Downar J, Lapenskie J, Anderson K, Parsons G, Polskaia N, Lalumiere G, Lawlor P", "journal": "Palliative medicine", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1177/02692163261416269", "pubmed_id": "41617652", "openalex_id": "https://openalex.org/W7126258550", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41617652/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41617652", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41617652/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41617652", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41617652/", "doi": "10.1177/02692163261416269", "pmid": "41617652", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 188, "title": "Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.", "authors": "Kazdan J, Ladha KS, Husain MI", "journal": "Pharmacology research & perspectives", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1002/prp2.70238", "pubmed_id": "41940853", "openalex_id": "https://openalex.org/W7150989008", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41940853/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41940853", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41940853/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41940853", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41940853/", "doi": "10.1002/prp2.70238", "pmid": "41940853", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 186, "title": "Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.", "authors": "Marazziti D, Gambini M, Gurrieri R, Russomanno G, Sità G, Pescini E, Digiuseppe FR, Mucci F", "journal": "Expert opinion on pharmacotherapy", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1080/14656566.2026.2654682", "pubmed_id": "41944071", "openalex_id": "https://openalex.org/W7151630586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41944071/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41944071", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41944071/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41944071", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41944071/", "doi": "10.1080/14656566.2026.2654682", "pmid": "41944071", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4054, "title": "Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders", "authors": "Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin", "journal": "Psychiatry and Clinical Psychopharmacology", "publication_date": "2026-03-30", "publication_year": 2026, "doi": "10.65801/pcp.3512", "pubmed_id": null, "openalex_id": "https://openalex.org/W7143411647", "source_url": "https://doi.org/10.65801/pcp.3512", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.65801/pcp.3512", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.65801/pcp.3512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.65801/pcp.3512", "source_url": "https://doi.org/10.65801/pcp.3512", "doi": "10.65801/pcp.3512", "pmid": "", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3663, "title": "Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression", "authors": "Sunnybrook Health Sciences Centre", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06072898", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06072898", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06072898", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06072898", "source_url": "https://clinicaltrials.gov/study/NCT06072898", "doi": "", "pmid": "", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3478, "title": "Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder", "authors": "Indiana University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07499583", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Default Mode Network,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07499583", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "source_url": "https://clinicaltrials.gov/study/NCT07499583", "doi": "", "pmid": "", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3696, "title": "Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression", "authors": "Federal University of Latin American Integration", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-27", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06898606", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06898606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "source_url": "https://clinicaltrials.gov/study/NCT06898606", "doi": "", "pmid": "", "publication_date": "2026-03-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4057, "title": "Classic psychedelic medicines for adolescent refractory mental health disease", "authors": "Aly Shah Aziz", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-03-26", "publication_year": 2026, "doi": "10.1556/2054.2026.00452", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140928407", "source_url": "https://doi.org/10.1556/2054.2026.00452", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00452", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00452", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00452", "source_url": "https://doi.org/10.1556/2054.2026.00452", "doi": "10.1556/2054.2026.00452", "pmid": "", "publication_date": "2026-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3037, "title": "Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial", "authors": "Broc A Pagni, Stephen Ross, Sarah Mennenga, Snehal R Bhatt, Richard J. Zeifman, Petros Petridis, Brennan Carrithers, Lindsay Worth, Samantha Podrebarac, Lindsey Owens", "journal": "PsyArXiv", "publication_date": "2026-03-26", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/7xfek_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/7xfek_v1", "source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "doi": "", "pmid": "", "publication_date": "2026-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 214, "title": "Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)", "authors": "Skalski Piotr, Pękacka-Falkowska Katarzyna, Pluto-Prądzyńska Agnieszka, Owecki Michał K.", "journal": "Brain Sciences", "publication_date": "2026-03-26", "publication_year": 2026, "doi": "10.3390/brainsci16040358", "pubmed_id": "42041769", "openalex_id": "https://openalex.org/W7140611633", "source_url": "https://doi.org/10.3390/brainsci16040358", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:42041769", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/brainsci16040358", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42041769", "source_url": "https://doi.org/10.3390/brainsci16040358", "doi": "10.3390/brainsci16040358", "pmid": "42041769", "publication_date": "2026-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3456, "title": "The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.", "authors": "Anders Fink-Jensen, MD, DMSci", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-24", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05416229", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Brain Imaging,Biomarkers,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05416229", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05416229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05416229", "source_url": "https://clinicaltrials.gov/study/NCT05416229", "doi": "", "pmid": "", "publication_date": "2026-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3447, "title": "Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial", "authors": "Medical University of Vienna", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-24", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07490353", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Wellbeing,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07490353", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07490353", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07490353", "source_url": "https://clinicaltrials.gov/study/NCT07490353", "doi": "", "pmid": "", "publication_date": "2026-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 222, "title": "Psychedelics in functional disorders: A scoping review.", "authors": "Bhagavan C, Carter O, Bryson A, Dandash O, Kanaan R", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2026-03-20", "publication_year": 2026, "doi": "10.1016/j.pnpbp.2026.111642", "pubmed_id": "41679377", "openalex_id": "https://openalex.org/W7128528342", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41679377/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41679377", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41679377/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41679377", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41679377/", "doi": "10.1016/j.pnpbp.2026.111642", "pmid": "41679377", "publication_date": "2026-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3641, "title": "Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study", "authors": "Gustavo Vazquez", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-18", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06818994", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Aging,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06818994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "source_url": "https://clinicaltrials.gov/study/NCT06818994", "doi": "", "pmid": "", "publication_date": "2026-03-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1976, "title": "Explainable AI framework for psilocybin depression treatment optimization", "authors": "Sungheetha Akey, Rajesh Sharma R., Aroba Oluwasegun Julius, Mahapatra Sheila, Mahendhiran P. D.", "journal": "Frontiers in Computer Science", "publication_date": "2026-03-16", "publication_year": 2026, "doi": "10.3389/fcomp.2025.1652190", "pubmed_id": null, "openalex_id": "https://openalex.org/W7136253679", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "doi": "10.3389/fcomp.2025.1652190", "pmid": "", "publication_date": "2026-03-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4064, "title": "Editorial: Psychedelic substances and neurological diseases: from basics to clinical application", "authors": "Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino", "journal": "Frontiers in Pharmacology", "publication_date": "2026-03-15", "publication_year": 2026, "doi": "10.3389/fphar.2026.1816812", "pubmed_id": "41919223", "openalex_id": "https://openalex.org/W7136503554", "source_url": "https://doi.org/10.3389/fphar.2026.1816812", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Wellbeing,Spirituality,Clinical Trial,Review Article,Animal Study,Toxicity,Proteomics,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41919223", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fphar.2026.1816812", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41919223", "source_url": "https://doi.org/10.3389/fphar.2026.1816812", "doi": "10.3389/fphar.2026.1816812", "pmid": "41919223", "publication_date": "2026-03-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 231, "title": "The renaissance of research on psychedelics in child and adolescent psychopharmacology.", "authors": "Crocq MA, Auby P", "journal": "Child and adolescent psychiatry and mental health", "publication_date": "2026-03-13", "publication_year": 2026, "doi": "10.1186/s13034-026-01069-6", "pubmed_id": "41826990", "openalex_id": "https://openalex.org/W7135184973", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41826990/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,OCD,Eating Disorders,Neuroplasticity,Pharmacology,Clinical Trial,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41826990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41826990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41826990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41826990/", "doi": "10.1186/s13034-026-01069-6", "pmid": "41826990", "publication_date": "2026-03-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 230, "title": "Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.", "authors": "Wood BJ, Vest MF, Carfagno C, Bartley KR, Sharma P, Halberstadt AL, Blough BE, Murnane KS", "journal": "ACS pharmacology & translational science", "publication_date": "2026-03-13", "publication_year": 2026, "doi": "10.1021/acsptsci.5c00484", "pubmed_id": "41852641", "openalex_id": "https://openalex.org/W7133349014", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41852641/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41852641", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41852641/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41852641", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41852641/", "doi": "10.1021/acsptsci.5c00484", "pmid": "41852641", "publication_date": "2026-03-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3473, "title": "Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06442423", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06442423", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "source_url": "https://clinicaltrials.gov/study/NCT06442423", "doi": "", "pmid": "", "publication_date": "2026-03-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3228, "title": "Age moderates the relationship between psychedelics use and mental health in naturalistic settings", "authors": "Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M.", "journal": "Research Square", "publication_date": "2026-03-10", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9022170/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Longevity,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:13", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "doi": "10.21203/rs.3.rs-9022170/v1", "pmid": "", "publication_date": "2026-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 242, "title": "Psilocybin or Nicotine Patch for Smoking Cessation", "authors": "Johnson Matthew W., Naudé Gideon P., Hendricks Peter S., Garcia-Romeu Albert", "journal": "JAMA Network Open", "publication_date": "2026-03-10", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.0972", "pubmed_id": "41805956", "openalex_id": "https://openalex.org/W7134891055", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.0972", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41805956", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.0972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41805956", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.0972", "doi": "10.1001/jamanetworkopen.2026.0972", "pmid": "41805956", "publication_date": "2026-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3616, "title": "A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.", "authors": "Psyence Australia Pty Ltd", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07072728", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07072728", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "source_url": "https://clinicaltrials.gov/study/NCT07072728", "doi": "", "pmid": "", "publication_date": "2026-03-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 258, "title": "Meaning and Psychedelics in Palliative Care: A Narrative Review.", "authors": "Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA", "journal": "Journal of pain and symptom management", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1016/j.jpainsymman.2025.10.015", "pubmed_id": "41173063", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41173063", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41173063", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "doi": "10.1016/j.jpainsymman.2025.10.015", "pmid": "41173063", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 248, "title": "Innovative Pharmacological Approaches to Eating Disorder Treatment.", "authors": "Keshen A, Touyz S, Lacroix E, Hay P, McElroy SL", "journal": "The Psychiatric clinics of North America", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1016/j.psc.2025.08.014", "pubmed_id": "41708265", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41708265/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41708265", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41708265/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41708265", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41708265/", "doi": "10.1016/j.psc.2025.08.014", "pmid": "41708265", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 244, "title": "Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.", "authors": "van der Meer PB, Schukking N, Dik M, van Reemst A, Fuentes JJ, Kaptein AA, Schoones JW, Verboeket S, de Waal MM, Goudriaan AE, Kramers C, Schellekens A, Bossong MG, Somers M, Batalla A", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1177/28314425251364182", "pubmed_id": "42130778", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42130778/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:42130778", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42130778/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42130778", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42130778/", "doi": "10.1177/28314425251364182", "pmid": "42130778", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4075, "title": "A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations", "authors": "Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1177/20451253261433836", "pubmed_id": "41918771", "openalex_id": "https://openalex.org/W7141801946", "source_url": "https://doi.org/10.1177/20451253261433836", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41918771", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253261433836", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41918771", "source_url": "https://doi.org/10.1177/20451253261433836", "doi": "10.1177/20451253261433836", "pmid": "41918771", "publication_date": "2026-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4076, "title": "Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making", "authors": "C Faria, Diana Dias da Silva, João José Sousa", "journal": "Instituto Politécnico do Porto", "publication_date": "2026-02-27", "publication_year": 2026, "doi": "10.26537/prpaeh.v4i3.7173", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166641777", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "doi": "10.26537/prpaeh.v4i3.7173", "pmid": "", "publication_date": "2026-02-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 260, "title": "Psychedelic therapy and cultural humility.", "authors": "Gearin A, Docherty J, Sun X, Cheung EH, Tanuseputro P", "journal": "Translational psychiatry", "publication_date": "2026-02-27", "publication_year": 2026, "doi": "10.1038/s41398-026-03913-x", "pubmed_id": "41748534", "openalex_id": "https://openalex.org/W7131675232", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41748534/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Spirituality,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41748534", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41748534/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41748534", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41748534/", "doi": "10.1038/s41398-026-03913-x", "pmid": "41748534", "publication_date": "2026-02-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3608, "title": "Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive Impairment", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06041152", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Brain Imaging,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06041152", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06041152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06041152", "source_url": "https://clinicaltrials.gov/study/NCT06041152", "doi": "", "pmid": "", "publication_date": "2026-02-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 263, "title": "Pilot study of psilocybin in patients with post-treatment lyme disease", "authors": "Garcia-Romeu Albert, Naudé Gideon P., Rebman Alison W., So Sara, Yaffe Abigail, Geithner Ian, Kozero Erica A., Yang Ting, Soloski Mark J., Aucott John N.", "journal": "Scientific Reports", "publication_date": "2026-02-25", "publication_year": 2026, "doi": "10.1038/s41598-026-38091-9", "pubmed_id": "41741501", "openalex_id": "https://openalex.org/W7131357000", "source_url": "https://doi.org/10.1038/s41598-026-38091-9", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41741501", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s41598-026-38091-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41741501", "source_url": "https://doi.org/10.1038/s41598-026-38091-9", "doi": "10.1038/s41598-026-38091-9", "pmid": "41741501", "publication_date": "2026-02-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3675, "title": "Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06005662", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Healthy Volunteers,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06005662", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06005662", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06005662", "source_url": "https://clinicaltrials.gov/study/NCT06005662", "doi": "", "pmid": "", "publication_date": "2026-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3032, "title": "Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial", "authors": "Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A.", "journal": "Research Square", "publication_date": "2026-02-23", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8319478/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:52", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "doi": "10.21203/rs.3.rs-8319478/v1", "pmid": "", "publication_date": "2026-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3182, "title": "Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives", "authors": "Christina Chwyl, Alissa Bazinet, Adie Wilson-Poe, Kim Hoffman, Kellie Pertl, Sara McCrimmon, Philip Korthuis, Jason Luoma", "journal": "PsyArXiv", "publication_date": "2026-02-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/mdz73_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/mdz73_v2", "source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "doi": "", "pmid": "", "publication_date": "2026-02-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1982, "title": "Effects of Psilocybin and Select Pharmaceutical Interactions", "authors": "Jordan McDowell, Jada Middleton, Alanna Bluett, Alisa Kozachenko, Bayan Attar, Yuvraj Singh Saini, Jennifer Burke, Cayden McPhee, Mutahera Mutahera, Talya Ahmed, Nabila Ibrahim, Gilbert Atukwatsibwe, Sulabha Adhikari, Mohammad Esmaili, Jean-Vital Yambayamba", "journal": "MacEwan University Student eJournal", "publication_date": "2026-02-18", "publication_year": 2026, "doi": "10.31542/bcek6t76", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130340064", "source_url": "https://doi.org/10.31542/bcek6t76", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Older Adults,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.31542/bcek6t76", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31542/bcek6t76", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31542/bcek6t76", "source_url": "https://doi.org/10.31542/bcek6t76", "doi": "10.31542/bcek6t76", "pmid": "", "publication_date": "2026-02-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4900, "title": "Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis.", "authors": "Khan Z, Weaver S, Dando RV, Schlag AK, Neill JC, Wainwright V", "journal": "Qualitative health research", "publication_date": "2026-02-17", "publication_year": 2026, "doi": "10.1177/10497323261419338", "pubmed_id": "41700878", "openalex_id": "https://openalex.org/W7129539813", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41700878/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 06:51:51", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41700878", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41700878/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41700878", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41700878/", "doi": "10.1177/10497323261419338", "pmid": "41700878", "publication_date": "2026-02-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 269, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.", "authors": "Beidas Z, Ragnhildstveit A, Blackman A, Anderson T, Fewster E, Syed OA, Sobolenko V, Kanca IK, Jaglinska M, Son T, Farb N, Petranker R", "journal": "BJPsych open", "publication_date": "2026-02-16", "publication_year": 2026, "doi": "10.1192/bjo.2025.10968", "pubmed_id": "41693474", "openalex_id": "https://openalex.org/W7129015437", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41693474/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity,Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41693474", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41693474/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41693474", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41693474/", "doi": "10.1192/bjo.2025.10968", "pmid": "41693474", "publication_date": "2026-02-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3541, "title": "A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07050368", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07050368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "source_url": "https://clinicaltrials.gov/study/NCT07050368", "doi": "", "pmid": "", "publication_date": "2026-02-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3425, "title": "Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07053917", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07053917", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07053917", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07053917", "source_url": "https://clinicaltrials.gov/study/NCT07053917", "doi": "", "pmid": "", "publication_date": "2026-02-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4084, "title": "Psilocybin and Animal Testing: Charting an End to the Use of Animals in Drug Development Research", "authors": "Amanda L. Elyse", "journal": "Digital Commons at University of Maryland Carey Law (University of Maryland Francis King Carey School of Law)", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7128760314", "source_url": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "source_url": "https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002&context=jhclp_online_issue", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4083, "title": "Development and assessment of a psychedelic-assisted therapy music playlist for clinical trials: Theory, intentionality, and metrics", "authors": "Rafael Lancelotta, Paul Nagib, Stacey B. Armstrong, Adam W. Levin, A. B. Davis", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-02-12", "publication_year": 2026, "doi": "10.1556/2054.2026.00462", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128677415", "source_url": "https://doi.org/10.1556/2054.2026.00462", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Emotional Processing,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00462", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00462", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00462", "source_url": "https://doi.org/10.1556/2054.2026.00462", "doi": "10.1556/2054.2026.00462", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3624, "title": "Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07405606", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07405606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "source_url": "https://clinicaltrials.gov/study/NCT07405606", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3514, "title": "Psilocybin-Assisted Cognitive Behavioral Therapy for Depression", "authors": "University of California, Los Angeles", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07281352", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07281352", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07281352", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07281352", "source_url": "https://clinicaltrials.gov/study/NCT07281352", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1983, "title": "Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study", "authors": "Matthew Hicks, Olivia Hicks, Ryan Bradley, Heather Zwickey", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-02-12", "publication_year": 2026, "doi": "10.1556/2054.2026.00485", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128687864", "source_url": "https://doi.org/10.1556/2054.2026.00485", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00485", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00485", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00485", "source_url": "https://doi.org/10.1556/2054.2026.00485", "doi": "10.1556/2054.2026.00485", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3690, "title": "Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers", "authors": "Hadassah Medical Organization", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07079930", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Clinical Trial,Observational Study,Animal Study,Healthy Volunteers,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07079930", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "source_url": "https://clinicaltrials.gov/study/NCT07079930", "doi": "", "pmid": "", "publication_date": "2026-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3550, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06206265", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Aging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06206265", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "source_url": "https://clinicaltrials.gov/study/NCT06206265", "doi": "", "pmid": "", "publication_date": "2026-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3486, "title": "Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study", "authors": "Nantes University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07391332", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07391332", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07391332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07391332", "source_url": "https://clinicaltrials.gov/study/NCT07391332", "doi": "", "pmid": "", "publication_date": "2026-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 280, "title": "Acute psilocin increased cortical activity in rat", "authors": "Liu Junhong, Wang Yuanyuan, Xia Ke, Wu Jinfeng, Zheng Danhao, Cai Aoling, Yan Haitao, Su Ruibin", "journal": "Frontiers in Neuroscience", "publication_date": "2026-02-04", "publication_year": 2026, "doi": "10.3389/fnins.2026.1593703", "pubmed_id": "41716660", "openalex_id": "https://openalex.org/W7127681443", "source_url": "https://doi.org/10.3389/fnins.2026.1593703", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:41716660", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fnins.2026.1593703", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41716660", "source_url": "https://doi.org/10.3389/fnins.2026.1593703", "doi": "10.3389/fnins.2026.1593703", "pmid": "41716660", "publication_date": "2026-02-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 310, "title": "Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?", "authors": "Vale LN, Ibrahim M, Fávaro-Pereira L, Soares JC, Meyer TD", "journal": "Journal of affective disorders", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120437", "pubmed_id": "41109422", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41109422/", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41109422", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41109422/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41109422", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41109422/", "doi": "10.1016/j.jad.2025.120437", "pmid": "41109422", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 307, "title": "Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.", "authors": "Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1177/07067437251389090", "pubmed_id": "41148143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41148143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41148143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "doi": "10.1177/07067437251389090", "pmid": "41148143", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 306, "title": "Psilocybin use in bipolar disorder: A comprehensive review.", "authors": "Do A, Cloutier L, Hébert-Tremblay L, Thauvin C", "journal": "Journal of affective disorders", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120485", "pubmed_id": "41177271", "openalex_id": "https://openalex.org/W4415742444", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41177271/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41177271", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41177271/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41177271", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41177271/", "doi": "10.1016/j.jad.2025.120485", "pmid": "41177271", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 298, "title": "Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).", "authors": "Hirsch D, Reed J, Naqvi A, Ngor A, Dugan L, Costa K, Ganasi RS, Truman K, Danovitch I, IsHak WW, Hedrick R", "journal": "CNS drugs", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1007/s40263-025-01248-7", "pubmed_id": "41313392", "openalex_id": "https://openalex.org/W4416780344", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41313392/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,OCD,Eating Disorders,Pharmacology,Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41313392", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41313392/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41313392", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41313392/", "doi": "10.1007/s40263-025-01248-7", "pmid": "41313392", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 297, "title": "New treatments for OCD? Evidence for cannabinoids and psychedelics.", "authors": "Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M", "journal": "Journal of psychiatric research", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.jpsychires.2025.11.021", "pubmed_id": "41317726", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41317726/", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Case Report,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41317726", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41317726/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41317726", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41317726/", "doi": "10.1016/j.jpsychires.2025.11.021", "pmid": "41317726", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 296, "title": "Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.", "authors": "Reid MR, Song J, Boehnke KF, Buchanan NT, Aday JS", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.neubiorev.2025.106516", "pubmed_id": "41365426", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41365426/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Aging,Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41365426", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41365426/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41365426", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41365426/", "doi": "10.1016/j.neubiorev.2025.106516", "pmid": "41365426", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 291, "title": "Psilocybin and Bipolar Depression: Promise and Prudence.", "authors": "Marques MG, Patarroyo-Rodriguez L, Singh B", "journal": "CNS drugs", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1007/s40263-025-01255-8", "pubmed_id": "41485178", "openalex_id": "https://openalex.org/W7118127068", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485178/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41485178", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41485178/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41485178", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485178/", "doi": "10.1007/s40263-025-01255-8", "pmid": "41485178", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 289, "title": "Patient perspectives on research gaps in cluster headache.", "authors": "Haghdoost F, Bahceci D, Delcourt C, Wijeratne T, Jensen RH, Cincinnato C, Tomlinson S, Wold B, Polito V, Carcel C, Ashraf U, Jenkins B, Petersen AS, Ray JC, Schindler EAD, Tsang B, Gianacas C, Rodgers A", "journal": "Headache", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1111/head.70031", "pubmed_id": "41562498", "openalex_id": "https://openalex.org/W7125283737", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41562498/", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Clinical Trial,Observational Study,Healthcare Workers,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41562498", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41562498/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41562498", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41562498/", "doi": "10.1111/head.70031", "pmid": "41562498", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 288, "title": "Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy.", "authors": "Ham R, Gardner J, Carter A, Liknaitzky P", "journal": "Brain and behavior", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1002/brb3.71262", "pubmed_id": "41699875", "openalex_id": "https://openalex.org/W7129297531", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41699875/", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41699875", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41699875/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41699875", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41699875/", "doi": "10.1002/brb3.71262", "pmid": "41699875", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1988, "title": "Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects", "authors": "Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz", "journal": "Quality in Sport", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.12775/qs.2026.51.68216", "pubmed_id": null, "openalex_id": "https://openalex.org/W7126403964", "source_url": "https://doi.org/10.12775/qs.2026.51.68216", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Meta-Analysis,Review Article,Animal Study,Cancer Patients,Treatment-Resistant Depression,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.51.68216", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.51.68216", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.51.68216", "source_url": "https://doi.org/10.12775/qs.2026.51.68216", "doi": "10.12775/qs.2026.51.68216", "pmid": "", "publication_date": "2026-01-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1989, "title": "PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION", "authors": "Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-28", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4711", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125929049", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "doi": "10.31435/ijitss.1(49).2026.4711", "pmid": "", "publication_date": "2026-01-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4101, "title": "Psychedelics in psychiatric treatment: a literature review", "authors": "Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska", "journal": "Quality in Sport", "publication_date": "2026-01-26", "publication_year": 2026, "doi": "10.12775/qs.2026.50.68013", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125801196", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.50.68013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.50.68013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.50.68013", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "doi": "10.12775/qs.2026.50.68013", "pmid": "", "publication_date": "2026-01-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4100, "title": "The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence", "authors": "Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-26", "publication_year": 2026, "doi": "10.5281/zenodo.18375715", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125699554", "source_url": "https://doi.org/10.5281/zenodo.18375715", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18375715", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18375715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18375715", "source_url": "https://doi.org/10.5281/zenodo.18375715", "doi": "10.5281/zenodo.18375715", "pmid": "", "publication_date": "2026-01-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1991, "title": "The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression", "authors": "Rishika Scott, James Smith", "journal": "Emerging Minds Journal for Student Research", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.59973/emjsr.317", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125652025", "source_url": "https://doi.org/10.59973/emjsr.317", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.59973/emjsr.317", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59973/emjsr.317", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59973/emjsr.317", "source_url": "https://doi.org/10.59973/emjsr.317", "doi": "10.59973/emjsr.317", "pmid": "", "publication_date": "2026-01-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3673, "title": "A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06796062", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06796062", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06796062", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06796062", "source_url": "https://clinicaltrials.gov/study/NCT06796062", "doi": "", "pmid": "", "publication_date": "2026-01-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4107, "title": "Is psilocybin only effective as part of psychotherapy?", "authors": "Tripdatabase", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.5281/zenodo.18339347", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125431792", "source_url": "https://doi.org/10.5281/zenodo.18339347", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18339347", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18339347", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18339347", "source_url": "https://doi.org/10.5281/zenodo.18339347", "doi": "10.5281/zenodo.18339347", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1992, "title": "THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS", "authors": "Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4582", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127606273", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "doi": "10.31435/ijitss.1(49).2026.4582", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4108, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.", "authors": "Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria", "journal": "Open Access CRIS of the University of Bern", "publication_date": "2026-01-21", "publication_year": 2026, "doi": "10.48620/94398", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128014083", "source_url": "https://doi.org/10.48620/94398", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.48620/94398", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48620/94398", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48620/94398", "source_url": "https://doi.org/10.48620/94398", "doi": "10.48620/94398", "pmid": "", "publication_date": "2026-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1993, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study", "authors": "Anthony L. Back, Bonnie A. McGregor, Leslie Lazar Thorn, Kelsey K. Baker, T. Gooley, Mendel Kaelen, Kalin Harvey, John M. Guy, Susanna Myers, Juliana Pérez, Peter Thompson, Lindsay Billingsley, Cheryl Sesnon", "journal": "Psychedelic Medicine", "publication_date": "2026-01-18", "publication_year": 2026, "doi": "10.1177/28314425251413856", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124682544", "source_url": "https://doi.org/10.1177/28314425251413856", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251413856", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251413856", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251413856", "source_url": "https://doi.org/10.1177/28314425251413856", "doi": "10.1177/28314425251413856", "pmid": "", "publication_date": "2026-01-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3029, "title": "Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial", "authors": "Benjamin Kelmendi, Thomas Adams, Terence Ching, Rachael Grazioplene, Stephen Kichuk, Geena Fram, Prerana Patel, Jeff Eilbott, Elizabeth D’Amico, Sarah Shnayder", "journal": "PsyArXiv", "publication_date": "2026-01-15", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "doi": "", "pmid": "", "publication_date": "2026-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 266, "title": "Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological Analysis", "authors": "Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna; id_orcid 0000-0002-2717-9739 Neill, Verity; id_orcid 0000-0002-9876-250X Wainwright", "journal": "Research Explorer (The University of Manchester)", "publication_date": "2026-01-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7128133091", "source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "doi": "", "pmid": "", "publication_date": "2026-01-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 329, "title": "From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.", "authors": "Mitchell J, Neitzke-Spruill L, Mathai DS, Robinson JO, Kavan Z, Averil LA, McGuire AL", "journal": "Translational behavioral medicine", "publication_date": "2026-01-07", "publication_year": 2026, "doi": "10.1093/tbm/ibag027", "pubmed_id": "42152689", "openalex_id": "https://openalex.org/W7161692886", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42152689/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:42152689", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42152689/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42152689", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42152689/", "doi": "10.1093/tbm/ibag027", "pmid": "42152689", "publication_date": "2026-01-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 334, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.", "authors": "Florineth GA, Klima I, Boeker AL, Catzeflis P, Wopfner A, Denier N, Bracht T, Adorjan K, Pfammatter M, Müller F, Soravia LM", "journal": "JAMA network open", "publication_date": "2026-01-02", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2025.54843", "pubmed_id": "41563753", "openalex_id": "https://openalex.org/W7125277592", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41563753/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Drug Interactions", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41563753", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41563753/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41563753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41563753/", "doi": "10.1001/jamanetworkopen.2025.54843", "pmid": "41563753", "publication_date": "2026-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4179, "title": "Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review", "authors": "Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate", "journal": "Open Science Framework", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.17605/osf.io/yu3n9", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162447643", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/yu3n9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/yu3n9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/yu3n9", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "doi": "10.17605/osf.io/yu3n9", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4178, "title": "Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin", "authors": "E. Lopez, J O Lundberg, F. Hieronymus, M. Beckman, H. Yngwe, C.J. Ekman, M. Tiger, N. Edvall", "journal": "Neuroscience Applied", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.nsa.2026.106904", "pubmed_id": null, "openalex_id": "https://openalex.org/W7161898772", "source_url": "https://doi.org/10.1016/j.nsa.2026.106904", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2026.106904", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2026.106904", "source_url": "https://doi.org/10.1016/j.nsa.2026.106904", "doi": "10.1016/j.nsa.2026.106904", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4175, "title": "Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression", "authors": "Yosr Ziadi, Taehwan Park", "journal": "Open MIND", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.17605/osf.io/nrt59", "pubmed_id": null, "openalex_id": "https://openalex.org/W7161800164", "source_url": "https://osf.io/nrt59", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/nrt59", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/nrt59", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/nrt59", "source_url": "https://osf.io/nrt59", "doi": "10.17605/osf.io/nrt59", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4171, "title": "Psychedelic-assisted psychotherapy: Clarifying the role of the \"psychotherapy\"", "authors": "Stefan Jerotić, Olga Čolović, Nađa Marić", "journal": "Medicinska istrazivanja", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.5937/medi0-62051", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130417929", "source_url": "https://doi.org/10.5937/medi0-62051", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.5937/medi0-62051", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5937/medi0-62051", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5937/medi0-62051", "source_url": "https://doi.org/10.5937/medi0-62051", "doi": "10.5937/medi0-62051", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4164, "title": "Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay Men", "authors": "Hannah Whitmore, Maria Mangini, Heather Leutwyler, Brian Anderson", "journal": "Palliative Medicine Reports", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/26892820251401798", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125776111", "source_url": "https://doi.org/10.1177/26892820251401798", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Emotional Processing,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1177/26892820251401798", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/26892820251401798", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/26892820251401798", "source_url": "https://doi.org/10.1177/26892820251401798", "doi": "10.1177/26892820251401798", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4158, "title": "Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial", "authors": "L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer", "journal": "Neuroscience Applied", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.nsa.2025.105779", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118005769", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "doi": "10.1016/j.nsa.2025.105779", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4157, "title": "The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial", "authors": "L. Marwood, M. Young, J. Chai-Rees, S. Mistry, S. Maxwell, G.M. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.nsa.2025.106572", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118005328", "source_url": "https://doi.org/10.1016/j.nsa.2025.106572", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106572", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106572", "source_url": "https://doi.org/10.1016/j.nsa.2025.106572", "doi": "10.1016/j.nsa.2025.106572", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4155, "title": "An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes", "authors": "N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.nsa.2025.106821", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117964120", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "doi": "10.1016/j.nsa.2025.106821", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4152, "title": "Psilocybin Treatment for Refractory Depression: A Clinical Review", "authors": "Jensen, Hailey A", "journal": "Digital Commons - Gardner-Webb University (Gardner-Webb University)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110564344", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "doi": "", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 851, "title": "Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users' Patterns of Use and Perceived Effects.", "authors": "Cuttler C, Stueber A, Simone J, Mayo LM", "journal": "Journal of psychoactive drugs", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1080/02791072.2025.2452226", "pubmed_id": "39878200", "openalex_id": "https://openalex.org/W4406930020", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39878200/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:39878200", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39878200/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39878200", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39878200/", "doi": "10.1080/02791072.2025.2452226", "pmid": "39878200", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 520, "title": "Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases.", "authors": "Gushken F, Fidalgo TM, Tardelli VS", "journal": "Journal of addiction medicine", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1097/adm.0000000000001580", "pubmed_id": "40919756", "openalex_id": "https://openalex.org/W4414064779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40919756/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:40919756", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40919756/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40919756", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40919756/", "doi": "10.1097/adm.0000000000001580", "pmid": "40919756", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 371, "title": "Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.", "authors": "Aghajanian S, Shafiee A, Parvizi Omran S, Rezaei Nejad A, Jafarabady K, Kohandel Gargari O, Rajai S, Mohammadi I, Bahrami Babaheidari T, Bakhtiyari M", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811241287542", "pubmed_id": "39480198", "openalex_id": "https://openalex.org/W4403943147", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39480198/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:39480198", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39480198/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39480198", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39480198/", "doi": "10.1177/02698811241287542", "pmid": "39480198", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 364, "title": "Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi.", "authors": "Foster K, Morrison I, Daniel S, Antoine J, Thankappan B, De La Haye W, Tyler M, Grant C, Delgoda R", "journal": "Journal of AOAC International", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1093/jaoacint/qsaf072", "pubmed_id": "40802522", "openalex_id": "https://openalex.org/W4413116294", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40802522/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Wellbeing,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40802522", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40802522/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40802522", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40802522/", "doi": "10.1093/jaoacint/qsaf072", "pmid": "40802522", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 361, "title": "Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.", "authors": "McGowan NM, Rucker JJ, Yehuda R, Agrawal M, Modlin NL, Simmons H, Tofil-Kaluza A, Das S, Goodwin GM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811251362390", "pubmed_id": "40883964", "openalex_id": "https://openalex.org/W4413839750", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883964/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Headache / Migraine,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:40883964", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40883964/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40883964", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883964/", "doi": "10.1177/02698811251362390", "pmid": "40883964", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 358, "title": "A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.", "authors": "Marek GJ, Makai-Bölöni S, Umbricht D, Christian EP, Winters J, Dvorak D, Raines S, Hughes ZA, Austin EW, Klein AK, Leong W, Krol FJ, Graaf AJV, Juachon MJ, Otto ME, Borghans LGJM, Jacobs G, Kruegel AC, Sporn J", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811251378512", "pubmed_id": "41099491", "openalex_id": "https://openalex.org/W4415246252", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41099491/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41099491", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41099491/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41099491", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41099491/", "doi": "10.1177/02698811251378512", "pmid": "41099491", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 357, "title": "Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use.", "authors": "Hutchison KE, Hooper JF, Karoly HC", "journal": "JAMA psychiatry", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2025.3038", "pubmed_id": "41191341", "openalex_id": "https://openalex.org/W4415929140", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41191341/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41191341", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41191341/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41191341", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41191341/", "doi": "10.1001/jamapsychiatry.2025.3038", "pmid": "41191341", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 354, "title": "Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.", "authors": "Konstantinou GN, Rosenblat J, Hales S, Husain MI, Blumberger DM", "journal": "General hospital psychiatry", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.genhosppsych.2025.12.005", "pubmed_id": "41401486", "openalex_id": "https://openalex.org/W4417166023", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41401486/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Mechanism of Action,Default Mode Network,Aging,Clinical Trial,Review Article,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41401486", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41401486/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41401486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41401486/", "doi": "10.1016/j.genhosppsych.2025.12.005", "pmid": "41401486", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 353, "title": "Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.", "authors": "Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S", "journal": "Palliative medicine", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02692163251383335", "pubmed_id": "41410211", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410211/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41410211", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41410211/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41410211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410211/", "doi": "10.1177/02692163251383335", "pmid": "41410211", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 352, "title": "Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill.", "authors": "Dwyer J, Johnston RB, O'Callaghan C, Ross M", "journal": "General hospital psychiatry", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.genhosppsych.2025.12.002", "pubmed_id": "41418682", "openalex_id": "https://openalex.org/W4417184349", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41418682/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41418682", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41418682/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41418682", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41418682/", "doi": "10.1016/j.genhosppsych.2025.12.002", "pmid": "41418682", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 348, "title": "Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.", "authors": "Rasheed S, Arif R, Raza AA, Samadi A", "journal": "Annals of medicine and surgery (2012)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1097/ms9.0000000000004349", "pubmed_id": "41497122", "openalex_id": "https://openalex.org/W4416592848", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497122/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41497122", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41497122/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41497122", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497122/", "doi": "10.1097/ms9.0000000000004349", "pmid": "41497122", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 347, "title": "Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin.", "authors": "Freitas da Costa B, Hartmann P, Pagnin D", "journal": "Human psychopharmacology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1002/hup.70032", "pubmed_id": "41502021", "openalex_id": "https://openalex.org/W7118595574", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41502021/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41502021", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41502021/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41502021", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41502021/", "doi": "10.1002/hup.70032", "pmid": "41502021", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 340, "title": "New Antidepressant Development in the Treatment of Depression.", "authors": "Spiti A, Caldirola D, Perna G", "journal": "Advances in experimental medicine and biology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/978-981-95-6872-7_23", "pubmed_id": "42036580", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036580/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:42036580", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42036580/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42036580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036580/", "doi": "10.1007/978-981-95-6872-7_23", "pmid": "42036580", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 316, "title": "A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry.", "authors": "Raza M, Kaur J", "journal": "Cureus", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.7759/cureus.102421", "pubmed_id": "41769492", "openalex_id": "https://openalex.org/W7125808618", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41769492/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Emotional Processing,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41769492", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41769492/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41769492", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41769492/", "doi": "10.7759/cureus.102421", "pmid": "41769492", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 218, "title": "Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.", "authors": "Evans M, Charrette A", "journal": "Frontiers in neuroscience", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.3389/fnins.2026.1816932", "pubmed_id": "41947857", "openalex_id": "https://openalex.org/W7140128776", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41947857/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Brain Imaging,Aging,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41947857", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41947857/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41947857", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41947857/", "doi": "10.3389/fnins.2026.1816932", "pmid": "41947857", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 205, "title": "Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology.", "authors": "Geraci J, Viirre E, Qorri B, Pani L", "journal": "Frontiers in pharmacology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.3389/fphar.2026.1777613", "pubmed_id": "41988526", "openalex_id": "https://openalex.org/W7143938647", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41988526/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41988526", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41988526/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41988526", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41988526/", "doi": "10.3389/fphar.2026.1777613", "pmid": "41988526", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 6, "title": "Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.", "authors": "Kervadec E, Bezo A, Serreau R, Strika-Bruneau L, Fauvel B, Amirouche A, Benyamina A, Romeo B", "journal": "Journal of clinical psychopharmacology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1097/jcp.0000000000002197", "pubmed_id": "42228481", "openalex_id": "https://openalex.org/W7163126953", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42228481/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42228481", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42228481/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42228481", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42228481/", "doi": "10.1097/jcp.0000000000002197", "pmid": "42228481", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3464, "title": "Microdosing Psychedelics to Improve Mood", "authors": "Rotem Petranker", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-30", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05259943", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05259943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "source_url": "https://clinicaltrials.gov/study/NCT05259943", "doi": "", "pmid": "", "publication_date": "2025-12-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3017, "title": "Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks", "authors": "Cervera-Sanchez MB, San-Juan D, Díaz-Peregrino R, Camacho-Castillo EZ, Bringas-Ortiz SA, Padilla-Cabezutd C.", "journal": "Authorea Preprints", "publication_date": "2025-12-29", "publication_year": 2025, "doi": "10.22541/au.176701186.65064859/v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117461912", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:49", "bibtex": null, "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "doi": "10.22541/au.176701186.65064859/v1", "pmid": "", "publication_date": "2025-12-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3043, "title": "Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex", "authors": "Houff J, Williams A, Allen O, Gisabella B, Pantazopoulos H, Del Arco A.", "journal": "bioRxiv", "publication_date": "2025-12-26", "publication_year": 2025, "doi": "10.64898/2025.12.22.696123", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2025.12.22.696123", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Biomarkers,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:53", "bibtex": null, "source_record_id": "DOI:10.64898/2025.12.22.696123", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2025.12.22.696123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2025.12.22.696123", "source_url": "https://doi.org/10.64898/2025.12.22.696123", "doi": "10.64898/2025.12.22.696123", "pmid": "", "publication_date": "2025-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4189, "title": "A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder", "authors": "Manasicha Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon, Maddison Vail", "journal": "Current Treatment Options in Psychiatry", "publication_date": "2025-12-25", "publication_year": 2025, "doi": "10.1007/s40501-025-00373-w", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117327267", "source_url": "https://doi.org/10.1007/s40501-025-00373-w", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 06:34:37", "bibtex": null, "source_record_id": "DOI:10.1007/s40501-025-00373-w", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40501-025-00373-w", "source_url": "https://doi.org/10.1007/s40501-025-00373-w", "doi": "10.1007/s40501-025-00373-w", "pmid": "", "publication_date": "2025-12-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3055, "title": "A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants", "authors": "Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA.", "journal": "medRxiv", "publication_date": "2025-12-23", "publication_year": 2025, "doi": "10.64898/2025.12.22.25342874", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2025.12.22.25342874", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Consciousness,Clinical Trial,Review Article,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:54", "bibtex": null, "source_record_id": "DOI:10.64898/2025.12.22.25342874", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2025.12.22.25342874", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2025.12.22.25342874", "source_url": "https://doi.org/10.64898/2025.12.22.25342874", "doi": "10.64898/2025.12.22.25342874", "pmid": "", "publication_date": "2025-12-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3585, "title": "Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-22", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07296328", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07296328", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07296328", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07296328", "source_url": "https://clinicaltrials.gov/study/NCT07296328", "doi": "", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 388, "title": "The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.", "authors": "Carlson LE, Richardson H, Shore R, Albertyn CP, Balneaves LG, Bates A, Burnell M, Chochinov HM, Clements D, Deleemans J, Horlock H, Mathews J, McKenzie M, Savard C, Soares CN, Tu W, Williams M", "journal": "Current oncology (Toronto, Ont.)", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.3390/curroncol33010007", "pubmed_id": "41590327", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41590327/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Cancer Patients,Healthcare Workers", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41590327", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41590327/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41590327", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41590327/", "doi": "10.3390/curroncol33010007", "pmid": "41590327", "publication_date": "2025-12-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 391, "title": "Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.", "authors": "Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-12-20", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111541", "pubmed_id": "41138900", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41138900/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41138900", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41138900/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41138900", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41138900/", "doi": "10.1016/j.pnpbp.2025.111541", "pmid": "41138900", "publication_date": "2025-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4196, "title": "From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications", "authors": "Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen", "journal": "Creative Science", "publication_date": "2025-12-19", "publication_year": 2025, "doi": "10.55674/cs.v18i1.264689", "pubmed_id": null, "openalex_id": "https://openalex.org/W7116104340", "source_url": "https://doi.org/10.55674/cs.v18i1.264689", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.55674/cs.v18i1.264689", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.55674/cs.v18i1.264689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.55674/cs.v18i1.264689", "source_url": "https://doi.org/10.55674/cs.v18i1.264689", "doi": "10.55674/cs.v18i1.264689", "pmid": "", "publication_date": "2025-12-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 392, "title": "Psilocybin reporting in media (PRiMe) for the treatment of depression.", "authors": "Brar G, Burke T, Gribben AD, Harrington C, Thuery G, Kelly JR", "journal": "Irish journal of psychological medicine", "publication_date": "2025-12-18", "publication_year": 2025, "doi": "10.1017/ipm.2025.10142", "pubmed_id": "41410115", "openalex_id": "https://openalex.org/W4417453981", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410115/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41410115", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41410115/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41410115", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410115/", "doi": "10.1017/ipm.2025.10142", "pmid": "41410115", "publication_date": "2025-12-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4200, "title": "Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment", "authors": "M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya", "journal": "˜The œjournal of desk research review and analysis.", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.4038/jdrra.v3i2.87", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115587785", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Older Adults,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "doi": "10.4038/jdrra.v3i2.87", "pmid": "", "publication_date": "2025-12-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 395, "title": "Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.", "authors": "Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI", "journal": "Journal of affective disorders", "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.1016/j.jad.2025.119952", "pubmed_id": "40684956", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40684956/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Eating Disorders,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40684956", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40684956/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40684956", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40684956/", "doi": "10.1016/j.jad.2025.119952", "pmid": "40684956", "publication_date": "2025-12-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 394, "title": "Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.", "authors": "Ledwos N, Baer J, Husain MI, Blumberger DM, Patterson R, Hollingdrake E, Cheung E, Hawco C, Zrenner C, Zrenner B, Feusner JD, Rossell SL, Castle DJ, Zai G", "journal": "BJPsych open", "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.1192/bjo.2025.10895", "pubmed_id": "41392767", "openalex_id": "https://openalex.org/W4417362478", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41392767/", "substance_tags": "psilocybin", "topic_tags": "OCD,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41392767", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41392767/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41392767", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41392767/", "doi": "10.1192/bjo.2025.10895", "pmid": "41392767", "publication_date": "2025-12-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3048, "title": "Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study", "authors": "Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S.", "journal": "Research Square", "publication_date": "2025-12-10", "publication_year": 2025, "doi": "10.21203/rs.3.rs-8079137/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:53", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "doi": "10.21203/rs.3.rs-8079137/v1", "pmid": "", "publication_date": "2025-12-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3040, "title": "Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review", "authors": "Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R.", "journal": "Qeios", "publication_date": "2025-12-09", "publication_year": 2025, "doi": "10.32388/xcfsag.2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.32388/xcfsag.2", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:52", "bibtex": null, "source_record_id": "DOI:10.32388/xcfsag.2", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.32388/xcfsag.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.32388/xcfsag.2", "source_url": "https://doi.org/10.32388/xcfsag.2", "doi": "10.32388/xcfsag.2", "pmid": "", "publication_date": "2025-12-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3513, "title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05398484", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05398484", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "source_url": "https://clinicaltrials.gov/study/NCT05398484", "doi": "", "pmid": "", "publication_date": "2025-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4212, "title": "Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears", "authors": "Spohn, Kyle", "journal": "eYLS (Yale Law School)", "publication_date": "2025-12-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112471464", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "doi": "", "pmid": "", "publication_date": "2025-12-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4215, "title": "Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care Patients", "authors": "Philip Garrity, Alicia Danforth, Brian Anderson, Jason M. Thompson", "journal": "Journal of Health Service Psychology", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1007/s42843-025-00145-3", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118121099", "source_url": "https://doi.org/10.1007/s42843-025-00145-3", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Chronic Pain,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.1007/s42843-025-00145-3", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s42843-025-00145-3", "source_url": "https://doi.org/10.1007/s42843-025-00145-3", "doi": "10.1007/s42843-025-00145-3", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 418, "title": "Exploring the therapeutic potential of psychedelics in treating substance use disorders.", "authors": "Li Y, Li H, Wang H, Wang X", "journal": "Molecular psychiatry", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1038/s41380-025-03168-w", "pubmed_id": "40830580", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40830580/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40830580", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40830580/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40830580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40830580/", "doi": "10.1038/s41380-025-03168-w", "pmid": "40830580", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 408, "title": "Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.", "authors": "Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.euroneuro.2025.09.011", "pubmed_id": "41205366", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41205366/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41205366", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41205366/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41205366", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41205366/", "doi": "10.1016/j.euroneuro.2025.09.011", "pmid": "41205366", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 401, "title": "Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.", "authors": "Modlin NL, Williamson V, Goodwin GM, Malievskaia E, Atli M, Elek Z, Gaillard A, Koelpin D, Cleare A, Agrawal M, Yehuda R, Kirlic N, Rucker J", "journal": "EClinicalMedicine", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103692", "pubmed_id": "41497513", "openalex_id": "https://openalex.org/W4417031290", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497513/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41497513", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41497513/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41497513", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497513/", "doi": "10.1016/j.eclinm.2025.103692", "pmid": "41497513", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 383, "title": "Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.", "authors": "Griffiths RR, Jesse R, Richards WA, Johnson MW, Sepeda ND, Bossis AP, Ross S", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1089/psymed.2023.0044", "pubmed_id": "41869007", "openalex_id": "https://openalex.org/W4410448036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869007/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41869007", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41869007/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41869007", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869007/", "doi": "10.1089/psymed.2023.0044", "pmid": "41869007", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 380, "title": "Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review.", "authors": "Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J", "journal": "Cureus", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.7759/cureus.99942", "pubmed_id": "41583322", "openalex_id": "https://openalex.org/W7116864166", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41583322/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41583322", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41583322/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41583322", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41583322/", "doi": "10.7759/cureus.99942", "pmid": "41583322", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4213, "title": "Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects", "authors": "Bjørn Holmøy, Kristoffer Andreas Aamodt Andersen", "journal": "Tidsskrift for Norsk psykologforening", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.52734/hgsn7664", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416844791", "source_url": "https://doi.org/10.52734/hgsn7664", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 06:34:38", "bibtex": null, "source_record_id": "DOI:10.52734/hgsn7664", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.52734/hgsn7664", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.52734/hgsn7664", "source_url": "https://doi.org/10.52734/hgsn7664", "doi": "10.52734/hgsn7664", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3681, "title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder", "authors": "University of Texas at Austin", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-26", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06132178", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06132178", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "source_url": "https://clinicaltrials.gov/study/NCT06132178", "doi": "", "pmid": "", "publication_date": "2025-11-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3700, "title": "Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life", "authors": "Charles S. Grob, M.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05403086", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05403086", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "source_url": "https://clinicaltrials.gov/study/NCT05403086", "doi": "", "pmid": "", "publication_date": "2025-11-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 423, "title": "Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.", "authors": "Kruger DJ, Mersereau G, Sullivan A, Barron J, Herberholz M, Pouyan N, Aday JS, Boehnke KF", "journal": "Harm reduction journal", "publication_date": "2025-11-25", "publication_year": 2025, "doi": "10.1186/s12954-025-01337-2", "pubmed_id": "41291774", "openalex_id": "https://openalex.org/W4416671509", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41291774/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41291774", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41291774/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41291774", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41291774/", "doi": "10.1186/s12954-025-01337-2", "pmid": "41291774", "publication_date": "2025-11-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3042, "title": "Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review", "authors": "Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R.", "journal": "Qeios", "publication_date": "2025-11-21", "publication_year": 2025, "doi": "10.32388/xcfsag", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.32388/xcfsag", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:53", "bibtex": null, "source_record_id": "DOI:10.32388/xcfsag", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.32388/xcfsag", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.32388/xcfsag", "source_url": "https://doi.org/10.32388/xcfsag", "doi": "10.32388/xcfsag", "pmid": "", "publication_date": "2025-11-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3548, "title": "A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07183748", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07183748", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "source_url": "https://clinicaltrials.gov/study/NCT07183748", "doi": "", "pmid": "", "publication_date": "2025-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3454, "title": "Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04882839", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Spirituality,Clinical Trial,Case Report,Animal Study,Cancer Patients,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04882839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "source_url": "https://clinicaltrials.gov/study/NCT04882839", "doi": "", "pmid": "", "publication_date": "2025-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3058, "title": "Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial", "authors": "Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily Fewster, Omer Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son", "journal": "PsyArXiv", "publication_date": "2025-11-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "doi": "", "pmid": "", "publication_date": "2025-11-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 436, "title": "Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.", "authors": "Martens MAG, Cunha BG, Erritzoe D, Nutt D, Carhart-Harris R, Harmer CJ", "journal": "Translational psychiatry", "publication_date": "2025-11-13", "publication_year": 2025, "doi": "10.1038/s41398-025-03693-w", "pubmed_id": "41257994", "openalex_id": "https://openalex.org/W4416593366", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41257994/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41257994", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41257994/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41257994", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41257994/", "doi": "10.1038/s41398-025-03693-w", "pmid": "41257994", "publication_date": "2025-11-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3489, "title": "A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05847686", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05847686", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "source_url": "https://clinicaltrials.gov/study/NCT05847686", "doi": "", "pmid": "", "publication_date": "2025-11-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4247, "title": "Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required", "authors": "Aisling McGuigan", "journal": "Drugs & Therapy Perspectives", "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.1007/s40267-025-01199-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415932492", "source_url": "https://doi.org/10.1007/s40267-025-01199-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 06:34:38", "bibtex": null, "source_record_id": "DOI:10.1007/s40267-025-01199-5", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40267-025-01199-5", "source_url": "https://doi.org/10.1007/s40267-025-01199-5", "doi": "10.1007/s40267-025-01199-5", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 449, "title": "Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review.", "authors": "Marinis J, Clarke ST, Guerin AA, Guastella AJ, Bedi G", "journal": "BJPsych open", "publication_date": "2025-11-03", "publication_year": 2025, "doi": "10.1192/bjo.2025.10847", "pubmed_id": "41178084", "openalex_id": "https://openalex.org/W4415782096", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41178084/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41178084", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41178084/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41178084", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41178084/", "doi": "10.1192/bjo.2025.10847", "pmid": "41178084", "publication_date": "2025-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 461, "title": "Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.", "authors": "Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S", "journal": "Health policy (Amsterdam, Netherlands)", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.healthpol.2025.105392", "pubmed_id": "40694950", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40694950/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40694950", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40694950/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40694950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40694950/", "doi": "10.1016/j.healthpol.2025.105392", "pmid": "40694950", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4256, "title": "Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications", "authors": "André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich", "journal": "Caderno Pedagógico", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.54033/cadpedv22n12-345", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415830103", "source_url": "https://doi.org/10.54033/cadpedv22n12-345", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Neuroplasticity,Pharmacology,Receptor Pharmacology,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.54033/cadpedv22n12-345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54033/cadpedv22n12-345", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54033/cadpedv22n12-345", "source_url": "https://doi.org/10.54033/cadpedv22n12-345", "doi": "10.54033/cadpedv22n12-345", "pmid": "", "publication_date": "2025-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 466, "title": "Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.", "authors": "d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G", "journal": "Translational psychiatry", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1038/s41398-025-03654-3", "pubmed_id": "41173871", "openalex_id": "https://openalex.org/W4415725218", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173871/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41173871", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41173871/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41173871", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173871/", "doi": "10.1038/s41398-025-03654-3", "pmid": "41173871", "publication_date": "2025-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3597, "title": "A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?", "authors": "Anna Rose Childress, Ph.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06786325", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Consciousness,Biomarkers,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06786325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "source_url": "https://clinicaltrials.gov/study/NCT06786325", "doi": "", "pmid": "", "publication_date": "2025-10-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 467, "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.", "authors": "Richardson C, Chan C, Macgregor E, Hare C, Hannon B, Black S, Schneider E, Buchman D, Wang S, Rac V, Abrahamyan L, Huszti E, Nissim R, Li M, Zimmermann C, Hapke E, Rosenbaum D, Hales S", "journal": "Pilot and feasibility studies", "publication_date": "2025-10-28", "publication_year": 2025, "doi": "10.1186/s40814-025-01706-5", "pubmed_id": "41152967", "openalex_id": "https://openalex.org/W4415616586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41152967/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41152967", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41152967/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41152967", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41152967/", "doi": "10.1186/s40814-025-01706-5", "pmid": "41152967", "publication_date": "2025-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4259, "title": "Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence", "authors": "James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir", "journal": "Psychedelics.", "publication_date": "2025-10-27", "publication_year": 2025, "doi": "10.61373/pp025i.0044", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415615338", "source_url": "https://doi.org/10.61373/pp025i.0044", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,OCD,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Animal Study,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025i.0044", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025i.0044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025i.0044", "source_url": "https://doi.org/10.61373/pp025i.0044", "doi": "10.61373/pp025i.0044", "pmid": "", "publication_date": "2025-10-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 470, "title": "A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.", "authors": "Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA", "journal": "Healthcare (Basel, Switzerland)", "publication_date": "2025-10-23", "publication_year": 2025, "doi": "10.3390/healthcare13212668", "pubmed_id": "41228035", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41228035/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41228035", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41228035/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41228035", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41228035/", "doi": "10.3390/healthcare13212668", "pmid": "41228035", "publication_date": "2025-10-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4262, "title": "Is there more to magic mushrooms than psilocybin?", "authors": "special to C EN Mara Johnson-Groh", "journal": "C&EN Global Enterprise", "publication_date": "2025-10-19", "publication_year": 2025, "doi": "10.1021/cen-10322-feature2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416285937", "source_url": "https://doi.org/10.1021/cen-10322-feature2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10322-feature2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10322-feature2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10322-feature2", "source_url": "https://doi.org/10.1021/cen-10322-feature2", "doi": "10.1021/cen-10322-feature2", "pmid": "", "publication_date": "2025-10-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3050, "title": "Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping Review", "authors": "Suspene J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R.", "journal": "Preprints.org", "publication_date": "2025-10-17", "publication_year": 2025, "doi": "10.20944/preprints202510.1355.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202510.1355.v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:53", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202510.1355.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202510.1355.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202510.1355.v1", "source_url": "https://doi.org/10.20944/preprints202510.1355.v1", "doi": "10.20944/preprints202510.1355.v1", "pmid": "", "publication_date": "2025-10-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3640, "title": "A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-14", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06644170", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06644170", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06644170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06644170", "source_url": "https://clinicaltrials.gov/study/NCT06644170", "doi": "", "pmid": "", "publication_date": "2025-10-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 476, "title": "Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice.", "authors": "Razidlo J, Cataldo N, Wenthur CJ", "journal": "ACS pharmacology & translational science", "publication_date": "2025-10-10", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00462", "pubmed_id": "41244305", "openalex_id": "https://openalex.org/W4414130775", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41244305/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41244305", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41244305/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41244305", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41244305/", "doi": "10.1021/acsptsci.5c00462", "pmid": "41244305", "publication_date": "2025-10-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3575, "title": "Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)", "authors": "Centre Hospitalier St Anne", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07210112", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07210112", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "source_url": "https://clinicaltrials.gov/study/NCT07210112", "doi": "", "pmid": "", "publication_date": "2025-10-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4488, "title": "Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD", "authors": "Mackenzie Hancock, Nicole Getz, Shambhu Prasad Adhikari", "journal": "Open Science Framework", "publication_date": "2025-10-06", "publication_year": 2025, "doi": "10.17605/osf.io/ar2s4", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106330185", "source_url": "https://osf.io/ar2s4", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/ar2s4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/ar2s4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/ar2s4", "source_url": "https://osf.io/ar2s4", "doi": "10.17605/osf.io/ar2s4", "pmid": "", "publication_date": "2025-10-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4275, "title": "Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders", "authors": "M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali", "journal": "Journal of Pharma Insights and Research.", "publication_date": "2025-10-05", "publication_year": 2025, "doi": "10.69613/thv1dn30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416779935", "source_url": "https://doi.org/10.69613/thv1dn30", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.69613/thv1dn30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.69613/thv1dn30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.69613/thv1dn30", "source_url": "https://doi.org/10.69613/thv1dn30", "doi": "10.69613/thv1dn30", "pmid": "", "publication_date": "2025-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5795, "title": "Psilocybin as a Treatment for Depression", "authors": "Arif Ersegün Kahraman", "journal": "University of Debrecen Electronic Archive", "publication_date": "2025-10-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7198794859", "source_url": "https://hdl.handle.net/2437/398317", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:16", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://hdl.handle.net/2437/398317", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/2437/398317", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://hdl.handle.net/2437/398317", "source_url": "https://hdl.handle.net/2437/398317", "doi": "", "pmid": "", "publication_date": "2025-10-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4276, "title": "Legal and Regulatory Barriers to Medical Psilocybin Use: An International Overview", "authors": "Chweikh Mohamad", "journal": "OSF Preprints", "publication_date": "2025-10-02", "publication_year": 2025, "doi": "10.31219/osf.io/dy5cu_v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414761184", "source_url": "https://doi.org/10.31219/osf.io/dy5cu_v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "preprint", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 09:00:16", "bibtex": null, "source_record_id": "DOI:10.31219/osf.io/dy5cu_v1", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.31219/osf.io/dy5cu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.31219/osf.io/dy5cu_v1", "source_url": "https://doi.org/10.31219/osf.io/dy5cu_v1", "doi": "10.31219/osf.io/dy5cu_v1", "pmid": "", "publication_date": "2025-10-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 502, "title": "Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.", "authors": "Chisamore N, Kaczmarek ES, Doyle Z, Johnson DE, Weiglein G, Meshkat S, Brudner RM, Blainey MG, Riva-Cambrin J, McIntyre RS, Rosenblat JD", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1177/07067437251328316", "pubmed_id": "40129307", "openalex_id": "https://openalex.org/W4408813813", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40129307/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40129307", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40129307/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40129307", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40129307/", "doi": "10.1177/07067437251328316", "pmid": "40129307", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 497, "title": "Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.", "authors": "Pellegrini L, Fineberg NA, O'Connor S, De Souza AMFLP, Godfrey K, Reed S, Peill J, Healy M, Rohani-Shukla C, Lee H, Carhart-Harris R, Robbins TW, Nutt D, Erritzoe D", "journal": "Comprehensive psychiatry", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1016/j.comppsych.2025.152619", "pubmed_id": "40618640", "openalex_id": "https://openalex.org/W4411969620", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40618640/", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Healthcare Workers,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40618640", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40618640/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40618640", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40618640/", "doi": "10.1016/j.comppsych.2025.152619", "pmid": "40618640", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 485, "title": "[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?].", "authors": "Sabé M, Seragnoli F, Penzenstadler L, Thorens G", "journal": "La Revue du praticien", "publication_date": "2025-10-01", "publication_year": 2025, "doi": null, "pubmed_id": "41575100", "openalex_id": "https://openalex.org/W7125566383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:41575100", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41575100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100/", "doi": "", "pmid": "41575100", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4283, "title": "3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception", "authors": "Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman", "journal": "Poster Abstracts", "publication_date": "2025-09-30", "publication_year": 2025, "doi": "10.1136/bmjno-2025-anzan.170", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415496150", "source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Microdosing,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:37:47", "bibtex": null, "source_record_id": "DOI:10.1136/bmjno-2025-anzan.170", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/bmjno-2025-anzan.170", "source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "doi": "10.1136/bmjno-2025-anzan.170", "pmid": "", "publication_date": "2025-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5796, "title": "Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review", "authors": "Pinelopi Vlotinou, Konstantinos Christodoulou, Anna Tsiakiri, Foteini Christidi, Aspasia Serdari", "journal": "Brazilian Journal of Science", "publication_date": "2025-09-29", "publication_year": 2025, "doi": "10.14295/bjs.v4i10.785", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414736657", "source_url": "https://doi.org/10.14295/bjs.v4i10.785", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:17", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.14295/bjs.v4i10.785", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.14295/bjs.v4i10.785", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.14295/bjs.v4i10.785", "source_url": "https://doi.org/10.14295/bjs.v4i10.785", "doi": "10.14295/bjs.v4i10.785", "pmid": "", "publication_date": "2025-09-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4287, "title": "Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat", "authors": "Egger, Klemens, Meling, Daniel, Polat, Firuze, Seifritz, Erich, Avram, Mihai, Scheidegger, Milan", "journal": "Universität Zürich, ZORA", "publication_date": "2025-09-29", "publication_year": 2025, "doi": "10.5167/uzh-280470", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106223303", "source_url": "https://doi.org/10.5167/uzh-280470", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.5167/uzh-280470", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5167/uzh-280470", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5167/uzh-280470", "source_url": "https://doi.org/10.5167/uzh-280470", "doi": "10.5167/uzh-280470", "pmid": "", "publication_date": "2025-09-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 508, "title": "Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.", "authors": "Caporuscio C, Poppe C, Gieselmann A, Repantis D", "journal": "Psychological medicine", "publication_date": "2025-09-29", "publication_year": 2025, "doi": "10.1017/s0033291725101761", "pubmed_id": "41017267", "openalex_id": "https://openalex.org/W4414616693", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41017267/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41017267", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41017267/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41017267", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41017267/", "doi": "10.1017/s0033291725101761", "pmid": "41017267", "publication_date": "2025-09-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3588, "title": "Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism", "authors": "Healing Advocacy Fund", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07189988", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Wellbeing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07189988", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "source_url": "https://clinicaltrials.gov/study/NCT07189988", "doi": "", "pmid": "", "publication_date": "2025-09-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4290, "title": "With great power comes great responsibility: Promise and caution in the new psychedelic renaissance", "authors": "Matthew Halma, R. Levy, Joseph Varón", "journal": "Brain Disorders", "publication_date": "2025-09-23", "publication_year": 2025, "doi": "10.1016/j.dscb.2025.100286", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414440106", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "doi": "10.1016/j.dscb.2025.100286", "pmid": "", "publication_date": "2025-09-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 509, "title": "Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.", "authors": "Knock E, Siefried KJ, Bedi G, Albert S, Day RO, Ezard N, Ross M, Liknaitzky P, Brett J", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-09-20", "publication_year": 2025, "doi": "10.1111/add.70187", "pubmed_id": "40974259", "openalex_id": "https://openalex.org/W4414374510", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40974259/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40974259", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40974259/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40974259", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40974259/", "doi": "10.1111/add.70187", "pmid": "40974259", "publication_date": "2025-09-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4292, "title": "S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial", "authors": "Benjamin R. Lewis (22279166), John Hendrick (22279169), Kevin Byrne (1610821), Madeleine Odette (22279172), Chaorong Wu (8444343), Eric L. Garland (4666660)", "journal": "Figshare", "publication_date": "2025-09-19", "publication_year": 2025, "doi": "10.1371/journal.pmed.1004519.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7110952270", "source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.1371/journal.pmed.1004519.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1371/journal.pmed.1004519.s001", "source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "doi": "10.1371/journal.pmed.1004519.s001", "pmid": "", "publication_date": "2025-09-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 511, "title": "Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US.", "authors": "Calin A, Burlec AF, Mircea C, Macovei I, Hancianu M, Corciova A", "journal": "Journal of clinical medicine", "publication_date": "2025-09-19", "publication_year": 2025, "doi": "10.3390/jcm14186613", "pubmed_id": "41010814", "openalex_id": "https://openalex.org/W4414341779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41010814/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41010814", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41010814/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41010814", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41010814/", "doi": "10.3390/jcm14186613", "pmid": "41010814", "publication_date": "2025-09-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3709, "title": "PRoMiSS: Psilocybin and the Role of Music in Set and Setting", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07180108", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Consciousness,Wellbeing,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07180108", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07180108", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07180108", "source_url": "https://clinicaltrials.gov/study/NCT07180108", "doi": "", "pmid": "", "publication_date": "2025-09-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4293, "title": "Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-Analyses", "authors": "Lopez, Alissa A, Salloum, Ihsan, Lopez-Alvarenga, Juan C", "journal": "ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley)", "publication_date": "2025-09-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110568410", "source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "doi": "", "pmid": "", "publication_date": "2025-09-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3699, "title": "Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-10", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164755", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Treatment-Resistant Depression,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164755", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "source_url": "https://clinicaltrials.gov/study/NCT07164755", "doi": "", "pmid": "", "publication_date": "2025-09-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3571, "title": "Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial", "authors": "Khyber Medical University Peshawar", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06746441", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06746441", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06746441", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06746441", "source_url": "https://clinicaltrials.gov/study/NCT06746441", "doi": "", "pmid": "", "publication_date": "2025-09-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4304, "title": "PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH", "authors": "Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.31435/ijitss.3(47).2025.3650", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413888032", "source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Neuroplasticity,Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.3(47).2025.3650", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.3(47).2025.3650", "source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "doi": "10.31435/ijitss.3(47).2025.3650", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 550, "title": "A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.", "authors": "Palitsky R, Maples-Keller JL, Peacock C, Dunlop BW, Mletzko T, Grant GH, Raison CL, Chao S, Shub I, Mendelbaum-Kweller M, Smolyar L, Kaplan DM, Rothbaum BO, Zarrabi AJ", "journal": "Psychotherapy (Chicago, Ill.)", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1037/pst0000551", "pubmed_id": "39804360", "openalex_id": "https://openalex.org/W4406306242", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39804360/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Spirituality,Clinical Trial,Cancer Patients,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:39804360", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39804360/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39804360", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39804360/", "doi": "10.1037/pst0000551", "pmid": "39804360", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 547, "title": "Psilocybin biosynthesis enhancement through gene source optimization.", "authors": "Keller MR, McKinney MG, Sen AK, Guagliardo FG, Hellwarth EB, Islam KN, Kaplan NA, Gibbons WJ, Kemmerly GE, Meers C, Wang X, Jones JA", "journal": "Metabolic engineering", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1016/j.ymben.2025.04.003", "pubmed_id": "40250599", "openalex_id": "https://openalex.org/W4409500508", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40250599/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Clinical Trial,Proteomics", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40250599", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40250599/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40250599", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40250599/", "doi": "10.1016/j.ymben.2025.04.003", "pmid": "40250599", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 546, "title": "Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review.", "authors": "Estric C, Duron T, Kabani S, Lopez-Castroman J", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1177/02698811251338214", "pubmed_id": "40353492", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40353492/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40353492", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40353492/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40353492", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40353492/", "doi": "10.1177/02698811251338214", "pmid": "40353492", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 538, "title": "Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.", "authors": "Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL", "journal": "CNS drugs", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1007/s40263-025-01199-z", "pubmed_id": "40640527", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40640527/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40640527", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40640527/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40640527", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40640527/", "doi": "10.1007/s40263-025-01199-z", "pmid": "40640527", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 537, "title": "Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics.", "authors": "Swieczkowski D, Kwaśny A, Ciurkowska P, Pruc M, Szarpak L, Cubała WJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1177/02698811251353250", "pubmed_id": "40643096", "openalex_id": "https://openalex.org/W4412197020", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40643096/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Aging,Clinical Trial,Review Article,Healthy Volunteers,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40643096", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40643096/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40643096", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40643096/", "doi": "10.1177/02698811251353250", "pmid": "40643096", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4303, "title": "A lexicon for psychedelic research and treatment", "authors": "David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill", "journal": "Drug Science Policy and Law", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1177/20503245251380511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414407628", "source_url": "https://doi.org/10.1177/20503245251380511", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/20503245251380511", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245251380511", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245251380511", "source_url": "https://doi.org/10.1177/20503245251380511", "doi": "10.1177/20503245251380511", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4312, "title": "Psychedelic minimalism: the case against music in psychedelic therapy settings", "authors": "Samir A Nader", "journal": "Frontiers in Psychiatry", "publication_date": "2025-08-26", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1652568", "pubmed_id": "40933801", "openalex_id": "https://openalex.org/W4413614435", "source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "PMID:40933801", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40933801", "source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "doi": "10.3389/fpsyt.2025.1652568", "pmid": "40933801", "publication_date": "2025-08-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4314, "title": "“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy", "authors": "Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Kimberly Roddy, James A. Tulsky, Manish Agrawal, Yvan Beaussant", "journal": "Psychedelic Medicine", "publication_date": "2025-08-25", "publication_year": 2025, "doi": "10.1177/28314425251370303", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414955208", "source_url": "https://doi.org/10.1177/28314425251370303", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251370303", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251370303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251370303", "source_url": "https://doi.org/10.1177/28314425251370303", "doi": "10.1177/28314425251370303", "pmid": "", "publication_date": "2025-08-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 560, "title": "Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion.", "authors": "Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V, Ross S, Erritzoe D, Carhart-Harris R", "journal": "Research square", "publication_date": "2025-08-22", "publication_year": 2025, "doi": "10.21203/rs.3.rs-7420529/v1", "pubmed_id": "40894046", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894046/", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40894046", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40894046/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40894046", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894046/", "doi": "10.21203/rs.3.rs-7420529/v1", "pmid": "40894046", "publication_date": "2025-08-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 561, "title": "Psychedelics and the Serotonin Hypothesis of Eating Disorders.", "authors": "Bilenker D, Avena NM", "journal": "Brain sciences", "publication_date": "2025-08-21", "publication_year": 2025, "doi": "10.3390/brainsci15080893", "pubmed_id": "40867224", "openalex_id": "https://openalex.org/W4413411862", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40867224/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40867224", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40867224/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40867224", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40867224/", "doi": "10.3390/brainsci15080893", "pmid": "40867224", "publication_date": "2025-08-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3466, "title": "A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05733546", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05733546", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "source_url": "https://clinicaltrials.gov/study/NCT05733546", "doi": "", "pmid": "", "publication_date": "2025-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3070, "title": "Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource", "authors": "Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD.", "journal": "medRxiv", "publication_date": "2025-08-16", "publication_year": 2025, "doi": "10.1101/2025.08.13.25333530", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.1101/2025.08.13.25333530", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.08.13.25333530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.08.13.25333530", "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "doi": "10.1101/2025.08.13.25333530", "pmid": "", "publication_date": "2025-08-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 565, "title": "Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.", "authors": "Repple J, Bayas M, Möser C, Kobayashi NF, Reif A", "journal": "Biological psychiatry", "publication_date": "2025-08-15", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.903", "pubmed_id": "40064389", "openalex_id": "https://openalex.org/W4408254485", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40064389/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40064389", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40064389/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40064389", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40064389/", "doi": "10.1016/j.biopsych.2025.02.903", "pmid": "40064389", "publication_date": "2025-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 567, "title": "Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.", "authors": "Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A", "journal": "Medical science monitor: international medical journal of experimental and clinical research", "publication_date": "2025-08-09", "publication_year": 2025, "doi": "10.12659/msm.948302", "pubmed_id": "40781763", "openalex_id": "https://openalex.org/W4411816478", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40781763/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40781763", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40781763/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40781763", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40781763/", "doi": "10.12659/msm.948302", "pmid": "40781763", "publication_date": "2025-08-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4316, "title": "Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders", "authors": "Harsha S. Krishna", "journal": "JUNIOR RESEARCHERS", "publication_date": "2025-08-08", "publication_year": 2025, "doi": "10.52340/jr.2025.03.03.09", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413142010", "source_url": "https://doi.org/10.52340/jr.2025.03.03.09", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Microbiome,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "DOI:10.52340/jr.2025.03.03.09", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.52340/jr.2025.03.03.09", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.52340/jr.2025.03.03.09", "source_url": "https://doi.org/10.52340/jr.2025.03.03.09", "doi": "10.52340/jr.2025.03.03.09", "pmid": "", "publication_date": "2025-08-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 568, "title": "The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal.", "authors": "Fernández-Borkel T, Borkel LF, Rojas-Hernández J, Hernández-Álvarez E, Quintana-Hernández DJ, Ponti LG, Henríquez-Hernández LA", "journal": "ACS pharmacology & translational science", "publication_date": "2025-08-08", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00445", "pubmed_id": "40894333", "openalex_id": "https://openalex.org/W4412475877", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894333/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Consciousness,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40894333", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40894333/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40894333", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894333/", "doi": "10.1021/acsptsci.5c00445", "pmid": "40894333", "publication_date": "2025-08-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 576, "title": "Latent Classes of Lifetime Use of Seven Hallucinogens in the United States.", "authors": "Meacham MC, Mian MN, Wang RC, Coker AR, Anderson BT, Montoy JCC", "journal": "Journal of psychoactive drugs", "publication_date": "2025-08-04", "publication_year": 2025, "doi": "10.1080/02791072.2025.2537040", "pubmed_id": "40760833", "openalex_id": "https://openalex.org/W4412950224", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40760833/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40760833", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40760833/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40760833", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40760833/", "doi": "10.1080/02791072.2025.2537040", "pmid": "40760833", "publication_date": "2025-08-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3235, "title": "229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL", "authors": "S Meikle, O Carter, P Liknaitzky, L Johansen, R Iyer, N Strauss, M Williams, D Castle, S Rossell", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359778", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359778", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359778", "source_url": "https://europepmc.org/article/PMC/PMC12359778", "doi": "", "pmid": "", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 594, "title": "Are \"mystical experiences\" essential for antidepressant actions of ketamine and the classic psychedelics?", "authors": "Hashimoto K", "journal": "European archives of psychiatry and clinical neuroscience", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1007/s00406-024-01770-7", "pubmed_id": "38411629", "openalex_id": "https://openalex.org/W4392193120", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38411629/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Mystical Experience,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:38411629", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38411629/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38411629", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38411629/", "doi": "10.1007/s00406-024-01770-7", "pmid": "38411629", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 588, "title": "Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.", "authors": "Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "Psychiatry research", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116559", "pubmed_id": "40440859", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440859/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40440859", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40440859/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40440859", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440859/", "doi": "10.1016/j.psychres.2025.116559", "pmid": "40440859", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 587, "title": "Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.", "authors": "Berkovitch L, Fauvel B, Preller KH, Gaillard R", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106239", "pubmed_id": "40456393", "openalex_id": "https://openalex.org/W4410910940", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40456393/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Healthy Volunteers", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40456393", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40456393/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40456393", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40456393/", "doi": "10.1016/j.neubiorev.2025.106239", "pmid": "40456393", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 583, "title": "Australia's psychedelic experiment: reflections from a psychiatrist clinical researcher.", "authors": "Bayes A", "journal": "Australasian psychiatry: bulletin of Royal Australian and New Zealand College of Psychiatrists", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1177/10398562251347890", "pubmed_id": "40574457", "openalex_id": "https://openalex.org/W4411736916", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40574457/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40574457", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40574457/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40574457", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40574457/", "doi": "10.1177/10398562251347890", "pmid": "40574457", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 580, "title": "Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.", "authors": "Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM", "journal": "Fundamental & clinical pharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1111/fcp.70038", "pubmed_id": "40670864", "openalex_id": "https://openalex.org/W4412489091", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40670864/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40670864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40670864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40670864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40670864/", "doi": "10.1111/fcp.70038", "pmid": "40670864", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 558, "title": "Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders:.", "authors": "Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1089/psymed.2024.0031", "pubmed_id": "40933206", "openalex_id": "https://openalex.org/W4406667777", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40933206/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40933206", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40933206/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40933206", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40933206/", "doi": "10.1089/psymed.2024.0031", "pmid": "40933206", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4335, "title": "577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES", "authors": "Hiroe Tani", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284846", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "doi": "10.1093/ijnp/pyaf052.377", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 597, "title": "Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.", "authors": "Cheung K, Brodie M, Chang SL, Deschamps P, Fallu JS, Farzin H, Hébert J, Stephan JF, Dorval M, Joly Y, P3A Study Group", "journal": "The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1017/jme.2025.10109", "pubmed_id": "40739983", "openalex_id": "https://openalex.org/W4412810429", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40739983/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40739983", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40739983/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40739983", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40739983/", "doi": "10.1017/jme.2025.10109", "pmid": "40739983", "publication_date": "2025-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4342, "title": "Preparing Social Work for Psychedelic-Assisted Therapy", "authors": "Heidi Allen, B. Stott", "journal": "Social Work", "publication_date": "2025-07-30", "publication_year": 2025, "doi": "10.1093/sw/swaf031", "pubmed_id": "40803340", "openalex_id": "https://openalex.org/W4413116433", "source_url": "https://doi.org/10.1093/sw/swaf031", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "PMID:40803340", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/sw/swaf031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40803340", "source_url": "https://doi.org/10.1093/sw/swaf031", "doi": "10.1093/sw/swaf031", "pmid": "40803340", "publication_date": "2025-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 598, "title": "Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.", "authors": "Modlin NL, Jessica L MK, Sarang M, Siebenaler L, Maggio C, Pick S, Williamson V, Cleare A, Rucker J", "journal": "Psychiatry and clinical psychopharmacology", "publication_date": "2025-07-30", "publication_year": 2025, "doi": "10.5152/pcp.2025.24934", "pubmed_id": "40864832", "openalex_id": "https://openalex.org/W4413381444", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40864832/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40864832", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40864832/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40864832", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40864832/", "doi": "10.5152/pcp.2025.24934", "pmid": "40864832", "publication_date": "2025-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 599, "title": "Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.", "authors": "Bevione F, Lacidogna MC, Lavalle R, Abbate Daga G, Preti A", "journal": "Eating and weight disorders: EWD", "publication_date": "2025-07-29", "publication_year": 2025, "doi": "10.1007/s40519-025-01771-y", "pubmed_id": "40730892", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40730892/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40730892", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40730892/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40730892", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40730892/", "doi": "10.1007/s40519-025-01771-y", "pmid": "40730892", "publication_date": "2025-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3424, "title": "Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-28", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05651126", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05651126", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05651126", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05651126", "source_url": "https://clinicaltrials.gov/study/NCT05651126", "doi": "", "pmid": "", "publication_date": "2025-07-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 602, "title": "Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.", "authors": "Luquiens A, Belahda D, Graux C, Igounenc N, Serrand C, Rochefort P, Mura T, Sergent F", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-07-24", "publication_year": 2025, "doi": "10.1111/add.70152", "pubmed_id": "40702912", "openalex_id": "https://openalex.org/W4412642858", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40702912/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40702912", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40702912/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40702912", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40702912/", "doi": "10.1111/add.70152", "pmid": "40702912", "publication_date": "2025-07-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 601, "title": "Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.", "authors": "Rodan SC, Meez N, Lloyd-Hurwitz S, Bedoya-Pérez MA, Suraev A, Sommer N, Greenstien K, Maguire S, McGregor IS", "journal": "Journal of eating disorders", "publication_date": "2025-07-24", "publication_year": 2025, "doi": "10.1186/s40337-025-01328-5", "pubmed_id": "40708053", "openalex_id": "https://openalex.org/W4412645629", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40708053/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Eating Disorders,Microdosing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40708053", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40708053/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40708053", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40708053/", "doi": "10.1186/s40337-025-01328-5", "pmid": "40708053", "publication_date": "2025-07-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3633, "title": "The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05506982", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05506982", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "source_url": "https://clinicaltrials.gov/study/NCT05506982", "doi": "", "pmid": "", "publication_date": "2025-07-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 608, "title": "Females in Psychedelic Research: A Perspective for Advancing Research and Practice.", "authors": "Cohen ZZ, Blest-Hopley G", "journal": "ACS pharmacology & translational science", "publication_date": "2025-07-11", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00255", "pubmed_id": "40672681", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40672681/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Receptor Pharmacology,Clinical Trial,Observational Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40672681", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40672681/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40672681", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40672681/", "doi": "10.1021/acsptsci.5c00255", "pmid": "40672681", "publication_date": "2025-07-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3313, "title": "Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies", "authors": "Rajwani K, Almonte MT, Feroz F, Hokanson J, Jacobs E, Savulescu J, Singh I, Yaden DB, Earp BD.", "journal": "Wellcome Open Res", "publication_date": "2025-07-08", "publication_year": 2025, "doi": "10.12688/wellcomeopenres.24181.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414213011", "source_url": "https://doi.org/10.12688/wellcomeopenres.24181.1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Observational Study,Adolescents", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.12688/wellcomeopenres.24181.1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.12688/wellcomeopenres.24181.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.12688/wellcomeopenres.24181.1", "source_url": "https://doi.org/10.12688/wellcomeopenres.24181.1", "doi": "10.12688/wellcomeopenres.24181.1", "pmid": "", "publication_date": "2025-07-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3216, "title": "Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging", "authors": "Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM.", "journal": "bioRxiv", "publication_date": "2025-07-03", "publication_year": 2025, "doi": "10.1101/2025.07.02.662710", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.07.02.662710", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:11", "bibtex": null, "source_record_id": "DOI:10.1101/2025.07.02.662710", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.07.02.662710", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.07.02.662710", "source_url": "https://doi.org/10.1101/2025.07.02.662710", "doi": "10.1101/2025.07.02.662710", "pmid": "", "publication_date": "2025-07-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 640, "title": "Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.", "authors": "Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS", "journal": "Psychopharmacology", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1007/s00213-024-06599-5", "pubmed_id": "38743110", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Mystical Experience,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:38743110", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38743110", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "doi": "10.1007/s00213-024-06599-5", "pmid": "38743110", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 633, "title": "Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "Pharmacopsychiatry", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1055/a-2529-7029", "pubmed_id": "40245934", "openalex_id": "https://openalex.org/W4409534321", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245934/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40245934", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40245934/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40245934", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245934/", "doi": "10.1055/a-2529-7029", "pmid": "40245934", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 629, "title": "Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.", "authors": "Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD", "journal": "Psychiatry research", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116532", "pubmed_id": "40354769", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40354769/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Clinical Trial,Systematic Review,Review Article,Case Report", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40354769", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40354769/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40354769", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40354769/", "doi": "10.1016/j.psychres.2025.116532", "pmid": "40354769", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 626, "title": "5-HT receptors: Pharmacology and functional selectivity.", "authors": "Cummins BR, Billac GB, Nichols DE, Nichols CD", "journal": "Pharmacological reviews", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.pharmr.2025.100059", "pubmed_id": "40418878", "openalex_id": "https://openalex.org/W4409723793", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40418878/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40418878", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40418878/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40418878", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40418878/", "doi": "10.1016/j.pharmr.2025.100059", "pmid": "40418878", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 618, "title": "Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.", "authors": "Hieronymus F, López E, Werin Sjögren H, Lundberg J", "journal": "JAMA network open", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1001/jamanetworkopen.2025.24119", "pubmed_id": "40736734", "openalex_id": "https://openalex.org/W4412738512", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40736734/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40736734", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40736734/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40736734", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40736734/", "doi": "10.1001/jamanetworkopen.2025.24119", "pmid": "40736734", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4356, "title": "Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics", "authors": "Mathieu Fradet", "journal": "Psychoactives", "publication_date": "2025-06-29", "publication_year": 2025, "doi": "10.3390/psychoactives4030021", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411824807", "source_url": "https://doi.org/10.3390/psychoactives4030021", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030021", "source_url": "https://doi.org/10.3390/psychoactives4030021", "doi": "10.3390/psychoactives4030021", "pmid": "", "publication_date": "2025-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 645, "title": "A Scoping Review of Research in Naturalistic Studies with Psychedelics.", "authors": "Carvalho LC, Encantado J, Kettner H, Timmermann C, Veiga D, Teixeira PJ", "journal": "Journal of psychoactive drugs", "publication_date": "2025-06-28", "publication_year": 2025, "doi": "10.1080/02791072.2025.2520221", "pubmed_id": "40581772", "openalex_id": "https://openalex.org/W4411777589", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40581772/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40581772", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40581772/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40581772", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40581772/", "doi": "10.1080/02791072.2025.2520221", "pmid": "40581772", "publication_date": "2025-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 652, "title": "Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.", "authors": "Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A", "journal": "ACS chemical neuroscience", "publication_date": "2025-06-18", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00152", "pubmed_id": "40474592", "openalex_id": "https://openalex.org/W4411103150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40474592/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40474592", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40474592/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40474592", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40474592/", "doi": "10.1021/acschemneuro.5c00152", "pmid": "40474592", "publication_date": "2025-06-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 654, "title": "Long-term benefits of single-dose psilocybin in depressed patients with cancer.", "authors": "Agrawal M, Roddy K, Jenkins B, Leeks C, Emanuel E", "journal": "Cancer", "publication_date": "2025-06-15", "publication_year": 2025, "doi": "10.1002/cncr.35889", "pubmed_id": "40518804", "openalex_id": "https://openalex.org/W4411327114", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518804/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40518804", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40518804/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40518804", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518804/", "doi": "10.1002/cncr.35889", "pmid": "40518804", "publication_date": "2025-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 656, "title": "Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.", "authors": "Erkizia-Santamaría I, Horrillo I, Martínez-Álvarez N, Pérez-Martínez D, Rivero G, Erdozain AM, Meana JJ, Ortega JE", "journal": "Translational psychiatry", "publication_date": "2025-06-14", "publication_year": 2025, "doi": "10.1038/s41398-025-03421-4", "pubmed_id": "40517150", "openalex_id": "https://openalex.org/W4411302754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40517150/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40517150", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40517150/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40517150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40517150/", "doi": "10.1038/s41398-025-03421-4", "pmid": "40517150", "publication_date": "2025-06-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 659, "title": "The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.", "authors": "Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL", "journal": "ACS pharmacology & translational science", "publication_date": "2025-06-13", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00208", "pubmed_id": "40534669", "openalex_id": "https://openalex.org/W4410859687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40534669/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40534669", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40534669/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40534669", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40534669/", "doi": "10.1021/acsptsci.5c00208", "pmid": "40534669", "publication_date": "2025-06-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3611, "title": "A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-12", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06643637", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06643637", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06643637", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06643637", "source_url": "https://clinicaltrials.gov/study/NCT06643637", "doi": "", "pmid": "", "publication_date": "2025-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4363, "title": "Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disorders", "authors": "Stephen Ross", "journal": "Psychedelics.", "publication_date": "2025-06-10", "publication_year": 2025, "doi": "10.61373/pp025k.0017", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411182514", "source_url": "https://doi.org/10.61373/pp025k.0017", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Adolescents,Cancer Patients,Genomics,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:20", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0017", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0017", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0017", "source_url": "https://doi.org/10.61373/pp025k.0017", "doi": "10.61373/pp025k.0017", "pmid": "", "publication_date": "2025-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3672, "title": "Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study", "authors": "Matthew Hicks", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06372197", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06372197", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "source_url": "https://clinicaltrials.gov/study/NCT06372197", "doi": "", "pmid": "", "publication_date": "2025-06-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3480, "title": "Optimizing Microdosing and Meditation", "authors": "National University of Natural Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06560658", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Microdosing,Wellbeing,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06560658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "source_url": "https://clinicaltrials.gov/study/NCT06560658", "doi": "", "pmid": "", "publication_date": "2025-06-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 681, "title": "Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.", "authors": "Becker AM, Humbert-Droz M, Mueller L, Jelušić A, Tolev A, Straumann I, Avedisian I, Erne L, Thomann J, Luethi D, Grünblatt E, Meyer Zu Schwabedissen H, Liechti ME", "journal": "Clinical pharmacology and therapeutics", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1002/cpt.3618", "pubmed_id": "40022427", "openalex_id": "https://openalex.org/W4408089698", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40022427/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40022427", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40022427/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40022427", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40022427/", "doi": "10.1002/cpt.3618", "pmid": "40022427", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 678, "title": "Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.", "authors": "Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH", "journal": "Expert opinion on emerging drugs", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1080/14728214.2025.2488786", "pubmed_id": "40178229", "openalex_id": "https://openalex.org/W4409148237", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40178229/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40178229", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40178229/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40178229", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40178229/", "doi": "10.1080/14728214.2025.2488786", "pmid": "40178229", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 677, "title": "Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.", "authors": "Meshkat S, Malik G, Zeifman RJ, Swainson J, Balachandra K, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Vermetten E, Mayo LM, Tanguay R, Jetly R, Bhat V", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106163", "pubmed_id": "40245969", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245969/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Aging,Microdosing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40245969", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40245969/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40245969", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245969/", "doi": "10.1016/j.neubiorev.2025.106163", "pmid": "40245969", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 649, "title": "The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.", "authors": "Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S", "journal": "Cureus", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.7759/cureus.86659", "pubmed_id": "40718283", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40718283/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Clinical Trial,Review Article,In Vitro Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40718283", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40718283/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40718283", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40718283/", "doi": "10.7759/cureus.86659", "pmid": "40718283", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3069, "title": "Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population", "authors": "Fitzgerald PB, Webb SL, Denning NC, Dowie T, Schweickle MM, Modak A, Chan G, Knight J, Waldron M, Gainsford K, Hawkes H, Zammit S, Sutanto NC, Fitzgibbon BM, Bailey NW.", "journal": "medRxiv", "publication_date": "2025-05-29", "publication_year": 2025, "doi": "10.1101/2025.05.28.25328532", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.05.28.25328532", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Mystical Experience,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.1101/2025.05.28.25328532", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.05.28.25328532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.05.28.25328532", "source_url": "https://doi.org/10.1101/2025.05.28.25328532", "doi": "10.1101/2025.05.28.25328532", "pmid": "", "publication_date": "2025-05-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 689, "title": "The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.", "authors": "Palmer C, Ferber AT, Greenwald BD", "journal": "Brain sciences", "publication_date": "2025-05-26", "publication_year": 2025, "doi": "10.3390/brainsci15060572", "pubmed_id": "40563744", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40563744/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Clinical Trial,Review Article,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40563744", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40563744/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40563744", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40563744/", "doi": "10.3390/brainsci15060572", "pmid": "40563744", "publication_date": "2025-05-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 693, "title": "In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes.", "authors": "Schäfer T, Sherwood A, Kirkland T, Krüger T, Worbs J, Kniemeyer O, Gressler M, Hoffmeister D", "journal": "Chemistry (Weinheim an der Bergstrasse, Germany)", "publication_date": "2025-05-22", "publication_year": 2025, "doi": "10.1002/chem.202501037", "pubmed_id": "40202903", "openalex_id": "https://openalex.org/W4409288174", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40202903/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40202903", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40202903/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40202903", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40202903/", "doi": "10.1002/chem.202501037", "pmid": "40202903", "publication_date": "2025-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5798, "title": "Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review", "authors": "Ritika Jagdeep Shah, Ashish Sarangi", "journal": "Alcoholism Treatment Quarterly", "publication_date": "2025-05-02", "publication_year": 2025, "doi": "10.1080/07347324.2025.2500345", "pubmed_id": null, "openalex_id": "https://openalex.org/W4410043539", "source_url": "https://doi.org/10.1080/07347324.2025.2500345", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:20", "last_checked": "2026-08-09 08:25:20", "bibtex": null, "source_record_id": "DOI:10.1080/07347324.2025.2500345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/07347324.2025.2500345", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/07347324.2025.2500345", "source_url": "https://doi.org/10.1080/07347324.2025.2500345", "doi": "10.1080/07347324.2025.2500345", "pmid": "", "publication_date": "2025-05-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 722, "title": "Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.", "authors": "Liebnau J, Betzler F, Kerber A", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1177/02698811241312866", "pubmed_id": "39829391", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39829391/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39829391", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39829391/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39829391", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39829391/", "doi": "10.1177/02698811241312866", "pmid": "39829391", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 712, "title": "Psilocybin for disorders of consciousness: A case-report study.", "authors": "Cardone P, Núñez P, Alnagger NLN, Martial C, van der Lande GJM, Sandell R, Carhart-Harris R, Gosseries O", "journal": "Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1016/j.clinph.2025.02.264", "pubmed_id": "40147181", "openalex_id": "https://openalex.org/W4408252744", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40147181/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Clinical Trial,Case Report,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40147181", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40147181/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40147181", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40147181/", "doi": "10.1016/j.clinph.2025.02.264", "pmid": "40147181", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 708, "title": "Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.", "authors": "Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1038/s41386-025-02091-6", "pubmed_id": "40258990", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40258990/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40258990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40258990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40258990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40258990/", "doi": "10.1038/s41386-025-02091-6", "pmid": "40258990", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 706, "title": "Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.", "authors": "Weintraub MJ, Miklowitz DJ, Jeffrey JK", "journal": "Journal of psychiatric practice", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1097/pra.0000000000000853", "pubmed_id": "40440674", "openalex_id": "https://openalex.org/W4410847086", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440674/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40440674", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40440674/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40440674", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440674/", "doi": "10.1097/pra.0000000000000853", "pmid": "40440674", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4382, "title": "The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review", "authors": "Sevander Saara Susan, Rissanen Marja-Liisa Susan", "journal": "Health, environment and sustainable development: interdisciplinary approach", "publication_date": "2025-04-30", "publication_year": 2025, "doi": "10.59476/hesdia.v0i1.700", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411419984", "source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:34:58", "bibtex": null, "source_record_id": "DOI:10.59476/hesdia.v0i1.700", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.59476/hesdia.v0i1.700", "source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "doi": "10.59476/hesdia.v0i1.700", "pmid": "", "publication_date": "2025-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 732, "title": "[Treatment with psychedelics: potential benefits in Parkinson's disease].", "authors": "Penzenstadler L, Baudois S, Lingenberg A, Catalano Chiuvé S, Tomkova E, Fleury V", "journal": "Revue medicale suisse", "publication_date": "2025-04-23", "publication_year": 2025, "doi": "10.53738/revmed.2025.21.915.47180", "pubmed_id": "40275842", "openalex_id": "https://openalex.org/W4409833807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40275842", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40275842", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842/", "doi": "10.53738/revmed.2025.21.915.47180", "pmid": "40275842", "publication_date": "2025-04-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3465, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia", "authors": "Kevin Boehnke", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05128162", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05128162", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "source_url": "https://clinicaltrials.gov/study/NCT05128162", "doi": "", "pmid": "", "publication_date": "2025-04-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 739, "title": "Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.", "authors": "Beesley VL, Kennedy TJ, Maccallum F, Ross M, Harvey R, Rossell SL, Sarris J, Perkins D, Neale RE, Bennett-Levy J, Johnson S, Beebe H, Roset N, Strobel J, Parker S", "journal": "BMJ open", "publication_date": "2025-04-15", "publication_year": 2025, "doi": "10.1136/bmjopen-2024-095992", "pubmed_id": "40233965", "openalex_id": "https://openalex.org/W4409449177", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40233965/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Psychological Flexibility,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40233965", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40233965/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40233965", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40233965/", "doi": "10.1136/bmjopen-2024-095992", "pmid": "40233965", "publication_date": "2025-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 742, "title": "Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.", "authors": "Ardini M, Angelucci F, Rea F, Paluzzi L, Gabriele F, Palerma M, Di Leandro L, Ippoliti R, Pitari G", "journal": "Biology direct", "publication_date": "2025-04-10", "publication_year": 2025, "doi": "10.1186/s13062-025-00632-z", "pubmed_id": "40211327", "openalex_id": "https://openalex.org/W4409331415", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40211327/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Epigenetics,Spirituality,Clinical Trial,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40211327", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40211327/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40211327", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40211327/", "doi": "10.1186/s13062-025-00632-z", "pmid": "40211327", "publication_date": "2025-04-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5800, "title": "188. Mapping Psilocybin Therapy: A Systematic Review of Therapeutic Frameworks, Adaptations, and Standardization Across Contemporary Clinical Trials", "authors": "Mary E. Kittur, L. Martínez, Brett D. M. Jones, Daniel M. Blumberger, Benoit H. Mulsant, Joshua D. Rosenblat, Ishrat Husain", "journal": "Biological Psychiatry", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.425", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409280622", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.425", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:21", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.425", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.425", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.425", "doi": "10.1016/j.biopsych.2025.02.425", "pmid": "", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4400, "title": "187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant Depression", "authors": "Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat", "journal": "Biological Psychiatry", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.424", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409281325", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.424", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.424", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.424", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.424", "doi": "10.1016/j.biopsych.2025.02.424", "pmid": "", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3446, "title": "Psilocybin-assisted Interpersonal Therapy for Depression", "authors": "University of Otago", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-09", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05581797", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05581797", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05581797", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05581797", "source_url": "https://clinicaltrials.gov/study/NCT05581797", "doi": "", "pmid": "", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 745, "title": "The Emergence of Psilocybin in Psychiatry and Neuroscience.", "authors": "Omidian H, Omidian A", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.3390/ph18040555", "pubmed_id": "40283990", "openalex_id": "https://openalex.org/W4409313347", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40283990/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40283990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40283990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40283990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40283990/", "doi": "10.3390/ph18040555", "pmid": "40283990", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4404, "title": "Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization", "authors": "Jennifer Jones", "journal": "Frontiers in Psychiatry", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1565852", "pubmed_id": "40264517", "openalex_id": "https://openalex.org/W4409274889", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Animal Study,Veterans,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "PMID:40264517", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40264517", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "doi": "10.3389/fpsyt.2025.1565852", "pmid": "40264517", "publication_date": "2025-04-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4405, "title": "Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)", "authors": "Emmanuelle A. D. Schindler, Christopher Gottschalk, Deepak Cyril D’Souza", "journal": "Neurology", "publication_date": "2025-04-07", "publication_year": 2025, "doi": "10.1212/wnl.0000000000210945", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409228190", "source_url": "https://doi.org/10.1212/wnl.0000000000210945", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.1212/wnl.0000000000210945", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1212/wnl.0000000000210945", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1212/wnl.0000000000210945", "source_url": "https://doi.org/10.1212/wnl.0000000000210945", "doi": "10.1212/wnl.0000000000210945", "pmid": "", "publication_date": "2025-04-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4421, "title": "Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial", "authors": "Nathalie M. Rieser, Raoul Bitar, Simon Halm, Christina Rossgoderer, Ladina P Gubser, Maeva Thévenaz, Yara Kreis, Robin von Rotz, Carlos Nordt, Monika Visentini, Flora Moujaes, Etna Engeli, Andres Ort, Erich Seifritz, Franz Xaver Vollenweider, Marcus Herdener, Katrin H. Preller", "journal": "Universität Zürich, ZORA", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.5167/uzh-284304", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127080333", "source_url": "https://doi.org/10.5167/uzh-284304", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.5167/uzh-284304", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5167/uzh-284304", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5167/uzh-284304", "source_url": "https://doi.org/10.5167/uzh-284304", "doi": "10.5167/uzh-284304", "pmid": "", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4420, "title": "Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders", "authors": "Ioana A. Cristea, G Tomei, Jazmín Freddi, A. Bonessio", "journal": "European Psychiatry", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1192/j.eurpsy.2025.393", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414208490", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2025.393", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2025.393", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "doi": "10.1192/j.eurpsy.2025.393", "pmid": "", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 754, "title": "Psilocybin Dispensaries and Online Health Claims in Canada.", "authors": "Matsukubo J, Dickson S, Xiao J, Friesen EL, Solmi M, Fiedorowicz JG, Fischer B, Myran DT", "journal": "JAMA network open", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1001/jamanetworkopen.2025.2853", "pubmed_id": "40168023", "openalex_id": "https://openalex.org/W4409086968", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40168023/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40168023", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40168023/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40168023", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40168023/", "doi": "10.1001/jamanetworkopen.2025.2853", "pmid": "40168023", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 737, "title": "Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.", "authors": "Mimms C, Sotelo K, Khaliq AS", "journal": "Cureus", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.7759/cureus.82532", "pubmed_id": "40385821", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40385821/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40385821", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40385821/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40385821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40385821/", "doi": "10.7759/cureus.82532", "pmid": "40385821", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3635, "title": "Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN", "authors": "Unity Health Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-30", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731335", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731335", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731335", "source_url": "https://clinicaltrials.gov/study/NCT06731335", "doi": "", "pmid": "", "publication_date": "2025-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3544, "title": "An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study", "authors": "McMaster University", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06225232", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06225232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06225232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06225232", "source_url": "https://clinicaltrials.gov/study/NCT06225232", "doi": "", "pmid": "", "publication_date": "2025-03-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3457, "title": "Psilocybin in Alcohol Use Disorder With Comorbid Depression", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06235411", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Observational Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06235411", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "source_url": "https://clinicaltrials.gov/study/NCT06235411", "doi": "", "pmid": "", "publication_date": "2025-03-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 781, "title": "Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.", "authors": "Meyer TD, Ibrahim M, Vale LN, Soares JC", "journal": "Journal of affective disorders", "publication_date": "2025-03-15", "publication_year": 2025, "doi": "10.1016/j.jad.2024.12.044", "pubmed_id": "39675677", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39675677/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:39675677", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39675677/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39675677", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39675677/", "doi": "10.1016/j.jad.2024.12.044", "pmid": "39675677", "publication_date": "2025-03-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3666, "title": "Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05523401", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05523401", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "source_url": "https://clinicaltrials.gov/study/NCT05523401", "doi": "", "pmid": "", "publication_date": "2025-03-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 788, "title": "Further education in psychedelic-assisted therapy - experiences from Switzerland.", "authors": "Aicher HD, Müller F, Gasser P", "journal": "BMC medical education", "publication_date": "2025-03-05", "publication_year": 2025, "doi": "10.1186/s12909-025-06871-y", "pubmed_id": "40045361", "openalex_id": "https://openalex.org/W4408219591", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40045361/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Consciousness,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40045361", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40045361/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40045361", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40045361/", "doi": "10.1186/s12909-025-06871-y", "pmid": "40045361", "publication_date": "2025-03-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4433, "title": "Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?", "authors": "Craig, Danny R, Blalock, Eric M.", "journal": "UKnowledge (University of Kentucky)", "publication_date": "2025-03-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110662772", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Cellular Senescence,Resilience,Clinical Trial,Randomized Controlled Trial,Animal Study,Older Adults,Adolescents,Treatment-Resistant Depression,Safety,Drug Interactions,Transcriptomics,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "doi": "", "pmid": "", "publication_date": "2025-03-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 811, "title": "Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.", "authors": "Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M", "journal": "Molecular psychiatry", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1038/s41380-024-02800-5", "pubmed_id": "39592825", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39592825/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39592825", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39592825/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39592825", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39592825/", "doi": "10.1038/s41380-024-02800-5", "pmid": "39592825", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 807, "title": "Elucidating the Phase I metabolism of psilocin in vitro", "authors": "Chen Junqi, Wang Ziteng, Yong Ching Yee, Goh Evelyn Mei Ling, Moy Hooi Yan, Chan Eric Chun Yong", "journal": "Archives of Toxicology", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1007/s00204-024-03952-7", "pubmed_id": "39751877", "openalex_id": "https://openalex.org/W4406036520", "source_url": "https://doi.org/10.1007/s00204-024-03952-7", "substance_tags": "psilocin", "topic_tags": "Pharmacology,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:39751877", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1007/s00204-024-03952-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:39751877", "source_url": "https://doi.org/10.1007/s00204-024-03952-7", "doi": "10.1007/s00204-024-03952-7", "pmid": "39751877", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 806, "title": "A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.", "authors": "Haft SL, Downey AE, Raymond-Flesch M, Fernandes-Osterhold G, Bradley ER, O'Donovan A, Woolley J", "journal": "Psychiatry research", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116359", "pubmed_id": "39823947", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39823947/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:39823947", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39823947/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39823947", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39823947/", "doi": "10.1016/j.psychres.2025.116359", "pmid": "39823947", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 797, "title": "Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.", "authors": "Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB", "journal": "Cancer medicine", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1002/cam4.70586", "pubmed_id": "40052631", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40052631/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40052631", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40052631/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40052631", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40052631/", "doi": "10.1002/cam4.70586", "pmid": "40052631", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 796, "title": "Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder.", "authors": "Gold ND, Pagni BA, Petridis PD, Bogenschutz MP", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1089/psymed.2024.0030", "pubmed_id": "40337752", "openalex_id": "https://openalex.org/W4404701866", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337752/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Consciousness,Personality Change,Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40337752", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40337752/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40337752", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337752/", "doi": "10.1089/psymed.2024.0030", "pmid": "40337752", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 795, "title": "Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.", "authors": "Modlin NL, McPhee T, Zazon N, Sarang M, Hignett R, Pick S, Cleare A, Williamson V, Rucker J", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1089/psymed.2024.0027", "pubmed_id": "40337755", "openalex_id": "https://openalex.org/W4404743266", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337755/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40337755", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40337755/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40337755", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337755/", "doi": "10.1089/psymed.2024.0027", "pmid": "40337755", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3764, "title": "Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample", "authors": "Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H.", "journal": "PsyArXiv", "publication_date": "2025-02-28", "publication_year": 2025, "doi": "10.31234/osf.io/26tz7_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/26tz7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/26tz7_v1", "source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "doi": "10.31234/osf.io/26tz7_v1", "pmid": "", "publication_date": "2025-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3196, "title": "Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample", "authors": "Dan Petrovitch, Samuel Hosford, Andrew K. Littlefield, Heather Austin-Robillard", "journal": "PsyArXiv", "publication_date": "2025-02-28", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/26tz7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/26tz7_v1", "source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "doi": "", "pmid": "", "publication_date": "2025-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4436, "title": "Psychedelics are Bringing a new wind to the Pharmacopoeia", "authors": "Michel Bourin", "journal": "Neuroscience and Neurological Surgery", "publication_date": "2025-02-27", "publication_year": 2025, "doi": "10.31579/2578-8868/360", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409567580", "source_url": "https://doi.org/10.31579/2578-8868/360", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "DOI:10.31579/2578-8868/360", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31579/2578-8868/360", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31579/2578-8868/360", "source_url": "https://doi.org/10.31579/2578-8868/360", "doi": "10.31579/2578-8868/360", "pmid": "", "publication_date": "2025-02-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 824, "title": "A qualitative analysis of the psychedelic mushroom come-up and come-down.", "authors": "Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL", "journal": "Npj mental health research", "publication_date": "2025-02-07", "publication_year": 2025, "doi": "10.1038/s44184-024-00095-6", "pubmed_id": "39915687", "openalex_id": "https://openalex.org/W4407207411", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39915687/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39915687", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39915687/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39915687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39915687/", "doi": "10.1038/s44184-024-00095-6", "pmid": "39915687", "publication_date": "2025-02-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 826, "title": "Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.", "authors": "Lucido MJ, Dunlop BW", "journal": "Brain sciences", "publication_date": "2025-02-06", "publication_year": 2025, "doi": "10.3390/brainsci15020161", "pubmed_id": "40002494", "openalex_id": "https://openalex.org/W4407195838", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40002494/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:40002494", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40002494/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40002494", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40002494/", "doi": "10.3390/brainsci15020161", "pmid": "40002494", "publication_date": "2025-02-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 825, "title": "The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.", "authors": "Hogea L, Tabugan DC, Costea I, Albai O, Nussbaum L, Cojocaru A, Corsaro L, Anghel T", "journal": "Medicina (Kaunas, Lithuania)", "publication_date": "2025-02-06", "publication_year": 2025, "doi": "10.3390/medicina61020278", "pubmed_id": "40005395", "openalex_id": "https://openalex.org/W4407224460", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40005395/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:40005395", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40005395/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40005395", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40005395/", "doi": "10.3390/medicina61020278", "pmid": "40005395", "publication_date": "2025-02-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 828, "title": "Psychological Support Approaches in Psychedelic Therapy: Results From a Survey of Psychedelic Practitioners.", "authors": "Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ", "journal": "The Journal of clinical psychiatry", "publication_date": "2025-02-05", "publication_year": 2025, "doi": "10.4088/jcp.24m15521", "pubmed_id": "39928849", "openalex_id": "https://openalex.org/W4407154479", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39928849/", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Spirituality,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39928849", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39928849/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39928849", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39928849/", "doi": "10.4088/jcp.24m15521", "pmid": "39928849", "publication_date": "2025-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 830, "title": "Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.", "authors": "de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL", "journal": "Expert opinion on drug discovery", "publication_date": "2025-02-03", "publication_year": 2025, "doi": "10.1080/17460441.2025.2460674", "pubmed_id": "39885729", "openalex_id": "https://openalex.org/W4407044130", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39885729/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39885729", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39885729/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39885729", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39885729/", "doi": "10.1080/17460441.2025.2460674", "pmid": "39885729", "publication_date": "2025-02-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4452, "title": "Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco Addiction", "authors": "Matthew Weirick Johnson", "journal": "Drug and Alcohol Dependence", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1016/j.drugalcdep.2024.112187", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407077022", "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112187", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2024.112187", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2024.112187", "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112187", "doi": "10.1016/j.drugalcdep.2024.112187", "pmid": "", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 837, "title": "The safety of psilocybin-assisted psychotherapy: A systematic review.", "authors": "Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1177/00048674241289024", "pubmed_id": "39670342", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39670342/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39670342", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39670342/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39670342", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39670342/", "doi": "10.1177/00048674241289024", "pmid": "39670342", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 835, "title": "Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.", "authors": "Geller J, Whitney E", "journal": "Current psychiatry reports", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1007/s11920-024-01577-2", "pubmed_id": "39699759", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699759/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Aging,Clinical Trial,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39699759", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39699759/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39699759", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699759/", "doi": "10.1007/s11920-024-01577-2", "pmid": "39699759", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 833, "title": "Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "Psychiatry research", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2024.116337", "pubmed_id": "39754904", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39754904/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39754904", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39754904/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39754904", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39754904/", "doi": "10.1016/j.psychres.2024.116337", "pmid": "39754904", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 846, "title": "Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.", "authors": "Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-01-30", "publication_year": 2025, "doi": "10.1111/add.16762", "pubmed_id": "39887551", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39887551/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39887551", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39887551/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39887551", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39887551/", "doi": "10.1111/add.16762", "pmid": "39887551", "publication_date": "2025-01-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3679, "title": "A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression", "authors": "Central Institute of Mental Health, Mannheim", "journal": "ClinicalTrials.gov", "publication_date": "2025-01-20", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04670081", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04670081", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "source_url": "https://clinicaltrials.gov/study/NCT04670081", "doi": "", "pmid": "", "publication_date": "2025-01-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 854, "title": "Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.", "authors": "Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2025-01-19", "publication_year": 2025, "doi": "10.3390/ph18010130", "pubmed_id": "39861191", "openalex_id": "https://openalex.org/W4406629036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39861191/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Emotional Processing,Spirituality,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39861191", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39861191/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39861191", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39861191/", "doi": "10.3390/ph18010130", "pmid": "39861191", "publication_date": "2025-01-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 867, "title": "The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.", "authors": "Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2024.111139", "pubmed_id": "39251080", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39251080/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Receptor Pharmacology,Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,In Vitro Study,Safety,Inflammation,Immune Function", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39251080", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39251080/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39251080", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39251080/", "doi": "10.1016/j.pnpbp.2024.111139", "pmid": "39251080", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 863, "title": "Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.", "authors": "Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111249", "pubmed_id": "39778644", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39778644/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39778644", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39778644/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39778644", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39778644/", "doi": "10.1016/j.pnpbp.2025.111249", "pmid": "39778644", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 862, "title": "Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.", "authors": "Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111251", "pubmed_id": "39788410", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39788410/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39788410", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39788410/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39788410", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39788410/", "doi": "10.1016/j.pnpbp.2025.111251", "pmid": "39788410", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3201, "title": "Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment", "authors": "Socoró Garrigosa M, Sanz Perl Y, Kringelbach ML, Carhart-Harris R, Vohryzek J, Deco G.", "journal": "bioRxiv", "publication_date": "2025-01-02", "publication_year": 2025, "doi": "10.1101/2025.01.01.631011", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.01.01.631011", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.1101/2025.01.01.631011", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.01.01.631011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.01.01.631011", "source_url": "https://doi.org/10.1101/2025.01.01.631011", "doi": "10.1101/2025.01.01.631011", "pmid": "", "publication_date": "2025-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5840, "title": "Exploring the therapeutic potential of psychedelics: Fear extinction mechanisms and amygdala modulation.", "authors": "Kelly TJ, Liu QS", "journal": "Psychedelics", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.61373/pp024b.0019", "pubmed_id": "42440716", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42440716/", "substance_tags": "psilocybin,psilocin", "topic_tags": "PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-08-09 08:28:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:42440716", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42440716/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42440716", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42440716/", "doi": "10.61373/pp024b.0019", "pmid": "42440716", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5688, "title": "[Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?].", "authors": "Papp N, Gonda X", "journal": "Psychiatria Hungarica: A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata", "publication_date": "2025-01-01", "publication_year": 2025, "doi": null, "pubmed_id": "42412648", "openalex_id": "https://openalex.org/W7167746766", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42412648/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-11 19:28:10", "last_checked": "2026-08-09 08:34:30", "bibtex": null, "source_record_id": "PMID:42412648", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42412648/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42412648", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42412648/", "doi": "", "pmid": "42412648", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4484, "title": "Alternative therapy for neurological and psychiatric disorders using psilocybin", "authors": "Machado Henrique Tofoli Vieira, Seixas Geovana Mendes de, Silva Luis Gustavo Alves, Brito Mariana Duarte Garcia, Castro Giovanna Miziara", "journal": "São Paulo Medical Journal", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.5327/1516-3180.cpn.1123", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417514861", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Wellbeing,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:35:10", "bibtex": null, "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "doi": "10.5327/1516-3180.cpn.1123", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 909, "title": "Practical considerations in the establishment of psychedelic research programs.", "authors": "Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS", "journal": "Psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1007/s00213-024-06722-6", "pubmed_id": "39627438", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39627438/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39627438", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39627438/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39627438", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39627438/", "doi": "10.1007/s00213-024-06722-6", "pmid": "39627438", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 906, "title": "Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.", "authors": "Kirlić N, Lennard-Jones M, Atli M, Malievskaia E, Modlin NL, Peck SK, Gaillard A, Goodwin GM, Koelpin D", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20230884", "pubmed_id": "39741434", "openalex_id": "https://openalex.org/W4405978092", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741434/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741434", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741434/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741434", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741434/", "doi": "10.1176/appi.ajp.20230884", "pmid": "39741434", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 904, "title": "Psilocybin: From Psychiatric Pariah to Perceived Panacea.", "authors": "Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20230682", "pubmed_id": "39741437", "openalex_id": "https://openalex.org/W4405978069", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741437/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Eating Disorders,Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741437", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741437/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741437", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741437/", "doi": "10.1176/appi.ajp.20230682", "pmid": "39741437", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 903, "title": "Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.", "authors": "Ramaekers JG, Reckweg JT, Mason NL", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20230890", "pubmed_id": "39741439", "openalex_id": "https://openalex.org/W4405955623", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741439/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741439", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741439/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741439", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741439/", "doi": "10.1176/appi.ajp.20230890", "pmid": "39741439", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 900, "title": "Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.", "authors": "Pagni BA, Zeifman RJ, Mennenga SE, Carrithers BM, Goldway N, Bhatt S, O'Donnell KC, Ross S, Bogenschutz MP", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20230887", "pubmed_id": "39741446", "openalex_id": "https://openalex.org/W4405955644", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741446/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Personality Change,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741446", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741446/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741446", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741446/", "doi": "10.1176/appi.ajp.20230887", "pmid": "39741446", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 899, "title": "Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.", "authors": "Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM", "journal": "Clinical neuropharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1097/wnf.0000000000000617", "pubmed_id": "39787428", "openalex_id": "https://openalex.org/W4405922737", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39787428/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article,Healthy Volunteers,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39787428", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39787428/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39787428", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39787428/", "doi": "10.1097/wnf.0000000000000617", "pmid": "39787428", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 898, "title": "Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial.", "authors": "Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL", "journal": "medRxiv: the preprint server for health sciences", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1101/2024.12.31.24319806", "pubmed_id": "39802794", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39802794/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39802794", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39802794/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39802794", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39802794/", "doi": "10.1101/2024.12.31.24319806", "pmid": "39802794", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 892, "title": "Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.", "authors": "Bires J", "journal": "Journal of psychosocial oncology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/07347332.2025.2482917", "pubmed_id": "40138527", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40138527/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40138527", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40138527/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40138527", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40138527/", "doi": "10.1080/07347332.2025.2482917", "pmid": "40138527", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 886, "title": "Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?", "authors": "Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.002", "pubmed_id": "40541311", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541311/", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Chronic Pain,Pharmacology,Microdosing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541311", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541311/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541311", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541311/", "doi": "10.1016/bs.irn.2025.03.002", "pmid": "40541311", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 885, "title": "Serotonergic psychedelics for depression: A comprehensive overview.", "authors": "Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.04.009", "pubmed_id": "40541312", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541312/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541312", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541312/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541312", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541312/", "doi": "10.1016/bs.irn.2025.04.009", "pmid": "40541312", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 884, "title": "Psychedelics and substance use disorder treatment.", "authors": "DuPont CM, Johnson MW", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.005", "pubmed_id": "40541314", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541314/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541314", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541314/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541314", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541314/", "doi": "10.1016/bs.irn.2025.03.005", "pmid": "40541314", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 883, "title": "Post-traumatic stress disorder in psychedelic research.", "authors": "Bostoen T, Tap S, Breeksema J, Schoevers R", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.02.004", "pubmed_id": "40541315", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541315/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541315", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541315/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541315", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541315/", "doi": "10.1016/bs.irn.2025.02.004", "pmid": "40541315", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 881, "title": "Clinical pharmacology.", "authors": "Vogt SB, Liechti ME", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.02.003", "pubmed_id": "40541320", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541320/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541320", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541320/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541320", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541320/", "doi": "10.1016/bs.irn.2025.02.003", "pmid": "40541320", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 827, "title": "Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy.", "authors": "Zamaria JA, Fernandes-Osterhold G, Shedler J, Yehuda R", "journal": "Frontiers in psychology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1505894", "pubmed_id": "39973948", "openalex_id": "https://openalex.org/W4407181198", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39973948/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39973948", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39973948/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39973948", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39973948/", "doi": "10.3389/fpsyg.2025.1505894", "pmid": "39973948", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 815, "title": "A review of psychedelics trials completed in depression, informed by European regulatory perspectives.", "authors": "Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P", "journal": "Neuroscience applied", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105516", "pubmed_id": "40654583", "openalex_id": "https://openalex.org/W4407959310", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40654583/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:40654583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40654583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40654583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40654583/", "doi": "10.1016/j.nsa.2025.105516", "pmid": "40654583", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 664, "title": "Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.", "authors": "Roseby W, Kettner H, Roseman L, Spriggs MJ, Lyons T, Peill J, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris RL", "journal": "Frontiers in psychology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1580663", "pubmed_id": "40547590", "openalex_id": "https://openalex.org/W4411107182", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40547590/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40547590", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40547590/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40547590", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40547590/", "doi": "10.3389/fpsyg.2025.1580663", "pmid": "40547590", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 575, "title": "Therapeutic and legal aspects of psilocybin in cancer-related depression.", "authors": "Małgorzata W, Kopczyk R, Gerlach A, Rymaszewska J", "journal": "Frontiers in psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1591864", "pubmed_id": "40831528", "openalex_id": "https://openalex.org/W4412939048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40831528/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40831528", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40831528/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40831528", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40831528/", "doi": "10.3389/fpsyt.2025.1591864", "pmid": "40831528", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 553, "title": "Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (): A Systematic Review.", "authors": "Thaoboonruang N, Lohitnavy M, Lohitnavy O", "journal": "Journal of psychoactive drugs", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/02791072.2024.2399128", "pubmed_id": "39257234", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39257234/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:39257234", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39257234/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39257234", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39257234/", "doi": "10.1080/02791072.2024.2399128", "pmid": "39257234", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 534, "title": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.", "authors": "Ludbrook G, Bryson N, Taylor B, Hocevar-Trnka J, Johnson MW, Hirman J, Morrish G, Alexander R, Pollack M", "journal": "Journal of clinical psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1097/jcp.0000000000002047", "pubmed_id": "40685873", "openalex_id": "https://openalex.org/W4412513351", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40685873/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Pharmacology,Mystical Experience,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40685873", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40685873/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40685873", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40685873/", "doi": "10.1097/jcp.0000000000002047", "pmid": "40685873", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 530, "title": "Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial.", "authors": "Ross ML, Iyer R, Williams ML, Boughey M, O'Callaghan C, Hiscock R, Dwyer J", "journal": "General hospital psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.08.001", "pubmed_id": "40858059", "openalex_id": "https://openalex.org/W4413190735", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40858059/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40858059", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40858059/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40858059", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40858059/", "doi": "10.1016/j.genhosppsych.2025.08.001", "pmid": "40858059", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 494, "title": "Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.", "authors": "Cheung K, Propes C, Graziosi M, Patch K, Yaden DB", "journal": "AJOB empirical bioethics", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/23294515.2025.2526339", "pubmed_id": "40668936", "openalex_id": "https://openalex.org/W4412488390", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40668936/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40668936", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40668936/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40668936", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40668936/", "doi": "10.1080/23294515.2025.2526339", "pmid": "40668936", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 483, "title": "Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial.", "authors": "Meikle S, Carter O, Liknaitzky P, Johansen L, Iyer R, Strauss N, Williams M, Castle D, Rossell SL", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251377187", "pubmed_id": "41050149", "openalex_id": "https://openalex.org/W4414745551", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41050149/", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41050149", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41050149/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41050149", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41050149/", "doi": "10.1177/20451253251377187", "pmid": "41050149", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 473, "title": "Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.", "authors": "Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251384513", "pubmed_id": "41122434", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41122434/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41122434", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41122434/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41122434", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41122434/", "doi": "10.1177/20451253251384513", "pmid": "41122434", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 455, "title": "Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders.", "authors": "Havlik JL, Isaac S, Raman P, Tran N, Hidalgo K, Suppes T", "journal": "Journal of clinical psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1097/jcp.0000000000002095", "pubmed_id": "40994136", "openalex_id": "https://openalex.org/W4414528095", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40994136/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Emotional Processing,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40994136", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40994136/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40994136", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40994136/", "doi": "10.1097/jcp.0000000000002095", "pmid": "40994136", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 450, "title": "Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.", "authors": "Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders J, Ljuslin M, Guérin B, Sholevar R, Roddy K, Tulsky JA, Agrawal M", "journal": "General hospital psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.10.010", "pubmed_id": "41109203", "openalex_id": "https://openalex.org/W4415081303", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41109203/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41109203", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41109203/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41109203", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41109203/", "doi": "10.1016/j.genhosppsych.2025.10.010", "pmid": "41109203", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 435, "title": "The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.", "authors": "McHerron D, Barber M, Ham R, Liknaitzky P, Carter A, Gardner J", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251377191", "pubmed_id": "41244962", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41244962/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41244962", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41244962/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41244962", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41244962/", "doi": "10.1177/20451253251377191", "pmid": "41244962", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 378, "title": "Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey.", "authors": "Afsharnia S, Liang V, Lunsky Y, Orsini AP, Tint A, Lin HY", "journal": "PLOS mental health", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1371/journal.pmen.0000514", "pubmed_id": "41662127", "openalex_id": "https://openalex.org/W7117295770", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41662127/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41662127", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41662127/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41662127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41662127/", "doi": "10.1371/journal.pmen.0000514", "pmid": "41662127", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 315, "title": "High hopes? Precision psychedelic addiction medicine.", "authors": "Zafar RR, Kleine P, Kurtin D, Wall M, Erritzoe D", "journal": "Frontiers in psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1681795", "pubmed_id": "41684524", "openalex_id": "https://openalex.org/W7125975363", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41684524/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Brain Imaging,Pharmacology,Biomarkers,Aging,Emotional Processing,Clinical Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41684524", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41684524/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41684524", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41684524/", "doi": "10.3389/fpsyt.2025.1681795", "pmid": "41684524", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4505, "title": "Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse", "authors": "Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly", "journal": "Saudi Journal of Medicine and Public Health", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.64483/20251153", "pubmed_id": null, "openalex_id": "https://openalex.org/W7104738164", "source_url": "https://doi.org/10.64483/20251153", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.64483/20251153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.64483/20251153", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.64483/20251153", "source_url": "https://doi.org/10.64483/20251153", "doi": "10.64483/20251153", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4504, "title": "Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy", "authors": "Mohammad Ali, Urbah Viqar", "journal": "Annals of Punjab Medical College", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.29054/apmc/2024.1658", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408418352", "source_url": "https://doi.org/10.29054/apmc/2024.1658", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Case Report,Observational Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.29054/apmc/2024.1658", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29054/apmc/2024.1658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29054/apmc/2024.1658", "source_url": "https://doi.org/10.29054/apmc/2024.1658", "doi": "10.29054/apmc/2024.1658", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4494, "title": "Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration", "authors": "Muniz, John Marco D.F.", "journal": "Journal of International Crisis and Risk Communication Research", "publication_date": "2024-12-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112971088", "source_url": "https://stars.library.ucf.edu/hut2024/268", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "https://stars.library.ucf.edu/hut2024/268", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://stars.library.ucf.edu/hut2024/268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://stars.library.ucf.edu/hut2024/268", "source_url": "https://stars.library.ucf.edu/hut2024/268", "doi": "", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 922, "title": "Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.", "authors": "Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G", "journal": "Deutsches Arzteblatt international", "publication_date": "2024-12-27", "publication_year": 2024, "doi": "10.3238/arztebl.m2024.0224", "pubmed_id": "39628414", "openalex_id": "https://openalex.org/W4405029114", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39628414/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39628414", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39628414/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39628414", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39628414/", "doi": "10.3238/arztebl.m2024.0224", "pmid": "39628414", "publication_date": "2024-12-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 923, "title": "Classic psychedelics and the treatment for alcoholism.", "authors": "Lodetti G, de Bitencourt RM, Rico EP", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2024-12-20", "publication_year": 2024, "doi": "10.1016/j.pnpbp.2024.111129", "pubmed_id": "39181308", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39181308/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39181308", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39181308/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39181308", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39181308/", "doi": "10.1016/j.pnpbp.2024.111129", "pmid": "39181308", "publication_date": "2024-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3101, "title": "Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways", "authors": "Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD.", "journal": "bioRxiv", "publication_date": "2024-12-17", "publication_year": 2024, "doi": "10.1101/2024.12.16.628764", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.12.16.628764", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Healthcare Workers,Transcriptomics", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:58", "bibtex": null, "source_record_id": "DOI:10.1101/2024.12.16.628764", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.12.16.628764", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.12.16.628764", "source_url": "https://doi.org/10.1101/2024.12.16.628764", "doi": "10.1101/2024.12.16.628764", "pmid": "", "publication_date": "2024-12-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4508, "title": "Disentangling debate about therapeutic and recreational use of psychedelics", "authors": "Christina M. Andrews, Wayne Hall, Keith Humphreys, John Marsden", "journal": "Addiction", "publication_date": "2024-12-15", "publication_year": 2024, "doi": "10.1111/add.16744", "pubmed_id": "39676069", "openalex_id": "https://openalex.org/W4405412696", "source_url": "https://doi.org/10.1111/add.16744", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "PMID:39676069", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.16744", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39676069", "source_url": "https://doi.org/10.1111/add.16744", "doi": "10.1111/add.16744", "pmid": "39676069", "publication_date": "2024-12-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5670, "title": "Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience.", "authors": "Wahba M, Hayes C, Kletter M, McAllister-Williams RH", "journal": "BJPsych open", "publication_date": "2024-12-10", "publication_year": 2024, "doi": "10.1192/bjo.2024.768", "pubmed_id": "39654264", "openalex_id": "https://openalex.org/W4405215942", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39654264/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Case Report,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 07:00:34", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39654264", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39654264/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39654264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39654264/", "doi": "10.1192/bjo.2024.768", "pmid": "39654264", "publication_date": "2024-12-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 936, "title": "Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.", "authors": "Back AL, Freeman-Young TK, Morgan L, Sethi T, Baker KK, Myers S, McGregor BA, Harvey K, Tai M, Kollefrath A, Thomas BJ, Sorta D, Kaelen M, Kelmendi B, Gooley TA", "journal": "JAMA network open", "publication_date": "2024-12-02", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.49026", "pubmed_id": "39636638", "openalex_id": "https://openalex.org/W4405031949", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39636638/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39636638", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39636638/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39636638", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39636638/", "doi": "10.1001/jamanetworkopen.2024.49026", "pmid": "39636638", "publication_date": "2024-12-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4514, "title": "God hasn’t died, it has merely been encapsulated - Psilocybin and ayahuasca in the psychedelic renaissance: Intersections between religion, indigenous cosmologies, spirituality, and science", "authors": "Juan Scuro", "journal": "Social Compass", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1177/00377686241301923", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405760007", "source_url": "https://doi.org/10.1177/00377686241301923", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.1177/00377686241301923", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00377686241301923", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00377686241301923", "source_url": "https://doi.org/10.1177/00377686241301923", "doi": "10.1177/00377686241301923", "pmid": "", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 950, "title": "New frontiers in the biosynthesis of psychoactive specialized metabolites.", "authors": "Li G, Facchini PJ", "journal": "Current opinion in plant biology", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1016/j.pbi.2024.102626", "pubmed_id": "39288539", "openalex_id": "https://openalex.org/W4402620626", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39288539/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39288539", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39288539/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39288539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39288539/", "doi": "10.1016/j.pbi.2024.102626", "pmid": "39288539", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 945, "title": "The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.", "authors": "Marwood L, Croal M, Mistry S, Simmons H, Tsai J, Young MB, Goodwin GM", "journal": "Journal of psychiatric research", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1016/j.jpsychires.2024.10.009", "pubmed_id": "39427449", "openalex_id": "https://openalex.org/W4403332337", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39427449/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39427449", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39427449/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39427449", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39427449/", "doi": "10.1016/j.jpsychires.2024.10.009", "pmid": "39427449", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 939, "title": "Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.", "authors": "Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB", "journal": "International review of psychiatry (Abingdon, England)", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1080/09540261.2024.2357668", "pubmed_id": "39980217", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39980217/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mystical Experience,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39980217", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39980217/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39980217", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39980217/", "doi": "10.1080/09540261.2024.2357668", "pmid": "39980217", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 934, "title": "Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy.", "authors": "Back A, Myers S, Guy J, Perez J, Lazar Thorn L, McGregor B", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0069", "pubmed_id": "40051480", "openalex_id": "https://openalex.org/W4396720923", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051480/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:40051480", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051480/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051480", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051480/", "doi": "10.1089/psymed.2023.0069", "pmid": "40051480", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 954, "title": "Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.", "authors": "Adams DR, Allen H, Nicol GE, Cabassa LJ", "journal": "Translational behavioral medicine", "publication_date": "2024-11-25", "publication_year": 2024, "doi": "10.1093/tbm/ibae053", "pubmed_id": "39419768", "openalex_id": "https://openalex.org/W4403502370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39419768/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39419768", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39419768/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39419768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39419768/", "doi": "10.1093/tbm/ibae053", "pmid": "39419768", "publication_date": "2024-11-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3488, "title": "Psilocybin Treatment in Obsessive-Compulsive Disorder: a Preliminary Efficacy Study and Exploratory Investigation of Neural Correlates.", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-20", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03356483", "substance_tags": "psilocybin", "topic_tags": "OCD,Brain Imaging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03356483", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03356483", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03356483", "source_url": "https://clinicaltrials.gov/study/NCT03356483", "doi": "", "pmid": "", "publication_date": "2024-11-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3512, "title": "A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05035927", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05035927", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "source_url": "https://clinicaltrials.gov/study/NCT05035927", "doi": "", "pmid": "", "publication_date": "2024-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 957, "title": "Expanding the Therapeutic Horizons of Psilocybin in Mental Health.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2024-11-14", "publication_year": 2024, "doi": "10.1021/acsmedchemlett.4c00488", "pubmed_id": "39563826", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39563826/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39563826", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39563826/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39563826", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39563826/", "doi": "10.1021/acsmedchemlett.4c00488", "pmid": "39563826", "publication_date": "2024-11-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4523, "title": "Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help", "authors": "Stéphanie Knatz Peck, Hannah M. Fisher, Jessie Kim, Samantha Shao, Julie Trim, Walter H. Kaye", "journal": "Psychedelics.", "publication_date": "2024-11-07", "publication_year": 2024, "doi": "10.61373/pp024e.0034", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404961618", "source_url": "https://doi.org/10.61373/pp024e.0034", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.61373/pp024e.0034", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp024e.0034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp024e.0034", "source_url": "https://doi.org/10.61373/pp024e.0034", "doi": "10.61373/pp024e.0034", "pmid": "", "publication_date": "2024-11-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3134, "title": "Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial", "authors": "Aday JS, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Harte SE, Pouyan N, Glynos NG, Baker AK, Guss J, Davis AK, Burgess HJ, Mashour GA, Clauw DJ, Boehnke KF.", "journal": "PsyArXiv", "publication_date": "2024-11-04", "publication_year": 2024, "doi": "10.31234/osf.io/j8zb5", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/j8zb5", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/j8zb5", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/j8zb5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/j8zb5", "source_url": "https://doi.org/10.31234/osf.io/j8zb5", "doi": "10.31234/osf.io/j8zb5", "pmid": "", "publication_date": "2024-11-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 776, "title": "Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial", "authors": "Jacob S. Aday, Jenna McAfee, Deirdre A. Conroy, Avinash Hosanagar, Vijay Tarnal, Cody Weston, Katharine Scott, Dana Horowitz, Steven E. Harte, Niloufar Pouyan", "journal": "PsyArXiv", "publication_date": "2024-11-04", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "doi": "", "pmid": "", "publication_date": "2024-11-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 980, "title": "Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.", "authors": "Kim A, Halton B, Shah A, Seecof OM, Ross S", "journal": "Annals of palliative medicine", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.21037/apm-24-35", "pubmed_id": "39168642", "openalex_id": "https://openalex.org/W4401779935", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39168642/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39168642", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39168642/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39168642", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39168642/", "doi": "10.21037/apm-24-35", "pmid": "39168642", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 970, "title": "Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.", "authors": "Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R", "journal": "Current psychiatry reports", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1007/s11920-024-01539-8", "pubmed_id": "39532819", "openalex_id": "https://openalex.org/W4404321372", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39532819/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39532819", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39532819/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39532819", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39532819/", "doi": "10.1007/s11920-024-01539-8", "pmid": "39532819", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 968, "title": "Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.", "authors": "Petridis PD, Grinband J, Agin-Liebes G, Kinslow CJ, Zeifman RJ, Bogenschutz MP, Griffiths RR, Ross S", "journal": "Nature. Mental health", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1038/s44220-024-00331-0", "pubmed_id": "41969367", "openalex_id": "https://openalex.org/W4403196849", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41969367/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:41969367", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41969367/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41969367", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41969367/", "doi": "10.1038/s44220-024-00331-0", "pmid": "41969367", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3136, "title": "Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts", "authors": "Luoma JB, Wilson-Poe A, Pertl K, Hoffman K, Bazinet A, Stauffer C, McCarty D, Korthuis P.", "journal": "PsyArXiv", "publication_date": "2024-10-31", "publication_year": 2024, "doi": "10.31234/osf.io/dwhcu_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/dwhcu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/dwhcu_v1", "source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "doi": "10.31234/osf.io/dwhcu_v1", "pmid": "", "publication_date": "2024-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 927, "title": "Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: Case report and thematic analysis of one participant's experience", "authors": "Wahba M, Hayes C, Kletter M, McAllister-Williams RH", "journal": "BJPsych Open", "publication_date": "2024-10-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7139416359", "source_url": "https://openalex.org/W7139416359", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Case Report,Treatment-Resistant Depression,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:25:59", "bibtex": null, "source_record_id": "https://openalex.org/W7139416359", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://openalex.org/W7139416359", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://openalex.org/W7139416359", "source_url": "https://openalex.org/W7139416359", "doi": "", "pmid": "", "publication_date": "2024-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 551, "title": "Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts", "authors": "Jason Luoma, Adie Wilson-Poe, Kellie Pertl, Kim Hoffman, Alissa Bazinet, Christopher Stauffer, Dennis McCarty, Philip Korthuis", "journal": "PsyArXiv", "publication_date": "2024-10-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "doi": "", "pmid": "", "publication_date": "2024-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3584, "title": "A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study", "authors": "Filament Health Corp.", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-30", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06666010", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06666010", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06666010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06666010", "source_url": "https://clinicaltrials.gov/study/NCT06666010", "doi": "", "pmid": "", "publication_date": "2024-10-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4531, "title": "“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin", "authors": "Pamela Kryskow, Paul Stamets, Joseph La Torre, Kathy Sattler, Vivian W. L. Tsang, Monnica T. Williams", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-10-29", "publication_year": 2024, "doi": "10.1556/2054.2024.00379", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403860154", "source_url": "https://doi.org/10.1556/2054.2024.00379", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00379", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00379", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00379", "source_url": "https://doi.org/10.1556/2054.2024.00379", "doi": "10.1556/2054.2024.00379", "pmid": "", "publication_date": "2024-10-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3644, "title": "Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-24", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03429075", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03429075", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03429075", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03429075", "source_url": "https://clinicaltrials.gov/study/NCT03429075", "doi": "", "pmid": "", "publication_date": "2024-10-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 989, "title": "Expert recommendations for Germany's integration of psychedelic-assisted therapy.", "authors": "Perez Rosal SR, La Torre JT, Birnkammer S, Chernoloz O, Williams MT, Faber SC", "journal": "BMC medical education", "publication_date": "2024-10-24", "publication_year": 2024, "doi": "10.1186/s12909-024-06141-3", "pubmed_id": "39443907", "openalex_id": "https://openalex.org/W4403667484", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39443907/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39443907", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39443907/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39443907", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39443907/", "doi": "10.1186/s12909-024-06141-3", "pmid": "39443907", "publication_date": "2024-10-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4540, "title": "Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study", "authors": "James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu", "journal": "Headache The Journal of Head and Face Pain", "publication_date": "2024-10-09", "publication_year": 2024, "doi": "10.1111/head.14846", "pubmed_id": "39382331", "openalex_id": "https://openalex.org/W4403248178", "source_url": "https://doi.org/10.1111/head.14846", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Pharmacology,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "PMID:39382331", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/head.14846", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39382331", "source_url": "https://doi.org/10.1111/head.14846", "doi": "10.1111/head.14846", "pmid": "39382331", "publication_date": "2024-10-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3469, "title": "A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06326606", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06326606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06326606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06326606", "source_url": "https://clinicaltrials.gov/study/NCT06326606", "doi": "", "pmid": "", "publication_date": "2024-10-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4545, "title": "PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial", "authors": "Daniel Spinosa, Stacy M. Fischer, Richard J. Zeifman, Carolyn Lefkowits, Petros Petridis, Stephen Ross", "journal": "International Journal of Gynecological Cancer", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1136/ijgc-2024-igcs.54", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405447055", "source_url": "https://doi.org/10.1136/ijgc-2024-igcs.54", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.1136/ijgc-2024-igcs.54", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/ijgc-2024-igcs.54", "source_url": "https://doi.org/10.1136/ijgc-2024-igcs.54", "doi": "10.1136/ijgc-2024-igcs.54", "pmid": "", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1013, "title": "Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.", "authors": "Conn K, Milton LK, Huang K, Munguba H, Ruuska J, Lemus MB, Greaves E, Homman-Ludiye J, Oldfield BJ, Foldi CJ", "journal": "Molecular psychiatry", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1038/s41380-024-02575-9", "pubmed_id": "38678087", "openalex_id": "https://openalex.org/W4395688958", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38678087/", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:38678087", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38678087/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38678087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38678087/", "doi": "10.1038/s41380-024-02575-9", "pmid": "38678087", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1003, "title": "The role of psilocybin in depressive disorders.", "authors": "Najib J", "journal": "Current medical research and opinion", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1080/03007995.2024.2396536", "pubmed_id": "39177339", "openalex_id": "https://openalex.org/W4401815070", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39177339/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39177339", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39177339/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39177339", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39177339/", "doi": "10.1080/03007995.2024.2396536", "pmid": "39177339", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1000, "title": "Artificial intelligence and psychedelic medicine.", "authors": "Sarris J, Halman A, Urokohara A, Lehrner M, Perkins D", "journal": "Annals of the New York Academy of Sciences", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1111/nyas.15229", "pubmed_id": "39308441", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39308441/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39308441", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39308441/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39308441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39308441/", "doi": "10.1111/nyas.15229", "pmid": "39308441", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 997, "title": "Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.", "authors": "Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R", "journal": "EClinicalMedicine", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1016/j.eclinm.2024.102799", "pubmed_id": "39764567", "openalex_id": "https://openalex.org/W4402747955", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39764567/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Safety,Contraindications", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39764567", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39764567/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39764567", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39764567/", "doi": "10.1016/j.eclinm.2024.102799", "pmid": "39764567", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1016, "title": "Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats.", "authors": "Fisher EL, Smith R, Conn K, Corcoran AW, Milton LK, Hohwy J, Foldi CJ", "journal": "Translational psychiatry", "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.1038/s41398-024-03103-7", "pubmed_id": "39349428", "openalex_id": "https://openalex.org/W4402975017", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39349428/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39349428", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39349428/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39349428", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39349428/", "doi": "10.1038/s41398-024-03103-7", "pmid": "39349428", "publication_date": "2024-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3546, "title": "The Effects of Psilocybin on Shared Experience in Film Processing", "authors": "Western University, Canada", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-27", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06529939", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Consciousness,Aging,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06529939", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06529939", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06529939", "source_url": "https://clinicaltrials.gov/study/NCT06529939", "doi": "", "pmid": "", "publication_date": "2024-09-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1018, "title": "Psychedelic research at a crossroads.", "authors": "Armstrong SB, Davis AK", "journal": "Science (New York, N.Y.)", "publication_date": "2024-09-20", "publication_year": 2024, "doi": "10.1126/science.adt1024", "pubmed_id": "39298596", "openalex_id": "https://openalex.org/W4402625697", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39298596/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39298596", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39298596/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39298596", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39298596/", "doi": "10.1126/science.adt1024", "pmid": "39298596", "publication_date": "2024-09-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4551, "title": "Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials", "authors": "Danielle B Rodrigues", "journal": "Journal of Complementary Medicine & Alternative Healthcare", "publication_date": "2024-09-16", "publication_year": 2024, "doi": "10.19080/jcmah.2024.13.555852", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408545862", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "doi": "10.19080/jcmah.2024.13.555852", "pmid": "", "publication_date": "2024-09-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1021, "title": "Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2024-09-12", "publication_year": 2024, "doi": "10.1021/acsmedchemlett.4c00414", "pubmed_id": "39291015", "openalex_id": "https://openalex.org/W4401734470", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39291015/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39291015", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39291015/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39291015", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39291015/", "doi": "10.1021/acsmedchemlett.4c00414", "pmid": "39291015", "publication_date": "2024-09-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4556, "title": "Usage of Psilocybin to Treat Huntington's Disease: A Research Protocol", "authors": "Cynthia Duan, Navid Farkhondehpay, Viana Safa, Emma Yuan", "journal": "Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal", "publication_date": "2024-09-05", "publication_year": 2024, "doi": "10.26685/urncst.644", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402270940", "source_url": "http://dx.doi.org/10.26685/urncst.644", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Biomarkers,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.26685/urncst.644", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.26685/urncst.644", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26685/urncst.644", "source_url": "http://dx.doi.org/10.26685/urncst.644", "doi": "10.26685/urncst.644", "pmid": "", "publication_date": "2024-09-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1040, "title": "Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.", "authors": "Köhne S, Hillemacher T, Glahn A, Bach P", "journal": "Expert opinion on emerging drugs", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1080/14728214.2024.2342951", "pubmed_id": "38606899", "openalex_id": "https://openalex.org/W4394750772", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38606899/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38606899", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38606899/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38606899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38606899/", "doi": "10.1080/14728214.2024.2342951", "pmid": "38606899", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1026, "title": "Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative Analysis.", "authors": "Smith CL, Sackett N, Stark BC, Dinh V, Romesburg EW, Roll J", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0074", "pubmed_id": "40051684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:40051684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "doi": "10.1089/psymed.2023.0074", "pmid": "40051684", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3141, "title": "The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting", "authors": "Klučková T, Nikolič M, Tylš F, Viktorin V, Vejmola Č, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Zach P, Hájková K, Kuchař M, Balíková M, Brunovský M, Horáček J, Páleníček T.", "journal": "medRxiv", "publication_date": "2024-08-26", "publication_year": 2024, "doi": "10.1101/2024.08.26.24311611", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.08.26.24311611", "substance_tags": "psilocybin,psilocin", "topic_tags": "Anxiety,Brain Imaging,Consciousness,Emotional Processing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:04", "bibtex": null, "source_record_id": "DOI:10.1101/2024.08.26.24311611", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.08.26.24311611", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.08.26.24311611", "source_url": "https://doi.org/10.1101/2024.08.26.24311611", "doi": "10.1101/2024.08.26.24311611", "pmid": "", "publication_date": "2024-08-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3075, "title": "­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study", "authors": "Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A.", "journal": "Research Square", "publication_date": "2024-08-23", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4947184/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4947184/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4947184/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "doi": "10.21203/rs.3.rs-4947184/v1", "pmid": "", "publication_date": "2024-08-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1049, "title": "Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.", "authors": "Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS", "journal": "BMJ (Clinical research ed.)", "publication_date": "2024-08-21", "publication_year": 2024, "doi": "10.1136/bmj-2023-078607", "pubmed_id": "39168500", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39168500/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39168500", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39168500/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39168500", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39168500/", "doi": "10.1136/bmj-2023-078607", "pmid": "39168500", "publication_date": "2024-08-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3268, "title": "A virtual clinical trial of psychedelics to treat patients with disorders of consciousness", "authors": "Alnagger NL, Cardone P, Martial C, Sanz Perl Y, Mindlin I, Sitt JD, Roseman L, Carhart-Harris R, Nutt D, Mallaroni P, Mason NL, Ramaekers JG, Bonhomme V, Laureys S, Deco G, Gosseries O, Nunez P, Annen J.", "journal": "bioRxiv", "publication_date": "2024-08-19", "publication_year": 2024, "doi": "10.1101/2024.08.16.608251", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.08.16.608251", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Consciousness,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:17", "bibtex": null, "source_record_id": "DOI:10.1101/2024.08.16.608251", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.08.16.608251", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.08.16.608251", "source_url": "https://doi.org/10.1101/2024.08.16.608251", "doi": "10.1101/2024.08.16.608251", "pmid": "", "publication_date": "2024-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1051, "title": "Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.", "authors": "Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M", "journal": "Brain sciences", "publication_date": "2024-08-18", "publication_year": 2024, "doi": "10.3390/brainsci14080829", "pubmed_id": "39199520", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39199520/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39199520", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39199520/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39199520", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39199520/", "doi": "10.3390/brainsci14080829", "pmid": "39199520", "publication_date": "2024-08-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3428, "title": "A 24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)", "authors": "Clairvoyant Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-15", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05646303", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05646303", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05646303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05646303", "source_url": "https://clinicaltrials.gov/study/NCT05646303", "doi": "", "pmid": "", "publication_date": "2024-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3438, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms", "authors": "Brugmann University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-07", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06160232", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06160232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "source_url": "https://clinicaltrials.gov/study/NCT06160232", "doi": "", "pmid": "", "publication_date": "2024-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4572, "title": "Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression", "authors": "Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach", "journal": "Nature Mental Health", "publication_date": "2024-08-05", "publication_year": 2024, "doi": "10.1038/s44220-024-00298-y", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401339608", "source_url": "https://doi.org/10.1038/s44220-024-00298-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.1038/s44220-024-00298-y", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s44220-024-00298-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1038/s44220-024-00298-y", "source_url": "https://doi.org/10.1038/s44220-024-00298-y", "doi": "10.1038/s44220-024-00298-y", "pmid": "", "publication_date": "2024-08-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1055, "title": "Psilocybin-assisted therapy and HIV-related shame.", "authors": "Mehtani NJ, Johnson MO, Hendricks PS, Mitchell J, Anderson BT", "journal": "Scientific reports", "publication_date": "2024-08-02", "publication_year": 2024, "doi": "10.1038/s41598-024-68908-4", "pubmed_id": "39095420", "openalex_id": "https://openalex.org/W4401257064", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39095420/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39095420", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39095420/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39095420", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39095420/", "doi": "10.1038/s41598-024-68908-4", "pmid": "39095420", "publication_date": "2024-08-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1069, "title": "The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.", "authors": "Kaminski D, Reinert JP", "journal": "The Annals of pharmacotherapy", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1177/10600280231205645", "pubmed_id": "37902038", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37902038/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:37902038", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37902038/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37902038", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37902038/", "doi": "10.1177/10600280231205645", "pmid": "37902038", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1065, "title": "Psychedelic-assisted psychotherapy: where is the psychotherapy research?", "authors": "Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD", "journal": "Psychopharmacology", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1007/s00213-024-06620-x", "pubmed_id": "38782821", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38782821", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38782821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "doi": "10.1007/s00213-024-06620-x", "pmid": "38782821", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1064, "title": "Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.", "authors": "Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD", "journal": "Journal of psychiatric research", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1016/j.jpsychires.2024.05.051", "pubmed_id": "38850581", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38850581/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38850581", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38850581/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38850581", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38850581/", "doi": "10.1016/j.jpsychires.2024.05.051", "pmid": "38850581", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1062, "title": "The cyclical revival of psychedelics in psychiatric treatment.", "authors": "Appiani FJ, Caroff SN", "journal": "Current medical research and opinion", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1080/03007995.2024.2368725", "pubmed_id": "38880945", "openalex_id": "https://openalex.org/W4399756902", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38880945/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38880945", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38880945/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38880945", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38880945/", "doi": "10.1080/03007995.2024.2368725", "pmid": "38880945", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1061, "title": "Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.", "authors": "Korthuis PT, Hoffman K, Wilson-Poe AR, Luoma JB, Bazinet A, Pertl K, Morgan DL, Cook RR, Bielavitz S, Myers R, Wolf RC, McCarty D, Stauffer CS", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1177/02698811241257839", "pubmed_id": "38888164", "openalex_id": "https://openalex.org/W4399780176", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38888164/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38888164", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38888164/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38888164", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38888164/", "doi": "10.1177/02698811241257839", "pmid": "38888164", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1058, "title": "Psilocybin desynchronizes the human brain.", "authors": "Siegel JS, Subramanian S, Perry D, Kay BP, Gordon EM, Laumann TO, Reneau TR, Metcalf NV, Chacko RV, Gratton C, Horan C, Krimmel SR, Shimony JS, Schweiger JA, Wong DF, Bender DA, Scheidter KM, Whiting FI, Padawer-Curry JA, Shinohara RT, Chen Y, Moser J, Yacoub E, Nelson SM, Vizioli L, Fair DA, Lenze EJ, Carhart-Harris R, Raison CL, Raichle ME, Snyder AZ, Nicol GE, Dosenbach NUF", "journal": "Nature", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1038/s41586-024-07624-5", "pubmed_id": "39020167", "openalex_id": "https://openalex.org/W4400729513", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39020167/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Brain Imaging,Default Mode Network,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39020167", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39020167/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39020167", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39020167/", "doi": "10.1038/s41586-024-07624-5", "pmid": "39020167", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1074, "title": "Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.", "authors": "de la Salle S, Kettner H, Thibault Lévesque J, Garel N, Dames S, Patchett-Marble R, Rej S, Gloeckler S, Erritzoe D, Carhart-Harris R, Greenway KT", "journal": "Scientific reports", "publication_date": "2024-07-17", "publication_year": 2024, "doi": "10.1038/s41598-024-66817-0", "pubmed_id": "39019922", "openalex_id": "https://openalex.org/W4400737202", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39019922/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Wellbeing,Spirituality,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:39019922", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39019922/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39019922", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39019922/", "doi": "10.1038/s41598-024-66817-0", "pmid": "39019922", "publication_date": "2024-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4587, "title": "Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)", "authors": "Kristoffer Andreas Aamodt Andersen, Bjørn Holmøy, Lowan H. Stewart", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-07-12", "publication_year": 2024, "doi": "10.1556/2054.2024.00346", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400581008", "source_url": "https://doi.org/10.1556/2054.2024.00346", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Consciousness,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:28", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00346", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00346", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00346", "source_url": "https://doi.org/10.1556/2054.2024.00346", "doi": "10.1556/2054.2024.00346", "pmid": "", "publication_date": "2024-07-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1079, "title": "The Black Book of Psychotropic Dosing and Monitoring.", "authors": "DeBattista C, Schatzberg AF", "journal": "Psychopharmacology bulletin", "publication_date": "2024-07-08", "publication_year": 2024, "doi": "10.64719/pb.4493", "pubmed_id": "38993656", "openalex_id": "https://openalex.org/W2983072139", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38993656/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38993656", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38993656/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38993656", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38993656/", "doi": "10.64719/pb.4493", "pmid": "38993656", "publication_date": "2024-07-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4590, "title": "Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence", "authors": "Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek", "journal": "Current Psychopharmacologye", "publication_date": "2024-07-04", "publication_year": 2024, "doi": "10.2174/0122115560288779240628043307", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400323479", "source_url": "https://doi.org/10.2174/0122115560288779240628043307", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:28", "bibtex": null, "source_record_id": "DOI:10.2174/0122115560288779240628043307", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0122115560288779240628043307", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/0122115560288779240628043307", "source_url": "https://doi.org/10.2174/0122115560288779240628043307", "doi": "10.2174/0122115560288779240628043307", "pmid": "", "publication_date": "2024-07-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2993, "title": "Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study.", "authors": "Peck SK, Shao S, Gruen T, Yang K, Babakanian A, Trim J, Finn DM, Kaye WH", "journal": "Focus (American Psychiatric Publishing)", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1176/appi.focus.24022013", "pubmed_id": "38988455", "openalex_id": "https://openalex.org/W4400572892", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38988455/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38988455", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38988455/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38988455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38988455/", "doi": "10.1176/appi.focus.24022013", "pmid": "38988455", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1097, "title": "Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.", "authors": "Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A", "journal": "Biological psychiatry", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1016/j.biopsych.2024.01.002", "pubmed_id": "38185235", "openalex_id": "https://openalex.org/W4390629750", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38185235/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Default Mode Network,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38185235", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38185235/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38185235", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38185235/", "doi": "10.1016/j.biopsych.2024.01.002", "pmid": "38185235", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1093, "title": "What is needed for the roll-out of psychedelic treatments?", "authors": "Xenakis SN, Shannon SM", "journal": "Current opinion in psychiatry", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1097/yco.0000000000000946", "pubmed_id": "38726805", "openalex_id": "https://openalex.org/W4396803137", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38726805/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38726805", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38726805/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38726805", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38726805/", "doi": "10.1097/yco.0000000000000946", "pmid": "38726805", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1084, "title": "Innovative and Emerging Treatments for Anorexia Nervosa.", "authors": "Downey AE, Gorrell S", "journal": "Focus (American Psychiatric Publishing)", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1176/appi.focus.20230041", "pubmed_id": "38988458", "openalex_id": "https://openalex.org/W4400573076", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38988458/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38988458", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38988458/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38988458", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38988458/", "doi": "10.1176/appi.focus.20230041", "pmid": "38988458", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 812, "title": "Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming.", "authors": "Brownstien M, Lazar M, Botvinnik A, Shevakh C, Blakolmer K, Lerer L, Lifschytz T, Lerer B", "journal": "bioRxiv: the preprint server for biology", "publication_date": "2024-06-29", "publication_year": 2024, "doi": "10.1101/2024.06.25.600634", "pubmed_id": "38979304", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38979304/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,OCD,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Animal Study,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38979304", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38979304/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38979304", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38979304/", "doi": "10.1101/2024.06.25.600634", "pmid": "38979304", "publication_date": "2024-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1103, "title": "At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.", "authors": "Parker C, Wood BM", "journal": "Social work", "publication_date": "2024-06-21", "publication_year": 2024, "doi": "10.1093/sw/swae019", "pubmed_id": "38697188", "openalex_id": "https://openalex.org/W4396599639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38697188/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38697188", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38697188/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38697188", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38697188/", "doi": "10.1093/sw/swae019", "pmid": "38697188", "publication_date": "2024-06-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1104, "title": "RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-,-diisopropyltryptamine.", "authors": "Bryson N, Alexander R, Asnis-Alibozek A, Ehlers MD", "journal": "ACS chemical neuroscience", "publication_date": "2024-06-19", "publication_year": 2024, "doi": "10.1021/acschemneuro.4c00058", "pubmed_id": "38758589", "openalex_id": "https://openalex.org/W4396988535", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38758589/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38758589", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38758589/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38758589", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38758589/", "doi": "10.1021/acschemneuro.4c00058", "pmid": "38758589", "publication_date": "2024-06-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1107, "title": "Licit use of illicit drugs for treating depression: the pill and the process.", "authors": "Torrado Pacheco A, Moghaddam B", "journal": "The Journal of clinical investigation", "publication_date": "2024-06-17", "publication_year": 2024, "doi": "10.1172/jci180217", "pubmed_id": "40047885", "openalex_id": "https://openalex.org/W4399715661", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047885/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Review Article,Animal Study,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:40047885", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40047885/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40047885", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047885/", "doi": "10.1172/jci180217", "pmid": "40047885", "publication_date": "2024-06-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4605, "title": "Psychedelics’ Use as Medicine Hits Significant Roadblock", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2024-06-12", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.07.7.54", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399577191", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "doi": "10.1176/appi.pn.2024.07.7.54", "pmid": "", "publication_date": "2024-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3791, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK.", "journal": "PsyArXiv", "publication_date": "2024-06-10", "publication_year": 2024, "doi": "10.31234/osf.io/adnpg", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/adnpg", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:27", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/adnpg", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/adnpg", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/adnpg", "source_url": "https://doi.org/10.31234/osf.io/adnpg", "doi": "10.31234/osf.io/adnpg", "pmid": "", "publication_date": "2024-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3445, "title": "A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "University of Sydney", "journal": "ClinicalTrials.gov", "publication_date": "2024-06-10", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06444243", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06444243", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "source_url": "https://clinicaltrials.gov/study/NCT06444243", "doi": "", "pmid": "", "publication_date": "2024-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3355, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "Dan Petrovitch, Sean M. Mitchell, Jason Van Allen, Andrew K. Littlefield", "journal": "PsyArXiv", "publication_date": "2024-06-10", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "doi": "", "pmid": "", "publication_date": "2024-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1126, "title": "[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].", "authors": "Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A", "journal": "Fortschritte der Neurologie-Psychiatrie", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1055/a-2046-5202", "pubmed_id": "37207669", "openalex_id": "https://openalex.org/W4377088482", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37207669/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:37207669", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37207669/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37207669", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37207669/", "doi": "10.1055/a-2046-5202", "pmid": "37207669", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1122, "title": "Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.", "authors": "Szigeti B, Weiss B, Rosas FE, Erritzoe D, Nutt D, Carhart-Harris R", "journal": "Psychological medicine", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1017/s0033291723003653", "pubmed_id": "38247730", "openalex_id": "https://openalex.org/W4391109410", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38247730/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38247730", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38247730/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38247730", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38247730/", "doi": "10.1017/s0033291723003653", "pmid": "38247730", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1106, "title": "A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?", "authors": "Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0051", "pubmed_id": "40051581", "openalex_id": "https://openalex.org/W4392242849", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051581/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:40051581", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051581/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051581", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051581/", "doi": "10.1089/psymed.2023.0051", "pmid": "40051581", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1105, "title": "Impact of Psilocybin on Peripheral Cytokine Production.", "authors": "DiRenzo D, Barrett FS, Perin J, Darrah E, Christopher-Stine L, Griffiths RR", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0039", "pubmed_id": "40051582", "openalex_id": "https://openalex.org/W4392242985", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051582/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:40051582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051582/", "doi": "10.1089/psymed.2023.0039", "pmid": "40051582", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1127, "title": "Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.", "authors": "Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM", "journal": "Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology", "publication_date": "2024-05-31", "publication_year": 2024, "doi": "10.9758/cpn.23.1134", "pubmed_id": "38627070", "openalex_id": "https://openalex.org/W4389203746", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38627070/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Default Mode Network,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38627070", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38627070/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38627070", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38627070/", "doi": "10.9758/cpn.23.1134", "pmid": "38627070", "publication_date": "2024-05-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3277, "title": "On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.", "authors": "Hoyer D.", "journal": "Authorea Preprints", "publication_date": "2024-05-23", "publication_year": 2024, "doi": "10.22541/au.171648613.31141136/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:18", "bibtex": null, "source_record_id": "DOI:10.22541/au.171648613.31141136/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.22541/au.171648613.31141136/v1", "source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "doi": "10.22541/au.171648613.31141136/v1", "pmid": "", "publication_date": "2024-05-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1132, "title": "Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.", "authors": "Bhagavan C, Glue P, Evans W, Reynolds L, Turner T, King C, Russell BR, Morunga E, Mills JL, Layton G, Menkes DB", "journal": "Trials", "publication_date": "2024-05-21", "publication_year": 2024, "doi": "10.1186/s13063-024-08174-x", "pubmed_id": "38773523", "openalex_id": "https://openalex.org/W4398156539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38773523/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Wellbeing,Personality Change,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38773523", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38773523/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38773523", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38773523/", "doi": "10.1186/s13063-024-08174-x", "pmid": "38773523", "publication_date": "2024-05-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3118, "title": "Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats", "authors": "Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ.", "journal": "bioRxiv", "publication_date": "2024-05-17", "publication_year": 2024, "doi": "10.1101/2024.05.16.594614", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.05.16.594614", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:00", "bibtex": null, "source_record_id": "DOI:10.1101/2024.05.16.594614", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.05.16.594614", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.05.16.594614", "source_url": "https://doi.org/10.1101/2024.05.16.594614", "doi": "10.1101/2024.05.16.594614", "pmid": "", "publication_date": "2024-05-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4623, "title": "Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens", "authors": "Shunichiro Ikeda, Toshihiko Kinoshita", "journal": "Psychiatry and Clinical Neurosciences Reports", "publication_date": "2024-05-16", "publication_year": 2024, "doi": "10.1002/pcn5.196", "pubmed_id": null, "openalex_id": "https://openalex.org/W4397013596", "source_url": "https://doi.org/10.1002/pcn5.196", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.1002/pcn5.196", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pcn5.196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pcn5.196", "source_url": "https://doi.org/10.1002/pcn5.196", "doi": "10.1002/pcn5.196", "pmid": "", "publication_date": "2024-05-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1138, "title": "Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT Receptor Agonists.", "authors": "M Ro Rsted E, Jensen AA, Smits G, Frydenvang K, Kristensen JL", "journal": "Journal of medicinal chemistry", "publication_date": "2024-05-09", "publication_year": 2024, "doi": "10.1021/acs.jmedchem.4c00082", "pubmed_id": "38648420", "openalex_id": "https://openalex.org/W4394993604", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38648420/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38648420", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38648420/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38648420", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38648420/", "doi": "10.1021/acs.jmedchem.4c00082", "pmid": "38648420", "publication_date": "2024-05-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3632, "title": "Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial", "authors": "University of Calgary", "journal": "ClinicalTrials.gov", "publication_date": "2024-05-07", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05995769", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05995769", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05995769", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05995769", "source_url": "https://clinicaltrials.gov/study/NCT05995769", "doi": "", "pmid": "", "publication_date": "2024-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4631, "title": "Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders", "authors": "Brancaccio Hanna", "journal": "Research Posters", "publication_date": "2024-05-02", "publication_year": 2024, "doi": "10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401380403", "source_url": "https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:35:11", "bibtex": null, "source_record_id": "DOI:10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "source_url": "https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "doi": "10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "pmid": "", "publication_date": "2024-05-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4633, "title": "From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine", "authors": "Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie", "journal": "European Journal of Arts Humanities and Social Sciences", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.59324/ejahss.2024.1(3).10", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399259513", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "doi": "10.59324/ejahss.2024.1(3).10", "pmid": "", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1150, "title": "Expectancy Effects in Psychedelic Trials.", "authors": "Szigeti B, Heifets BD", "journal": "Biological psychiatry. Cognitive neuroscience and neuroimaging", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1016/j.bpsc.2024.02.004", "pubmed_id": "38387698", "openalex_id": "https://openalex.org/W4391953134", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38387698/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38387698", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38387698/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38387698", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38387698/", "doi": "10.1016/j.bpsc.2024.02.004", "pmid": "38387698", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1148, "title": "Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.", "authors": "Erritzoe D, Barba T, Spriggs MJ, Rosas FE, Nutt DJ, Carhart-Harris R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1177/02698811241237870", "pubmed_id": "38520045", "openalex_id": "https://openalex.org/W4393118291", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38520045/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38520045", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38520045/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38520045", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38520045/", "doi": "10.1177/02698811241237870", "pmid": "38520045", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1142, "title": "Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.", "authors": "Metaxa AM, Clarke M", "journal": "BMJ (Clinical research ed.)", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1136/bmj-2023-078084", "pubmed_id": "38692686", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38692686/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38692686", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38692686/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38692686", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38692686/", "doi": "10.1136/bmj-2023-078084", "pmid": "38692686", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1158, "title": "In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin", "authors": "Thomann Jan, Kolaczynska Karolina E., Stoeckmann Oliver V., Rudin Deborah, Vizeli Patrick, Hoener Marius C., Pryce Christopher R., Vollenweider Franz X., Liechti Matthias E., Duthaler Urs", "journal": "Frontiers in Pharmacology", "publication_date": "2024-04-29", "publication_year": 2024, "doi": "10.3389/fphar.2024.1391689", "pubmed_id": "38741590", "openalex_id": "https://openalex.org/W4396224564", "source_url": "https://doi.org/10.3389/fphar.2024.1391689", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,In Vitro Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:38741590", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fphar.2024.1391689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:38741590", "source_url": "https://doi.org/10.3389/fphar.2024.1391689", "doi": "10.3389/fphar.2024.1391689", "pmid": "38741590", "publication_date": "2024-04-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1161, "title": "The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.", "authors": "Whelan TP, Daly E, Puts NA, Smith P, Allison C, Baron-Cohen S, Malievskaia E, Murphy DGM, McAlonan GM", "journal": "BMC psychiatry", "publication_date": "2024-04-25", "publication_year": 2024, "doi": "10.1186/s12888-024-05768-2", "pubmed_id": "38658877", "openalex_id": "https://openalex.org/W4395462414", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38658877/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38658877", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38658877/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38658877", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38658877/", "doi": "10.1186/s12888-024-05768-2", "pmid": "38658877", "publication_date": "2024-04-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1162, "title": "Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.", "authors": "Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M", "journal": "Journal of eating disorders", "publication_date": "2024-04-24", "publication_year": 2024, "doi": "10.1186/s40337-024-01005-z", "pubmed_id": "38659049", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38659049/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Headache / Migraine,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38659049", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38659049/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38659049", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38659049/", "doi": "10.1186/s40337-024-01005-z", "pmid": "38659049", "publication_date": "2024-04-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4638, "title": "MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-04-23", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.05.5.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4395032120", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "doi": "10.1176/appi.pn.2024.05.5.1", "pmid": "", "publication_date": "2024-04-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3366, "title": "The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents", "authors": "Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL.", "journal": "bioRxiv", "publication_date": "2024-04-22", "publication_year": 2024, "doi": "10.1101/2024.04.19.590212", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.04.19.590212", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "DOI:10.1101/2024.04.19.590212", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.04.19.590212", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.04.19.590212", "source_url": "https://doi.org/10.1101/2024.04.19.590212", "doi": "10.1101/2024.04.19.590212", "pmid": "", "publication_date": "2024-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3434, "title": "The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2024-04-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04630964", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04630964", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "source_url": "https://clinicaltrials.gov/study/NCT04630964", "doi": "", "pmid": "", "publication_date": "2024-04-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1166, "title": "Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.", "authors": "Sloshower J, Zeifman RJ, Guss J, Krause R, Safi-Aghdam H, Pathania S, Pittman B, D'Souza DC", "journal": "Scientific reports", "publication_date": "2024-04-17", "publication_year": 2024, "doi": "10.1038/s41598-024-58318-x", "pubmed_id": "38632313", "openalex_id": "https://openalex.org/W4394886406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38632313/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Psychological Flexibility,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38632313", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38632313/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38632313", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38632313/", "doi": "10.1038/s41598-024-58318-x", "pmid": "38632313", "publication_date": "2024-04-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4640, "title": "Psychedelic therapists, pharma collaborate on clinical trial", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2024-04-13", "publication_year": 2024, "doi": "10.1002/mhw.34009", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394786197", "source_url": "https://doi.org/10.1002/mhw.34009", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34009", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.34009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.34009", "source_url": "https://doi.org/10.1002/mhw.34009", "doi": "10.1002/mhw.34009", "pmid": "", "publication_date": "2024-04-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4642, "title": "Who will staff the psychedelic resurgence?", "authors": "Erika Dyck", "journal": "Open Access Government", "publication_date": "2024-04-09", "publication_year": 2024, "doi": "10.56367/oag-042-10690", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394904988", "source_url": "http://dx.doi.org/10.56367/oag-042-10690", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.56367/oag-042-10690", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56367/oag-042-10690", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56367/oag-042-10690", "source_url": "http://dx.doi.org/10.56367/oag-042-10690", "doi": "10.56367/oag-042-10690", "pmid": "", "publication_date": "2024-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3726, "title": "[Psychedelic psychiatry].", "authors": "López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J", "journal": "Lakartidningen", "publication_date": "2024-04-04", "publication_year": 2024, "doi": null, "pubmed_id": "38572715", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38572715/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 11:08:41", "last_checked": "2026-08-09 08:34:30", "bibtex": null, "source_record_id": "PMID:38572715", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38572715/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38572715", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38572715/", "doi": "", "pmid": "38572715", "publication_date": "2024-04-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4658, "title": "Current situation regarding psychedelics and magic mushroom in Korea", "authors": "J. S. Seo", "journal": "European Psychiatry", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.1695", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401921810", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "doi": "10.1192/j.eurpsy.2024.1695", "pmid": "", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4646, "title": "Microdosing psychedelics in the treatment of ADHD and comorbid disorders", "authors": "Kim P. C. Kuypers", "journal": "European Psychiatry", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.44", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401920710", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Default Mode Network,Microdosing,Personality Change,Emotional Processing,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.44", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.44", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "doi": "10.1192/j.eurpsy.2024.44", "pmid": "", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1186, "title": "Evidence versus expectancy: the development of psilocybin therapy.", "authors": "Rucker JJ", "journal": "BJPsych bulletin", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1192/bjb.2023.28", "pubmed_id": "37246405", "openalex_id": "https://openalex.org/W4378640469", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37246405/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:37246405", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37246405/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37246405", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37246405/", "doi": "10.1192/bjb.2023.28", "pmid": "37246405", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1183, "title": "Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.", "authors": "Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders JJ, Ljuslin M, Guérin B, Thambi P, Tulsky JA, Agrawal M", "journal": "Cancer", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1002/cncr.35024", "pubmed_id": "38105653", "openalex_id": "https://openalex.org/W4389895437", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105653/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Cancer Patients,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38105653", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38105653/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38105653", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105653/", "doi": "10.1002/cncr.35024", "pmid": "38105653", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1181, "title": "Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.", "authors": "Agrawal M, Richards W, Beaussant Y, Shnayder S, Ameli R, Roddy K, Stevens N, Richards B, Schor N, Honstein H, Jenkins B, Bates M, Thambi P", "journal": "Cancer", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1002/cncr.35010", "pubmed_id": "38105655", "openalex_id": "https://openalex.org/W4389900078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105655/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38105655", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38105655/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38105655", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105655/", "doi": "10.1002/cncr.35010", "pmid": "38105655", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1172, "title": "Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.", "authors": "Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J", "journal": "JAMA network open", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.5960", "pubmed_id": "38598236", "openalex_id": "https://openalex.org/W4394693583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598236/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38598236", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38598236/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38598236", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598236/", "doi": "10.1001/jamanetworkopen.2024.5960", "pmid": "38598236", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1170, "title": "The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.", "authors": "Wilkes R, Roberts DM, Liknaitzky P, Brett J", "journal": "Clinical toxicology (Philadelphia, Pa.)", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1080/15563650.2024.2346612", "pubmed_id": "38753585", "openalex_id": "https://openalex.org/W4396977515", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38753585/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38753585", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38753585/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38753585", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38753585/", "doi": "10.1080/15563650.2024.2346612", "pmid": "38753585", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4660, "title": "MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-03-26", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393210403", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Pharmacology,Clinical Trial,Review Article,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "doi": "10.1176/appi.pn.2024.04.4.1", "pmid": "", "publication_date": "2024-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4663, "title": "Psychedelic Renaissance: Evidence and Culture", "authors": "Adrian Preda", "journal": "Psychiatric News", "publication_date": "2024-03-21", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.39", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393030764", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Emotional Processing,Spirituality,Clinical Trial,Animal Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "doi": "10.1176/appi.pn.2024.04.4.39", "pmid": "", "publication_date": "2024-03-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1194, "title": "Ethical considerations for psychedelic-assisted therapy in military clinical settings.", "authors": "Hoener S, Wolfgang A, Nissan D, Howe E", "journal": "Journal of medical ethics", "publication_date": "2024-03-20", "publication_year": 2024, "doi": "10.1136/jme-2023-108943", "pubmed_id": "37253556", "openalex_id": "https://openalex.org/W4378782490", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37253556/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:37253556", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37253556/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37253556", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37253556/", "doi": "10.1136/jme-2023-108943", "pmid": "37253556", "publication_date": "2024-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4664, "title": "Psychedelic drugs and the law: What’s next?", "authors": "Ben Seal", "journal": "Knowable Magazine", "publication_date": "2024-03-14", "publication_year": 2024, "doi": "10.1146/knowable-031424-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392794286", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1146/knowable-031424-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1146/knowable-031424-2", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "doi": "10.1146/knowable-031424-2", "pmid": "", "publication_date": "2024-03-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1205, "title": "New evidence for flexible psilocybin dosing in patients with treatment-resistant depression.", "authors": "Aaronson ST, Kozak Z", "journal": "Med (New York, N.Y.)", "publication_date": "2024-03-08", "publication_year": 2024, "doi": "10.1016/j.medj.2024.01.014", "pubmed_id": "38359837", "openalex_id": "https://openalex.org/W4391810224", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359837/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38359837", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38359837/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38359837", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359837/", "doi": "10.1016/j.medj.2024.01.014", "pmid": "38359837", "publication_date": "2024-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1204, "title": "Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.", "authors": "Rosenblat JD, Meshkat S, Doyle Z, Kaczmarek E, Brudner RM, Kratiuk K, Mansur RB, Schulz-Quach C, Sethi R, Abate A, Ali S, Bawks J, Blainey MG, Brietzke E, Cronin V, Danilewitz J, Dhawan S, Di Fonzo A, Di Fonzo M, Drzadzewski P, Dunlop W, Fiszter H, Gomes FA, Grewal S, Leon-Carlyle M, McCallum M, Mofidi N, Offman H, Riva-Cambrin J, Schmidt J, Smolkin M, Quinn JM, Zumrova A, Marlborough M, McIntyre RS", "journal": "Med (New York, N.Y.)", "publication_date": "2024-03-08", "publication_year": 2024, "doi": "10.1016/j.medj.2024.01.005", "pubmed_id": "38359838", "openalex_id": "https://openalex.org/W4391810199", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359838/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Personality Change,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38359838", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38359838/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38359838", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359838/", "doi": "10.1016/j.medj.2024.01.005", "pmid": "38359838", "publication_date": "2024-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4667, "title": "Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder", "authors": "Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe", "journal": "International Journal of Mental Health and Addiction", "publication_date": "2024-03-07", "publication_year": 2024, "doi": "10.1007/s11469-024-01253-9", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392550813", "source_url": "https://doi.org/10.1007/s11469-024-01253-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1007/s11469-024-01253-9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s11469-024-01253-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s11469-024-01253-9", "source_url": "https://doi.org/10.1007/s11469-024-01253-9", "doi": "10.1007/s11469-024-01253-9", "pmid": "", "publication_date": "2024-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1214, "title": "Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.", "authors": "Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1016/j.euroneuro.2023.12.006", "pubmed_id": "38141403", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38141403/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38141403", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38141403/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38141403", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38141403/", "doi": "10.1016/j.euroneuro.2023.12.006", "pmid": "38141403", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1201, "title": "American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey.", "authors": "Barnett BS, Arakelian M, Beebe D, Ontko J, Riegal C, Siu WO, Weleff J, Pope HG", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0036", "pubmed_id": "40051760", "openalex_id": "https://openalex.org/W4386824127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051760/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:40051760", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051760/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051760", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051760/", "doi": "10.1089/psymed.2023.0036", "pmid": "40051760", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3282, "title": "The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s Journey", "authors": "Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL.", "journal": "Research Square", "publication_date": "2024-02-23", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3941205/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3941205/v1", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:18", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3941205/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3941205/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3941205/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3941205/v1", "doi": "10.21203/rs.3.rs-3941205/v1", "pmid": "", "publication_date": "2024-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1232, "title": "Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.", "authors": "Pagni BA, Petridis PD, Podrebarac SK, Grinband J, Claus ED, Bogenschutz MP", "journal": "Scientific reports", "publication_date": "2024-02-07", "publication_year": 2024, "doi": "10.1038/s41598-024-52967-8", "pubmed_id": "38326432", "openalex_id": "https://openalex.org/W4391617258", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38326432/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Aging,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38326432", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38326432/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38326432", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38326432/", "doi": "10.1038/s41598-024-52967-8", "pmid": "38326432", "publication_date": "2024-02-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1231, "title": "Psychedelics and sexual functioning: a mixed-methods study.", "authors": "Barba T, Kettner H, Radu C, Peill JM, Roseman L, Nutt DJ, Erritzoe D, Carhart-Harris R, Giribaldi B", "journal": "Scientific reports", "publication_date": "2024-02-07", "publication_year": 2024, "doi": "10.1038/s41598-023-49817-4", "pubmed_id": "38326446", "openalex_id": "https://openalex.org/W4391630740", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38326446/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38326446", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38326446/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38326446", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38326446/", "doi": "10.1038/s41598-023-49817-4", "pmid": "38326446", "publication_date": "2024-02-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1235, "title": "Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.", "authors": "Breeksema JJ, Niemeijer A, Krediet E, Karsten T, Kamphuis J, Vermetten E, van den Brink W, Schoevers R", "journal": "Scientific reports", "publication_date": "2024-02-05", "publication_year": 2024, "doi": "10.1038/s41598-024-53188-9", "pubmed_id": "38316896", "openalex_id": "https://openalex.org/W4391540455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38316896/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38316896", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38316896/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38316896", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38316896/", "doi": "10.1038/s41598-024-53188-9", "pmid": "38316896", "publication_date": "2024-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1247, "title": "The development of psilocybin therapy for treatment-resistant depression: an update.", "authors": "Borissova A, Rucker JJ", "journal": "BJPsych bulletin", "publication_date": "2024-02-01", "publication_year": 2024, "doi": "10.1192/bjb.2023.25", "pubmed_id": "37357767", "openalex_id": "https://openalex.org/W4382010877", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37357767/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:37357767", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37357767/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37357767", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37357767/", "doi": "10.1192/bjb.2023.25", "pmid": "37357767", "publication_date": "2024-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1246, "title": "The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.", "authors": "Videira NB, Nair V, Paquet V, Calhoun D", "journal": "Journal of applied toxicology: JAT", "publication_date": "2024-02-01", "publication_year": 2024, "doi": "10.1002/jat.4533", "pubmed_id": "37646119", "openalex_id": "https://openalex.org/W4386272089", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37646119/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Emotional Processing,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:37646119", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37646119/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37646119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37646119/", "doi": "10.1002/jat.4533", "pmid": "37646119", "publication_date": "2024-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4677, "title": "Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach", "authors": "Phil Wolfson, Gita Vaid", "journal": "Frontiers in Psychiatry", "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1209419", "pubmed_id": "38362026", "openalex_id": "https://openalex.org/W4391444130", "source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 06:34:44", "bibtex": null, "source_record_id": "PMID:38362026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38362026", "source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "doi": "10.3389/fpsyt.2024.1209419", "pmid": "38362026", "publication_date": "2024-01-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4681, "title": "Psilocybin-assisted psychotherapy for cancer patients", "authors": "Houman Farzin", "journal": "International Journal of Whole Person Care", "publication_date": "2024-01-29", "publication_year": 2024, "doi": "10.26443/ijwpc.v11i1.390", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391329406", "source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Consciousness,Spirituality,Clinical Trial,Case Report,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "DOI:10.26443/ijwpc.v11i1.390", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26443/ijwpc.v11i1.390", "source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "doi": "10.26443/ijwpc.v11i1.390", "pmid": "", "publication_date": "2024-01-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5807, "title": "How should psychotherapy proceed when adjoined with psychedelics?", "authors": "Marc J. Weintraub, David J. Miklowitz", "journal": "World Psychiatry", "publication_date": "2024-01-12", "publication_year": 2024, "doi": "10.1002/wps.21170", "pubmed_id": "38214635", "openalex_id": "https://openalex.org/W4390795044", "source_url": "https://doi.org/10.1002/wps.21170", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Consciousness,Emotional Processing,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:31", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "PMID:38214635", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.21170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38214635", "source_url": "https://doi.org/10.1002/wps.21170", "doi": "10.1002/wps.21170", "pmid": "38214635", "publication_date": "2024-01-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1260, "title": "Serotonin 2A Receptor (5-HTR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.", "authors": "Duan W, Cao D, Wang S, Cheng J", "journal": "Chemical reviews", "publication_date": "2024-01-10", "publication_year": 2024, "doi": "10.1021/acs.chemrev.3c00375", "pubmed_id": "38033123", "openalex_id": "https://openalex.org/W4389164252", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38033123/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38033123", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38033123/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38033123", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38033123/", "doi": "10.1021/acs.chemrev.3c00375", "pmid": "38033123", "publication_date": "2024-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3623, "title": "Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2024-01-05", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05562973", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05562973", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05562973", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05562973", "source_url": "https://clinicaltrials.gov/study/NCT05562973", "doi": "", "pmid": "", "publication_date": "2024-01-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3174, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial", "authors": "Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X.", "journal": "Research Square", "publication_date": "2024-01-04", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3829237/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "doi": "10.21203/rs.3.rs-3829237/v1", "pmid": "", "publication_date": "2024-01-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5808, "title": "Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary", "authors": "Michael D. Alpert, Kelley C. O’Donnell, Casey A. Paleos, Evan Sola, Christopher S. Stauffer, Anne Catherine Wagner, Christopher R. Nicholas, Michael C. Mithoefer", "journal": "American Journal of Psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230665", "pubmed_id": "38161307", "openalex_id": "https://openalex.org/W4390485036", "source_url": "https://doi.org/10.1176/appi.ajp.20230665", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:31", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "PMID:38161307", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230665", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38161307", "source_url": "https://doi.org/10.1176/appi.ajp.20230665", "doi": "10.1176/appi.ajp.20230665", "pmid": "38161307", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4700, "title": "Psychedelics: The New Kid on the Block", "authors": "Prosenjit Ghosh, Avinash Desousa", "journal": "Annals of Indian Psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.4103/aip.aip_195_23", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392949566", "source_url": "https://doi.org/10.4103/aip.aip_195_23", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,End-of-Life Distress,Chronic Pain,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Adolescents,Cancer Patients,Treatment-Resistant Depression,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.4103/aip.aip_195_23", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4103/aip.aip_195_23", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4103/aip.aip_195_23", "source_url": "https://doi.org/10.4103/aip.aip_195_23", "doi": "10.4103/aip.aip_195_23", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1296, "title": "Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.", "authors": "Koning E, Brietzke E", "journal": "Trends in psychiatry and psychotherapy", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.47626/2237-6089-2022-0597", "pubmed_id": "37126863", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37126863/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Emotional Processing,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37126863", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37126863/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37126863", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37126863/", "doi": "10.47626/2237-6089-2022-0597", "pmid": "37126863", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1295, "title": "Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.", "authors": "Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D", "journal": "Psychological medicine", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1017/s0033291723001514", "pubmed_id": "37264814", "openalex_id": "https://openalex.org/W4379093876", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37264814/", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37264814", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37264814/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37264814", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37264814/", "doi": "10.1017/s0033291723001514", "pmid": "37264814", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1289, "title": "When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.", "authors": "Jacobs E, Murphy-Beiner A, Rouiller I, Nutt D, Spriggs MJ", "journal": "Neuroethics", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1007/s12152-023-09536-z", "pubmed_id": "37942467", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37942467/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37942467", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37942467/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37942467", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37942467/", "doi": "10.1007/s12152-023-09536-z", "pmid": "37942467", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1287, "title": "The psychedelic effects of cannabis: A review of the literature.", "authors": "Wolinsky D, Barrett FS, Vandrey R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1177/02698811231209194", "pubmed_id": "37947321", "openalex_id": "https://openalex.org/W4388557290", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37947321/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Consciousness,Aging,Mystical Experience,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37947321", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37947321/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37947321", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37947321/", "doi": "10.1177/02698811231209194", "pmid": "37947321", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1285, "title": "Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.", "authors": "Hovmand OR, Poulsen ED, Arnfred S", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1177/02698811231200019", "pubmed_id": "37969069", "openalex_id": "https://openalex.org/W4388731626", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37969069/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37969069", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37969069/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37969069", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37969069/", "doi": "10.1177/02698811231200019", "pmid": "37969069", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1281, "title": "Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.", "authors": "Borkel LF, Rojas-Hernández J, Henríquez-Hernández LA, Santana Del Pino Á, Quintana-Hernández DJ", "journal": "Expert review of clinical pharmacology", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/17512433.2023.2295997", "pubmed_id": "38108102", "openalex_id": "https://openalex.org/W4389900041", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38108102/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Wellbeing,Personality Change,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38108102", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38108102/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38108102", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38108102/", "doi": "10.1080/17512433.2023.2295997", "pmid": "38108102", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1273, "title": "CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.", "authors": "Madsen MK, Petersen AS, Stenbaek DS, Sørensen IM, Schiønning H, Fjeld T, Nykjaer CH, Larsen SMU, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM", "journal": "Headache", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1111/head.14656", "pubmed_id": "38238974", "openalex_id": "https://openalex.org/W4391036082", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38238974/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38238974", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38238974/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38238974", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38238974/", "doi": "10.1111/head.14656", "pmid": "38238974", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1272, "title": "Older adults in psychedelic-assisted therapy trials: A systematic review.", "authors": "Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1177/02698811231215420", "pubmed_id": "38240068", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38240068/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Aging,Clinical Trial,Systematic Review,Review Article,Older Adults,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38240068", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38240068/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38240068", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38240068/", "doi": "10.1177/02698811231215420", "pmid": "38240068", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1271, "title": "The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.", "authors": "Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R", "journal": "Current neuropharmacology", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.2174/1570159x22666231027111147", "pubmed_id": "38284341", "openalex_id": "https://openalex.org/W4390628394", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38284341/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38284341", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38284341/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38284341", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38284341/", "doi": "10.2174/1570159x22666231027111147", "pmid": "38284341", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1257, "title": "Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.", "authors": "E-Wen McCulloch D, Liechti ME, Kuypers KP, Nutt D, Lundberg J, Stenbæk DS, Goodwin GM, Gründer G, Butlen-Ducuing F, Haberkamp M, Thirstrup S, Knudsen GM", "journal": "Neuroscience applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.103938", "pubmed_id": "40656112", "openalex_id": "https://openalex.org/W4390754521", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656112/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:40656112", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656112/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656112/", "doi": "10.1016/j.nsa.2024.103938", "pmid": "40656112", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1225, "title": "Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.", "authors": "Fang S, Yang X, Zhang W", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1359088", "pubmed_id": "38426002", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38426002/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38426002", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38426002/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38426002", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38426002/", "doi": "10.3389/fpsyt.2024.1359088", "pmid": "38426002", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1210, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS", "journal": "American journal of therapeutics", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001727", "pubmed_id": "38518266", "openalex_id": "https://openalex.org/W4393098943", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518266/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthcare Workers,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38518266", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38518266/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38518266", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518266/", "doi": "10.1097/mjt.0000000000001727", "pmid": "38518266", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1209, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS", "journal": "American journal of therapeutics", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001724", "pubmed_id": "38518269", "openalex_id": "https://openalex.org/W4393098899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518269/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38518269", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38518269/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38518269", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518269/", "doi": "10.1097/mjt.0000000000001724", "pmid": "38518269", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1199, "title": "The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.", "authors": "Levin AW, Lancelotta R, Sepeda ND, Gukasyan N, Nayak S, Wagener TL, Barrett FS, Griffiths RR, Davis AK", "journal": "PloS one", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1371/journal.pone.0300501", "pubmed_id": "38483940", "openalex_id": "https://openalex.org/W4392797453", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38483940/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38483940", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38483940/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38483940", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38483940/", "doi": "10.1371/journal.pone.0300501", "pmid": "38483940", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1187, "title": "Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.", "authors": "Thomas KL, Jesse R, Mehtani NJ, Mitchell JM, Anderson BT", "journal": "Journal of psychoactive drugs", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/02791072.2023.2201244", "pubmed_id": "37061961", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37061961/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:37061961", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37061961/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37061961", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37061961/", "doi": "10.1080/02791072.2023.2201244", "pmid": "37061961", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1167, "title": "The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov.", "authors": "Norring SA, Spigarelli MG", "journal": "Drug design, development and therapy", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.2147/dddt.s443177", "pubmed_id": "38618282", "openalex_id": "https://openalex.org/W4394684735", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38618282/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38618282", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38618282/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38618282", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38618282/", "doi": "10.2147/dddt.s443177", "pmid": "38618282", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1110, "title": "Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.", "authors": "Szafoni S, Gręblowski P, Grabowska K, Więckiewicz G", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1406888", "pubmed_id": "38919636", "openalex_id": "https://openalex.org/W4399572299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38919636/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38919636", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38919636/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38919636", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38919636/", "doi": "10.3389/fpsyt.2024.1406888", "pmid": "38919636", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1100, "title": "Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension.", "authors": "Jones GM, Ricard JA, Nock MK", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1169686", "pubmed_id": "38979507", "openalex_id": "https://openalex.org/W4399977372", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38979507/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38979507", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38979507/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38979507", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38979507/", "doi": "10.3389/fpsyt.2024.1169686", "pmid": "38979507", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1076, "title": "Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.", "authors": "Do A, Michaud V, Stephan JF, Moreau M, Benoît É, Bérubé FA, Bibaud-De Serres A, Taillefer A, Vincent P", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1394962", "pubmed_id": "39086732", "openalex_id": "https://openalex.org/W4400695899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39086732/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Case Report,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:39086732", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39086732/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39086732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39086732/", "doi": "10.3389/fpsyt.2024.1394962", "pmid": "39086732", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1053, "title": "The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.", "authors": "Chen MH, Cheng SL, Kao YC, Tseng PT, Hsu CW, Yu CL, Yang FC, Thompson T, Hsu TW, Liang CS", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1439347", "pubmed_id": "39193583", "openalex_id": "https://openalex.org/W4401603200", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39193583/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39193583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39193583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39193583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39193583/", "doi": "10.3389/fpsyt.2024.1439347", "pmid": "39193583", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 986, "title": "A narrative exploration of psilocybin's potential in mental health.", "authors": "Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1429373", "pubmed_id": "39540010", "openalex_id": "https://openalex.org/W4403895310", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39540010/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39540010", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39540010/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39540010", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39540010/", "doi": "10.3389/fpsyt.2024.1429373", "pmid": "39540010", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 974, "title": "Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.", "authors": "Rucker J, Butler M, Hambleton S, Bird C, Seynaeve M, Cheema S, Campbell-Coker K, Maggio C, Dunbar F, Lambru G, Matharu M", "journal": "Headache", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1111/head.14837", "pubmed_id": "39301810", "openalex_id": "https://openalex.org/W4402697828", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39301810/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Receptor Pharmacology,Consciousness,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39301810", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39301810/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39301810", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39301810/", "doi": "10.1111/head.14837", "pmid": "39301810", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 928, "title": "Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.", "authors": "Brett J, Knock E, Watson K, Albert S, Siefried KJ, Guss J", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1490907", "pubmed_id": "39713770", "openalex_id": "https://openalex.org/W4405122998", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39713770/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Aging,Emotional Processing,Clinical Trial,Case Report,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39713770", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39713770/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39713770", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39713770/", "doi": "10.3389/fpsyt.2024.1490907", "pmid": "39713770", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5702, "title": "Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge", "authors": "Verheijen Marcha C.T.", "journal": "Journal of the Netherlands Society of Toxicology", "publication_date": "2023-12-30", "publication_year": 2023, "doi": "10.61833/jnst.2024.0002", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399023496", "source_url": "https://doi.org/10.61833/jnst.2024.0002", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.61833/jnst.2024.0002", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.61833/jnst.2024.0002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.61833/jnst.2024.0002", "source_url": "https://doi.org/10.61833/jnst.2024.0002", "doi": "10.61833/jnst.2024.0002", "pmid": "", "publication_date": "2023-12-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3780, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": "10.31234/osf.io/byms6", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/byms6", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-08-09 08:15:20", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/byms6", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/byms6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/byms6", "source_url": "https://doi.org/10.31234/osf.io/byms6", "doi": "10.31234/osf.io/byms6", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3751, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": "10.31234/osf.io/a8xwk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-08-09 08:15:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/a8xwk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/a8xwk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/a8xwk", "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "doi": "10.31234/osf.io/a8xwk", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3293, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/byms6_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/byms6_v1", "source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "doi": "", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3133, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "doi": "", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4725, "title": "Application of psilocybin in mental health disorders", "authors": "Jingxuan Chen", "journal": "Theoretical and Natural Science", "publication_date": "2023-12-20", "publication_year": 2023, "doi": "10.54254/2753-8818/21/20230859", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390006951", "source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.54254/2753-8818/21/20230859", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54254/2753-8818/21/20230859", "source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "doi": "10.54254/2753-8818/21/20230859", "pmid": "", "publication_date": "2023-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1306, "title": "Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats.", "authors": "Reinwald JR, Schmitz CN, Skorodumov I, Kuchar M, Weber-Fahr W, Spanagel R, Meinhardt MW", "journal": "Translational psychiatry", "publication_date": "2023-12-14", "publication_year": 2023, "doi": "10.1038/s41398-023-02690-1", "pubmed_id": "38097569", "openalex_id": "https://openalex.org/W4389728826", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38097569/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Default Mode Network,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38097569", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38097569/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38097569", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38097569/", "doi": "10.1038/s41398-023-02690-1", "pmid": "38097569", "publication_date": "2023-12-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3152, "title": "Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms", "authors": "Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C.", "journal": "bioRxiv", "publication_date": "2023-12-13", "publication_year": 2023, "doi": "10.1101/2023.12.12.571374", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.12.12.571374", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:05", "bibtex": null, "source_record_id": "DOI:10.1101/2023.12.12.571374", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.12.12.571374", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.12.12.571374", "source_url": "https://doi.org/10.1101/2023.12.12.571374", "doi": "10.1101/2023.12.12.571374", "pmid": "", "publication_date": "2023-12-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4726, "title": "Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin", "authors": "Ivana Turek", "journal": "Medical Writing", "publication_date": "2023-12-11", "publication_year": 2023, "doi": "10.56012/tsen2260", "pubmed_id": null, "openalex_id": "https://openalex.org/W4389763815", "source_url": "http://dx.doi.org/10.56012/tsen2260", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.56012/tsen2260", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56012/tsen2260", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56012/tsen2260", "source_url": "http://dx.doi.org/10.56012/tsen2260", "doi": "10.56012/tsen2260", "pmid": "", "publication_date": "2023-12-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4731, "title": "A history and future of psychedelics: The case of the Canadian military.", "authors": "Dyck E, Marchildon GP", "journal": "Journal of military, veteran and family health", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.3138/jmvfh-2023-0010", "pubmed_id": "42533891", "openalex_id": "https://openalex.org/W4389614071", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42533891/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Veterans", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:42533891", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42533891/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42533891", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42533891/", "doi": "10.3138/jmvfh-2023-0010", "pmid": "42533891", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1327, "title": "Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.", "authors": "Gramling R, Bennett E, Curtis K, Richards W, Rizzo DM, Arnoldy F, Hegg L, Porter J, Honstein H, Pratt S, Tarbi E, Reblin M, Thambi P, Agrawal M", "journal": "Journal of palliative medicine", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1089/jpm.2023.0189", "pubmed_id": "37590474", "openalex_id": "https://openalex.org/W4385932674", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37590474/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Consciousness,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37590474", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37590474/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37590474", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37590474/", "doi": "10.1089/jpm.2023.0189", "pmid": "37590474", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1324, "title": "Potential use of psilocybin drugs in the treatment of depression.", "authors": "Śladowska K, Kawalec P, Brzostek T, Pilc A", "journal": "Expert opinion on emerging drugs", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1080/14728214.2023.2264180", "pubmed_id": "37817501", "openalex_id": "https://openalex.org/W4387516067", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817501/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37817501", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37817501/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37817501", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817501/", "doi": "10.1080/14728214.2023.2264180", "pmid": "37817501", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1323, "title": "Cardiovascular safety of psychedelic medicine: current status and future directions.", "authors": "Wsół A", "journal": "Pharmacological reports: PR", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1007/s43440-023-00539-4", "pubmed_id": "37874530", "openalex_id": "https://openalex.org/W4387893679", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37874530/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Microdosing,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37874530", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37874530/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37874530", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37874530/", "doi": "10.1007/s43440-023-00539-4", "pmid": "37874530", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1321, "title": "Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.", "authors": "Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST", "journal": "Drug discovery today", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1016/j.drudis.2023.103818", "pubmed_id": "37925136", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37925136/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37925136", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37925136/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37925136", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37925136/", "doi": "10.1016/j.drudis.2023.103818", "pmid": "37925136", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1314, "title": "Perceptions of psychedelic-assisted therapy among Black Americans.", "authors": "Carter S, Packard G, Coghlan C, George JR, Brown AJ, Ching THW, Julian J, Maples-Keller JL", "journal": "Journal of mood and anxiety disorders", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1016/j.xjmad.2023.100023", "pubmed_id": "40656968", "openalex_id": "https://openalex.org/W4387063622", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656968/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Observational Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:40656968", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656968/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656968", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656968/", "doi": "10.1016/j.xjmad.2023.100023", "pmid": "40656968", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1309, "title": "Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.", "authors": "Weintraub MJ, Jeffrey JK, Grob CS, Ichinose MC, Bergman RL, Cooper ZD, Miklowitz DJ", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0018", "pubmed_id": "40046861", "openalex_id": "https://openalex.org/W4386469528", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046861/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:40046861", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046861/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046861", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046861/", "doi": "10.1089/psymed.2023.0018", "pmid": "40046861", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1308, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.", "authors": "Brennan W, Kelman AR, Belser AB", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0007", "pubmed_id": "40046864", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046864/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:40046864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046864/", "doi": "10.1089/psymed.2023.0007", "pmid": "40046864", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4733, "title": "Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials", "authors": "Tahlia R. Harrison", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-20", "publication_year": 2023, "doi": "10.1556/2054.2023.00267", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388822593", "source_url": "https://doi.org/10.1556/2054.2023.00267", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00267", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2023.00267", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00267", "source_url": "https://doi.org/10.1556/2054.2023.00267", "doi": "10.1556/2054.2023.00267", "pmid": "", "publication_date": "2023-11-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4735, "title": "Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness", "authors": "Danelle Jones", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-16", "publication_year": 2023, "doi": "10.1556/2054.2023.00306", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388730617", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00306", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00306", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "doi": "10.1556/2054.2023.00306", "pmid": "", "publication_date": "2023-11-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1349, "title": "\"But the reality is it's happening\": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.", "authors": "Downey AE, Boyd M, Chaphekar AV, Woolley J, Raymond-Flesch M", "journal": "The International journal of eating disorders", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1002/eat.24041", "pubmed_id": "37551650", "openalex_id": "https://openalex.org/W4385664009", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37551650/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37551650", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37551650/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37551650", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37551650/", "doi": "10.1002/eat.24041", "pmid": "37551650", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1342, "title": "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.", "authors": "Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD", "journal": "Psychiatry research", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1016/j.psychres.2023.115531", "pubmed_id": "37844352", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37844352/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37844352", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37844352/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37844352", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37844352/", "doi": "10.1016/j.psychres.2023.115531", "pmid": "37844352", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1358, "title": "Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2023-10-12", "publication_year": 2023, "doi": "10.1021/acsmedchemlett.3c00390", "pubmed_id": "37849550", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37849550/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37849550", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37849550/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37849550", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37849550/", "doi": "10.1021/acsmedchemlett.3c00390", "pmid": "37849550", "publication_date": "2023-10-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4754, "title": "Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?", "authors": "Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain", "journal": "Clinical Pharmacology & Therapeutics", "publication_date": "2023-10-05", "publication_year": 2023, "doi": "10.1002/cpt.3050", "pubmed_id": "37795632", "openalex_id": "https://openalex.org/W4387357883", "source_url": "https://doi.org/10.1002/cpt.3050", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Microdosing,Wellbeing,Clinical Trial,Healthcare Workers,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "PMID:37795632", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cpt.3050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37795632", "source_url": "https://doi.org/10.1002/cpt.3050", "doi": "10.1002/cpt.3050", "pmid": "37795632", "publication_date": "2023-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1360, "title": "An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).", "authors": "Donegan CJ, Daldegan-Bueno D, Sumner R, Menkes D, Evans W, Hoeh N, Sundram F, Reynolds L, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Forsyth A, Bansal M, Muthukumaraswamy S", "journal": "Pilot and feasibility studies", "publication_date": "2023-10-05", "publication_year": 2023, "doi": "10.1186/s40814-023-01399-8", "pubmed_id": "37798662", "openalex_id": "https://openalex.org/W4387372869", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37798662/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37798662", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37798662/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37798662", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37798662/", "doi": "10.1186/s40814-023-01399-8", "pmid": "37798662", "publication_date": "2023-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4758, "title": "6.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the Research", "authors": "Amanda E. Downey", "journal": "Journal of the American Academy of Child & Adolescent Psychiatry", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1016/j.jaac.2023.07.666", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387494383", "source_url": "https://doi.org/10.1016/j.jaac.2023.07.666", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.jaac.2023.07.666", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jaac.2023.07.666", "source_url": "https://doi.org/10.1016/j.jaac.2023.07.666", "doi": "10.1016/j.jaac.2023.07.666", "pmid": "", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1368, "title": "Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.", "authors": "Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S", "journal": "Journal of palliative medicine", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1089/jpm.2022.0604", "pubmed_id": "37167080", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Mechanism of Action,Spirituality,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37167080", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37167080", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "doi": "10.1089/jpm.2022.0604", "pmid": "37167080", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1364, "title": "Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.", "authors": "Wolfgang AS, Hoge CW", "journal": "Current psychiatry reports", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1007/s11920-023-01446-4", "pubmed_id": "37682446", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37682446/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Review Article,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37682446", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37682446/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37682446", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37682446/", "doi": "10.1007/s11920-023-01446-4", "pmid": "37682446", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1362, "title": "Use of Psychedelics for Pain: A Scoping Review.", "authors": "Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS", "journal": "Anesthesiology", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1097/aln.0000000000004673", "pubmed_id": "37698433", "openalex_id": "https://openalex.org/W4386624716", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37698433/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37698433", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37698433/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37698433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37698433/", "doi": "10.1097/aln.0000000000004673", "pmid": "37698433", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5704, "title": "Psilocybin-Assisted Therapy: A scoping review of participants’ and facilitators’ experiences in qualitative studies", "authors": "Schuitmaker Nicole", "journal": "Research, Society and Development", "publication_date": "2023-09-22", "publication_year": 2023, "doi": "10.33448/rsd-v12i9.43308", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387215851", "source_url": "https://doi.org/10.33448/rsd-v12i9.43308", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "DOI:10.33448/rsd-v12i9.43308", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.33448/rsd-v12i9.43308", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.33448/rsd-v12i9.43308", "source_url": "https://doi.org/10.33448/rsd-v12i9.43308", "doi": "10.33448/rsd-v12i9.43308", "pmid": "", "publication_date": "2023-09-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4764, "title": "Expectancies for Subjective and Antidepressant Effects in Psilocybin Users", "authors": "Mitch Earleywine, Maha N. Mian, Joseph A. De Leo", "journal": "Journal of Humanistic Psychology", "publication_date": "2023-09-22", "publication_year": 2023, "doi": "10.1177/00221678231194798", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386958768", "source_url": "https://doi.org/10.1177/00221678231194798", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "DOI:10.1177/00221678231194798", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678231194798", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678231194798", "source_url": "https://doi.org/10.1177/00221678231194798", "doi": "10.1177/00221678231194798", "pmid": "", "publication_date": "2023-09-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3573, "title": "Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-21", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04141501", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04141501", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04141501", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04141501", "source_url": "https://clinicaltrials.gov/study/NCT04141501", "doi": "", "pmid": "", "publication_date": "2023-09-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4769, "title": "The psychedelic experience and treatment-resistant depression", "authors": "Guy M. Goodwin", "journal": "World Psychiatry", "publication_date": "2023-09-15", "publication_year": 2023, "doi": "10.1002/wps.21140", "pubmed_id": "37713542", "openalex_id": "https://openalex.org/W4386765441", "source_url": "http://dx.doi.org/10.1002/wps.21140", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "PMID:37713542", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/wps.21140", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37713542", "source_url": "http://dx.doi.org/10.1002/wps.21140", "doi": "10.1002/wps.21140", "pmid": "37713542", "publication_date": "2023-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1374, "title": "Psychedelics: Threshold of a Therapeutic Revolution.", "authors": "Heal DJ, Smith SL, Belouin SJ, Henningfield JE", "journal": "Neuropharmacology", "publication_date": "2023-09-15", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109610", "pubmed_id": "37247807", "openalex_id": "https://openalex.org/W4378549583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37247807/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37247807", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37247807/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37247807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37247807/", "doi": "10.1016/j.neuropharm.2023.109610", "pmid": "37247807", "publication_date": "2023-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3543, "title": "Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions", "authors": "Lobe Sciences Ltd.", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-13", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06035900", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06035900", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06035900", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06035900", "source_url": "https://clinicaltrials.gov/study/NCT06035900", "doi": "", "pmid": "", "publication_date": "2023-09-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4775, "title": "Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training", "authors": "Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout, Jeremy Weleff", "journal": "American Journal of Psychiatry Residents Journal", "publication_date": "2023-09-08", "publication_year": 2023, "doi": "10.1176/appi.ajp-rj.2023.190103", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386544759", "source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "DOI:10.1176/appi.ajp-rj.2023.190103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.ajp-rj.2023.190103", "source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "doi": "10.1176/appi.ajp-rj.2023.190103", "pmid": "", "publication_date": "2023-09-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1379, "title": "Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.", "authors": "Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR", "journal": "JAMA", "publication_date": "2023-09-05", "publication_year": 2023, "doi": "10.1001/jama.2023.14530", "pubmed_id": "37651119", "openalex_id": "https://openalex.org/W4386305655", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37651119", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37651119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "doi": "10.1001/jama.2023.14530", "pmid": "37651119", "publication_date": "2023-09-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1393, "title": "Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.", "authors": "Goodwin GM, Croal M, Feifel D, Kelly JR, Marwood L, Mistry S, O'Keane V, Peck SK, Simmons H, Sisa C, Stansfield SC, Tsai J, Williams S, Malievskaia E", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1038/s41386-023-01648-7", "pubmed_id": "37443386", "openalex_id": "https://openalex.org/W4384130479", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37443386/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37443386", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37443386/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37443386", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37443386/", "doi": "10.1038/s41386-023-01648-7", "pmid": "37443386", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1389, "title": "The Potential of Psychedelics for the Treatment of Episodic Migraine.", "authors": "Schindler EAD", "journal": "Current pain and headache reports", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1007/s11916-023-01145-y", "pubmed_id": "37540398", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37540398/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37540398", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37540398/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37540398", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37540398/", "doi": "10.1007/s11916-023-01145-y", "pmid": "37540398", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1387, "title": "Psilocybin history, action and reaction: A narrative clinical review.", "authors": "Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1177/02698811231190858", "pubmed_id": "37650489", "openalex_id": "https://openalex.org/W4386305913", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37650489/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37650489", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37650489/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37650489", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37650489/", "doi": "10.1177/02698811231190858", "pmid": "37650489", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1375, "title": "Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0030", "pubmed_id": "40046570", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Resilience,Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:40046570", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046570", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "doi": "10.1089/psymed.2023.0030", "pmid": "40046570", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4786, "title": "Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2023-08-15", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.09.9.20", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385829163", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "doi": "10.1176/appi.pn.2023.09.9.20", "pmid": "", "publication_date": "2023-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3618, "title": "A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2023-08-15", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05478278", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05478278", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05478278", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05478278", "source_url": "https://clinicaltrials.gov/study/NCT05478278", "doi": "", "pmid": "", "publication_date": "2023-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1409, "title": "Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy.", "authors": "Thase ME", "journal": "The Journal of clinical psychiatry", "publication_date": "2023-08-14", "publication_year": 2023, "doi": "10.4088/jcp.mulmdd3048sho", "pubmed_id": "37585245", "openalex_id": "https://openalex.org/W4385689299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37585245/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37585245", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37585245/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37585245", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37585245/", "doi": "10.4088/jcp.mulmdd3048sho", "pmid": "37585245", "publication_date": "2023-08-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4788, "title": "Psilocybin's Emerging Role in Combating Depressive Disorder", "authors": "Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek", "journal": "Journal of Education Health and Sport", "publication_date": "2023-08-08", "publication_year": 2023, "doi": "10.12775/jehs.2023.40.01.011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385658334", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Neurogenesis,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Review Article,Animal Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "doi": "10.12775/jehs.2023.40.01.011", "pmid": "", "publication_date": "2023-08-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1413, "title": "[Not Available].", "authors": "Ibrahim IB, Videbech P, Straszek SPV", "journal": "Ugeskrift for laeger", "publication_date": "2023-08-07", "publication_year": 2023, "doi": null, "pubmed_id": "37615227", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37615227/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:37615227", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37615227/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37615227", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37615227/", "doi": "", "pmid": "37615227", "publication_date": "2023-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1424, "title": "Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.", "authors": "Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A", "journal": "Neuropharmacology", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109528", "pubmed_id": "37015315", "openalex_id": "https://openalex.org/W4362508370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37015315/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Spirituality,Clinical Trial,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37015315", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37015315/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37015315", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37015315/", "doi": "10.1016/j.neuropharm.2023.109528", "pmid": "37015315", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1420, "title": "Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.", "authors": "Jing X, Hoeh NR, Menkes DB", "journal": "Palliative & supportive care", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1017/s147895152300069x", "pubmed_id": "37334486", "openalex_id": "https://openalex.org/W4381158131", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37334486/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37334486", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37334486/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37334486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37334486/", "doi": "10.1017/s147895152300069x", "pmid": "37334486", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4791, "title": "Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-07-27", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.08.8.3", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385324763", "source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.08.8.3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.08.8.3", "source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "doi": "10.1176/appi.pn.2023.08.8.3", "pmid": "", "publication_date": "2023-07-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3519, "title": "The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study", "authors": "Brain and Cognition Discovery Foundation", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-27", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05029466", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05029466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "source_url": "https://clinicaltrials.gov/study/NCT05029466", "doi": "", "pmid": "", "publication_date": "2023-07-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3422, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions", "authors": "William Brennan, Alex Kelman, Alexander B. Belser", "journal": "PsyArXiv", "publication_date": "2023-07-18", "publication_year": 2023, "doi": "10.1089/psymed.2023.00071", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:04:24", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "DOI:10.1089/psymed.2023.00071", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1089/psymed.2023.00071", "source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "doi": "10.1089/psymed.2023.00071", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3380, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions", "authors": "Brennan B, Kelman A, Belser AB.", "journal": "PsyArXiv", "publication_date": "2023-07-18", "publication_year": 2023, "doi": "10.31234/osf.io/2ab59", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/2ab59", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:30", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/2ab59", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/2ab59", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/2ab59", "source_url": "https://doi.org/10.31234/osf.io/2ab59", "doi": "10.31234/osf.io/2ab59", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4792, "title": "Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings", "authors": "Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway", "journal": "Frontiers in Human Neuroscience", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.3389/fnhum.2023.1200393", "pubmed_id": "37533588", "openalex_id": "https://openalex.org/W4384695430", "source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 06:34:45", "bibtex": null, "source_record_id": "PMID:37533588", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37533588", "source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "doi": "10.3389/fnhum.2023.1200393", "pmid": "37533588", "publication_date": "2023-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5816, "title": "Outcomes of usage of psychedelics by people reporting an eating disorder in clinical and non-clinical settings: a scoping review", "authors": "Jorge Valdiviezo-Oña, Lizbeth Toscano-Molina, Juan Fernando Chávez, Jonathan Elias Herrera Criollo, Clara Paz", "journal": "Advances in Mental Health", "publication_date": "2023-07-13", "publication_year": 2023, "doi": "10.1080/18387357.2023.2235030", "pubmed_id": null, "openalex_id": "https://openalex.org/W4384154266", "source_url": "http://dx.doi.org/10.1080/18387357.2023.2235030", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Receptor Pharmacology,Wellbeing,Spirituality,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:35", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1080/18387357.2023.2235030", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1080/18387357.2023.2235030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/18387357.2023.2235030", "source_url": "http://dx.doi.org/10.1080/18387357.2023.2235030", "doi": "10.1080/18387357.2023.2235030", "pmid": "", "publication_date": "2023-07-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1432, "title": "[Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models].", "authors": "Chernoff T, Kliger B, Venturini DH", "journal": "Vertex (Buenos Aires, Argentina)", "publication_date": "2023-07-10", "publication_year": 2023, "doi": "10.53680/vertex.v34i160.463", "pubmed_id": "37562384", "openalex_id": "https://openalex.org/W4385197804", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37562384/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37562384", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37562384/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37562384", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37562384/", "doi": "10.53680/vertex.v34i160.463", "pmid": "37562384", "publication_date": "2023-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4799, "title": "Psychedelic drug psilocybin shows promise treating anorexia in early trials", "authors": "Grace Wade", "journal": "The New Scientist", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1016/s0262-4079(23)01394-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385336292", "source_url": "https://doi.org/10.1016/s0262-4079(23)01394-5", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1016/s0262-4079(23)01394-5", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0262-4079(23)01394-5", "source_url": "https://doi.org/10.1016/s0262-4079(23)01394-5", "doi": "10.1016/s0262-4079(23)01394-5", "pmid": "", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1451, "title": "The need for establishing best practices and gold standards in psychedelic medicine.", "authors": "Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM", "journal": "Journal of affective disorders", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.03.083", "pubmed_id": "37003433", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37003433/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37003433", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37003433/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37003433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37003433/", "doi": "10.1016/j.jad.2023.03.083", "pmid": "37003433", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1449, "title": "A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.", "authors": "Weiss B, Erritzoe D, Giribaldi B, Nutt DJ, Carhart-Harris RL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231167848", "pubmed_id": "37122239", "openalex_id": "https://openalex.org/W4367053025", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37122239/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37122239", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37122239/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37122239", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37122239/", "doi": "10.1177/02698811231167848", "pmid": "37122239", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1438, "title": "Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.", "authors": "Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231180276", "pubmed_id": "37403379", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37403379/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37403379", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37403379/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37403379", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37403379/", "doi": "10.1177/02698811231180276", "pmid": "37403379", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4801, "title": "FDA issues first draft guidance on psychedelic research", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2023-06-30", "publication_year": 2023, "doi": "10.1002/mhw.33697", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382680172", "source_url": "http://dx.doi.org/10.1002/mhw.33697", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.33697", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/mhw.33697", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.33697", "source_url": "http://dx.doi.org/10.1002/mhw.33697", "doi": "10.1002/mhw.33697", "pmid": "", "publication_date": "2023-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3538, "title": "Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder", "authors": "Halucenex Life Sciences Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2023-06-29", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05243329", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Neurogenesis,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05243329", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "source_url": "https://clinicaltrials.gov/study/NCT05243329", "doi": "", "pmid": "", "publication_date": "2023-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4803, "title": "Experts Offer Tips on Talking With Patients About Psychedelics", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-06-28", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.07.7.51", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382360061", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "doi": "10.1176/appi.pn.2023.07.7.51", "pmid": "", "publication_date": "2023-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1465, "title": "Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.", "authors": "Wulff AB, Nichols CD, Thompson SM", "journal": "Neuropharmacology", "publication_date": "2023-06-15", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109504", "pubmed_id": "36921889", "openalex_id": "https://openalex.org/W4324045013", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36921889/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:36921889", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36921889/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36921889", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36921889/", "doi": "10.1016/j.neuropharm.2023.109504", "pmid": "36921889", "publication_date": "2023-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4808, "title": "Psilocybin therapy: A novel approach to treating depression", "authors": "Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala", "journal": "International Journal of Surgery Global Health", "publication_date": "2023-06-02", "publication_year": 2023, "doi": "10.1097/gh9.0000000000000175", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379142909", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000175", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000175", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "doi": "10.1097/gh9.0000000000000175", "pmid": "", "publication_date": "2023-06-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1472, "title": "Global species diversity and distribution of the psychedelic fungal genus.", "authors": "Strauss D, Ghosh S, Murray Z, Gryzenhout M", "journal": "Heliyon", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1016/j.heliyon.2023.e16338", "pubmed_id": "37274634", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37274634/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37274634", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37274634/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37274634", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37274634/", "doi": "10.1016/j.heliyon.2023.e16338", "pmid": "37274634", "publication_date": "2023-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1466, "title": "Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.", "authors": "Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1089/psymed.2022.0011", "pubmed_id": "40046728", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Clinical Trial,Review Article,Cancer Patients,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:40046728", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046728", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "doi": "10.1089/psymed.2022.0011", "pmid": "40046728", "publication_date": "2023-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3219, "title": "Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism", "authors": "Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM.", "journal": "medRxiv", "publication_date": "2023-05-26", "publication_year": 2023, "doi": "10.1101/2023.05.25.23290521", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.05.25.23290521", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:12", "bibtex": null, "source_record_id": "DOI:10.1101/2023.05.25.23290521", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.05.25.23290521", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2023.05.25.23290521", "source_url": "https://doi.org/10.1101/2023.05.25.23290521", "doi": "10.1101/2023.05.25.23290521", "pmid": "", "publication_date": "2023-05-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3683, "title": "Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-19", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04842045", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04842045", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "source_url": "https://clinicaltrials.gov/study/NCT04842045", "doi": "", "pmid": "", "publication_date": "2023-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3063, "title": "Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders", "authors": "Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ.", "journal": "bioRxiv", "publication_date": "2023-05-18", "publication_year": 2023, "doi": "10.1101/2023.05.16.540994", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.05.16.540994", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:54", "bibtex": null, "source_record_id": "DOI:10.1101/2023.05.16.540994", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.05.16.540994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.05.16.540994", "source_url": "https://doi.org/10.1101/2023.05.16.540994", "doi": "10.1101/2023.05.16.540994", "pmid": "", "publication_date": "2023-05-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3634, "title": "A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-15", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05467761", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05467761", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "source_url": "https://clinicaltrials.gov/study/NCT05467761", "doi": "", "pmid": "", "publication_date": "2023-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1491, "title": "Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.", "authors": "Davis AK, Levin AW, Nagib PB, Armstrong SB, Lancelotta RL", "journal": "BMJ open", "publication_date": "2023-05-04", "publication_year": 2023, "doi": "10.1136/bmjopen-2022-068884", "pubmed_id": "37142308", "openalex_id": "https://openalex.org/W4372336620", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37142308/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Pharmacology,Clinical Trial,Review Article,Veterans,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37142308", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37142308/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37142308", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37142308/", "doi": "10.1136/bmjopen-2022-068884", "pmid": "37142308", "publication_date": "2023-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1497, "title": "Unblinding and demand characteristics in the treatment of depression.", "authors": "Goodwin GM, Croal M, Marwood L, Malievskaia E", "journal": "Journal of affective disorders", "publication_date": "2023-05-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.02.030", "pubmed_id": "36781142", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36781142", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36781142", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "doi": "10.1016/j.jad.2023.02.030", "pmid": "36781142", "publication_date": "2023-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1493, "title": "Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.", "authors": "Schneier FR, Feusner J, Wheaton MG, Gomez GJ, Cornejo G, Naraindas AM, Hellerstein DJ", "journal": "Journal of psychiatric research", "publication_date": "2023-05-01", "publication_year": 2023, "doi": "10.1016/j.jpsychires.2023.03.031", "pubmed_id": "37004409", "openalex_id": "https://openalex.org/W4361279088", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37004409/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37004409", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37004409/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37004409", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37004409/", "doi": "10.1016/j.jpsychires.2023.03.031", "pmid": "37004409", "publication_date": "2023-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3176, "title": "A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy", "authors": "Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R.", "journal": "medRxiv", "publication_date": "2023-04-19", "publication_year": 2023, "doi": "10.1101/2023.04.12.23288325", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.04.12.23288325", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.1101/2023.04.12.23288325", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.04.12.23288325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2023.04.12.23288325", "source_url": "https://doi.org/10.1101/2023.04.12.23288325", "doi": "10.1101/2023.04.12.23288325", "pmid": "", "publication_date": "2023-04-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1502, "title": "Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Atli M, Bennett JC, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Lennard-Jones MR, Licht RW, Marwood L, Mistry S, Páleníček T, Redjep O, Repantis D, Schoevers RA, Septimus B, Simmons HJ, Soares JC, Somers M, Stansfield SC, Stuart JR, Tadley HH, Thiara NK, Tsai J, Wahba M, Williams S, Winzer RI, Young AH, Young MB, Zisook S, Malievskaia E", "journal": "Journal of affective disorders", "publication_date": "2023-04-14", "publication_year": 2023, "doi": "10.1016/j.jad.2023.01.108", "pubmed_id": "36740140", "openalex_id": "https://openalex.org/W4319067008", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36740140/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36740140", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36740140/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36740140", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36740140/", "doi": "10.1016/j.jad.2023.01.108", "pmid": "36740140", "publication_date": "2023-04-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4826, "title": "Psychedelic Medicine: From Brain Science to Clinical Trials", "authors": "David Nutt", "journal": "Biological Psychiatry", "publication_date": "2023-04-09", "publication_year": 2023, "doi": "10.1016/j.biopsych.2023.02.022", "pubmed_id": null, "openalex_id": "https://openalex.org/W4363673488", "source_url": "http://dx.doi.org/10.1016/j.biopsych.2023.02.022", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Receptor Pharmacology,Default Mode Network,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 06:34:46", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2023.02.022", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2023.02.022", "source_url": "http://dx.doi.org/10.1016/j.biopsych.2023.02.022", "doi": "10.1016/j.biopsych.2023.02.022", "pmid": "", "publication_date": "2023-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1520, "title": "Microdosing psilocybin for chronic pain: a case series.", "authors": "Lyes M, Yang KH, Castellanos J, Furnish T", "journal": "Pain", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1097/j.pain.0000000000002778", "pubmed_id": "36066961", "openalex_id": "https://openalex.org/W4294804950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36066961/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Microdosing,Clinical Trial,Case Report", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36066961", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36066961/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36066961", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36066961/", "doi": "10.1097/j.pain.0000000000002778", "pmid": "36066961", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1518, "title": "Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.", "authors": "Holze F, Becker AM, Kolaczynska KE, Duthaler U, Liechti ME", "journal": "Clinical pharmacology and therapeutics", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1002/cpt.2821", "pubmed_id": "36507738", "openalex_id": "https://openalex.org/W4311205265", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36507738/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36507738", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36507738/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36507738", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36507738/", "doi": "10.1002/cpt.2821", "pmid": "36507738", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1517, "title": "Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.", "authors": "Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ", "journal": "Neurosurgery", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1227/neu.0000000000002275", "pubmed_id": "36512813", "openalex_id": "https://openalex.org/W4311273096", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36512813/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36512813", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36512813/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36512813", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36512813/", "doi": "10.1227/neu.0000000000002275", "pmid": "36512813", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1526, "title": "Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.", "authors": "Domanegg K, Sommer WH, Meinhardt MW", "journal": "Cells", "publication_date": "2023-03-22", "publication_year": 2023, "doi": "10.3390/cells12060963", "pubmed_id": "36980303", "openalex_id": "https://openalex.org/W4353070324", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36980303/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Epigenetics,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36980303", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36980303/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36980303", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36980303/", "doi": "10.3390/cells12060963", "pmid": "36980303", "publication_date": "2023-03-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3782, "title": "Understanding psychedelic 'mystical experience'-A case example", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": "10.31234/osf.io/dh92g", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/dh92g", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-08-09 08:15:21", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/dh92g", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/dh92g", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/dh92g", "source_url": "https://doi.org/10.31234/osf.io/dh92g", "doi": "10.31234/osf.io/dh92g", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3767, "title": "Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": "10.31234/osf.io/t6k9b", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/t6k9b", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/t6k9b", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/t6k9b", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/t6k9b", "source_url": "https://doi.org/10.31234/osf.io/t6k9b", "doi": "10.31234/osf.io/t6k9b", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3305, "title": "Understanding psychedelic 'mystical experience'-A case example", "authors": "Mika Turkia", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dh92g_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Wellbeing,Personality Change,Mystical Experience,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dh92g_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dh92g_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dh92g_v1", "source_url": "https://osf.io/preprints/psyarxiv/dh92g_v1", "doi": "", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3207, "title": "Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study", "authors": "Mika Turkia", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "doi": "", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4833, "title": "Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?", "authors": "Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand", "journal": "Clinical Chemistry", "publication_date": "2023-03-07", "publication_year": 2023, "doi": "10.1093/clinchem/hvad016", "pubmed_id": "36881769", "openalex_id": "https://openalex.org/W4323351497", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "PMID:36881769", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36881769", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "doi": "10.1093/clinchem/hvad016", "pmid": "36881769", "publication_date": "2023-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1542, "title": "Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.", "authors": "Jha MK, Mathew SJ", "journal": "The American journal of psychiatry", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1176/appi.ajp.20230025", "pubmed_id": "36855876", "openalex_id": "https://openalex.org/W4322719045", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36855876/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36855876", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36855876/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36855876", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36855876/", "doi": "10.1176/appi.ajp.20230025", "pmid": "36855876", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1534, "title": "A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression.", "authors": "Hibicke M, Kramer HM, Nichols CD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1089/psymed.2022.0012", "pubmed_id": "40047006", "openalex_id": "https://openalex.org/W4323041020", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047006/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Adolescents", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:40047006", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40047006/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40047006", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047006/", "doi": "10.1089/psymed.2022.0012", "pmid": "40047006", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1533, "title": "Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.", "authors": "Aday JS, Skiles Z, Eaton N, Fredenburg L, Pleet M, Mantia J, Bradley ER, Fernandes-Osterhold G, Woolley JD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1089/psymed.2022.0004", "pubmed_id": "40047007", "openalex_id": "https://openalex.org/W4321016287", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047007/", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Review Article,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:40047007", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40047007/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40047007", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047007/", "doi": "10.1089/psymed.2022.0004", "pmid": "40047007", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4844, "title": "Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease", "authors": "Ashish Sarangi, Omotola Akinkunmi", "journal": "American Journal of Geriatric Psychiatry", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1016/j.jagp.2022.12.201", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321014012", "source_url": "https://doi.org/10.1016/j.jagp.2022.12.201", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 06:34:46", "bibtex": null, "source_record_id": "DOI:10.1016/j.jagp.2022.12.201", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jagp.2022.12.201", "source_url": "https://doi.org/10.1016/j.jagp.2022.12.201", "doi": "10.1016/j.jagp.2022.12.201", "pmid": "", "publication_date": "2023-02-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1558, "title": "Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.", "authors": "Shnayder S, Ameli R, Sinaii N, Berger A, Agrawal M", "journal": "Journal of affective disorders", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1016/j.jad.2022.11.046", "pubmed_id": "36513161", "openalex_id": "https://openalex.org/W4312196530", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36513161/", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Spirituality,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36513161", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36513161/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36513161", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36513161/", "doi": "10.1016/j.jad.2022.11.046", "pmid": "36513161", "publication_date": "2023-02-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4848, "title": "The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy", "authors": "Jeffery Heilman", "journal": "Journal of Scientific Exploration", "publication_date": "2023-02-11", "publication_year": 2023, "doi": "10.31275/20222633", "pubmed_id": null, "openalex_id": "https://openalex.org/W4320035163", "source_url": "http://dx.doi.org/10.31275/20222633", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.31275/20222633", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.31275/20222633", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31275/20222633", "source_url": "http://dx.doi.org/10.31275/20222633", "doi": "10.31275/20222633", "pmid": "", "publication_date": "2023-02-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1573, "title": "Novel antidepressant drugs: Beyond monoamine targets.", "authors": "Gonda X, Dome P, Neill JC, Tarazi FI", "journal": "CNS spectrums", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1017/s1092852921000791", "pubmed_id": "34588093", "openalex_id": "https://openalex.org/W3204478846", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34588093/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:34588093", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34588093/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34588093", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34588093/", "doi": "10.1017/s1092852921000791", "pmid": "34588093", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1572, "title": "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.", "authors": "Ko K, Kopra EI, Cleare AJ, Rucker JJ", "journal": "Journal of affective disorders", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1016/j.jad.2022.09.168", "pubmed_id": "36209780", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36209780/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36209780", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36209780/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36209780", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36209780/", "doi": "10.1016/j.jad.2022.09.168", "pmid": "36209780", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1567, "title": "Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.", "authors": "von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX", "journal": "EClinicalMedicine", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1016/j.eclinm.2022.101809", "pubmed_id": "36636296", "openalex_id": "https://openalex.org/W4313530670", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36636296/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36636296", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36636296/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36636296", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36636296/", "doi": "10.1016/j.eclinm.2022.101809", "pmid": "36636296", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1566, "title": "Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.", "authors": "von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX", "journal": "EClinicalMedicine", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1016/j.eclinm.2023.101841", "pubmed_id": "36747965", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36747965/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36747965", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36747965/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36747965", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36747965/", "doi": "10.1016/j.eclinm.2023.101841", "pmid": "36747965", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3695, "title": "SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2023-01-30", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05601648", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05601648", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05601648", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05601648", "source_url": "https://clinicaltrials.gov/study/NCT05601648", "doi": "", "pmid": "", "publication_date": "2023-01-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1575, "title": "Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.", "authors": "Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P", "journal": "International journal of environmental research and public health", "publication_date": "2023-01-19", "publication_year": 2023, "doi": "10.3390/ijerph20031870", "pubmed_id": "36767234", "openalex_id": "https://openalex.org/W4317517597", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36767234/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36767234", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36767234/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36767234", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36767234/", "doi": "10.3390/ijerph20031870", "pmid": "36767234", "publication_date": "2023-01-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4855, "title": "Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial", "authors": "Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-01-18", "publication_year": 2023, "doi": "10.1556/2054.2022.00222", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317355030", "source_url": "https://doi.org/10.1556/2054.2022.00222", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00222", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00222", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00222", "source_url": "https://doi.org/10.1556/2054.2022.00222", "doi": "10.1556/2054.2022.00222", "pmid": "", "publication_date": "2023-01-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3568, "title": "Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "Keith Heinzerling", "journal": "ClinicalTrials.gov", "publication_date": "2023-01-17", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04410913", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Mystical Experience,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04410913", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04410913", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04410913", "source_url": "https://clinicaltrials.gov/study/NCT04410913", "doi": "", "pmid": "", "publication_date": "2023-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1577, "title": "On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression.", "authors": "Gukasyan N", "journal": "Med (New York, N.Y.)", "publication_date": "2023-01-13", "publication_year": 2023, "doi": "10.1016/j.medj.2022.12.003", "pubmed_id": "36640755", "openalex_id": "https://openalex.org/W4315874306", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36640755/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36640755", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36640755/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36640755", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36640755/", "doi": "10.1016/j.medj.2022.12.003", "pmid": "36640755", "publication_date": "2023-01-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5819, "title": "The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review", "authors": "Kaden Venugopal, Nefissa Bedri", "journal": "Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal", "publication_date": "2023-01-05", "publication_year": 2023, "doi": "10.26685/urncst.420", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313557238", "source_url": "https://doi.org/10.26685/urncst.420", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Microdosing,Spirituality,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:37", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.26685/urncst.420", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26685/urncst.420", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26685/urncst.420", "source_url": "https://doi.org/10.26685/urncst.420", "doi": "10.26685/urncst.420", "pmid": "", "publication_date": "2023-01-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4884, "title": "Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial", "authors": "Guy M. Goodwin, Megan Croal, J. Chai-Rees, Lindsey Marwood, S. Mistry, Anna Nowakowska, H. Clifton Simmons, Jeng-Yu Tsai", "journal": "Neuroscience Applied", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/j.nsa.2023.103487", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390222321", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103487", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.103487", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.103487", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103487", "doi": "10.1016/j.nsa.2023.103487", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4878, "title": "Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data", "authors": "Peter Hess", "journal": "The Transmitter", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.53053/etcr6498", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367666053", "source_url": "http://dx.doi.org/10.53053/etcr6498", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.53053/etcr6498", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.53053/etcr6498", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53053/etcr6498", "source_url": "http://dx.doi.org/10.53053/etcr6498", "doi": "10.53053/etcr6498", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4875, "title": "Going on Trial: Arbaclofen reboot; cell implants; psilocybin microdoses", "authors": "Peter Hess", "journal": "The Transmitter", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.53053/nbdr8957", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317889950", "source_url": "http://dx.doi.org/10.53053/nbdr8957", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.53053/nbdr8957", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.53053/nbdr8957", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53053/nbdr8957", "source_url": "http://dx.doi.org/10.53053/nbdr8957", "doi": "10.53053/nbdr8957", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4869, "title": "Psychedelic Drug Therapy for Mental Disorders?", "authors": "John R. Rossiter", "journal": "Open Journal of Medical Psychology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.4236/ojmp.2023.123010", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386593692", "source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.4236/ojmp.2023.123010", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4236/ojmp.2023.123010", "source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "doi": "10.4236/ojmp.2023.123010", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1611, "title": "The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.", "authors": "Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2022.2044096", "pubmed_id": "35225726", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225726/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35225726", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35225726/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35225726", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225726/", "doi": "10.1080/02791072.2022.2044096", "pmid": "35225726", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1608, "title": "The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.", "authors": "Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/07067437221111371", "pubmed_id": "35975555", "openalex_id": "https://openalex.org/W4292262959", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975555/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35975555", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35975555/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35975555", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975555/", "doi": "10.1177/07067437221111371", "pmid": "35975555", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1606, "title": "The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.", "authors": "Johnston CB, Mangini M, Grob C, Anderson B", "journal": "The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/j.jagp.2022.08.007", "pubmed_id": "36184377", "openalex_id": "https://openalex.org/W4294723946", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36184377/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36184377", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36184377/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36184377", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36184377/", "doi": "10.1016/j.jagp.2022.08.007", "pmid": "36184377", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1601, "title": "Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.", "authors": "Kious B, Schwartz Z, Lewis B", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/02698811221133461", "pubmed_id": "36377548", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36377548/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36377548", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36377548/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36377548", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36377548/", "doi": "10.1177/02698811221133461", "pmid": "36377548", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1597, "title": "Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.", "authors": "Morton E, Sakai K, Ashtari A, Pleet M, Michalak EE, Woolley J", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/02698811221131997", "pubmed_id": "36515370", "openalex_id": "https://openalex.org/W4311477082", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36515370/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36515370", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36515370/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36515370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36515370/", "doi": "10.1177/02698811221131997", "pmid": "36515370", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1595, "title": "Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.", "authors": "Henningfield JE, Ashworth J, Heal DJ, Smith SL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/02698811221140004", "pubmed_id": "36588452", "openalex_id": "https://openalex.org/W4313424238", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36588452/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36588452", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36588452/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36588452", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36588452/", "doi": "10.1177/02698811221140004", "pmid": "36588452", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1585, "title": "Efficacy and Safety of Psychedelics in Treating Anxiety Disorders.", "authors": "Feulner L, Sermchaiwong T, Rodland N, Galarneau D", "journal": "Ochsner journal", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.31486/toj.23.0076", "pubmed_id": "38143548", "openalex_id": "https://openalex.org/W4389868195", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38143548/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:38143548", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38143548/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38143548", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38143548/", "doi": "10.31486/toj.23.0076", "pmid": "38143548", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1584, "title": "Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment.", "authors": "Edelsohn GA, Sisti D", "journal": "Perspectives in biology and medicine", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1353/pbm.2023.0007", "pubmed_id": "38662012", "openalex_id": "https://openalex.org/W4324007078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38662012/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Personality Change,Clinical Trial,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:38662012", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38662012/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38662012", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38662012/", "doi": "10.1353/pbm.2023.0007", "pmid": "38662012", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1563, "title": "Therapeutic effect of psilocybin in addiction: A systematic review.", "authors": "van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE, Kramers K, Schellekens A, Somers M, Bossong MG, Batalla A", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1134454", "pubmed_id": "36846225", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36846225/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36846225", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36846225/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36846225", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36846225/", "doi": "10.3389/fpsyt.2023.1134454", "pmid": "36846225", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1530, "title": "Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.", "authors": "Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR, Patterson JC, Stauffer CS", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1123424", "pubmed_id": "36998623", "openalex_id": "https://openalex.org/W4324145541", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36998623/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36998623", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36998623/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36998623", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36998623/", "doi": "10.3389/fpsyt.2023.1123424", "pmid": "36998623", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1509, "title": "The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.", "authors": "IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I", "journal": "Innovations in clinical neuroscience", "publication_date": "2023-01-01", "publication_year": 2023, "doi": null, "pubmed_id": "37387703", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37387703/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:37387703", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37387703/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37387703", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37387703/", "doi": "", "pmid": "37387703", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1506, "title": "Use of Selective Alternative Therapies for Treatment of OCD.", "authors": "Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A", "journal": "Neuropsychiatric disease and treatment", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.2147/ndt.s403997", "pubmed_id": "37041856", "openalex_id": "https://openalex.org/W4362614112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37041856/", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37041856", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37041856/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37041856", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37041856/", "doi": "10.2147/ndt.s403997", "pmid": "37041856", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1480, "title": "Acute psilocybin increased cortical activities in rats.", "authors": "Liu J, Wang Y, Xia K, Wu J, Zheng D, Cai A, Yan H, Su R", "journal": "Frontiers in neuroscience", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fnins.2023.1168911", "pubmed_id": "37287797", "openalex_id": "https://openalex.org/W4378084778", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37287797/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37287797", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37287797/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37287797", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37287797/", "doi": "10.3389/fnins.2023.1168911", "pmid": "37287797", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1456, "title": "Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.", "authors": "De La Haye W, Walcott G, Eaton J, Beckford J, Greene J", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1136990", "pubmed_id": "37457761", "openalex_id": "https://openalex.org/W4382602456", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37457761/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Personality Change,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37457761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37457761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37457761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37457761/", "doi": "10.3389/fpsyt.2023.1136990", "pmid": "37457761", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1435, "title": "Adapting psychedelic medicine for headache and chronic pain disorders.", "authors": "Schindler EAD, Hendricks PS", "journal": "Expert review of neurotherapeutics", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/14737175.2023.2246655", "pubmed_id": "37652000", "openalex_id": "https://openalex.org/W4386317658", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37652000/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Clinical Trial,Review Article,Case Report,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37652000", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37652000/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37652000", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37652000/", "doi": "10.1080/14737175.2023.2246655", "pmid": "37652000", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1434, "title": "Assessing potential of psilocybin for depressive disorders.", "authors": "Kozak Z, Johnson MW, Aaronson ST", "journal": "Expert opinion on investigational drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/13543784.2023.2273493", "pubmed_id": "37869790", "openalex_id": "https://openalex.org/W4387866078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869790/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37869790", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37869790/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37869790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869790/", "doi": "10.1080/13543784.2023.2273493", "pmid": "37869790", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1402, "title": "Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.", "authors": "Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2022.2125467", "pubmed_id": "36127639", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Consciousness,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:36127639", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36127639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "doi": "10.1080/02791072.2022.2125467", "pmid": "36127639", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1399, "title": "An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.", "authors": "Kruger DJ, Glynos NG, Fields CW, Herberholz M, Boehnke KF", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2022.2142709", "pubmed_id": "36328419", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36328419/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Clinical Trial,Observational Study,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:36328419", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36328419/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36328419", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36328419/", "doi": "10.1080/02791072.2022.2142709", "pmid": "36328419", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1373, "title": "Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder.", "authors": "Heinzerling KG, Sergi K, Linton M, Rich R, Youssef B, Bentancourt I, Bramen J, Siddarth P, Schwartzberg L, Kelly DF", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1215972", "pubmed_id": "37795513", "openalex_id": "https://openalex.org/W4386849390", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37795513/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37795513", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37795513/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37795513", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37795513/", "doi": "10.3389/fpsyt.2023.1215972", "pmid": "37795513", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1361, "title": "Bedside to bench: the outlook for psychedelic research.", "authors": "Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK", "journal": "Frontiers in pharmacology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fphar.2023.1240295", "pubmed_id": "37869749", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Epigenetics,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37869749", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37869749", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "doi": "10.3389/fphar.2023.1240295", "pmid": "37869749", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1359, "title": "Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.", "authors": "Ko K, Carter B, Cleare AJ, Rucker JJ", "journal": "Neuropsychiatric disease and treatment", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.2147/ndt.s426193", "pubmed_id": "37818448", "openalex_id": "https://openalex.org/W4387389328", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37818448/", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Mystical Experience,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37818448", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37818448/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37818448", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37818448/", "doi": "10.2147/ndt.s426193", "pmid": "37818448", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1335, "title": "Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.", "authors": "Kvam TM, Uthaug MV, Andersen KAA, Refsum BB, Tunstad PA, Stewart LH, Jacobsen HB, Grønnerød C", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1287196", "pubmed_id": "38025484", "openalex_id": "https://openalex.org/W4388646562", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38025484/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:38025484", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38025484/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38025484", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38025484/", "doi": "10.3389/fpsyt.2023.1287196", "pmid": "38025484", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1256, "title": "Psychedelics, epilepsy, and seizures: a review.", "authors": "Freidel N, Kreuder L, Rabinovitch BS, Chen FY, Huang RST, Lewis EC", "journal": "Frontiers in pharmacology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fphar.2023.1326815", "pubmed_id": "38283836", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38283836/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Observational Study,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38283836", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38283836/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38283836", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38283836/", "doi": "10.3389/fphar.2023.1326815", "pmid": "38283836", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1615, "title": "Psilocybin for Depression: From Credibility to Feasibility, What's Missing?", "authors": "Munafò A, Arillotta D, Mannaioni G, Schifano F, Bernardini R, Cantarella G", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3390/ph16010068", "pubmed_id": "36678564", "openalex_id": "https://openalex.org/W4313471532", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36678564/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36678564", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36678564/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36678564", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36678564/", "doi": "10.3390/ph16010068", "pmid": "36678564", "publication_date": "2022-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1631, "title": "Set and setting in microdosing: an oft-overlooked principle.", "authors": "Hartogsohn I, Petranker R", "journal": "Psychopharmacology", "publication_date": "2022-12-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06249-8", "pubmed_id": "36289109", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36289109/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36289109", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36289109/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36289109", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36289109/", "doi": "10.1007/s00213-022-06249-8", "pmid": "36289109", "publication_date": "2022-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1630, "title": "Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.", "authors": "O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J, Ross S, Forcehimes AA, Bogenschutz MP", "journal": "Contemporary clinical trials", "publication_date": "2022-12-01", "publication_year": 2022, "doi": "10.1016/j.cct.2022.106976", "pubmed_id": "36332827", "openalex_id": "https://openalex.org/W4308040950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36332827/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36332827", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36332827/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36332827", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36332827/", "doi": "10.1016/j.cct.2022.106976", "pmid": "36332827", "publication_date": "2022-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1627, "title": "Psychedelic-Assisted Therapy for People with Eating Disorders.", "authors": "Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS", "journal": "Current psychiatry reports", "publication_date": "2022-12-01", "publication_year": 2022, "doi": "10.1007/s11920-022-01394-5", "pubmed_id": "36374357", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36374357", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36374357", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "doi": "10.1007/s11920-022-01394-5", "pmid": "36374357", "publication_date": "2022-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1642, "title": "Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E", "journal": "The New England journal of medicine", "publication_date": "2022-11-03", "publication_year": 2022, "doi": "10.1056/nejmoa2206443", "pubmed_id": "36322843", "openalex_id": "https://openalex.org/W4308146982", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36322843/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36322843", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36322843/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36322843", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36322843/", "doi": "10.1056/nejmoa2206443", "pmid": "36322843", "publication_date": "2022-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4910, "title": "The psychedelic renaissance: can psilocybin possibly combat depression?", "authors": "Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh", "journal": "International Journal of Surgery Global Health", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1097/gh9.0000000000000089", "pubmed_id": null, "openalex_id": "https://openalex.org/W4318965036", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Wellbeing,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:25:39", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000089", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000089", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "doi": "10.1097/gh9.0000000000000089", "pmid": "", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1653, "title": "Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.", "authors": "Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR", "journal": "Pharmacology & therapeutics", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1016/j.pharmthera.2022.108195", "pubmed_id": "35489438", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35489438/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35489438", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35489438/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35489438", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35489438/", "doi": "10.1016/j.pharmthera.2022.108195", "pmid": "35489438", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1651, "title": "The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.", "authors": "Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L", "journal": "Psychopharmacology", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06187-5", "pubmed_id": "35939083", "openalex_id": "https://openalex.org/W4290631853", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35939083/", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35939083", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35939083/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35939083", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35939083/", "doi": "10.1007/s00213-022-06187-5", "pmid": "35939083", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1635, "title": "Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.", "authors": "Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J", "journal": "Cureus", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.7759/cureus.31796", "pubmed_id": "36569662", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36569662/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36569662", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36569662/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36569662", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36569662/", "doi": "10.7759/cureus.31796", "pmid": "36569662", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1659, "title": "Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).", "authors": "Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A", "journal": "BMJ open", "publication_date": "2022-10-14", "publication_year": 2022, "doi": "10.1136/bmjopen-2022-066019", "pubmed_id": "36241352", "openalex_id": "https://openalex.org/W4306177192", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36241352/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36241352", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36241352/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36241352", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36241352/", "doi": "10.1136/bmjopen-2022-066019", "pmid": "36241352", "publication_date": "2022-10-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3685, "title": "An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)", "authors": "Beckley Psytech Limited", "journal": "ClinicalTrials.gov", "publication_date": "2022-10-12", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04905121", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04905121", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04905121", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04905121", "source_url": "https://clinicaltrials.gov/study/NCT04905121", "doi": "", "pmid": "", "publication_date": "2022-10-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1689, "title": "If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.", "authors": "Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC", "journal": "The journal of pain", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1016/j.jpain.2022.05.003", "pubmed_id": "35643270", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Consciousness,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35643270", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35643270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "doi": "10.1016/j.jpain.2022.05.003", "pmid": "35643270", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1686, "title": "Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.", "authors": "Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J", "journal": "Current psychiatry reports", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1007/s11920-022-01361-0", "pubmed_id": "35953638", "openalex_id": "https://openalex.org/W4291162385", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35953638/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35953638", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35953638/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35953638", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35953638/", "doi": "10.1007/s11920-022-01361-0", "pmid": "35953638", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1681, "title": "Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.", "authors": "Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L", "journal": "JAMA psychiatry", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1001/jamapsychiatry.2022.2096", "pubmed_id": "36001306", "openalex_id": "https://openalex.org/W4292937262", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36001306/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36001306", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36001306/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36001306", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36001306/", "doi": "10.1001/jamapsychiatry.2022.2096", "pmid": "36001306", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1680, "title": "Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.", "authors": "Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1177/02698811221116926", "pubmed_id": "36017784", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36017784/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36017784", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36017784/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36017784", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36017784/", "doi": "10.1177/02698811221116926", "pmid": "36017784", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1677, "title": "Expectancy in placebo-controlled trials of psychedelics: if so, so what?", "authors": "Butler M, Jelen L, Rucker J", "journal": "Psychopharmacology", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06221-6", "pubmed_id": "36063208", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36063208/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36063208", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36063208/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36063208", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36063208/", "doi": "10.1007/s00213-022-06221-6", "pmid": "36063208", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3244, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA.", "journal": "PsyArXiv", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.31234/osf.io/kh3cx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:14", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/kh3cx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/kh3cx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/kh3cx", "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "doi": "10.31234/osf.io/kh3cx", "pmid": "", "publication_date": "2022-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 643, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "Robert F. Dougherty, Patrick Clarke, Merve Alti, Joanna Kuc, Danielle Schlosser, Boadie W. Dunlop, David J. Hellerstein, Scott T. Aaronson, Sidney Zisook, Allan H Young", "journal": "PsyArXiv", "publication_date": "2022-09-30", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "doi": "", "pmid": "", "publication_date": "2022-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4923, "title": "The psychedelic escape from depression", "authors": "Michael Eisenstein", "journal": "Nature", "publication_date": "2022-09-27", "publication_year": 2022, "doi": "10.1038/d41586-022-02872-9", "pubmed_id": "36171370", "openalex_id": "https://openalex.org/W4297493645", "source_url": "https://doi.org/10.1038/d41586-022-02872-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 06:51:56", "bibtex": null, "source_record_id": "PMID:36171370", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36171370", "source_url": "https://doi.org/10.1038/d41586-022-02872-9", "doi": "10.1038/d41586-022-02872-9", "pmid": "36171370", "publication_date": "2022-09-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1693, "title": "Psychedelic drugs for psychiatric disorders.", "authors": "da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M", "journal": "Journal of the neurological sciences", "publication_date": "2022-09-15", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120332", "pubmed_id": "35841696", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35841696/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Consciousness,Aging,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35841696", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35841696/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35841696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35841696/", "doi": "10.1016/j.jns.2022.120332", "pmid": "35841696", "publication_date": "2022-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3178, "title": "Effective connectivity of emotion and cognition under psilocybin", "authors": "Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A.", "journal": "medRxiv", "publication_date": "2022-09-09", "publication_year": 2022, "doi": "10.1101/2022.09.06.22279626", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.09.06.22279626", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Default Mode Network,Biomarkers,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.1101/2022.09.06.22279626", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.09.06.22279626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.09.06.22279626", "source_url": "https://doi.org/10.1101/2022.09.06.22279626", "doi": "10.1101/2022.09.06.22279626", "pmid": "", "publication_date": "2022-09-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1696, "title": "Psilocybin therapy reduces heavy drinking.", "authors": "O'Leary K", "journal": "Nature medicine", "publication_date": "2022-09-08", "publication_year": 2022, "doi": "10.1038/d41591-022-00093-1", "pubmed_id": "36076081", "openalex_id": "https://openalex.org/W4295004963", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36076081/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36076081", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36076081", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36076081/", "doi": "10.1038/d41591-022-00093-1", "pmid": "36076081", "publication_date": "2022-09-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1698, "title": "Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.", "authors": "Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R", "journal": "BJPsych open", "publication_date": "2022-09-06", "publication_year": 2022, "doi": "10.1192/bjo.2022.565", "pubmed_id": "36065128", "openalex_id": "https://openalex.org/W4294808278", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36065128/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36065128", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36065128/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36065128", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36065128/", "doi": "10.1192/bjo.2022.565", "pmid": "36065128", "publication_date": "2022-09-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5632, "title": "Psychedelics’ binding depends on receptor mutations", "authors": "special to C EN Attabey Rodríguez Benítez", "journal": "C&EN Global Enterprise", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.1021/cen-10031-scicon6", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294310361", "source_url": "https://doi.org/10.1021/cen-10031-scicon6", "substance_tags": "psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:10", "last_checked": "2026-07-04 06:52:10", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10031-scicon6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10031-scicon6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10031-scicon6", "source_url": "https://doi.org/10.1021/cen-10031-scicon6", "doi": "10.1021/cen-10031-scicon6", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4932, "title": "Psychedelics in the Treatment of Substance Use Disorders", "authors": "Brian S. Barnett, Jeremy Weleff", "journal": "Psychiatric Annals", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.3928/00485713-20220804-01", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294911981", "source_url": "https://doi.org/10.3928/00485713-20220804-01", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Observational Study,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:25:40", "bibtex": null, "source_record_id": "DOI:10.3928/00485713-20220804-01", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3928/00485713-20220804-01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3928/00485713-20220804-01", "source_url": "https://doi.org/10.3928/00485713-20220804-01", "doi": "10.3928/00485713-20220804-01", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1702, "title": "[The use of psilocybin for treatment-resistant depression].", "authors": "Johannesdottir A, Sigurdsson E", "journal": "Laeknabladid", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.17992/lbl.2022.09.706", "pubmed_id": "36040772", "openalex_id": "https://openalex.org/W4293778673", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36040772/", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36040772", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36040772/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36040772", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36040772/", "doi": "10.17992/lbl.2022.09.706", "pmid": "36040772", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1694, "title": "The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.", "authors": "Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME", "journal": "Cureus", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.7759/cureus.29167", "pubmed_id": "36259015", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36259015", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36259015", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "doi": "10.7759/cureus.29167", "pmid": "36259015", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4938, "title": "Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative", "authors": "Neşe Devenot, Trey Conner, Richard Doyle", "journal": "Anthropology of Consciousness", "publication_date": "2022-08-22", "publication_year": 2022, "doi": "10.1111/anoc.12154", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292574083", "source_url": "https://doi.org/10.1111/anoc.12154", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:25:40", "bibtex": null, "source_record_id": "DOI:10.1111/anoc.12154", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/anoc.12154", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/anoc.12154", "source_url": "https://doi.org/10.1111/anoc.12154", "doi": "10.1111/anoc.12154", "pmid": "", "publication_date": "2022-08-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4941, "title": "A-118 Psychedelic Interventions for Neuropsychological Conditions", "authors": "Brian Peacock", "journal": "Archives of Clinical Neuropsychology", "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1093/arclin/acac060.118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292089187", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety,Contraindications", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1093/arclin/acac060.118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/arclin/acac060.118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/arclin/acac060.118", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "doi": "10.1093/arclin/acac060.118", "pmid": "", "publication_date": "2022-08-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1713, "title": "Review of potential psychedelic treatments for PTSD.", "authors": "Henner RL, Keshavan MS, Hill KP", "journal": "Journal of the neurological sciences", "publication_date": "2022-08-15", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120302", "pubmed_id": "35700643", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35700643/", "substance_tags": "psilocybin,psilocin", "topic_tags": "PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35700643", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35700643/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35700643", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35700643/", "doi": "10.1016/j.jns.2022.120302", "pmid": "35700643", "publication_date": "2022-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3554, "title": "Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study", "authors": "Gitte Moos Knudsen", "journal": "ClinicalTrials.gov", "publication_date": "2022-08-10", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04280055", "substance_tags": "psilocybin,psilocin", "topic_tags": "Chronic Pain,Headache / Migraine,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04280055", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04280055", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04280055", "source_url": "https://clinicaltrials.gov/study/NCT04280055", "doi": "", "pmid": "", "publication_date": "2022-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4946, "title": "Med Check: Psilocybin for OCD, Nuplazid Vote, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.08.8.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4289781881", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Headache / Migraine,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "doi": "10.1176/appi.pn.2022.08.8.2", "pmid": "", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4948, "title": "Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples", "authors": "James A. Kaduk, Alexander M. Sherwood, Robert B. Kargbo, Kristi W. Kaylo, Poncho Meisenheimer, Nicholas V. Cozzi", "journal": "Acta Crystallographica Section A Foundations and Advances", "publication_date": "2022-07-29", "publication_year": 2022, "doi": "10.1107/s2053273322097261", "pubmed_id": null, "openalex_id": "https://openalex.org/W4295955816", "source_url": "https://doi.org/10.1107/s2053273322097261", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1107/s2053273322097261", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1107/s2053273322097261", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1107/s2053273322097261", "source_url": "https://doi.org/10.1107/s2053273322097261", "doi": "10.1107/s2053273322097261", "pmid": "", "publication_date": "2022-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3594, "title": "Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2022-07-25", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04661514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04661514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "source_url": "https://clinicaltrials.gov/study/NCT04661514", "doi": "", "pmid": "", "publication_date": "2022-07-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3220, "title": "Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity", "authors": "Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM.", "journal": "medRxiv", "publication_date": "2022-07-10", "publication_year": 2022, "doi": "10.1101/2022.07.10.22277414", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.07.10.22277414", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:12", "bibtex": null, "source_record_id": "DOI:10.1101/2022.07.10.22277414", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.07.10.22277414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.07.10.22277414", "source_url": "https://doi.org/10.1101/2022.07.10.22277414", "doi": "10.1101/2022.07.10.22277414", "pmid": "", "publication_date": "2022-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1738, "title": "Psychedelics in the treatment of unipolar and bipolar depression.", "authors": "Bosch OG, Halm S, Seifritz E", "journal": "International journal of bipolar disorders", "publication_date": "2022-07-05", "publication_year": 2022, "doi": "10.1186/s40345-022-00265-5", "pubmed_id": "35788817", "openalex_id": "https://openalex.org/W4283813871", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35788817/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35788817", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35788817/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35788817", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35788817/", "doi": "10.1186/s40345-022-00265-5", "pmid": "35788817", "publication_date": "2022-07-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1750, "title": "From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.", "authors": "Kozlowska U, Nichols C, Wiatr K, Figiel M", "journal": "Journal of neurochemistry", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1111/jnc.15509", "pubmed_id": "34519052", "openalex_id": "https://openalex.org/W3201526264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34519052/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Review Article,Animal Study,Drug Interactions,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34519052", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34519052/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34519052", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34519052/", "doi": "10.1111/jnc.15509", "pmid": "34519052", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1747, "title": "A systematic literature review of clinical trials and therapeutic applications of ibogaine.", "authors": "Köck P, Froelich K, Walter M, Lang U, Dürsteler KM", "journal": "Journal of substance abuse treatment", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1016/j.jsat.2021.108717", "pubmed_id": "35012793", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35012793/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Systematic Review,Review Article,Case Report,Observational Study", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35012793", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35012793/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35012793", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35012793/", "doi": "10.1016/j.jsat.2021.108717", "pmid": "35012793", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1746, "title": "Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.", "authors": "Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H", "journal": "Pharmacopsychiatry", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1055/a-1714-9097", "pubmed_id": "35045580", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35045580/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35045580", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35045580/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35045580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35045580/", "doi": "10.1055/a-1714-9097", "pmid": "35045580", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1745, "title": "Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS.", "authors": "Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y, Dang Y", "journal": "Drug testing and analysis", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1002/dta.3255", "pubmed_id": "35312166", "openalex_id": "https://openalex.org/W4220970406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35312166/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Biomarkers,Epigenetics,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35312166", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35312166/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35312166", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35312166/", "doi": "10.1002/dta.3255", "pmid": "35312166", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3653, "title": "Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults", "authors": "Wake Network, Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2022-06-30", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04989972", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04989972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "source_url": "https://clinicaltrials.gov/study/NCT04989972", "doi": "", "pmid": "", "publication_date": "2022-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4955, "title": "Applying Lessons From Cannabis to the Psychedelic Highway", "authors": "Kevin F. Boehnke, Alan K. Davis, Jenna McAfee", "journal": "JAMA Health Forum", "publication_date": "2022-06-17", "publication_year": 2022, "doi": "10.1001/jamahealthforum.2022.1618", "pubmed_id": "36219016", "openalex_id": "https://openalex.org/W4283029950", "source_url": "https://doi.org/10.1001/jamahealthforum.2022.1618", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "PMID:36219016", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamahealthforum.2022.1618", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36219016", "source_url": "https://doi.org/10.1001/jamahealthforum.2022.1618", "doi": "10.1001/jamahealthforum.2022.1618", "pmid": "36219016", "publication_date": "2022-06-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1759, "title": "Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies.", "authors": "Hibicke M, Nichols CD", "journal": "Scientific reports", "publication_date": "2022-06-15", "publication_year": 2022, "doi": "10.1038/s41598-022-14165-2", "pubmed_id": "35705666", "openalex_id": "https://openalex.org/W4282963889", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35705666/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35705666", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35705666/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35705666", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35705666/", "doi": "10.1038/s41598-022-14165-2", "pmid": "35705666", "publication_date": "2022-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4956, "title": "Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions", "authors": "Annie M. McCartney, H. T. McGovern, Alexander De Foe", "journal": "Journal of Psychedelic Studies", "publication_date": "2022-06-09", "publication_year": 2022, "doi": "10.1556/2054.2022.00211", "pubmed_id": null, "openalex_id": "https://openalex.org/W4282040347", "source_url": "https://doi.org/10.1556/2054.2022.00211", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00211", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00211", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00211", "source_url": "https://doi.org/10.1556/2054.2022.00211", "doi": "10.1556/2054.2022.00211", "pmid": "", "publication_date": "2022-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4961, "title": "Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin", "authors": "Anthony Principe", "journal": "SURG Journal", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.21083/surg.v14i1.6870", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281736251", "source_url": "https://doi.org/10.21083/surg.v14i1.6870", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.21083/surg.v14i1.6870", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21083/surg.v14i1.6870", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21083/surg.v14i1.6870", "source_url": "https://doi.org/10.21083/surg.v14i1.6870", "doi": "10.21083/surg.v14i1.6870", "pmid": "", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1773, "title": "Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.", "authors": "Bender D, Hellerstein DJ", "journal": "Psychopharmacology", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s00213-021-06049-6", "pubmed_id": "35022823", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35022823/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article,Case Report,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35022823", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35022823/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35022823", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35022823/", "doi": "10.1007/s00213-021-06049-6", "pmid": "35022823", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1771, "title": "Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.", "authors": "Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S", "journal": "Psychopharmacology", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06066-z", "pubmed_id": "35076721", "openalex_id": "https://openalex.org/W4206965048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35076721/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35076721", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35076721/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35076721", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35076721/", "doi": "10.1007/s00213-022-06066-z", "pmid": "35076721", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1769, "title": "The therapeutic potential of psilocybin: a systematic review.", "authors": "van Amsterdam J, van den Brink W", "journal": "Expert opinion on drug safety", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2047929", "pubmed_id": "35225143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225143/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35225143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35225143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35225143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225143/", "doi": "10.1080/14740338.2022.2047929", "pmid": "35225143", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1765, "title": "The promises and perils of psychedelic pharmacology for psychiatry.", "authors": "McClure-Begley TD, Roth BL", "journal": "Nature reviews. Drug discovery", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1038/s41573-022-00421-7", "pubmed_id": "35301459", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35301459/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35301459", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35301459/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35301459", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35301459/", "doi": "10.1038/s41573-022-00421-7", "pmid": "35301459", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1761, "title": "Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.", "authors": "Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG", "journal": "Expert opinion on drug safety", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2066650", "pubmed_id": "35426754", "openalex_id": "https://openalex.org/W4223893856", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35426754/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35426754", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35426754/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35426754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35426754/", "doi": "10.1080/14740338.2022.2066650", "pmid": "35426754", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1753, "title": "3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.", "authors": "Inouye A, Wolfgang A", "journal": "Cureus", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.7759/cureus.26402", "pubmed_id": "35915689", "openalex_id": "https://openalex.org/W4283698346", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35915689/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35915689", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35915689/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35915689", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35915689/", "doi": "10.7759/cureus.26402", "pmid": "35915689", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4959, "title": "The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.", "authors": "Manish Agrawal, Paul Thambi, Sarah Shnayder", "journal": "Journal of Clinical Oncology", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1200/jco.2022.40.16_suppl.12097", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281784879", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "doi": "10.1200/jco.2022.40.16_suppl.12097", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3676, "title": "Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression", "authors": "National Institute of Mental Health, Czech Republic", "journal": "ClinicalTrials.gov", "publication_date": "2022-05-20", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05383313", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05383313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "source_url": "https://clinicaltrials.gov/study/NCT05383313", "doi": "", "pmid": "", "publication_date": "2022-05-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4968, "title": "The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis", "authors": "Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan", "journal": "Current Psychiatry Research and Reviews", "publication_date": "2022-05-15", "publication_year": 2022, "doi": "10.2174/2666082218666220513142002", "pubmed_id": null, "openalex_id": "https://openalex.org/W4280584826", "source_url": "https://doi.org/10.2174/2666082218666220513142002", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.2174/2666082218666220513142002", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/2666082218666220513142002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/2666082218666220513142002", "source_url": "https://doi.org/10.2174/2666082218666220513142002", "doi": "10.2174/2666082218666220513142002", "pmid": "", "publication_date": "2022-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1780, "title": "Unraveling the Mysteries of Mental Illness With Psilocybin.", "authors": "Sotille R, Singh H, Weisman A, Vida T", "journal": "Cureus", "publication_date": "2022-05-01", "publication_year": 2022, "doi": "10.7759/cureus.25414", "pubmed_id": "35769681", "openalex_id": "https://openalex.org/W4281664591", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35769681/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35769681", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35769681/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35769681", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35769681/", "doi": "10.7759/cureus.25414", "pmid": "35769681", "publication_date": "2022-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3659, "title": "Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2022-04-29", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03715127", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Resilience,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03715127", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03715127", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03715127", "source_url": "https://clinicaltrials.gov/study/NCT03715127", "doi": "", "pmid": "", "publication_date": "2022-04-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4974, "title": "P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression", "authors": "Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes", "journal": "Biological Psychiatry", "publication_date": "2022-04-27", "publication_year": 2022, "doi": "10.1016/j.biopsych.2022.02.624", "pubmed_id": null, "openalex_id": "https://openalex.org/W4225010514", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.624", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2022.02.624", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2022.02.624", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.624", "doi": "10.1016/j.biopsych.2022.02.624", "pmid": "", "publication_date": "2022-04-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1793, "title": "Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.", "authors": "Hackl B, Todt H, Kubista H, Hilber K, Koenig X", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2022-04-19", "publication_year": 2022, "doi": "10.1093/ijnp/pyab085", "pubmed_id": "34871422", "openalex_id": "https://openalex.org/W4200455094", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34871422/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Aging,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34871422", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34871422/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34871422", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34871422/", "doi": "10.1093/ijnp/pyab085", "pmid": "34871422", "publication_date": "2022-04-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1796, "title": "Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.", "authors": "Jones G, Ricard JA, Lipson J, Nock MK", "journal": "Scientific reports", "publication_date": "2022-04-07", "publication_year": 2022, "doi": "10.1038/s41598-022-08085-4", "pubmed_id": "35393455", "openalex_id": "https://openalex.org/W4223525754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35393455/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35393455", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35393455/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35393455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35393455/", "doi": "10.1038/s41598-022-08085-4", "pmid": "35393455", "publication_date": "2022-04-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1798, "title": "Increased global integration in the brain after psilocybin therapy for depression.", "authors": "Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R", "journal": "Nature medicine", "publication_date": "2022-04-01", "publication_year": 2022, "doi": "10.1038/s41591-022-01744-z", "pubmed_id": "35411074", "openalex_id": "https://openalex.org/W4223491164", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35411074/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35411074", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35411074/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35411074", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35411074/", "doi": "10.1038/s41591-022-01744-z", "pmid": "35411074", "publication_date": "2022-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4980, "title": "Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?", "authors": "Michael Avissar, Adrian Jacques H. Ambrose", "journal": "Psychiatric News", "publication_date": "2022-03-24", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.04.4.35", "pubmed_id": null, "openalex_id": "https://openalex.org/W4220982704", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:42", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "doi": "10.1176/appi.pn.2022.04.4.35", "pmid": "", "publication_date": "2022-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1808, "title": "Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.", "authors": "Pearson C, Siegel J, Gold JA", "journal": "Journal of the neurological sciences", "publication_date": "2022-03-15", "publication_year": 2022, "doi": "10.1016/j.jns.2021.120096", "pubmed_id": "34942586", "openalex_id": "https://openalex.org/W4200117112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34942586/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34942586", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34942586/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34942586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34942586/", "doi": "10.1016/j.jns.2021.120096", "pmid": "34942586", "publication_date": "2022-03-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1821, "title": "Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).", "authors": "Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S", "journal": "ACS omega", "publication_date": "2022-02-15", "publication_year": 2022, "doi": "10.1021/acsomega.1c06708", "pubmed_id": "35187358", "openalex_id": "https://openalex.org/W4210846812", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35187358/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35187358", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35187358/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35187358", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35187358/", "doi": "10.1021/acsomega.1c06708", "pmid": "35187358", "publication_date": "2022-02-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1829, "title": "Analysis of recreational psychedelic substance use experiences classified by substance.", "authors": "Hase A, Erdmann M, Limbach V, Hasler G", "journal": "Psychopharmacology", "publication_date": "2022-02-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06062-3", "pubmed_id": "35031816", "openalex_id": "https://openalex.org/W4205576215", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35031816/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Biomarkers,Emotional Processing,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35031816", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35031816/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35031816", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35031816/", "doi": "10.1007/s00213-022-06062-3", "pmid": "35031816", "publication_date": "2022-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1825, "title": "Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.", "authors": "Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR", "journal": "Cureus", "publication_date": "2022-02-01", "publication_year": 2022, "doi": "10.7759/cureus.21944", "pubmed_id": "35273885", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35273885/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35273885", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35273885/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35273885", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35273885/", "doi": "10.7759/cureus.21944", "pmid": "35273885", "publication_date": "2022-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4993, "title": "Psilocybine vergeleken met escitalopram bij depressie", "authors": "Jurriaan F. M. Strous", "journal": "Pure Amsterdam UMC", "publication_date": "2022-01-17", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7132220122", "source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "doi": "", "pmid": "", "publication_date": "2022-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1834, "title": "[Psilocybin compared with escitalopram for depression].", "authors": "Strous JFM", "journal": "Nederlands tijdschrift voor geneeskunde", "publication_date": "2022-01-17", "publication_year": 2022, "doi": null, "pubmed_id": "35138714", "openalex_id": "https://openalex.org/W4221159545", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35138714/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:29", "bibtex": null, "source_record_id": "PMID:35138714", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35138714/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35138714", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35138714/", "doi": "", "pmid": "35138714", "publication_date": "2022-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4994, "title": "Pennsylvania bill seeks clinical research on psychedelics", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2022-01-14", "publication_year": 2022, "doi": "10.1002/mhw.33077", "pubmed_id": null, "openalex_id": "https://openalex.org/W4205137701", "source_url": "https://doi.org/10.1002/mhw.33077", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Veterans", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.33077", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.33077", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.33077", "source_url": "https://doi.org/10.1002/mhw.33077", "doi": "10.1002/mhw.33077", "pmid": "", "publication_date": "2022-01-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5005, "title": "The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial", "authors": "G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100213", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313200620", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "doi": "10.1016/j.nsa.2022.100213", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5002, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial", "authors": "G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313199626", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "doi": "10.1016/j.nsa.2022.100511", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4999, "title": "Standards Without Labs: Drug Development in the Psychedelic Underground", "authors": "John Bailey, Joanna Kempner", "journal": "Citizen Science Theory and Practice", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.5334/cstp.527", "pubmed_id": null, "openalex_id": "https://openalex.org/W4312994437", "source_url": "https://doi.org/10.5334/cstp.527", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.5334/cstp.527", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5334/cstp.527", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5334/cstp.527", "source_url": "https://doi.org/10.5334/cstp.527", "doi": "10.5334/cstp.527", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4998, "title": "An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma", "authors": "F. N. Smith, Joanna C. Neill, Verity Wainwright", "journal": "Drug Science Policy and Law", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/20503245221124117", "pubmed_id": null, "openalex_id": "https://openalex.org/W4295169116", "source_url": "https://doi.org/10.1177/20503245221124117", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1177/20503245221124117", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245221124117", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245221124117", "source_url": "https://doi.org/10.1177/20503245221124117", "doi": "10.1177/20503245221124117", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1864, "title": "Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.", "authors": "Leger RF, Unterwald EM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211044688", "pubmed_id": "34519567", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34519567/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34519567", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34519567/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34519567", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34519567/", "doi": "10.1177/02698811211044688", "pmid": "34519567", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1863, "title": "Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.", "authors": "Li NX, Hu YR, Chen WN, Zhang B", "journal": "Journal of affective disorders", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.jad.2021.09.041", "pubmed_id": "34587546", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34587546/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34587546", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34587546/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34587546", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34587546/", "doi": "10.1016/j.jad.2021.09.041", "pmid": "34587546", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1862, "title": "United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.", "authors": "Barnett BS, Parker SE, Weleff J", "journal": "The International journal on drug policy", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.drugpo.2021.103473", "pubmed_id": "34624734", "openalex_id": "https://openalex.org/W3203419443", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34624734/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34624734", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34624734/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34624734", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34624734/", "doi": "10.1016/j.drugpo.2021.103473", "pmid": "34624734", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1857, "title": "Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.", "authors": "Agin-Liebes G, Davis AK", "journal": "Current topics in behavioral neurosciences", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/7854_2021_282", "pubmed_id": "34811715", "openalex_id": "https://openalex.org/W3216485471", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34811715/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34811715", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34811715/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34811715", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34811715/", "doi": "10.1007/7854_2021_282", "pmid": "34811715", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1854, "title": "Psychedelic medicines for mood disorders: current evidence and clinical considerations.", "authors": "Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D", "journal": "Current opinion in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1097/yco.0000000000000759", "pubmed_id": "34855694", "openalex_id": "https://openalex.org/W3214407741", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34855694/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Neurogenesis,Mechanism of Action,Aging,Microdosing,Clinical Trial,Animal Study,Treatment-Resistant Depression,Genomics,Microbiome,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34855694", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34855694/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34855694", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34855694/", "doi": "10.1097/yco.0000000000000759", "pmid": "34855694", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1850, "title": "Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.", "authors": "Sherwood AM, Kargbo RB, Kaylo KW, Cozzi NV, Meisenheimer P, Kaduk JA", "journal": "Acta crystallographica. Section C, Structural chemistry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1107/s2053229621013164", "pubmed_id": "34982048", "openalex_id": "https://openalex.org/W4200445562", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34982048/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34982048", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34982048/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34982048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34982048/", "doi": "10.1107/s2053229621013164", "pmid": "34982048", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1847, "title": "The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.", "authors": "Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211064720", "pubmed_id": "35090363", "openalex_id": "https://openalex.org/W4205906672", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35090363/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35090363", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35090363/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35090363", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35090363/", "doi": "10.1177/02698811211064720", "pmid": "35090363", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1845, "title": "Human behavioral pharmacology of psychedelics.", "authors": "Strickland JC, Johnson MW", "journal": "Advances in pharmacology (San Diego, Calif.)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/bs.apha.2021.10.003", "pubmed_id": "35341564", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35341564/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Abuse Liability", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35341564", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35341564/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35341564", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35341564/", "doi": "10.1016/bs.apha.2021.10.003", "pmid": "35341564", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1844, "title": "Psilocybin Conspectus: Status, Production Methods, and Considerations.", "authors": "Plotnik L, Gibbs G, Graham T", "journal": "International journal of medicinal mushrooms", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1615/intjmedmushrooms.2021041921", "pubmed_id": "35442591", "openalex_id": "https://openalex.org/W3214903520", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35442591/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35442591", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35442591/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35442591", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35442591/", "doi": "10.1615/intjmedmushrooms.2021041921", "pmid": "35442591", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1811, "title": "Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.", "authors": "Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G", "journal": "Neuroscience applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100104", "pubmed_id": "40656230", "openalex_id": "https://openalex.org/W4220708535", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656230/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:40656230", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656230/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656230", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656230/", "doi": "10.1016/j.nsa.2022.100104", "pmid": "40656230", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1807, "title": "Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Raison CL, Jain R, Penn AD, Cole SP, Jain S", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.831092", "pubmed_id": "35370864", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35370864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35370864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "doi": "10.3389/fpsyt.2022.831092", "pmid": "35370864", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1803, "title": "Psilocybin-Assisted Compassion Focused Therapy for Depression.", "authors": "Pots W, Chakhssi F", "journal": "Frontiers in psychology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyg.2022.812930", "pubmed_id": "35401294", "openalex_id": "https://openalex.org/W4221031753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35401294/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35401294", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35401294/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35401294", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35401294/", "doi": "10.3389/fpsyg.2022.812930", "pmid": "35401294", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1649, "title": "A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.", "authors": "Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI", "journal": "Journal of clinical psychopharmacology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1097/jcp.0000000000001608", "pubmed_id": "36193898", "openalex_id": "https://openalex.org/W4301392523", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36193898/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36193898", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36193898/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36193898", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36193898/", "doi": "10.1097/jcp.0000000000001608", "pmid": "36193898", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1620, "title": "\"A sense of the bigger picture:\" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.", "authors": "DellaCrosse M, Pleet M, Morton E, Ashtari A, Sakai K, Woolley J, Michalak E", "journal": "PloS one", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1371/journal.pone.0279073", "pubmed_id": "36516137", "openalex_id": "https://openalex.org/W4311439362", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36516137/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36516137", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36516137/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36516137", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36516137/", "doi": "10.1371/journal.pone.0279073", "pmid": "36516137", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1579, "title": "The association between naturalistic use of psychedelics and co-occurring substance use disorders.", "authors": "Rabinowitz J, Lev-Ran S, Gross R", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.1066369", "pubmed_id": "36704738", "openalex_id": "https://openalex.org/W4315488427", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36704738/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36704738", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36704738/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36704738", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36704738/", "doi": "10.3389/fpsyt.2022.1066369", "pmid": "36704738", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3526, "title": "LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2021-12-22", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03153579", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03153579", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03153579", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03153579", "source_url": "https://clinicaltrials.gov/study/NCT03153579", "doi": "", "pmid": "", "publication_date": "2021-12-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1871, "title": "Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.", "authors": "Niles H, Fogg C, Kelmendi B, Lazenby M", "journal": "BMC palliative care", "publication_date": "2021-12-20", "publication_year": 2021, "doi": "10.1186/s12904-021-00889-x", "pubmed_id": "34930220", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Spirituality,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34930220", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34930220", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "doi": "10.1186/s12904-021-00889-x", "pmid": "34930220", "publication_date": "2021-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5030, "title": "Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs", "authors": "Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek", "journal": "Behavioural Pharmacology", "publication_date": "2021-12-13", "publication_year": 2021, "doi": "10.1097/fbp.0000000000000662", "pubmed_id": "35007231", "openalex_id": "https://openalex.org/W4200050959", "source_url": "https://doi.org/10.1097/fbp.0000000000000662", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "PMID:35007231", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000662", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:35007231", "source_url": "https://doi.org/10.1097/fbp.0000000000000662", "doi": "10.1097/fbp.0000000000000662", "pmid": "35007231", "publication_date": "2021-12-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1879, "title": "Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.", "authors": "Horton DM, Morrison B, Schmidt J", "journal": "American journal of psychotherapy", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1176/appi.psychotherapy.20200055", "pubmed_id": "34293927", "openalex_id": "https://openalex.org/W3183684219", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34293927/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34293927", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34293927/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34293927", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34293927/", "doi": "10.1176/appi.psychotherapy.20200055", "pmid": "34293927", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1878, "title": "Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.", "authors": "Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS", "journal": "The International journal on drug policy", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1016/j.drugpo.2021.103380", "pubmed_id": "34329952", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34329952/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34329952", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34329952/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34329952", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34329952/", "doi": "10.1016/j.drugpo.2021.103380", "pmid": "34329952", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1875, "title": "Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.", "authors": "Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A", "journal": "BMJ open", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1136/bmjopen-2021-056091", "pubmed_id": "34853114", "openalex_id": "https://openalex.org/W3215511316", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34853114/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34853114", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34853114/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34853114", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34853114/", "doi": "10.1136/bmjopen-2021-056091", "pmid": "34853114", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3459, "title": "The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder", "authors": "Maryland Oncology Hematology, PA", "journal": "ClinicalTrials.gov", "publication_date": "2021-10-15", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04593563", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04593563", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "source_url": "https://clinicaltrials.gov/study/NCT04593563", "doi": "", "pmid": "", "publication_date": "2021-10-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5054, "title": "Delix to synthesize psychedelic drugs", "authors": "Ryan Cross", "journal": "C&EN Global Enterprise", "publication_date": "2021-10-03", "publication_year": 2021, "doi": "10.1021/cen-09936-buscon3", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367158646", "source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09936-buscon3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09936-buscon3", "source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "doi": "10.1021/cen-09936-buscon3", "pmid": "", "publication_date": "2021-10-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1901, "title": "Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.", "authors": "Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT", "journal": "Experimental and clinical psychopharmacology", "publication_date": "2021-10-01", "publication_year": 2021, "doi": "10.1037/pha0000490", "pubmed_id": "34096755", "openalex_id": "https://openalex.org/W3171546624", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34096755/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34096755", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34096755/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34096755", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34096755/", "doi": "10.1037/pha0000490", "pmid": "34096755", "publication_date": "2021-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1899, "title": "Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.", "authors": "Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS", "journal": "Psychiatry investigation", "publication_date": "2021-10-01", "publication_year": 2021, "doi": "10.30773/pi.2021.0209", "pubmed_id": "34619818", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34619818/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34619818", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34619818/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34619818", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34619818/", "doi": "10.30773/pi.2021.0209", "pmid": "34619818", "publication_date": "2021-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5063, "title": "Is MDD the right target for early-stage psychedelic-assisted therapy trials?", "authors": "Benjamin R. Lewis, Kevin Byrne", "journal": "Journal of Psychedelic Studies", "publication_date": "2021-09-15", "publication_year": 2021, "doi": "10.1556/2054.2021.00180", "pubmed_id": null, "openalex_id": "https://openalex.org/W3199274122", "source_url": "https://doi.org/10.1556/2054.2021.00180", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2021.00180", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2021.00180", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2021.00180", "source_url": "https://doi.org/10.1556/2054.2021.00180", "doi": "10.1556/2054.2021.00180", "pmid": "", "publication_date": "2021-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5065, "title": "New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy", "authors": "Tehseen Noorani, Jonny Martell", "journal": "Frontiers in Psychiatry", "publication_date": "2021-09-10", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.727050", "pubmed_id": "34566724", "openalex_id": "https://openalex.org/W3201103091", "source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "PMID:34566724", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34566724", "source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "doi": "10.3389/fpsyt.2021.727050", "pmid": "34566724", "publication_date": "2021-09-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1915, "title": "Blinding and expectancy confounds in psychedelic randomized controlled trials.", "authors": "Muthukumaraswamy SD, Forsyth A, Lumley T", "journal": "Expert review of clinical pharmacology", "publication_date": "2021-09-01", "publication_year": 2021, "doi": "10.1080/17512433.2021.1933434", "pubmed_id": "34038314", "openalex_id": "https://openalex.org/W3164618783", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34038314/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34038314", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34038314/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34038314", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34038314/", "doi": "10.1080/17512433.2021.1933434", "pmid": "34038314", "publication_date": "2021-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5069, "title": "Beckley raises funds for psychedelic drugs", "authors": "Ryan Cross", "journal": "C&EN Global Enterprise", "publication_date": "2021-08-22", "publication_year": 2021, "doi": "10.1021/cen-09930-buscon17", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367017439", "source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09930-buscon17", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09930-buscon17", "source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "doi": "10.1021/cen-09930-buscon17", "pmid": "", "publication_date": "2021-08-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3371, "title": "Psychedelics and psychiatric disorders: A emerging role", "authors": "Peixoto C, Santos F, Rego D, Medeiros H.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2021-08-13", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9470409", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9470409", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9470409", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9470409", "source_url": "https://europepmc.org/article/PMC/PMC9470409", "doi": "", "pmid": "", "publication_date": "2021-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3211, "title": "Effects of psilocybin-assisted therapy on treatment-resistant depression", "authors": "Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2021-08-13", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9480034", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:11", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9480034", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9480034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9480034", "source_url": "https://europepmc.org/article/PMC/PMC9480034", "doi": "", "pmid": "", "publication_date": "2021-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3156, "title": "Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?", "authors": "Descalço N, Medeiros A, Santos C, Borges G.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2021-08-13", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9476072", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,OCD,Receptor Pharmacology,Aging,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9476072", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9476072", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9476072", "source_url": "https://europepmc.org/article/PMC/PMC9476072", "doi": "", "pmid": "", "publication_date": "2021-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5071, "title": "What can we learn from the history of research on psychedelic drugs in the addictions?", "authors": "Wayne Hall, Michael Farrell", "journal": "Addiction", "publication_date": "2021-08-12", "publication_year": 2021, "doi": "10.1111/add.15560", "pubmed_id": "34382252", "openalex_id": "https://openalex.org/W3187445852", "source_url": "https://doi.org/10.1111/add.15560", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Healthcare Workers,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "PMID:34382252", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.15560", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34382252", "source_url": "https://doi.org/10.1111/add.15560", "doi": "10.1111/add.15560", "pmid": "34382252", "publication_date": "2021-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2139, "title": "The Potential Role of Serotonergic Hallucinogens in Depression Treatment.", "authors": "Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M", "journal": "Life (Basel, Switzerland)", "publication_date": "2021-07-29", "publication_year": 2021, "doi": "10.3390/life11080765", "pubmed_id": "34440508", "openalex_id": "https://openalex.org/W3193251618", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34440508/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34440508", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34440508/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34440508", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34440508/", "doi": "10.3390/life11080765", "pmid": "34440508", "publication_date": "2021-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3481, "title": "A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2021-07-22", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04959253", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04959253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "source_url": "https://clinicaltrials.gov/study/NCT04959253", "doi": "", "pmid": "", "publication_date": "2021-07-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2148, "title": "Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.", "authors": "Mertens LJ, Preller KH", "journal": "Pharmacopsychiatry", "publication_date": "2021-07-01", "publication_year": 2021, "doi": "10.1055/a-1341-1907", "pubmed_id": "33472250", "openalex_id": "https://openalex.org/W3124059976", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33472250/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33472250", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33472250/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33472250", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33472250/", "doi": "10.1055/a-1341-1907", "pmid": "33472250", "publication_date": "2021-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2147, "title": "Cannabis-induced oceanic boundlessness.", "authors": "Earleywine M, Ueno LF, Mian MN, Altman BR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2021-07-01", "publication_year": 2021, "doi": "10.1177/0269881121997099", "pubmed_id": "33779383", "openalex_id": "https://openalex.org/W3151652679", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33779383/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Mystical Experience,Clinical Trial,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33779383", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33779383/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33779383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33779383/", "doi": "10.1177/0269881121997099", "pmid": "33779383", "publication_date": "2021-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3786, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "McCartney A, McGovern H, De Foe A.", "journal": "PsyArXiv", "publication_date": "2021-06-27", "publication_year": 2021, "doi": "10.31234/osf.io/9kuhs", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:25", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/9kuhs", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/9kuhs", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/9kuhs", "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "doi": "10.31234/osf.io/9kuhs", "pmid": "", "publication_date": "2021-06-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3336, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "Annie McCartney, Hugh McGovern, Alexander De Foe", "journal": "PsyArXiv", "publication_date": "2021-06-27", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "doi": "", "pmid": "", "publication_date": "2021-06-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3400, "title": "Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses", "authors": "McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM.", "journal": "PsyArXiv", "publication_date": "2021-06-10", "publication_year": 2021, "doi": "10.31234/osf.io/64kyg", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/64kyg", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:32", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/64kyg", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/64kyg", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/64kyg", "source_url": "https://doi.org/10.31234/osf.io/64kyg", "doi": "10.31234/osf.io/64kyg", "pmid": "", "publication_date": "2021-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1743, "title": "Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses", "authors": "Drummond E-Wen McCulloch, Gitte Moos Knudsen, Frederick Streeter Barrett, Manoj Doss, Gustavo Deco, Robin Carhart-Harris, Fernando Rosas, Katrin Preller, Johannes Ramaekers, Natasha Mason", "journal": "PsyArXiv", "publication_date": "2021-06-10", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/64kyg_v1", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/64kyg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/64kyg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/64kyg_v1", "source_url": "https://osf.io/preprints/psyarxiv/64kyg_v1", "doi": "", "pmid": "", "publication_date": "2021-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3385, "title": "Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders", "authors": "Chao YS, Horton J.", "journal": "Canadian Agency for Drugs and Technologies in Health, Ottawa (ON)", "publication_date": "2021-06-01", "publication_year": 2021, "doi": null, "pubmed_id": "36170470", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36170470", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:31", "bibtex": null, "source_record_id": "PMID:36170470", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36170470", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36170470", "source_url": "https://europepmc.org/article/MED/36170470", "doi": "", "pmid": "36170470", "publication_date": "2021-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2151, "title": "Psychedelic science in post-COVID-19 psychiatry.", "authors": "Kelly JR, Crockett MT, Alexander L, Haran M, Baker A, Burke L, Brennan C, O'Keane V", "journal": "Irish journal of psychological medicine", "publication_date": "2021-06-01", "publication_year": 2021, "doi": "10.1017/ipm.2020.94", "pubmed_id": "32811575", "openalex_id": "https://openalex.org/W3054886531", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32811575/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:32811575", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32811575/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32811575", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32811575/", "doi": "10.1017/ipm.2020.94", "pmid": "32811575", "publication_date": "2021-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3230, "title": "Decreased brain modularity after psilocybin therapy for depression.", "authors": "Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2021-05-20", "publication_year": 2021, "doi": "10.21203/rs.3.rs-513323/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:13", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-513323/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-513323/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "doi": "10.21203/rs.3.rs-513323/v1", "pmid": "", "publication_date": "2021-05-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3420, "title": "Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network", "authors": "Evan Lewis-Healey, Ruben Eero Laukkonen, Michiel van Elk", "journal": "PsyArXiv", "publication_date": "2021-05-19", "publication_year": 2021, "doi": "10.1037/pne0000290", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281568156", "source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:04:24", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1037/pne0000290", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1037/pne0000290", "source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "doi": "10.1037/pne0000290", "pmid": "", "publication_date": "2021-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3247, "title": "Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network", "authors": "Lewis-Healey E, Laukkonen RE, van Elk M.", "journal": "PsyArXiv", "publication_date": "2021-05-19", "publication_year": 2021, "doi": "10.31234/osf.io/q3ymd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/q3ymd", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:14", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/q3ymd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/q3ymd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/q3ymd", "source_url": "https://doi.org/10.31234/osf.io/q3ymd", "doi": "10.31234/osf.io/q3ymd", "pmid": "", "publication_date": "2021-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5091, "title": "The need for publicly funded research on therapeutic use of psychedelic drugs", "authors": "Wayne Hall", "journal": "World Psychiatry", "publication_date": "2021-05-18", "publication_year": 2021, "doi": "10.1002/wps.20847", "pubmed_id": "34002493", "openalex_id": "https://openalex.org/W3162774823", "source_url": "https://doi.org/10.1002/wps.20847", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "PMID:34002493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20847", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34002493", "source_url": "https://doi.org/10.1002/wps.20847", "doi": "10.1002/wps.20847", "pmid": "34002493", "publication_date": "2021-05-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2160, "title": "Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.", "authors": "Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR", "journal": "JAMA psychiatry", "publication_date": "2021-05-01", "publication_year": 2021, "doi": "10.1001/jamapsychiatry.2020.3285", "pubmed_id": "33146667", "openalex_id": "https://openalex.org/W3096208965", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33146667/", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33146667", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33146667/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33146667", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33146667/", "doi": "10.1001/jamapsychiatry.2020.3285", "pmid": "33146667", "publication_date": "2021-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2024, "title": "Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signaling", "authors": "Senese Nicolas, Nguyen Thu, Cologna Stephanie, Rasenick Mark", "journal": "The FASEB Journal", "publication_date": "2021-05-01", "publication_year": 2021, "doi": "10.1096/fasebj.2021.35.s1.03168", "pubmed_id": null, "openalex_id": "https://openalex.org/W3168028697", "source_url": "https://doi.org/10.1096/fasebj.2021.35.s1.03168", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Biomarkers,Clinical Trial,Proteomics", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:50", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.2021.35.s1.03168", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1096/fasebj.2021.35.s1.03168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1096/fasebj.2021.35.s1.03168", "source_url": "https://doi.org/10.1096/fasebj.2021.35.s1.03168", "doi": "10.1096/fasebj.2021.35.s1.03168", "pmid": "", "publication_date": "2021-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3487, "title": "Characterization of Altered Waking States of Consciousness in Healthy Humans", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2021-04-29", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03853577", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03853577", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03853577", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03853577", "source_url": "https://clinicaltrials.gov/study/NCT03853577", "doi": "", "pmid": "", "publication_date": "2021-04-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5105, "title": "Have Norwegians tried psilocybin, and do they accept it as a medicine?", "authors": "Henrik Børsting Jacobsen, Audun Stubhaug, Bjørn Holmøy, Tor Morten Kvam, Silje Endresen Rème", "journal": "Journal of Psychedelic Studies", "publication_date": "2021-04-16", "publication_year": 2021, "doi": "10.1556/2054.2021.00167", "pubmed_id": null, "openalex_id": "https://openalex.org/W3152965122", "source_url": "https://doi.org/10.1556/2054.2021.00167", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2021.00167", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2021.00167", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2021.00167", "source_url": "https://doi.org/10.1556/2054.2021.00167", "doi": "10.1556/2054.2021.00167", "pmid": "", "publication_date": "2021-04-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2165, "title": "Trial of Psilocybin versus Escitalopram for Depression.", "authors": "Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ", "journal": "The New England journal of medicine", "publication_date": "2021-04-15", "publication_year": 2021, "doi": "10.1056/nejmoa2032994", "pubmed_id": "33852780", "openalex_id": "https://openalex.org/W3156937150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33852780/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33852780", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33852780/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33852780", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33852780/", "doi": "10.1056/nejmoa2032994", "pmid": "33852780", "publication_date": "2021-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2173, "title": "On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.", "authors": "Zeifman RJ, Singhal N, Breslow L, Weissman CR", "journal": "ACS pharmacology & translational science", "publication_date": "2021-04-09", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00024", "pubmed_id": "33860173", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860173/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33860173", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33860173/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33860173", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860173/", "doi": "10.1021/acsptsci.1c00024", "pmid": "33860173", "publication_date": "2021-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2168, "title": "Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.", "authors": "Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE", "journal": "ACS pharmacology & translational science", "publication_date": "2021-04-09", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00020", "pubmed_id": "33860185", "openalex_id": "https://openalex.org/W3138429576", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860185/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33860185", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33860185/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33860185", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860185/", "doi": "10.1021/acsptsci.1c00020", "pmid": "33860185", "publication_date": "2021-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3255, "title": "Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies", "authors": "Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD.", "journal": "medRxiv", "publication_date": "2021-04-07", "publication_year": 2021, "doi": "10.1101/2021.04.02.21254838", "pubmed_id": null, "openalex_id": "https://openalex.org/W3201512146", "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1101/2021.04.02.21254838", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.04.02.21254838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2021.04.02.21254838", "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "doi": "10.1101/2021.04.02.21254838", "pmid": "", "publication_date": "2021-04-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5113, "title": "Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?", "authors": "Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges", "journal": "European Psychiatry", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1192/j.eurpsy.2021.1114", "pubmed_id": null, "openalex_id": "https://openalex.org/W4212954018", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,OCD,Receptor Pharmacology,Aging,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2021.1114", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2021.1114", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "doi": "10.1192/j.eurpsy.2021.1114", "pmid": "", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5112, "title": "Effects of psilocybin-assisted therapy on treatment-resistant depression", "authors": "A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho", "journal": "European Psychiatry", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1192/j.eurpsy.2021.1836", "pubmed_id": null, "openalex_id": "https://openalex.org/W3212256162", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2021.1836", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2021.1836", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "doi": "10.1192/j.eurpsy.2021.1836", "pmid": "", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5115, "title": "The Return of Psychedelics: Still Time to Prevent Tragedy", "authors": "Stanley N. Caroff", "journal": "Psychiatric News", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.4.8", "pubmed_id": null, "openalex_id": "https://openalex.org/W3147930394", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Case Report,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "doi": "10.1176/appi.pn.2021.4.8", "pmid": "", "publication_date": "2021-03-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3804, "title": "Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials", "authors": "Muthukumaraswamy S, Forsyth A, Lumley T.", "journal": "PsyArXiv", "publication_date": "2021-03-08", "publication_year": 2021, "doi": "10.31234/osf.io/q2hzm", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/q2hzm", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-08-09 08:15:31", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/q2hzm", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/q2hzm", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/q2hzm", "source_url": "https://doi.org/10.31234/osf.io/q2hzm", "doi": "10.31234/osf.io/q2hzm", "pmid": "", "publication_date": "2021-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3390, "title": "Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials", "authors": "Suresh Muthukumaraswamy, Anna Forsyth, Thomas Lumley", "journal": "PsyArXiv", "publication_date": "2021-03-08", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "source_url": "https://osf.io/preprints/psyarxiv/q2hzm_v1", "doi": "", "pmid": "", "publication_date": "2021-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5827, "title": "Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2", "authors": "Avinash Hosanagar, Joseph Cusimano, Rajiv Radhakrishnan", "journal": "The Journal of Clinical Psychiatry", "publication_date": "2021-02-23", "publication_year": 2021, "doi": "10.4088/jcp.20ac13787", "pubmed_id": "33988930", "openalex_id": "https://openalex.org/W3135459718", "source_url": "https://doi.org/10.4088/jcp.20ac13787", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:46", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "PMID:33988930", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4088/jcp.20ac13787", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33988930", "source_url": "https://doi.org/10.4088/jcp.20ac13787", "doi": "10.4088/jcp.20ac13787", "pmid": "33988930", "publication_date": "2021-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2200, "title": "Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.", "authors": "Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J", "journal": "Psychopharmacology", "publication_date": "2021-02-01", "publication_year": 2021, "doi": "10.1007/s00213-020-05719-1", "pubmed_id": "33427944", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33427944/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Healthy Volunteers", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33427944", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33427944/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33427944", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33427944/", "doi": "10.1007/s00213-020-05719-1", "pmid": "33427944", "publication_date": "2021-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5126, "title": "Behandeling met psilocybine", "authors": "Joost J. Breeksema, Martijn H B Koolen, Metten Somers, Robert A. Schoevers", "journal": "Data Archiving and Networked Services (DANS)", "publication_date": "2021-01-21", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3169076037", "source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "doi": "", "pmid": "", "publication_date": "2021-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2203, "title": "[Treatment with psilocybin: applications for patients with psychiatric disorders].", "authors": "Breeksema JJ, Koolen MHB, Somers M, Schoevers RA", "journal": "Nederlands tijdschrift voor geneeskunde", "publication_date": "2021-01-21", "publication_year": 2021, "doi": null, "pubmed_id": "33560605", "openalex_id": "https://openalex.org/W3127548368", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33560605/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:34:29", "bibtex": null, "source_record_id": "PMID:33560605", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33560605/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33560605", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33560605/", "doi": "", "pmid": "33560605", "publication_date": "2021-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2214, "title": "Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.", "authors": "Inserra A, De Gregorio D, Gobbi G", "journal": "Pharmacological reviews", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1124/pharmrev.120.000056", "pubmed_id": "33328244", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33328244/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33328244", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33328244/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33328244", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33328244/", "doi": "10.1124/pharmrev.120.000056", "pmid": "33328244", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2211, "title": "Psychedelic Medicines in Major Depression: Progress and Future Challenges.", "authors": "Bouso JC, Ona G, Dos Santos RG, Hallak JEC", "journal": "Advances in experimental medicine and biology", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1007/978-981-33-6044-0_26", "pubmed_id": "33834416", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33834416/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33834416", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33834416/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33834416", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33834416/", "doi": "10.1007/978-981-33-6044-0_26", "pmid": "33834416", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2198, "title": "Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.", "authors": "Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.586682", "pubmed_id": "33643087", "openalex_id": "https://openalex.org/W3127909847", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33643087/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33643087", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33643087/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33643087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33643087/", "doi": "10.3389/fpsyt.2021.586682", "pmid": "33643087", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2197, "title": "What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.", "authors": "Castro Santos H, Gama Marques J", "journal": "Porto biomedical journal", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1097/j.pbj.0000000000000128", "pubmed_id": "33884324", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33884324/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33884324", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33884324/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33884324", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33884324/", "doi": "10.1097/j.pbj.0000000000000128", "pmid": "33884324", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2191, "title": "The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.", "authors": "Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE", "journal": "Risk management and healthcare policy", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.2147/rmhp.s300656", "pubmed_id": "33707976", "openalex_id": "https://openalex.org/W4392135761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33707976/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33707976", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33707976/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33707976", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33707976/", "doi": "10.2147/rmhp.s300656", "pmid": "33707976", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2164, "title": "Psilocybin: From Serendipity to Credibility?", "authors": "Rucker JJ, Young AH", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.659044", "pubmed_id": "33967860", "openalex_id": "https://openalex.org/W3154999065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33967860/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33967860", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33967860/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33967860", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33967860/", "doi": "10.3389/fpsyt.2021.659044", "pmid": "33967860", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2036, "title": "Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin", "authors": "Dahmane Elyes, Hutson Paul R., Gobburu Jogarao V. S.", "journal": "Clinical Pharmacology in Drug Development", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1002/cpdd.796", "pubmed_id": "32250059", "openalex_id": "https://openalex.org/W3014341075", "source_url": "https://doi.org/10.1002/cpdd.796", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:50", "bibtex": null, "source_record_id": "PMID:32250059", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/cpdd.796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:32250059", "source_url": "https://doi.org/10.1002/cpdd.796", "doi": "10.1002/cpdd.796", "pmid": "32250059", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1894, "title": "Study Protocol for \"Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study\".", "authors": "Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.735523", "pubmed_id": "34744825", "openalex_id": "https://openalex.org/W3205506305", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34744825/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,End-of-Life Distress,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34744825", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34744825/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34744825", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34744825/", "doi": "10.3389/fpsyt.2021.735523", "pmid": "34744825", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1889, "title": "Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.", "authors": "Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.737738", "pubmed_id": "34803761", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "substance_tags": "psilocybin", "topic_tags": "Depression,Creativity,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34803761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34803761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "doi": "10.3389/fpsyt.2021.737738", "pmid": "34803761", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2228, "title": "The emerging role of psilocybin and MDMA in the treatment of mental illness.", "authors": "Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS", "journal": "Expert review of neurotherapeutics", "publication_date": "2020-12-01", "publication_year": 2020, "doi": "10.1080/14737175.2020.1826931", "pubmed_id": "32954860", "openalex_id": "https://openalex.org/W3087462486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32954860/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32954860", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32954860/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32954860", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32954860/", "doi": "10.1080/14737175.2020.1826931", "pmid": "32954860", "publication_date": "2020-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2233, "title": "Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.", "authors": "Mason NL, Kuypers KPC, Müller F, Reckweg J, Tse DHY, Toennes SW, Hutten NRPW, Jansen JFA, Stiers P, Feilding A, Ramaekers JG", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2020-11-01", "publication_year": 2020, "doi": "10.1038/s41386-020-0718-8", "pubmed_id": "32446245", "openalex_id": "https://openalex.org/W3027590463", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32446245/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32446245", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32446245/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32446245", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32446245/", "doi": "10.1038/s41386-020-0718-8", "pmid": "32446245", "publication_date": "2020-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3402, "title": "A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy", "authors": "Luoma JB, Chwyl C, Bathje G, Davis AK, Lancelotta RL.", "journal": "PsyArXiv", "publication_date": "2020-10-28", "publication_year": 2020, "doi": "10.31234/osf.io/nhbjk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/nhbjk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:33", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/nhbjk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/nhbjk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/nhbjk", "source_url": "https://doi.org/10.31234/osf.io/nhbjk", "doi": "10.31234/osf.io/nhbjk", "pmid": "", "publication_date": "2020-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3829, "title": "The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.", "authors": "Olivia Gosseries, Charlotte Martial", "journal": "Open Repository and Bibliography (University of Liège)", "publication_date": "2020-10-12", "publication_year": 2020, "doi": "10.34700/gv0w-y052", "pubmed_id": null, "openalex_id": "https://openalex.org/W3118817849", "source_url": "https://orbi.uliege.be/handle/2268/254726", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.34700/gv0w-y052", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://orbi.uliege.be/handle/2268/254726", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34700/gv0w-y052", "source_url": "https://orbi.uliege.be/handle/2268/254726", "doi": "10.34700/gv0w-y052", "pmid": "", "publication_date": "2020-10-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3831, "title": "The Role of Psychedelics and Counseling in Mental Health Treatment", "authors": "Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch", "journal": "Journal of Mental Health Counseling", "publication_date": "2020-10-01", "publication_year": 2020, "doi": "10.17744/mehc.42.4.03", "pubmed_id": null, "openalex_id": "https://openalex.org/W3094549229", "source_url": "https://doi.org/10.17744/mehc.42.4.03", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "DOI:10.17744/mehc.42.4.03", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17744/mehc.42.4.03", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17744/mehc.42.4.03", "source_url": "https://doi.org/10.17744/mehc.42.4.03", "doi": "10.17744/mehc.42.4.03", "pmid": "", "publication_date": "2020-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2241, "title": "Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials.", "authors": "Cozzi NV, Daley PF", "journal": "Drug testing and analysis", "publication_date": "2020-10-01", "publication_year": 2020, "doi": "10.1002/dta.2889", "pubmed_id": "32608093", "openalex_id": "https://openalex.org/W3038172304", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32608093/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32608093", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32608093/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32608093", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32608093/", "doi": "10.1002/dta.2889", "pmid": "32608093", "publication_date": "2020-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3834, "title": "Wait for the Science Before Widespread Use of Psilocybin", "authors": "Nicole Harrington Cirino", "journal": "Psychiatric News", "publication_date": "2020-09-29", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.10a32", "pubmed_id": null, "openalex_id": "https://openalex.org/W3091539953", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "doi": "10.1176/appi.pn.2020.10a32", "pmid": "", "publication_date": "2020-09-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2246, "title": "Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.", "authors": "Vitkauskas M, Mathuru AS", "journal": "International journal of molecular sciences", "publication_date": "2020-09-07", "publication_year": 2020, "doi": "10.3390/ijms21186525", "pubmed_id": "32906643", "openalex_id": "https://openalex.org/W3083433593", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32906643/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32906643", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32906643/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32906643", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32906643/", "doi": "10.3390/ijms21186525", "pmid": "32906643", "publication_date": "2020-09-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2247, "title": "Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.", "authors": "Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L", "journal": "Biomedicines", "publication_date": "2020-09-05", "publication_year": 2020, "doi": "10.3390/biomedicines8090331", "pubmed_id": "32899469", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32899469/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32899469", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32899469/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32899469", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32899469/", "doi": "10.3390/biomedicines8090331", "pmid": "32899469", "publication_date": "2020-09-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2251, "title": "Psilocybin occasioned mystical-type experiences.", "authors": "James E, Robertshaw TL, Hoskins M, Sessa B", "journal": "Human psychopharmacology", "publication_date": "2020-09-01", "publication_year": 2020, "doi": "10.1002/hup.2742", "pubmed_id": "32573835", "openalex_id": "https://openalex.org/W3037497292", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32573835/", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32573835", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32573835/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32573835", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32573835/", "doi": "10.1002/hup.2742", "pmid": "32573835", "publication_date": "2020-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3842, "title": "4 Psychedelics: therapeutic mechanisms", "authors": "Robin Carhart-Harris", "journal": "Journal of Neurology Neurosurgery & Psychiatry", "publication_date": "2020-07-20", "publication_year": 2020, "doi": "10.1136/jnnp-2020-bnpa.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W3044110502", "source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1136/jnnp-2020-bnpa.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/jnnp-2020-bnpa.4", "source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "doi": "10.1136/jnnp-2020-bnpa.4", "pmid": "", "publication_date": "2020-07-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2265, "title": "Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin.", "authors": "Fricke J, Kargbo R, Regestein L, Lenz C, Peschel G, Rosenbaum MA, Sherwood A, Hoffmeister D", "journal": "Chemistry (Weinheim an der Bergstrasse, Germany)", "publication_date": "2020-07-02", "publication_year": 2020, "doi": "10.1002/chem.202000134", "pubmed_id": "32101345", "openalex_id": "https://openalex.org/W3007311584", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32101345/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32101345", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32101345/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32101345", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32101345/", "doi": "10.1002/chem.202000134", "pmid": "32101345", "publication_date": "2020-07-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2267, "title": "Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives.", "authors": "Milne N, Thomsen P, Mølgaard Knudsen N, Rubaszka P, Kristensen M, Borodina I", "journal": "Metabolic engineering", "publication_date": "2020-07-01", "publication_year": 2020, "doi": "10.1016/j.ymben.2019.12.007", "pubmed_id": "32224264", "openalex_id": "https://openalex.org/W3013100262", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32224264/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32224264", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32224264/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32224264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32224264/", "doi": "10.1016/j.ymben.2019.12.007", "pmid": "32224264", "publication_date": "2020-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2266, "title": "Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.", "authors": "Meinhardt MW, Güngör C, Skorodumov I, Mertens LJ, Spanagel R", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2020-07-01", "publication_year": 2020, "doi": "10.1038/s41386-020-0694-z", "pubmed_id": "32369828", "openalex_id": "https://openalex.org/W3020950088", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32369828/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Microdosing,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32369828", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32369828/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32369828", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32369828/", "doi": "10.1038/s41386-020-0694-z", "pmid": "32369828", "publication_date": "2020-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3404, "title": "A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy", "authors": "Luoma JB.", "journal": "PsyArXiv", "publication_date": "2020-06-12", "publication_year": 2020, "doi": "10.31234/osf.io/sgujx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/sgujx", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:33", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/sgujx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/sgujx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/sgujx", "source_url": "https://doi.org/10.31234/osf.io/sgujx", "doi": "10.31234/osf.io/sgujx", "pmid": "", "publication_date": "2020-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2269, "title": "Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.", "authors": "Greenway KT, Garel N, Jerome L, Feduccia AA", "journal": "Expert review of clinical pharmacology", "publication_date": "2020-06-01", "publication_year": 2020, "doi": "10.1080/17512433.2020.1772054", "pubmed_id": "32478631", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32478631/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32478631", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32478631/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32478631", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32478631/", "doi": "10.1080/17512433.2020.1772054", "pmid": "32478631", "publication_date": "2020-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3850, "title": "Psychedelics, Safety and Clinical Trial Design", "authors": "Ron Shore", "journal": "QSpace (Queen's University Library)", "publication_date": "2020-05-19", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3043468905", "source_url": "http://hdl.handle.net/1974/27835", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://hdl.handle.net/1974/27835", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/1974/27835", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/1974/27835", "source_url": "http://hdl.handle.net/1974/27835", "doi": "", "pmid": "", "publication_date": "2020-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2279, "title": "Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.", "authors": "Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M", "journal": "Psychopharmacology", "publication_date": "2020-05-01", "publication_year": 2020, "doi": "10.1007/s00213-020-05477-0", "pubmed_id": "32043165", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32043165", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32043165", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "doi": "10.1007/s00213-020-05477-0", "pmid": "32043165", "publication_date": "2020-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2209, "title": "Psychedelics and Psychedelic-Assisted Psychotherapy.", "authors": "Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research", "journal": "The American journal of psychiatry", "publication_date": "2020-05-01", "publication_year": 2020, "doi": "10.1176/appi.ajp.2019.19010035", "pubmed_id": "32098487", "openalex_id": "https://openalex.org/W32098487", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32098487/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Brain Imaging,Aging,Clinical Trial,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32098487", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32098487/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32098487", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32098487/", "doi": "10.1176/appi.ajp.2019.19010035", "pmid": "32098487", "publication_date": "2020-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3451, "title": "Pharmacokinetics of Psilocybin in Normal Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2020-04-15", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02163707", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02163707", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02163707", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02163707", "source_url": "https://clinicaltrials.gov/study/NCT02163707", "doi": "", "pmid": "", "publication_date": "2020-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3858, "title": "Psychedelics for Psychiatric Disorders: More Research Needed", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2020-04-13", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.4a14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3017294991", "source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.4a14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.4a14", "source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "doi": "10.1176/appi.pn.2020.4a14", "pmid": "", "publication_date": "2020-04-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3863, "title": "Can Psychedelics Radically Change SUD Treatment?", "authors": "Katie O’Connor", "journal": "Psychiatric News", "publication_date": "2020-03-20", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.2a12", "pubmed_id": null, "openalex_id": "https://openalex.org/W3012401750", "source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Addiction,Chronic Pain,Pharmacology,Consciousness,Clinical Trial,Observational Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.2a12", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.2a12", "source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "doi": "10.1176/appi.pn.2020.2a12", "pmid": "", "publication_date": "2020-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2289, "title": "Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression.", "authors": "Hibicke M, Landry AN, Kramer HM, Talman ZK, Nichols CD", "journal": "ACS chemical neuroscience", "publication_date": "2020-03-18", "publication_year": 2020, "doi": "10.1021/acschemneuro.9b00493", "pubmed_id": "32133835", "openalex_id": "https://openalex.org/W3010499243", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32133835/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32133835", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32133835/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32133835", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32133835/", "doi": "10.1021/acschemneuro.9b00493", "pmid": "32133835", "publication_date": "2020-03-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5713, "title": "Psilocybin Therapy for Depression: A Scoping Review Protocol", "authors": "Dalton Budhram, Preet Dhaliwal", "journal": "Open MIND", "publication_date": "2020-01-01", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7167303937", "source_url": "https://osf.io/4syt6", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "https://osf.io/4syt6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/4syt6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://osf.io/4syt6", "source_url": "https://osf.io/4syt6", "doi": "", "pmid": "", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2315, "title": "Microdosing psychedelics: Motivations, subjective effects and harm reduction.", "authors": "Lea T, Amada N, Jungaberle H, Schecke H, Klein M", "journal": "The International journal on drug policy", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1016/j.drugpo.2019.11.008", "pubmed_id": "31778967", "openalex_id": "https://openalex.org/W2990036135", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31778967/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Clinical Trial,Randomized Controlled Trial,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31778967", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31778967/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31778967", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31778967/", "doi": "10.1016/j.drugpo.2019.11.008", "pmid": "31778967", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1083, "title": "Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.", "authors": "Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ", "journal": "Frontiers in neuroscience", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.3389/fnins.2020.00043", "pubmed_id": "32116500", "openalex_id": "https://openalex.org/W3005218696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32116500/", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32116500", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32116500/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32116500", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32116500/", "doi": "10.3389/fnins.2020.00043", "pmid": "32116500", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3891, "title": "The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder", "authors": "Sofia Gyllvik", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3083741926", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3883, "title": "Development of an improved psilocybin synthesis", "authors": "Reham Shaba", "journal": "Uppsala University Publications (Uppsala University)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3089446948", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3285, "title": "Mapping Psilocybin-Assisted Therapies: A Scoping Review", "authors": "Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On.", "journal": "medRxiv", "publication_date": "2019-12-12", "publication_year": 2019, "doi": "10.1101/2019.12.04.19013896", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:18", "bibtex": null, "source_record_id": "DOI:10.1101/2019.12.04.19013896", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2019.12.04.19013896", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2019.12.04.19013896", "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "doi": "10.1101/2019.12.04.19013896", "pmid": "", "publication_date": "2019-12-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3905, "title": "P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression", "authors": "Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris", "journal": "European Neuropsychopharmacology", "publication_date": "2019-12-01", "publication_year": 2019, "doi": "10.1016/j.euroneuro.2019.09.593", "pubmed_id": null, "openalex_id": "https://openalex.org/W4248055189", "source_url": "https://doi.org/10.1016/j.euroneuro.2019.09.593", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2019.09.593", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2019.09.593", "source_url": "https://doi.org/10.1016/j.euroneuro.2019.09.593", "doi": "10.1016/j.euroneuro.2019.09.593", "pmid": "", "publication_date": "2019-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2317, "title": "In vivo production of psilocybin in E. coli.", "authors": "Adams AM, Kaplan NA, Wei Z, Brinton JD, Monnier CS, Enacopol AL, Ramelot TA, Jones JA", "journal": "Metabolic engineering", "publication_date": "2019-12-01", "publication_year": 2019, "doi": "10.1016/j.ymben.2019.09.009", "pubmed_id": "31550507", "openalex_id": "https://openalex.org/W2973895336", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31550507/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31550507", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31550507/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31550507", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31550507/", "doi": "10.1016/j.ymben.2019.09.009", "pmid": "31550507", "publication_date": "2019-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2319, "title": "Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin.", "authors": "Fricke J, Sherwood A, Kargbo R, Orry A, Blei F, Naschberger A, Rupp B, Hoffmeister D", "journal": "Chembiochem: a European journal of chemical biology", "publication_date": "2019-11-18", "publication_year": 2019, "doi": "10.1002/cbic.201900358", "pubmed_id": "31150155", "openalex_id": "https://openalex.org/W2948005519", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31150155/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Epigenetics,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31150155", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31150155/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31150155", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31150155/", "doi": "10.1002/cbic.201900358", "pmid": "31150155", "publication_date": "2019-11-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2320, "title": "Classical psychedelics for the treatment of depression and anxiety: A systematic review.", "authors": "Muttoni S, Ardissino M, John C", "journal": "Journal of affective disorders", "publication_date": "2019-11-01", "publication_year": 2019, "doi": "10.1016/j.jad.2019.07.076", "pubmed_id": "31382100", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31382100/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31382100", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31382100/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31382100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31382100/", "doi": "10.1016/j.jad.2019.07.076", "pmid": "31382100", "publication_date": "2019-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2322, "title": "Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.", "authors": "Dos Santos RG, Bouso JC, Hallak JEC", "journal": "BMC psychiatry", "publication_date": "2019-10-28", "publication_year": 2019, "doi": "10.1186/s12888-019-2288-z", "pubmed_id": "31660905", "openalex_id": "https://openalex.org/W2981489145", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31660905/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31660905", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31660905/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31660905", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31660905/", "doi": "10.1186/s12888-019-2288-z", "pmid": "31660905", "publication_date": "2019-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3915, "title": "Johns Hopkins Opens Research Center on Psychedelics", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-10-27", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.10a16", "pubmed_id": null, "openalex_id": "https://openalex.org/W2982427347", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Consciousness,Biomarkers,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "doi": "10.1176/appi.pn.2019.10a16", "pmid": "", "publication_date": "2019-10-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3918, "title": "Modified E. coli pump out psilocybin", "authors": "Megha Satyanarayana", "journal": "C&EN Global Enterprise", "publication_date": "2019-10-06", "publication_year": 2019, "doi": "10.1021/cen-09739-scicon9", "pubmed_id": null, "openalex_id": "https://openalex.org/W2981873322", "source_url": "https://doi.org/10.1021/cen-09739-scicon9", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09739-scicon9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-09739-scicon9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09739-scicon9", "source_url": "https://doi.org/10.1021/cen-09739-scicon9", "doi": "10.1021/cen-09739-scicon9", "pmid": "", "publication_date": "2019-10-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3920, "title": "Psilocybin for depression: Considerations for clinical trial design", "authors": "Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz", "journal": "Journal of Psychedelic Studies", "publication_date": "2019-09-01", "publication_year": 2019, "doi": "10.1556/2054.2019.026", "pubmed_id": null, "openalex_id": "https://openalex.org/W2974814938", "source_url": "https://doi.org/10.1556/2054.2019.026", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2019.026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2019.026", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2019.026", "source_url": "https://doi.org/10.1556/2054.2019.026", "doi": "10.1556/2054.2019.026", "pmid": "", "publication_date": "2019-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2338, "title": "REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.", "authors": "Carhart-Harris RL, Friston KJ", "journal": "Pharmacological reviews", "publication_date": "2019-07-01", "publication_year": 2019, "doi": "10.1124/pr.118.017160", "pubmed_id": "31221820", "openalex_id": "https://openalex.org/W2949457836", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31221820/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31221820", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31221820/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31221820", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31221820/", "doi": "10.1124/pr.118.017160", "pmid": "31221820", "publication_date": "2019-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3926, "title": "The Potential of Psilocybin Administration in Terminal Cancer Patients", "authors": "Richard Simoneaux", "journal": "Oncology Times", "publication_date": "2019-06-28", "publication_year": 2019, "doi": "10.1097/01.cot.0000574916.46844.cf", "pubmed_id": null, "openalex_id": "https://openalex.org/W2956046898", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "doi": "10.1097/01.cot.0000574916.46844.cf", "pmid": "", "publication_date": "2019-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3940, "title": "Psychedelics Improve the Mental Health of Rats", "authors": "Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2019-04-01", "publication_year": 2019, "doi": "10.1096/fasebj.2019.33.1_supplement.666.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W3175025894", "source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.2019.33.1_supplement.666.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.2019.33.1_supplement.666.1", "source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "doi": "10.1096/fasebj.2019.33.1_supplement.666.1", "pmid": "", "publication_date": "2019-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5830, "title": "Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens", "authors": "Jenna Varley", "journal": "Journal of Psychedelic Studies", "publication_date": "2019-02-25", "publication_year": 2019, "doi": "10.1556/2054.2019.005", "pubmed_id": null, "openalex_id": "https://openalex.org/W2915910581", "source_url": "https://doi.org/10.1556/2054.2019.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:50", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2019.005", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2019.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2019.005", "source_url": "https://doi.org/10.1556/2054.2019.005", "doi": "10.1556/2054.2019.005", "pmid": "", "publication_date": "2019-02-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2361, "title": "Production Options for Psilocybin: Making of the Magic.", "authors": "Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D", "journal": "Chemistry (Weinheim an der Bergstrasse, Germany)", "publication_date": "2019-01-18", "publication_year": 2019, "doi": "10.1002/chem.201802758", "pubmed_id": "30011099", "openalex_id": "https://openalex.org/W2884828036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30011099/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30011099", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30011099/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30011099", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30011099/", "doi": "10.1002/chem.201802758", "pmid": "30011099", "publication_date": "2019-01-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2363, "title": "Psychedelic drugs-a new era in psychiatry?.", "authors": "Nutt D", "journal": "Dialogues in clinical neuroscience", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.31887/dcns.2019.21.2/dnutt", "pubmed_id": "31636488", "openalex_id": "https://openalex.org/W2985843276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31636488/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31636488", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31636488/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31636488", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31636488/", "doi": "10.31887/dcns.2019.21.2/dnutt", "pmid": "31636488", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2351, "title": "The Past and Future of Psychedelic Science: An Introduction to This Issue.", "authors": "Doblin RE, Christiansen M, Jerome L, Burge B", "journal": "Journal of psychoactive drugs", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1080/02791072.2019.1606472", "pubmed_id": "31132970", "openalex_id": "https://openalex.org/W2947995541", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31132970/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Creativity,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31132970", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31132970/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31132970", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31132970/", "doi": "10.1080/02791072.2019.1606472", "pmid": "31132970", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2329, "title": "Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.", "authors": "Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC", "journal": "Frontiers in psychiatry", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.3389/fpsyt.2019.00672", "pubmed_id": "31572246", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Microdosing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31572246", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31572246", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "doi": "10.3389/fpsyt.2019.00672", "pmid": "31572246", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2377, "title": "Psychiatry & the psychedelic drugs. Past, present & future.", "authors": "Rucker JJH, Iliff J, Nutt DJ", "journal": "Neuropharmacology", "publication_date": "2018-11-01", "publication_year": 2018, "doi": "10.1016/j.neuropharm.2017.12.040", "pubmed_id": "29284138", "openalex_id": "https://openalex.org/W2781316183", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29284138/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29284138", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29284138/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29284138", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29284138/", "doi": "10.1016/j.neuropharm.2017.12.040", "pmid": "29284138", "publication_date": "2018-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2384, "title": "Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).", "authors": "Nichols DE", "journal": "ACS chemical neuroscience", "publication_date": "2018-10-17", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00043", "pubmed_id": "29461039", "openalex_id": "https://openalex.org/W2788130744", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29461039/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Mystical Experience,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29461039", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29461039/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29461039", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29461039/", "doi": "10.1021/acschemneuro.8b00043", "pmid": "29461039", "publication_date": "2018-10-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2383, "title": "Psychedelics and Personality.", "authors": "Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC", "journal": "ACS chemical neuroscience", "publication_date": "2018-10-17", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00237", "pubmed_id": "29863323", "openalex_id": "https://openalex.org/W2805186158", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29863323/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29863323", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29863323/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29863323", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29863323/", "doi": "10.1021/acschemneuro.8b00237", "pmid": "29863323", "publication_date": "2018-10-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2380, "title": "DARK Classics in Chemical Neuroscience: Ibogaine.", "authors": "Wasko MJ, Witt-Enderby PA, Surratt CK", "journal": "ACS chemical neuroscience", "publication_date": "2018-10-17", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00294", "pubmed_id": "30216039", "openalex_id": "https://openalex.org/W2891949993", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30216039/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30216039", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30216039/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30216039", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30216039/", "doi": "10.1021/acschemneuro.8b00294", "pmid": "30216039", "publication_date": "2018-10-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2394, "title": "Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.", "authors": "Ross S", "journal": "International review of psychiatry (Abingdon, England)", "publication_date": "2018-08-01", "publication_year": 2018, "doi": "10.1080/09540261.2018.1482261", "pubmed_id": "30102082", "openalex_id": "https://openalex.org/W2886232664", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102082/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30102082", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30102082/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30102082", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102082/", "doi": "10.1080/09540261.2018.1482261", "pmid": "30102082", "publication_date": "2018-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2424, "title": "Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.", "authors": "Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2018-02-02", "publication_year": 2018, "doi": "10.1016/j.pnpbp.2017.09.012", "pubmed_id": "28947181", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947181/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28947181", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28947181/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28947181", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947181/", "doi": "10.1016/j.pnpbp.2017.09.012", "pmid": "28947181", "publication_date": "2018-02-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2427, "title": "Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.", "authors": "Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4771-x", "pubmed_id": "29119217", "openalex_id": "https://openalex.org/W2767530231", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29119217/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29119217", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29119217/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29119217", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29119217/", "doi": "10.1007/s00213-017-4771-x", "pmid": "29119217", "publication_date": "2018-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5178, "title": "Unlearning to See: Linking the Perceptual and Clinical Effects of Psychedelic Drugs.", "authors": "Link Swanson", "journal": "Cognitive Science", "publication_date": "2018-01-01", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2941699004", "source_url": "https://escholarship.org/uc/item/67x0n7rq", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "https://escholarship.org/uc/item/67x0n7rq", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://escholarship.org/uc/item/67x0n7rq", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://escholarship.org/uc/item/67x0n7rq", "source_url": "https://escholarship.org/uc/item/67x0n7rq", "doi": "", "pmid": "", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5176, "title": "Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological Distress", "authors": "Thomas Cody Swift", "journal": "Western CEDAR (Western Washington University)", "publication_date": "2018-01-01", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2911249940", "source_url": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "source_url": "https://cedar.wwu.edu/pci/lectures_events/holistic_pain_management/3", "doi": "", "pmid": "", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2441, "title": "Therapeutic Applications of Classic Hallucinogens.", "authors": "Bogenschutz MP, Ross S", "journal": "Current topics in behavioral neurosciences", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1007/7854_2016_464", "pubmed_id": "28512684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28512684/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Observational Study,In Vitro Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28512684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28512684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28512684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28512684/", "doi": "10.1007/7854_2016_464", "pmid": "28512684", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2435, "title": "Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.", "authors": "Canal CE", "journal": "Handbook of experimental pharmacology", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1007/164_2018_107", "pubmed_id": "29532180", "openalex_id": "https://openalex.org/W2789541163", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29532180/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29532180", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29532180/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29532180", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29532180/", "doi": "10.1007/164_2018_107", "pmid": "29532180", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2423, "title": "Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.", "authors": "Bogenschutz MP, Podrebarac SK, Duane JH, Amegadzie SS, Malone TC, Owens LT, Ross S, Mennenga SE", "journal": "Frontiers in pharmacology", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.3389/fphar.2018.00100", "pubmed_id": "29515439", "openalex_id": "https://openalex.org/W2788524689", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29515439/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Consciousness,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29515439", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29515439/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29515439", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29515439/", "doi": "10.3389/fphar.2018.00100", "pmid": "29515439", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2422, "title": "The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.", "authors": "Nielson EM, May DG, Forcehimes AA, Bogenschutz MP", "journal": "Frontiers in pharmacology", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.3389/fphar.2018.00132", "pubmed_id": "29515449", "openalex_id": "https://openalex.org/W2793096639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29515449/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29515449", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29515449/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29515449", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29515449/", "doi": "10.3389/fphar.2018.00132", "pmid": "29515449", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2398, "title": "Psilocybin and Mental Health-Don't Lose Control.", "authors": "Barnby JM, Mehta MA", "journal": "Frontiers in psychiatry", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.3389/fpsyt.2018.00293", "pubmed_id": "30018574", "openalex_id": "https://openalex.org/W2807830955", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30018574/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30018574", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30018574/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30018574", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30018574/", "doi": "10.3389/fpsyt.2018.00293", "pmid": "30018574", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2446, "title": "Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.", "authors": "Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR", "journal": "Clinical pharmacokinetics", "publication_date": "2017-12-01", "publication_year": 2017, "doi": "10.1007/s40262-017-0540-6", "pubmed_id": "28353056", "openalex_id": "https://openalex.org/W2600624779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28353056/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28353056", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28353056/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28353056", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28353056/", "doi": "10.1007/s40262-017-0540-6", "pmid": "28353056", "publication_date": "2017-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2449, "title": "Psychedelic Drugs in Biomedicine.", "authors": "Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV", "journal": "Trends in pharmacological sciences", "publication_date": "2017-11-01", "publication_year": 2017, "doi": "10.1016/j.tips.2017.08.003", "pubmed_id": "28947075", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947075/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28947075", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28947075/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28947075", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947075/", "doi": "10.1016/j.tips.2017.08.003", "pmid": "28947075", "publication_date": "2017-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2456, "title": "The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.", "authors": "Carhart-Harris RL, Goodwin GM", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2017-10-01", "publication_year": 2017, "doi": "10.1038/npp.2017.84", "pubmed_id": "28443617", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28443617/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28443617", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28443617/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28443617", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28443617/", "doi": "10.1038/npp.2017.84", "pmid": "28443617", "publication_date": "2017-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5198, "title": "Navigating Psychedelic Medicines through (Inter)national Regulation", "authors": "Jonathan Nash", "journal": "Northumbria Research Link (Northumbria University)", "publication_date": "2017-07-01", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2756506476", "source_url": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "source_url": "http://nrl.northumbria.ac.uk/id/eprint/31692/1/__Client_H%24_Documents_Breaking%20Convention%202017%20Final.pptx", "doi": "", "pmid": "", "publication_date": "2017-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5832, "title": "Should addiction researchers be interested in psychedelic science?", "authors": "Stephen Bright, M.L. Williams, David Caldicott", "journal": "Drug and Alcohol Review", "publication_date": "2017-04-10", "publication_year": 2017, "doi": "10.1111/dar.12544", "pubmed_id": "28397321", "openalex_id": "https://openalex.org/W2606394595", "source_url": "https://doi.org/10.1111/dar.12544", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Observational Study,Veterans,Safety,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:52", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "PMID:28397321", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/dar.12544", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:28397321", "source_url": "https://doi.org/10.1111/dar.12544", "doi": "10.1111/dar.12544", "pmid": "28397321", "publication_date": "2017-04-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5208, "title": "Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma models", "authors": "Thomas W. Flanagan, Melaine N. Sebastian, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2017-04-01", "publication_year": 2017, "doi": "10.1096/fasebj.31.1_supplement.820.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W2970574043", "source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.31.1_supplement.820.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.31.1_supplement.820.4", "source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "doi": "10.1096/fasebj.31.1_supplement.820.4", "pmid": "", "publication_date": "2017-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2464, "title": "Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.", "authors": "Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR", "journal": "Frontiers in psychology", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.3389/fpsyg.2017.01238", "pubmed_id": "28790944", "openalex_id": "https://openalex.org/W2738683289", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28790944/", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28790944", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28790944/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28790944", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28790944/", "doi": "10.3389/fpsyg.2017.01238", "pmid": "28790944", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2450, "title": "Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.", "authors": "Thomas K, Malcolm B, Lastra D", "journal": "Journal of psychoactive drugs", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.1080/02791072.2017.1320734", "pubmed_id": "28481178", "openalex_id": "https://openalex.org/W2612228298", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28481178/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Default Mode Network,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28481178", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28481178/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28481178", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28481178/", "doi": "10.1080/02791072.2017.1320734", "pmid": "28481178", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2431, "title": "Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.", "authors": "Roseman L, Nutt DJ, Carhart-Harris RL", "journal": "Frontiers in pharmacology", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.3389/fphar.2017.00974", "pubmed_id": "29387009", "openalex_id": "https://openalex.org/W2792444257", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29387009/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29387009", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29387009/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29387009", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29387009/", "doi": "10.3389/fphar.2017.00974", "pmid": "29387009", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2497, "title": "Psychedelics in the treatment of unipolar mood disorders: a systematic review.", "authors": "Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116679368", "pubmed_id": "27856684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856684/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27856684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27856684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27856684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856684/", "doi": "10.1177/0269881116679368", "pmid": "27856684", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2486, "title": "Return of the psychedelics: Psilocybin for treatment resistant depression.", "authors": "Patra S", "journal": "Asian journal of psychiatry", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1016/j.ajp.2016.08.010", "pubmed_id": "27931907", "openalex_id": "https://openalex.org/W2512668841", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27931907/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27931907", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27931907/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27931907", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27931907/", "doi": "10.1016/j.ajp.2016.08.010", "pmid": "27931907", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5227, "title": "Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism", "authors": "Michael P. Bogenschutz, Alyssa A. Forcehimes", "journal": "Journal of Humanistic Psychology", "publication_date": "2016-10-16", "publication_year": 2016, "doi": "10.1177/0022167816673493", "pubmed_id": null, "openalex_id": "https://openalex.org/W2537388000", "source_url": "https://doi.org/10.1177/0022167816673493", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "DOI:10.1177/0022167816673493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0022167816673493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/0022167816673493", "source_url": "https://doi.org/10.1177/0022167816673493", "doi": "10.1177/0022167816673493", "pmid": "", "publication_date": "2016-10-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2508, "title": "Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.", "authors": "Howland RH", "journal": "Journal of psychosocial nursing and mental health services", "publication_date": "2016-07-01", "publication_year": 2016, "doi": "10.3928/02793695-20160616-09", "pubmed_id": "27362381", "openalex_id": "https://openalex.org/W2470545286", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27362381/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27362381", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27362381/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27362381", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27362381/", "doi": "10.3928/02793695-20160616-09", "pmid": "27362381", "publication_date": "2016-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2513, "title": "Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.", "authors": "Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2016-06-01", "publication_year": 2016, "doi": "10.1177/2045125316638008", "pubmed_id": "27354908", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/27354908/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27354908", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27354908/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27354908", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27354908/", "doi": "10.1177/2045125316638008", "pmid": "27354908", "publication_date": "2016-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2048, "title": "Sex differences and serotonergic mechanisms in the behavioural effects of psilocin", "authors": "Tylš Filip, Páleníček Tomáš, Kadeřábek Lukáš, Lipski Michaela, Kubešová Anna, Horáček Jiří", "journal": "Behavioural Pharmacology", "publication_date": "2016-06-01", "publication_year": 2016, "doi": "10.1097/fbp.0000000000000198", "pubmed_id": "26461483", "openalex_id": "https://openalex.org/W2318447563", "source_url": "https://doi.org/10.1097/fbp.0000000000000198", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:50", "bibtex": null, "source_record_id": "PMID:26461483", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000198", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:26461483", "source_url": "https://doi.org/10.1097/fbp.0000000000000198", "doi": "10.1097/fbp.0000000000000198", "pmid": "26461483", "publication_date": "2016-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3410, "title": "PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG", "authors": "Tyls F, Michaela Viktorinova T, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J.", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2016-05-27", "publication_year": 2016, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC5616440", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:53", "last_checked": "2026-08-09 08:15:34", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC5616440", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC5616440", "source_url": "https://europepmc.org/article/PMC/PMC5616440", "doi": "", "pmid": "", "publication_date": "2016-05-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5238, "title": "PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG", "authors": "Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský, Jiřı́ Horáček", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2016-05-26", "publication_year": 2016, "doi": "10.1093/ijnp/pyw041.506", "pubmed_id": null, "openalex_id": "https://openalex.org/W3095530399", "source_url": "https://doi.org/10.1093/ijnp/pyw041.506", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Receptor Pharmacology,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyw041.506", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyw041.506", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyw041.506", "source_url": "https://doi.org/10.1093/ijnp/pyw041.506", "doi": "10.1093/ijnp/pyw041.506", "pmid": "", "publication_date": "2016-05-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2519, "title": "Psychedelics.", "authors": "Nichols DE", "journal": "Pharmacological reviews", "publication_date": "2016-04-01", "publication_year": 2016, "doi": "10.1124/pr.115.011478", "pubmed_id": "26841800", "openalex_id": "https://openalex.org/W4386471172", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26841800/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Default Mode Network,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:26841800", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/26841800/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:26841800", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26841800/", "doi": "10.1124/pr.115.011478", "pmid": "26841800", "publication_date": "2016-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2523, "title": "Classic hallucinogens in the treatment of addictions.", "authors": "Bogenschutz MP, Johnson MW", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2016-01-04", "publication_year": 2016, "doi": "10.1016/j.pnpbp.2015.03.002", "pubmed_id": "25784600", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/25784600/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Mystical Experience,Clinical Trial,Meta-Analysis,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25784600", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25784600/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25784600", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25784600/", "doi": "10.1016/j.pnpbp.2015.03.002", "pmid": "25784600", "publication_date": "2016-01-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5261, "title": "The Psyche in Psychedelic", "authors": "Stephen Mo Hanan", "journal": "Tikkun", "publication_date": "2015-10-30", "publication_year": 2015, "doi": "10.1215/08879982-3328661", "pubmed_id": null, "openalex_id": "https://openalex.org/W2272829599", "source_url": "https://doi.org/10.1215/08879982-3328661", "substance_tags": "psilocybin", "topic_tags": "PTSD,End-of-Life Distress,Chronic Pain,Consciousness,Aging,Creativity,Spirituality,Clinical Trial,Cancer Patients,Veterans", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1215/08879982-3328661", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1215/08879982-3328661", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1215/08879982-3328661", "source_url": "https://doi.org/10.1215/08879982-3328661", "doi": "10.1215/08879982-3328661", "pmid": "", "publication_date": "2015-10-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5266, "title": "Discovery of a new caerulescent Psilocybe mushroom in Germany: Psilocybe germanica sp.nov.", "authors": "Jochen Gartz, Georg Wiedemann", "journal": "Drug Testing and Analysis", "publication_date": "2015-03-31", "publication_year": 2015, "doi": "10.1002/dta.1795", "pubmed_id": "25826697", "openalex_id": "https://openalex.org/W2111988752", "source_url": "https://doi.org/10.1002/dta.1795", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Aging,Clinical Trial,Case Report", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "PMID:25826697", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/dta.1795", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:25826697", "source_url": "https://doi.org/10.1002/dta.1795", "doi": "10.1002/dta.1795", "pmid": "25826697", "publication_date": "2015-03-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2545, "title": "Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.", "authors": "Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2015-03-01", "publication_year": 2015, "doi": "10.1177/0269881114565144", "pubmed_id": "25586396", "openalex_id": "https://openalex.org/W2075238613", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25586396/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25586396", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25586396/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25586396", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25586396/", "doi": "10.1177/0269881114565144", "pmid": "25586396", "publication_date": "2015-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2548, "title": "Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.", "authors": "Halberstadt AL", "journal": "Behavioural brain research", "publication_date": "2015-01-15", "publication_year": 2015, "doi": "10.1016/j.bbr.2014.07.016", "pubmed_id": "25036425", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/25036425/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25036425", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25036425/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25036425", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25036425/", "doi": "10.1016/j.bbr.2014.07.016", "pmid": "25036425", "publication_date": "2015-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2558, "title": "Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.", "authors": "Baumeister D, Barnes G, Giaroli G, Tracy D", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2014-08-01", "publication_year": 2014, "doi": "10.1177/2045125314527985", "pubmed_id": "25083275", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Spirituality,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25083275", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25083275", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "doi": "10.1177/2045125314527985", "pmid": "25083275", "publication_date": "2014-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5304, "title": "Stanislav Grof's Contributions to FDA Drug Development Research with Psychedelics", "authors": "Rick Doblin", "journal": "CIIS Digital Commons (California Institute of Integral Studies)", "publication_date": "2014-01-01", "publication_year": 2014, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2550063776", "source_url": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Addiction,End-of-Life Distress,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "source_url": "https://digitalcommons.ciis.edu/stanislavgrof2014/12", "doi": "", "pmid": "", "publication_date": "2014-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2567, "title": "The Heffter Research Institute: past and hopeful future.", "authors": "Nichols DE", "journal": "Journal of psychoactive drugs", "publication_date": "2014-01-01", "publication_year": 2014, "doi": "10.1080/02791072.2014.873688", "pubmed_id": "24830182", "openalex_id": "https://openalex.org/W1982006269", "source_url": "https://pubmed.ncbi.nlm.nih.gov/24830182/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:24830182", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/24830182/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:24830182", "source_url": "https://pubmed.ncbi.nlm.nih.gov/24830182/", "doi": "10.1080/02791072.2014.873688", "pmid": "24830182", "publication_date": "2014-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2577, "title": "A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.", "authors": "Burdick BV, Adinoff B", "journal": "The American journal of drug and alcohol abuse", "publication_date": "2013-09-01", "publication_year": 2013, "doi": "10.3109/00952990.2013.811513", "pubmed_id": "23968172", "openalex_id": "https://openalex.org/W2043530175", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23968172/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mystical Experience,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23968172", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23968172/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23968172", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23968172/", "doi": "10.3109/00952990.2013.811513", "pmid": "23968172", "publication_date": "2013-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2591, "title": "Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.", "authors": "Young SN", "journal": "Journal of psychiatry & neuroscience: JPN", "publication_date": "2013-03-01", "publication_year": 2013, "doi": "10.1503/jpn.120128", "pubmed_id": "23171696", "openalex_id": "https://openalex.org/W23171696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23171696/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23171696", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23171696/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23171696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23171696/", "doi": "10.1503/jpn.120128", "pmid": "23171696", "publication_date": "2013-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2589, "title": "Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.", "authors": "Bogenschutz MP", "journal": "Current drug abuse reviews", "publication_date": "2013-03-01", "publication_year": 2013, "doi": "10.2174/15733998113099990002", "pubmed_id": "23627783", "openalex_id": "https://openalex.org/W1996607457", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23627783/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23627783", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23627783/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23627783", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23627783/", "doi": "10.2174/15733998113099990002", "pmid": "23627783", "publication_date": "2013-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2606, "title": "Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.", "authors": "Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ", "journal": "The British journal of psychiatry: the journal of mental science", "publication_date": "2012-03-01", "publication_year": 2012, "doi": "10.1192/bjp.bp.111.103309", "pubmed_id": "22282432", "openalex_id": "https://openalex.org/W2119134849", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22282432/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:22282432", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/22282432/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:22282432", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22282432/", "doi": "10.1192/bjp.bp.111.103309", "pmid": "22282432", "publication_date": "2012-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2675, "title": "The adverse effects of hallucinogens from intramural perspective.", "authors": "Frecska E, Luna LE", "journal": "Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology", "publication_date": "2006-12-01", "publication_year": 2006, "doi": null, "pubmed_id": "17211054", "openalex_id": "https://openalex.org/W110752286", "source_url": "https://pubmed.ncbi.nlm.nih.gov/17211054/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:34:29", "bibtex": null, "source_record_id": "PMID:17211054", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/17211054/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:17211054", "source_url": "https://pubmed.ncbi.nlm.nih.gov/17211054/", "doi": "", "pmid": "17211054", "publication_date": "2006-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2714, "title": "Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.", "authors": "Riba J, Rodríguez-Fornells A, Barbanoj MJ", "journal": "Psychopharmacology", "publication_date": "2002-12-01", "publication_year": 2002, "doi": "10.1007/s00213-002-1237-5", "pubmed_id": "12474114", "openalex_id": "https://openalex.org/W2129582923", "source_url": "https://pubmed.ncbi.nlm.nih.gov/12474114/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:29", "bibtex": null, "source_record_id": "PMID:12474114", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/12474114/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:12474114", "source_url": "https://pubmed.ncbi.nlm.nih.gov/12474114/", "doi": "10.1007/s00213-002-1237-5", "pmid": "12474114", "publication_date": "2002-12-01", "importer_version": "2.1.3", "text_redistributed": false } } ] }